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Abstract 
 
The desire to synthesise molecules in new and improved ways is arguably what 
motivates research across all of organic chemistry. This thesis will describe efforts in 
two areas that are consistent with this broad objective, concerning the synthesis of 
natural products, and the development of methods for the synthesis of designed 
molecules. Our desire to better utilise the Diels-Alder reaction – a powerful means for 
the formation of carbon-carbon bonds, sits as a guiding principle behind these 
investigations. 
 
Part 1 of this thesis concerns the synthesis of the ramonanin natural products: four 
dimeric structures formed biosynthetically through a Diels-Alder dimerisation 
reaction.  
 
Chapter 1 will review the prior art on natural products formed using a Diels-Alder 
dimerisation as a key step. The area has not been reviewed substantively thus far – 
something overdue given the rapid development in this area over the past 15 years or 
so. Biomimetic synthesis is a recurrent theme of the chapter, with the vast majority of 
syntheses covered to some extent inspired by a consideration of the target’s 
biosynthetic origin. 
 
Chapter 2 will cover original research performed in the total synthesis of the 
ramonanin family of the natural products. The chapter begins with a discussion of the 
possible biosynthetic origins of the ramonanins, and the ways this might be applied in 
a biomimetic synthesis. After this, an account is given of the successful forward 
synthesis of the ramonanin natural products. This begins with an account of the 
synthesis of the ramonanin monomeric subunit, followed by a detailed discussion of 
the dimerisation event from which the natural products were formed.  
 
Part 2 concerns the use of tricarbonyliron-diene complexes as building blocks in the 
synthesis of reactive cross-conjugated hydrocarbons. 
 
 XIV 
Chapter 5 concerns a methods-driven investigation, aimed at establishing the basic 
means by which cross-conjugated hydrocarbons might be assembled from a 
tricarbonyliron-diene starting material. A range of 1-[3]dehydrodendralenes and 1-
(Z)-[3]dendralenes were prepared using this general method – the first general 
method for the synthesis of either class of hydrocarbon. 
 
Chapter 6 concerns the repurposing of the methods of chapter 5 to greater ends. In 
the first part of the chapter, the synthesis of higher and greatly more reactive polyenes 
using these general methods is detailed. The second part of the chapter details the use 
of a 1-(Z)-[3]dendralenes in a Diels-Alder cascade – a model for future applications 
in target-driven synthesis that might follow. 
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Tiger got to hunt, 
Bird got to fly; 
Man got to sit and wonder, "Why, why, why?" 
 
Tiger got to sleep, 
Bird got to land; 
Man got to tell himself he understand. 
 
 
Kurt Vonnegut, Cat’s Cradle. 
   
	  
 
 
 
 
PART 1:  
THE TOTAL SYNTHESIS OF THE 
RAMONANIN FAMILY OF NATURAL 
PRODUCTS 
 
 
 
 
 
 
  
  
  
 CHAPTER 1 
 
DIELS-ALDER DIMERISATIONS  
IN THE SYNTHESIS OF  
DIMERIC NATURAL PRODUCTS 
 
1.1 Dimeric Natural Products 
 
The abundance of dimeric structural features in natural products is hard to overstate. 
In a metaanalysis by Greer and coworkers, bilateral symmetry, in which the molecule 
in question can be conceptualised as bearing two symmetrical halves, was found to be 
present in 7% of reported natural products.[1] Many more dimers do not carry such a 
simple relationship between their monomeric units, often not bearing any elements of 
symmetry despite their obvious dimeric character. This review will offer a brief 
overview of the types of dimeric character found in natural products, before offering 
an in-depth examination of one subset of these – dimers formed through a Diels-
Alder reaction. 
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1.1.1 Simple Dimers: Dimers which Bear Bilateral Symmetry 
 
Bilateral symmetrical relationships found in natural products may be classified as 
falling into the C2, Cs, C2v, C2h and S2 point groups. 
 
C2 symmetrical relationships are those where a rotational axis exists around which the 
natural product is symmetrical. This is far and away the most commonly encountered 
form of symmetry, accounting for 69% of bilaterally symmetrical natural products 
found in Greer and coworkers’ survey. Examples of this in a molecular context are 
depicted below:[2-5] 
 
 
Figure	  1.1.	  C2	  symmetrical	  molecules	  sceptrin,	  amauromine	  and	  cyanolide	  A.	  
 
Cs symmetrical relationships are those where the molecule bears mirror symmetry. 
14% of bilaterally symmetrical natural products were found by Greer and coworkers to 
fall into this category. Some examples are shown below:[6,7] 
 
Figure	  1.2.	  Cs	  symmetrical	  molecules	  homoaerothionin	  and	  divanillyltetrahydrofuran.	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C2v symmetrical relationships are those where the molecule bears two planes of mirror 
symmetry. In Greer and coworkers’ study, 16% of bilaterally symmetrical molecules 
were found to fit into this category.[8,9] 
 
 
Figure	  1.3.	  C2v	  symmetrical	  molecules	  curcumin	  and	  hypericin.	  
 
The other two point groups, C2h (a rotational axis of symmetry and a mirror plane of 
symmetry) and S2 (an inversion centre) are rare, only accounting for ~1% of 
bilaterally-symmetrical natural products found. Squalene is an example of a natural 
product bearing S2 symmetry: 
 
 
Figure	  1.4.	  S2	  symmetrical	  molecule	  squalene.	  
 
Natural products bearing other symmetries have not been reported. 
 
 
1.1.2 Complex Dimers: Dimers which do not Bear Bilateral 
Symmetry 
 
Many natural products do not possess point symmetry, despite bearing obvious 
dimeric character. Monomeric units may dimerise unsymmetrically, or the dimer may 
undergo subsequent rearrangements which break the symmetry that once existed. One 
may attempt to classify these dimers by the means by which dimerisation occurs 
biosynthetically – a few examples are listed below,[10-15] however a full survey extends 
O O
HO
H3CO OCH3
OH
curcumin
HO
HO
O
O
hypericin
squalene
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beyond the scope of this review.[16] Rather, this review will be limited to providing an 
in-depth review of one mode of dimerisation – the Diels-Alder dimerisation. 
 
 
 
 
 
 
Figure	  1.5.	  Non-­‐symmetrical	  dimeric	  natural	  products	  and	  their	  precursors.	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1.2 The Diels-Alder Reaction 
 
The Diels-Alder reaction is a powerful reaction for the synthesis of six-membered 
rings. In a single step one can form two carbon-carbon sigma bonds, with control over 
the formation of four stereogenic centres.[17] The utility of this reaction was 
recognised in 1950 with the award of the Nobel Prize to the reaction’s discoverers 
Otto Diels and Kurt Alder. The Diels-Alder reaction has been used extensively 
throughout history in the synthesis of natural products. The reaction has been, and 
continues to be one of the most important tools for carbon-carbon bond formation in 
organic chemistry. 
 
The Diels-Alder reaction is of particular value in dimerisations for the complexity it 
can install, often existing as part of a multi-bond forming process,[18] desymmetrising 
monomeric units and setting stereochemical relationships. The reaction is known to 
nature in both its intermolecular and intramolecular forms, with many scientists 
having adapted this reactivity for use in biomimetic synthesis. 
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1.3 Diels-Alder Dimerisations in Total Synthesis 
 
What follows is a survey of the major bodies of work involving application of the 
Diels-Alder dimerisation in total synthesis. The examples chosen not only 
demonstrate the effectiveness of this strategy, but also contextualise the author’s own 
work, presented subsequently in chapter 2. For the sake of brevity, this review will be 
limited in focus to the key dimerisation event, and will not offer an exhaustive 
overview of every application reported in the literature.[19-38] No comprehensive review 
of Diels-Alder dimerisations has previously been written, although they have been 
touched upon in reviews concerning biomimetic dimerisations in general.[39-46] 
 
 
1.3.1 Carpanone 
 
Perhaps the most classic example of the Diels-Alder dimerisation is Chapman’s 
synthesis of carpanone.[47] The molecule is a lignan – a dimer of phenylpropanoid 
units. Chapman’s synthesis is remarkable for the success that he and his coworkers 
had in accessing this symmetry, enabling the remarkably expedient synthesis of their 
target. 
 
 
Figure	  1.6.	  Proposed	  biosynthetic	  origins	  of	  carpanone.	  
 
A biosynthesis for carpanone can be proposed in which two units of phenylpropanoid 
carpacin (or its O-desmethyl homologue) are unified by a β-β phenolic coupling event 
to give the proposed intermediate 1.1. This precursor is then positioned to undergo a 
spontaneous hetero-Diels-Alder reaction, forming the natural product. 
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Chapman and coworkers’ approach was to mimic the proposed biosynthetic pathway 
as closely as possible:  
 
 
Scheme	  1.1.	  Synthesis	  of	  carpanone	  by	  Chapman	  and	  coworkers.	  
 
Palladium(II) chloride was used as a two electron oxidising agent to selectively 
dimerise O-desmethylcarpacin at its beta-beta positions. From this point the Diels-
Alder reaction was observed to occur spontaneously, giving carpanone in the one pot 
directly from O-desmethylcarpacin. The legacy of Chapman’s synthesis is hard to 
exaggerate,[48] and should be acknowledged as the inspiration behind many of the 
biomimetic syntheses which follow. 
 
 
1.3.2 Epoxyquinone Natural Products 
 
Endeavours in this area concern the synthesis of torreyanic acid, epoxyquinols A and 
B, panepophenanthrin and hexacyclinol. A comprehensive review of this work 
follows. 
 
 
1.3.2.1 Torreyanic Acid 
 
Investigations in this area began with Porco and coworkers’ synthesis of torreyanic 
acid.[49]  
O
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Figure	  1.7.	  Proposed	  biosynthetic	  origins	  of	  torreyanic	  acid.	  
 
Biosynthetically, torreyanic acid can be conceived of as a heterodimer of precursors 
1.2a and 1.2b. In the prevailing biosynthetic hypothesis,[50] alcohol 1.4 is oxidised 
enzymatically at its primary alcohol to give its corresponding aldehyde 1.3. This 
intermediate spontaneously undergoes 6π electrocyclisation to form the cis- and trans- 
diastereomers of the corresponding 2H-pyran 1.2a and 1.2b. These diastereomers 
undergo a cross-Diels-Alder dimerisation (potentially acid-catalysed) to give the 
natural product. 
 
Porco and coworkers synthesised torreyanic acid using a biomimetic approach which 
mimicked this process:[49]  
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Scheme	  1.2.	  Porco	  and	  coworkers’	  synthesis	  of	  (±)-­‐torreyanic	  acid	  and	  (±)-­‐iso-­‐torreyanic	  
acid.	  
 
In the first generation synthesis, racemic epoxyquinone 1.4 was prepared in a longest 
linear sequence of 16 steps from commercially available materials. Oxidation of the 
alcohol followed by a spontaneous electrocyclisation gave the dimerisation precursor, 
as a mixture of cis- and trans-diastereomers 1.2a and 1.2b. This mixture was subjected 
to acidic conditions to give dimeric structures corresponding to torreyanic acid (the 
heterodimer of cis- and trans-monomer, reacting from their least sterically-congested 
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faces) and iso-torreyanic acid (the heterodimer of either enantiomer of cis-monomer, 
reacting from their least sterically-congested faces), in racemic form, in a 1:1 ratio.  
 
The dimerisation is remarkably selective when one considers the abundance of other 
dimerisation reactions possible. Both enantiomers of each of the cis- and trans-
electrocyclisation products are present: 4 reactants in total. Restricting the Diels-
Alder reaction to being endo-, regio- and facially selective, 16 possible products of the 
dimerisation of these monomers are possible. Only four dimerisation products are 
observed in appreciable quantity: each enantiomer of torreyanic acid and each 
enantiomer of the dimerisation product of heterochiral cis-monomer. 
 
Mehta and coworkers subsequently published a formal synthesis of racemic torreyanic 
acid, in which Porco and coworkers’ precursor to the torreyanic acid monomer 1.8 
was accessed with a longest linear sequence of 17 steps starting from allyl 
benzoquinone (1.7):[51] 
 
 
Scheme	  1.3.	  Mehta	  and	  coworkers’	  synthesis	  of	  torreyanic	  acid	  intermediate	  1.8.	  
 
Porco and coworkers later devised a second-generation, enantioselective synthesis.[52] 
Central to this was the synthesis of an enantiomerically-enriched precursor to the 
torreyanic acid monomer, prepared utilising some tartrate-mediated nucleophilic 
epoxidation methodology:[53] 
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O
17 steps HO O
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Scheme	  1.4.	  Synthesis	  of	  enantioenriched	  precursor	  1.4	  by	  Porco	  and	  coworkers.	  
 
With enantioenriched alcohol 1.4 in hand, Porco and coworkers could subject this 
material to their previously developed dimerisation conditions: 
 
 
Scheme	  1.5.	  Synthesis	  of	  (+)-­‐torreyanic	  acid	  by	  Porco	  and	  coworkers.	  
 
Starting from enantiomerically-enriched alcohol 1.4, the oxidation/electrocyclisation 
sequence imparted selectivity for just two products: the cis- and trans- diastereomers 
of pyran 1.2, each formed as single enantiomers corresponding in stereochemistry to 
that of the natural product. These were subjected to the aforementioned dimerisation 
conditions to give the precursor to the natural enantiomer of torreyanic acid. 
Conveniently, use of enantiomerically pure alcohol also prevented formation of the 
iso-torreyanic acid side-product. Iso-torreyanic acid forms from the homodimerisation 
of heterochiral cis-monomer, but if only one enantiomer of the pyran is present, this 
cannot happen. So the use of enantiomerically-enriched alcohol 1.4 imparts not just 
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enantioselectivity, but limits the formation of unwanted diastereomeric side products 
as well. 
 
 
1.3.2.2 The Epoxyquinol Family of Natural Products 
 
Drawing upon lessons learned in the synthesis of torreyanic acid, the groups of 
Hayashi and Porco independently developed syntheses of the related natural products 
epoxyquinols A and B (plus other related structures): 
 
 
Figure	  1.8.	  Biosynthetic	  origins	  of	  epoxyquinols	  A	  and	  B.	  
 
Epoxyquinol A is quite alike torreyanic acid in that it appears biosynthetically to be 
the dimerisation product of cis- and trans- monomeric units 1.10a and 1.10b, reacting 
through an endo Diels-Alder transition state.[54] Epoxyquinol B differs in that it is the 
exo dimerisation product of two identical units of 1.10a[55] – reactivity not observed 
with the torreyanic acid monomer. 
 
The first reported synthesis of epoxyquinols A and B – that of Hayashi and 
coworkers,[56,57] involves the synthesis of the primary alcohol precursor 1.11 in a 
longest linear sequence of 14 steps from furan and Corey’s chiral acrylate 1.12.[58] 
Porco and coworkers produced the same precursor in a longest linear sequence of 12 
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steps, drawing upon some of their earlier chemistry, including use of their tartrate-
mediated epoxidation for setting the absolute stereochemistry of the monomer:[59,60] 
 
 
Figure	  1.9.	  Starting	  materials	  and	  step	  counts	  for	  the	  synthesis	  of	  epoxyquinol	  monomer	  
precursor	  1.11.	  
 
From this point both groups employ largely comparable chemistry to perform the 
dimerisation:  
 
 
Scheme	  1.6.	  Synthesis	  of	  epoxyquinols	  A	  and	  B	  by	  Hayashi	  and	  coworkers	  and	  Porco	  and	  
Coworkers.	  
 
Hayashi and coworkers favoured MnO2 in CH2Cl2 for the selective oxidation of 
primary alcohol 1.11. The crude product of this reaction was noted to dimerise 
rapidly as a neat gum (four hours at room temperature) to give epoxyquinols A and B 
in a combined yield of 65% in a 62:38 ratio. 
 
Porco and coworkers elected to perform the oxidation of alcohol 1.11 using TEMPO, 
O2 and CuCl in DMF. Dissolving the crude product of this reaction in CDCl3 they 
noticed dimerisation occurring spontaneously over 30 hours to give a mixture of 
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epoxyquinols A and B in a 55:45 ratio. Some selectivity (80:20) could be gained for 
epoxyquinol A by performing the dimerisation in 40% aqueous methanol. 
 
 
1.3.2.3 Panepophenanthrin 
 
Efforts in this area were next extended to the synthesis of the epoxyquinol dimer 
panepophenanthrin. 
 
 
Figure	  1.10.	  Proposed	  biosynthetic	  origins	  of	  panepophenanthrin.	  
 
Biosynthetically, panepophenanthrin may be proposed to be the hemiketal of the 
endo-Diels-Alder homodimer 1.14 of proposed monomer 1.15. Monomer 1.15 bears 
a close relationship to co-isolated natural products, being the conjugated diene isomer 
of panepoxydon.[61] 
 
Biomimetic total syntheses have been completed by the groups of Porco,[61] 
Baldwin,[62,63] Mehta[64] and Hayashi.[65] A summary of starting materials and step 
count to the monomer follows: 
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Figure	  1.11.	  Starting	  materials	  and	  step	  counts	  for	  the	  synthesis	  of	  panepophenanthrin	  
monomer	  1.15.	  
 
All groups accessed the natural enantiomer of monomer 1.15, with Porco and 
Hayashi developing asymmetric syntheses, and Mehta and Baldwin relying on chiral 
resolution. Every research team used the same conditions for dimerisation, leaving the 
monomer standing at room temperature as a neat gum. Strong selectivity was 
observed for the natural product, with yields for the dimerisation reported as being 
between 75-80%. 
 
 
Scheme	  1.7.	  Synthesis	  of	  panepophenanthrin	  from	  monomer	  1.15.	  
 
Several hypotheses have been drawn in effort to explain the rapidity and selectivity of 
this reaction. In addition to the most intuitive possibility – a normal intermolecular 
[4+2] cycloaddition, intramolecular ketalisation pathway, Porco and coworkers 
proposed three alternatives: a tethered cationic [4+2] cycloaddition pathway, a 
tethered inverse demand [4+2] cycloaddition pathway, and a hydrogen bond-
organised [4+2] cycloaddition pathway: 
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Figure	  1.12.	  Potential	  modes	  of	  dimerisation	  for	  panepophenanthrin	  precursor	  1.15.	  
 
Porco and coworkers performed an experimental and computational study to 
investigate which of these pathways is most likely operative. Their conclusion was that 
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it is likely pathway 1 which predominates. A computational study reported in Baldwin 
and coworkers’ full account concluded similarly.  
 
Porco and coworkers later adapted this work in order to synthesise Rychnovsky’s 
proposed structure of hexacyclinol:[66] 
 
 
Figure	  1.13.	  Structures	  of	  hexacyclinol	  as	  proposed	  by	  Gräfe	  and	  coworkers	  and	  Rychnovsky.	  
 
The full motivation behind Rychnovsky and Porco’s work in this area provides 
interesting reading that is beyond the scope of this review.[67] Synthetic work was 
prompted by Rychnovsky’s computational study, from which he reassigned 
hexacyclinol from Grafe’s proposed and unprecedented structure 1.19a[68] to 1.19b: 
the rearrangement product of panepophenanthrin in acidic methanol:[69] 
 
 
Figure	  1.14.	  Rychnovsky’s	  proposed	  biosynthesis	  of	  hexacyclinol.	  
 
Porco and coworkers tested this hypothesis by preparing and dimerising a methylated 
analogue of the panepophenanthrin monomer 1.20. Treatment of this product with 
acidic clay converted the dimer into Rychnovsky’s proposed structure of hexacyclinol.  
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Scheme	  1.8.	  Synthesis	  of	  Rychnovsky’s	  proposed	  structure	  of	  (+)-­‐hexacyclinol	  1.19b	  by	  Porco	  
and	  coworkers.	  
 
The analytical data gathered for this compound provided identical data to that 
recorded for natural hexacyclinol. 
 
 
1.3.3 Guaianolide and Xanthanolide dimers 
 
Work in this area largely concerns the synthesis of guaianolide dimers, with some 
additional work having been undertaken towards the synthesis of xanthanolide 
dimers. A comprehensive review of the area follows. 
 
 
1.3.3.1 Absinthin 
 
Work in this area began with Zhai and coworkers’ synthesis of absinthin:[70] 
 
 
Figure	  1.15.	  Proposed	  biosynthetic	  origins	  of	  absinthin.	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Absinthin can be proposed to form biosynthetically through the endo-Diels-Alder 
dimerisation of monomer 1.22, the rearrangement product of the natural product 
artabsin.[71] This same group observed artabsin to form as a thermolysis product of 
absinthin.  
 
Rather than target the proposed biosynthetic precursor 1.22, Zhai and coworkers 
targeted its acylated epimer 1.23: 
 
 
Scheme	  1.9.	  Synthesis	  of	  absinthin	  by	  Zhai	  and	  coworkers.	  
 
Monomer 1.23 proved an attractive target for synthesis as it could be accessed from 
commercially available santonin in just 4 steps. The compound underwent 
spontaneous dimerisation neat at room temperature, giving the C10/C10’ di-epimer 
of absinthin 1.24 under biomimetic conditions with excellent regioselectivity and 
diastereoselectivity. A five step process was then used to deprotect and epimerise the 
adduct, giving the natural product. 
 
 
1.3.3.2 The Ainsliadimer and Gochnatiolide Families of Natural 
Products 
 
Progress in this area can be seen in Lei and coworkers’ syntheses on the ainsliadimers 
and gochnatiolides.[72,73]  
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Figure	  1.16.	  Proposed	  biosynthetic	  origins	  of	  ainsliadimer	  A.	  
 
Ainsliadimer A may be hypothesised to form through an acid-catalysed 
rearrangement of dimer 1.25, the exo-hetero-Diels-Alder adduct of known natural 
product dehydrozaluzanin C.[74] Of interest to Lei and coworkers was whether or not 
the hypothesised hetero-Diels-Alder reaction was enzymatically-catalysed, and if so, 
whether that process could be mimicked in some way. 
 
  
Scheme	  1.10.	  Synthesis	  of	  ainsliadimer	  A	  by	  Lei	  and	  coworkers.	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Dehydrozaluzanin C was made through a semi-synthetic approach starting from 
santonin, utilising the same photochemically-promoted rearrangement as earlier 
employed by Zhai and coworkers.[70] Monomer in hand, it was found that catalysis 
was necessary to trigger the hetero-Diels-Alder dimerisation. Interestingly it was the 
hydrogen bonding catalyst BINOL which proved effective, a catalyst which the 
authors note can act as a mimic of enzymatic processes. The resulting pyran was 
subjected to a hydrolysis, aldol sequence to complete the synthesis. 
 
Lei and coworkers later extended this chemistry for the total synthesis of the related 
natural products ainsliadimer B and gochnatiolides A-C.  
 
 
Figure	  1.17.	  Proposed	  biosynthetic	  origins	  of	  gochnatiolides	  A,	  B,	  C	  and	  ainsliadimer	  B.	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Gochnatiolides A-C were hypothesised by Lei and coworkers to form from the 
rearrangement or rearrangement and oxidation of intermediate 1.27, which may be 
proposed to form by the heterodimerisation of dehydrozaluzanin C and its dehydro-
homologue 1.27:[73] Ainsliadimer B was proposed to form from the hydration of 
gochnatiolide B. 
 
 
Scheme	  1.11.	  Synthesis	  of	  gochnatiolides	  A,	  B	  and	  C	  by	  Lei	  and	  coworkers.	  
 
The successful strategy for the synthesis of gochnatiolides A-C involved conversion of 
dehydrozaluzanin C to its TMS enol ether 1.28, followed by Saegusa oxidation of this 
precursor to enone 1.29 in the presence of dehydrozaluzanin C, prompting 
spontaneous heterodimerisation. Under optimal conditions gochnatiolides A, B and 
C were accessed in a 40:6:9 ratio respectively. This noted, a slight improvement in the 
yield of gochnatiolide C could be gained by performing the reaction in an oxygen free 
environment (15% yield, no other dimers formed). 
 
The gochnatiolides in hand, ainsliadimer B was successfully accessed through selective 
hydration of the exocyclic enone of gochnatiolide B: 
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Scheme	  1.12.	  Conversion	  of	  gochnatiolide	  B	  to	  ainsliadimer	  B	  by	  Lei	  and	  coworkers.	  
 
Qin and coworkers subsequently reported an alternative route to ainsliadimer A and 
gochnatiolides A and B. Their approach involved the reaction of dehydrozaluzanin C 
with a homologue bearing an electron-rich diene system: 
 
 
Scheme	  1.13.	  Synthesis	  of	  gochnatiolides	  A	  and	  B	  and	  ainsliadimer	  B	  by	  Qin	  and	  coworkers.	  
 
Qin and coworkers opted to synthesise diene 1.30, designed as a more electron rich, 
more electronically activated alternative to Lei and coworkers’ diene 1.29. While the 
use of this diene did not afford the benefits anticipated (the Diels-Alder reaction still 
proceeded quite slowly), dimer 1.31 could still be accessed, from which gochnatiolides 
A and B and ainsliadimer B could be synthesised selectively over several steps each. 
 
 
1.3.3.3 The Mogolide Family of Natural Products 
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Similar reactivity has been accessed for the dimerisation of xanthanolides, as told by 
Tang and coworkers in their intriguing account of the discovery and synthesis of the 
mogolide natural products. 
 
Tang and coworkers were initially engaged in an alternative endeavor, seeking to 
prepare 4b,5b-epoxy-xanthatin-1a,4a-endoperoxide from its proposed biosynthetic 
precursor xanthatin:[75] 
 
 
Figure	  1.18.	  4b,5b-­‐epoxy-­‐xanthatin-­‐1a,4a-­‐endoperoxide	  and	  its	  proposed	  biosynthetic	  
precursor	  xanthatin.	  
 
However, under some of the reaction conditions screened when attempting this 
transformation, a different reaction was observed to occur: 
 
 
Scheme	  1.14.	  Synthesis	  of	  mogolide	  A	  and	  3-­‐epi-­‐mogolide	  A	  by	  Tang	  and	  coworkers.	  
 
Tang and coworkers were attempting to perform a 6π electrocyclisation, [4+2] singlet 
oxygen hetero-Diels-Alder sequence on xanthatin. Rather than observing the product 
of this reaction, Tang and coworkers noticed the formation of head-to-head dimers 
mogolide A and 3-epi-mogolide A. Under optimised conditions, these products could 
be accessed in a combined 74% yield, in a 4:3 diastereomeric ratio. Tang and 
coworkers proposed the following mechanism to account for this outcome: 
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Figure	  1.19.	  Proposed	  mechanism	  for	  the	  formation	  of	  mogolide	  A	  and	  3-­‐epi-­‐mogolide	  A	  
from	  xanthatin.	  
 
Xanthatin could potentially isomerise under photochemical conditions to its 
tortionally-strained Z-isomer 1.32. This could react to give dimer 1.33, a structure 
which Tang and coworkers had noticed forming under the conditions of the reaction. 
This intermediate could then undergo a further [2+2] cycloaddition to complete the 
sequence. 
 
By experimenting with alternative reaction conditions, Tang and coworkers isolated 
two more xanthanolide dimers, both head-to-tail dimers of xanthatin: 
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Scheme	  1.15.	  Synthesis	  of	  mogolide	  B	  and	  mogolide	  C	  by	  Tang	  and	  Coworkers.	  
 
Mogolides B and C differ as a result of differences in facial selectivity observed when 
the dimerisation is performed in solution or the solid state. The exact origins of this 
selectivity are unclear. 
 
At this point in the study, neither mogolide A, 3-epi-mogolide A, mogolide B or 
mogolide C had been isolated as natural products. Suspecting that they were in fact 
naturally-occurring molecules, Tang and coworkers sought to isolate them. By 
screening plant extracts from a range of plants known to produce xanthatin and 
related sesquiterpenoids, Tang and coworkers eventually found mogolide A and 
mogolide C to be naturally-occurring molecules. 
 
 
1.3.4 Paracaseolide 
 
A significant body of work exists concerning the total synthesis of paracaseolide, an 
unusual lipid bearing a polyoxygenated bowl-shaped core. 
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Scheme	  1.16.	  Proposed	  biosynthetic	  origins	  of	  paracaseolide.	  
 
A biosynthetic proposal was made in which paracaseolide forms through an endo-
Diels-Alder dimerisation / dehydration sequence from lipid 1.35, a hydroxylated 
variant of known natural product akolactone A.[76] 
 
Such a proposed biosynthesis raises several interesting questions. Depicted above is 
the pathway in which an intermolecular Diels-Alder reaction is succeeded by an 
intramolecular ketalisation. An alternative is also possible where ketalisation occurs 
intermolecularly, followed by an intramolecular Diels-Alder reaction.  
 
Another issue is the observed stereochemistry of the natural product. The Diels-
Alder, ketalisation sequence presented does not give the stereochemistry observed for 
paracaseolide – it gives that of its C7 epimer. In order to get the stereochemistry of 
paracaseolide something different must occur: a hetero-dimerisation between (E, E) 
and (E, Z) monomers, a “non-concerted” Diels-Alder reaction, or a fast epimerisation 
of the Diels-Alder adduct, amongst other possibilities. 
 
 
Figure	  1.20.	  Expected	  outcome	  of	  a	  Diels-­‐Alder	  dimerisation	  of	  the	  proposed	  monomer	  1.35.	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It is unclear whether an enzyme is involved in this dimerisation, ketalisation sequence. 
If the natural product were known to be enantiomerically pure, this would be evidence 
to suggest that one was. Unfortunately, the isolation group was noncommittal on this 
aspect of their assignment.A 
 
In light of these unanswered and intriguing questions, several groups have sought an 
answer through biomimetic synthesis,[77-82] before an answer ultimately appears to 
have been provided by the Hoye group.[83]  
 
A summary of approaches to the monomer follows: 
 
 
Figure	  1.21.	  Approaches	  to	  the	  paracaseolide	  monomer	  1.35.	  
 
From the initial approach of Vassilikogiannikis, the groups of Khan and Mehta, 
Stark, Li, Li and Nan, and Boukouvalas have all published concise and unique routes 
to the monomer 1.35.  
 
In Vassilikogiannikis’ first-published synthesis of racemic paracaseolide, the following 
conditions were employed for dimerisation: 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
A The authors reported an optical rotation value within the limits of experimental 
error ([α]24D +0.9 (c 0.33, CHCl3)), and did not comment on its significance. 	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Scheme	  1.17.	  Synthesis	  of	  paracaseolide	  from	  proposed	  monomer	  1.35.	  
 
These conditions were later employed by Khan and Mehta, Stark, Li, Li and Nan, 
and Boukouvalas in formal racemic syntheses of the natural product. Stark and 
coworkers noted their inability to effect a dimerisation of the monomer using Lewis 
acid conditions, as part of their efforts towards an enantioselective synthesis. The fact 
that the dimerisation was only observed to occur at extremely elevated, non-
biomimetic temperatures suggested at the possible involvement of an enzyme. 
 
Vassilikogiannikis and coworkers noted that paracaseolide was only dimeric product 
they observed forming under their reaction conditions. In the absence of any of the 
C7-epimer, Vassilikogiannikis proposes a fast epimerisation of epi-paracaseolide 
under reaction conditions to its less sterically-congested congener paracaseolide. Both 
the groups of Khan and Mehta, and Stark challenged this hypothesis. In their hands, 
monomer 1.35 dimerised under Vassilikogiannikis’ conditions to form a mixture of 
both paracaseolide and epi-paracaseolide. Exposure of pure epi-paracaseolide to a 
range of conditions, including those under which the dimerisation was performed, 
failed to induce epimerisation. 
 
In a bid to elucidate the reaction mechanism, Mehta, Khan and Ganguly embarked 
upon a computational investigation.[84] While not offering an exhaustive investigation 
of all possibilities,B the study suggested at the unlikelihood of a concerted Diels-Alder 
hetero-dimerisation between (E, E) and (E, Z) monomers, or of the C7-centre of epi-
paracaseolide being epimerisable. The work does however suggest at the possibility of 
a stepwise Diels-Alder-like mechanism: 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
B Amongst other things, the possibility of an intramolecular Diels-Alder on the ketal 
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Figure	  1.22.	  Mehta,	  Khan	  and	  Ganguly’s	  proposed	  mechanism	  for	  the	  formation	  of	  
paracaseolide	  and	  epi-­‐paracaseolide.	  
 
Under such a mechanism, free rotation of the marked bond gives rise to the hydrated 
forms of both paracaseolide and epi-paracaseolide. Dehydration then occurs to give 
both products. 
 
At this point the story takes an interesting turn, when a paper was released by the 
Hoye group that challenged the conclusions formed by all of the aforementioned 
researchers. In their study, they claim that the paracaseolide monomer (which they 
prepared through existing approaches) dimerises far more rapidly than has been 
reported previously. They report the Diels-Alder dimerisation proceeding with a half-
life of 6 days when performed neat at 35 °C, giving the hydrated, ring opened exo 
adduct 1.42. Heating of this adduct caused dehydration with a concommitant 
epimerisation of the C2 stereogenic centre, giving paracaseolide. It was this reactivity 
– something inexplicably missed by all of the preceding researchers, that explains the 
selectivities observed.  
 
 
Scheme	  1.18.	  Hoye	  and	  coworkers’	  conditions	  for	  the	  dimerisation	  of	  1.35	  and	  subsequent	  
synthesis	  of	  paracaseolide.	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A supporting computational study suggested that the dimerisation proceeds through 
an exo, bis-pericyclic transition state. This conclusion was in direct contradiction to 
the earlier proposition of Mehta, Khan and Ganguly. Additionally, a deuterium 
labeling experiment confirmed facile epimerisation of the C2 stereogenic centre (not 
the C7 centre) of the hydrated adduct at room temperature, thus explaining how the 
epimerisation occurs. Hoye and coworkers also resolved enantiomerically pure 
samples of paracaseolide, with optical rotations reported of +92° and −86° for each 
enantiomer. Taken together these results make a substantial contribution to 
addressing conjecture about the biosynthetic origins of paracaseolide, with the natural 
product now observed to form racemically at ambient temperatures, consistent with 
the absence of a Diels-Alderase in its biosynthesis.  
 
The authors of the previous studies have yet to respond to Hoye and coworkers’ 
report. It appears for the time being that the puzzles behind the biosynthesis of this 
intriguing natural product have been solved. 
 
 
1.3.5 Cyclohexadienols: Bisorbicillinol and Aquaticol 
 
Many total syntheses have been completed which utilise the propensity of cyclohexa-
2,4-dienones to rapidly dimerise.[85-95] For the sake of brevity, this review will cover 
this reactivity with two representative examples: the total syntheses of bisorbicillinol 
and aquaticol. 
 
 
1.3.5.1 Bisorbicillinol 
 
The most classic and most advanced application of this reactivity is in the biomimetic 
synthesis of bisorbicillinol and its rearrangement products bisorbibutenolide and 
bisorbicillinolide, three of many sorbicillinol dimers known to nature. 
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Figure	  1.23.	  Biosynthetic	  origin	  and	  relationships	  of	  bisorbicillinolide,	  bisorbibutenolide	  and	  
bisorbicillinol	  
 
Bisorbicillinolide is postulated to be an anionic rearrangement, Michael addition 
product of bisorbibutenolide, itself the anionic rearrangement product of 
bisorbicillinol. Bisorbibutenolide is proposed to be the product of a Diels-Alder 
heterodimerisation between either tautomer of oxidatively dearomatised derivative 
1.43 of known natural product sorbicillinol.[96] 
 
Syntheses of bisorbicillinol have been performed by the groups of Nicolaou,[97] 
Pettus[98] and Deng[99]. A summary of their approaches to the reactive monomer 
follows: 
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Figure	  1.24.	  Syntheses	  of	  the	  reactive	  precursors	  to	  bisorbicillinol,	  1.43a	  and	  1.43b.	  
 
In Nicolaou’s first-reported synthesis, sorbicillinol was prepared in two steps from 
commercially available starting materials. This was converted to its α-acetoxy dienone 
1.44, which was hydrolysed to give the reactive monomer as a racemate. Quantities of 
enantiomerically pure monomer were prepared by chiral HPLC. Pettus and 
coworkers attempted to modify this approach to give an enantioselective synthesis of 
the monomer. Preparing sorbicillinol using Nicolaou’s protocol, then reacting this 
with a chiral reagent, precursor 1.45 was generated with moderate 
diastereoselectivity C  Deng and coworkers later succeeded in an enantioselective 
synthesis, generating an enantiomerically pure precursor 1.47 through a 9 step 
sequence. 
 
Nicolaou and coworkers developed two sets of conditions for the dimerisation, as 
illustrated in the following scheme: 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
C The authors do not report the diastereomeric ratio of products formed, but they 
report that the diastereomeric mixture was used to generate bisorbicillinol with an e.e. 
or 51%. 
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Scheme	  1.19.	  Nicolaou	  and	  coworkers’	  synthesis	  of	  bisorbicillinol.	  
 
Under Nicolaou and coworkers’ first set of conditions, precursor 1.44 was 
deacetylated and deprotonated under basic conditions to form its corresponding 
diquinolate 1.48. This was then quenched with acid, forming bisorbicillinol 
instantaneously with no observation of the postulated quinol monomer 1.43. Under 
the second set of conditions, the acetate of precursor 1.44 was cleaved under acidic 
conditions, directly forming reactive monomer 1.43. Consumption of precursor 1.44 
was accompanied by proportionate formation of bisorbicillinol, again without 
observation of postulated intermediate 1.43. 
 
Pettus and coworkers and Deng and coworkers later utilised this reactivity, accessing 
the reactive monomer through deprotection of their own precursor compounds: 
 
 
Scheme	  1.20.	  Pettus	  and	  coworkers’	  and	  Deng	  and	  coworkers’	  syntheses	  of	  bisorbicillinol.	  
 
Bisorbicillinol in hand, Nicolaou and coworkers proved it possible to biomimetically 
transform this molecule into its rearrangement product bisorbibutenolide. Deng and 
coworkers later extended this work, converting bisorbicillinol into another of its 
rearrangement products bisorbicillinolide: 
 
OO
O
O
O
KOH
then  HCl
OO
OH
O
O
HO
HO
HObisorbicillinol
Pettus:
OHO
O
PMBO
TFA
Deng:
54%30%
scalemic 1.45 (+)-1.47
DIELS-ALDER DIMERISATIONS IN TOTAL SYNTHESIS 35 
 
Scheme	  1.21.	  Conversion	  of	  bisorbicillinol	  into	  bisorbibutenolide	  and	  bisorbicillinolide.	  
 
 
1.3.5.2 Aquaticol 
 
Another area where this reactivity has been utilised is in the total synthesis of 
aquaticol: 
 
 
Figure	  1.25.	  Proposed	  biosynthetic	  origins	  of	  aquaticol.	  
 
Biosynthetically, aquaticol can be hypothesised to form through the dimerisation of 
dienone 1.49a, formed through the oxidative-dearomatisation of hydroxycuparene, a 
known natural product.[100] 
 
Two total syntheses of aquaticol exist, developed by Quideau and coworkers,[101] and 
Porco and coworkers.[102] 
 
OO
OH
O
O
HO
HO
HO
bisorbicillinol
KHMDS
then HCl
OO
OH
OHO
bisorbibutenolide
O
O
OH
OO
OH
O
O
HO
HO
HO
bisorbicillinol
OO
OH
O
HO
bisorbicillinolide
O
H
OH
O
Nicolaou:
Deng:
MeOH
64%
THF
80%
O
HO
O OH H
H
OH
aquaticol hydroxycuparene
O
HO
O OHintermolecularDiels-Alder
endo-TS
oxidative
dearomatisation1.49a
1.49a
DIELS-ALDER DIMERISATIONS IN TOTAL SYNTHESIS 36 
 
Scheme	  1.22.	  Quideau	  and	  coworkers’	  synthesis	  of	  (+)-­‐aquaticol	  and	  its	  C3,	  C10	  epimer.	  
 
In Quideau and coworkers’ synthesis, racemic cuparene was converted to racemic 
hydroxycuparene in two steps, then resolved using preparative chiral HPLC. This 
intermediate was treated with a stabilised IBX variant to give the reactive monomer 
1.49a plus its C6-epimer 1.49b. These intermediates selectively homodimerised to 
give aquaticol and its C3, C10 epimer, which could be separated using HPLC. 
 
An intriguing aspect of this dimerisation is the diastereoselectivity observed. The 
dimerisation of both the aquaticol monomer and its epimer occurs through an endo 
transition state, in which the hydroxyl groups of either molecule are facing inwards. 
The lowest energy transition state calculated for this transformation was non-polar 
with C2 symmetry – a bis-pericyclic transition state. This was the first instance of such 
reactivity being knowingly harnessed in total synthesis.D 
 
Porco and coworkers later improved this sequence through the application of some 
asymmetric oxidative dearomatisation methodology: 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
D Followed by the author’s own work, then the synthesis of paracaseolide by Hoye 
and coworkers. 
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Scheme	  1.23.	  Porco	  and	  coworkers’	  synthesis	  of	  (+)-­‐aquaticol.	  
 
Using the chiral reagent shown, (+)-hydroxycuparene could be oxidised to form a 
single diastereomer of the reactive monomer 1.49a. This then dimerised 
spontaneously, forming the natural enantiomer of aquaticol E  in improved yield, 
without the need for purification using HPLC. 
 
 
1.3.6 The Kingianin Family of Natural Products 
 
A substantial body of work exists concerning the total synthesis of the kingianins, a 
large family of dimeric polyketide natural products. 
 
 
Figure	  1.26.	  Proposed	  biosynthetic	  origins	  of	  kingianin	  A.	  
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
E Porco and coworkers claim the absolute stereochemistry of aquaticol as reported by 
Quideau and coworkers is incorrect, claiming that (+)-aquaticol forms from (+)-
hydroxycuparene rather than (−)-hydroxycuparene. 
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For illustrative purposes the proposed biosynthesis of kingianin A is depicted above, 
although all members of the family likely form through similar processes. Kingianin A 
is proposed to form diastereoselectively through the endo, facially selective Diels-
Alder dimerisation of bicyclo[4.2.0]octadiene precursor 1.50a. Bicyclooctadiene 1.50a 
is proposed to form through a spontaneous 8π-6π electrocyclisation cascade of either 
the (E,Z,Z,E) or (Z,Z,Z,Z) isomer of tetraene 1.51.[103] 
 
The 8π-6π electrocyclisation cascade is a stereodivergent event, giving rise to two 
enantiomeric pairs of diastereomer. These may be assigned as endo/exo, with reference 
to the positioning of the positioning of the methylenedioxyphenyl substituent relative 
to the cyclohexadiene unit: 
 
  
Figure	  1.27.	  Stereodivergent	  synthesis	  of	  diastereomerically	  and	  enantiomerically	  related	  
products	  from	  a	  common	  precursor.	  
 
It is the identity of the monomeric unit which undergoes homodimerisation or 
heterodimerisation which determines the identity of the kingianin formed. All 
members are proposed to form biogenetically through an endo Diels-Alder 
dimerisation with analogous regioselectivity. This can be seen with respect to 
kingianins A, D and F, as depicted below. 
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Figure	  1.28.	  Divergent	  dimerisations	  in	  the	  synthesis	  of	  kinganins	  A,	  D	  and	  F.	  
 
Kingianin A forms through the dimerisation of two homochiral units of monomer 
1.50a. Kingianin D forms through the dimerisation of two heterochiral units of 
monomer 150a. Kingianin F forms through the dimerisation of two homochiral units 
of monomer 150b. The divergent nature of this process causes much of the diversity 
in the kingianin family. That the process is so divergent suggests it occurs in the 
absence of an enzyme, something unexpected given the known inertness of 
cyclohexadienes towards Diels-Alder dimerisation.[104] 
 
Syntheses of certain kingianins have been completed by the groups of Parker, 
Sherburn and Moses, all of whom employed biomimetic strategies. Approaches to the 
monomer are summarised in the following scheme: 
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Scheme	  1.24.	  Synthesis	  of	  precursors	  for	  the	  Diels-­‐Alder	  dimerisation.	  
 
In Moses and coworkers’ first generation approach the nitrile-capped (E,Z,Z,E) 
tetraene 1.53 was prepared in 5 steps from safrole.[105] This spontaneously underwent 
cyclisation to give the corresponding bicyclooctadiene 1.54 as a mixture of isomers. 
Parker and coworkers’ approach bore some similarity to this work, involving 
preparation and spontaneous cyclisation of the corresponding OTBDPS-capped 
(E,Z,Z,E) polyene 1.55 in just 3 steps.[106] Sherburn and coworkers opted for a 
different approach, preparing the (Z,Z,Z,Z) polyene 1.58 in 5 steps, then cyclising 
this product under alternative conditions to access bicyclooctadiene 1.59.[107] 
 
Various protocols have been developed for dimerisation of homologues of the 
kingianin monomer. The first was a tethered approach published by Parker and 
coworkers:[106] 
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Scheme	  1.25.	  Synthesis	  of	  kingianin	  A	  by	  Parker	  and	  coworkers.	  
 
A single diastereomer of electrocyclisation product 1.60 was converted over three 
steps to tethered intermediate 1.61, formed as a mixture of diastereomers. These were 
subjected to radical cation Diels-Alder (“RCDA”) reaction conditions, with the C2 
symmetrical precursor reacting to give a product with the core structure of kingianin 
A. This was converted to kingianin A over five additional steps. 
 
Shortly afterwards Sherburn and coworkers published their synthesis of kingianins A, 
D and F, utilising an intermolecular RCDA approach:[107] 
 
 
Scheme	  1.26.	  Synthesis	  of	  kingianins	  A,	  D	  and	  F	  by	  Sherburn	  and	  coworkers.	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Electrocyclisation product 1.63 was converted to its corresponding carboxylic acid 
1.59 over a two step sequence, with diastereomerically-pure samples of the monomer 
accessed by HPLC. These were independently subjected to RCDA conditions, with 
the enantiomeric mixture of endo adduct giving dimers 1.64a and 1.64f, and the 
enantiomeric mixture of exo adducts giving adduct 1.64f, amongst other dimeric 
structures. These were converted in one step to their corresponding amides, then 
purified by an additional round of HPLC to give analytically-pure samples of 
kingianins A, D and F respectively. 
 
Subsequently, Parker and coworkers published their own intermolecular RCDA 
dimerisation approach to kingianins A, D, F, H and J:[108] 
 
 
Scheme	  1.27.	  Parker	  and	  coworkers’	  synthesis	  of	  kingianins	  A,	  D,	  F,	  H	  and	  J.	  
 
Dimeric structures 1.65a, 1.65d and 1.65f were prepared from bicyclooctadienes 
1.56a and 1.56b under similar conditions to those used by Sherburn and coworkers. 
These were converted through a series of homologations and functional group 
interconversions to the structures of kingianins A, D, F, H and J. 
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Subsequently, Moses and coworkers published their own conditions for dimerisation 
of the kingianin monomer:[109] 
 
 
Scheme	  1.28.	  Formal	  synthesis	  of	  kingianins	  A	  and	  H	  by	  Moses	  and	  coworkers.	  
 
Seeking to demonstrate alternative conditions for performing RCDA reactions, 
Moses and coworkers prepared Parker’s monomeric intermediate then performed its 
dimerisation electrochemically. In doing so they accessed Parker’s dimeric 
intermediate in the synthesis of kingianins A and H. 
 
Though very interesting in and of themselves, this body of work has a broader 
significance, suggesting that the RCDA reaction might be used in the biosynthesis of 
these natural products. Of significance is the observation made by all groups that the 
dimerisation of kingianin monomer could not be observed to occur under any other 
set of conditions. 
 
 
1.3.7 Longithorone A 
 
The review will end with a particularly novel and advanced application of the Diels-
Alder dimerisation: Shair and coworkers’ synthesis of longithorone A: 
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Figure	  1.29.	  Proposed	  biosynthetic	  origins	  of	  longithorone	  A.	  
 
Schmitz and coworkers have proposed a provocative biosynthetic origin for 
longithorone A, in which longithorone A forms from an intermolecular, transannular 
Diels-Alder reaction series from longithorone B and a proposed intermediate 1.66.[110] 
These monomeric units are structurally similar, differing only in the oxidation of C13 
and the geometry of the alkene between C2 and C3. Note also the isolation of 
longithorone C, which has the same geometry at the C2-C3 alkene as proposed 
intermediate 1.66 but lacks the C13 aldehyde. The order in which the intermolecular 
Diels-Alder, transannular Diels-Alder sequence occurs is unclear, but the isolation of 
longithorone I suggests that it is potentially the intermolecular reaction which 
happens first.[111] It was proposed that a Diels-Alderase might be involved in either of 
these steps. 
 
In a bid to answer these questions and others, Shair and coworkers embarked upon a 
total synthesis of longithorone A using a bioinspired approach:[112] 
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Scheme	  1.29.	  Shair	  and	  coworkers’	  synthesis	  of	  longithorone	  A.	  
 
Monomers 1.67 and 1.68 were accessed in enantiopure form in 14 steps each from 
commercially available starting materials. These precursors in hand, Shair and 
coworkers set about attempting the intermolecular Diels-Alder dimerisation. 
Intriguingly, the reaction only proceeded in the presence of the Lewis acid catalyst, 
and only provided dimer 1.69 as a 1:1.4 mixture with its diastereomer, disfavouring 
the desired adduct. Shair and coworkers propose this outcome as potential evidence of 
the involvement of a Diels-Alderase in the biosynthesis, the involvement of which 
could both accelerate the reaction and provide diastereoselectivity.[113] Heterodimer 
1.69a was then deprotected and oxidised over two steps to its corresponding 
bisquinone 1.70. This product spontaneously underwent the predicted transannular 
Diels-Alder reaction, giving longithorone A. 
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1.4 Conclusion 
 
The Diels-Alder reaction occupies a special place as one of the most useful and most 
effectively applied reactions in the history of organic chemistry. This review has 
provided an overview of just one of its many applications – the biomimetic synthesis 
of dimeric natural products. While not comprehensive, it is hoped that this review has 
provided an overview of the breadth of its application, and an impression of its 
effectiveness when properly utilised. It is also hoped that this review contextualises 
what is to follow in chapter 2, being our own contributions to this area. 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
 
CHAPTER 2 
 
THE TOTAL SYNTHESIS OF  
THE RAMONANIN FAMILY  
OF NATURAL PRODUCTS 
 
2.1 An Introduction to the Ramonanins 
 
Guaiacum officinale and Guaiacum sanctum are trees with an impressively storied past. 
The plants are best known as the source of the trade wood lignum vitae (“wood of 
life”), prized by 16th century traders in the Caribbean for its remarkable strength, 
toughness and durability. That said, the plants’ resin is also of particular importance. 
Once used as a traditional remedy for skin cancers and warts,[114,115] the resin has 
found application in colorimetric tests for oxidative stress.[116-118] These uses amongst 
others have given the trees a unique cultural significance in Caribbean communities. 
In recognition of this, Guaiacum sanctum has been declared the national tree of the 
Bahamas, while the flower of Guaiacum officinale is the national flower of Jamaica.  
 
Unfortunately the trees’ usefulness, combined with their slow rate of growth, has 
contributed to a marked decline in population numbers. Both Guaiacum officinale and 
Guaiacum sanctum are listed on the Red List of the International Union for the 
TOTAL SYNTHESIS OF THE RAMONANINS 48 
Conservation of Nature. This is of non-trivial consequence for researchers seeking to 
explore these plants’ medicinal potential, as any appreciable quantity of medicinally 
active metabolite will ultimately have to be procured through synthesis. 
 
In 2011, Schroeder and coworkers undertook a study of the biological activity of 
Guaiacum officinale and Guaiacum sanctum heartwood resin. As a product of these 
investigations they isolated and assigned the structures of ramonanins A-D (2.1):[119] 
 
 
Figure	  2.1.	  Ramonanins	  A-­‐D.	  
 
Extracts of the heartwood of Guaiacum officinale were screened for biological activity, 
leading to the isolation of pure samples of ramonanins A and B (ramonanins C and D 
were isolated from non-biologically-active fractions). Preliminary investigation 
showed only modest cytotoxic activity (IC50 of 18 µM), however it was noticed that 
the extracts appeared to be inducing apoptotic cell death. Subsequent studies in vitro 
revealed that ramonanins A and B induce apoptotic cell death at a rate comparable to 
that of the leading treatment camptothecin. Intriguingly, the percentage of cells 
observed to be in the S phase of the cell cycle was considerably lower for samples 
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treated with ramonanins A and B versus a control. This suggests a mode of action in 
which progression from the G1 to S phases of the cell cycle is inhibited. 
 
Biological activity is a pleasant attribute to have in any synthetic target, however as 
synthetic chemists it was the structures of these molecules that really attracted our 
interest. At the time of isolation, the ramonanin natural products were unique for the 
unprecedented furano-2-oxaspiro[4,5]decane core shared amongst its members.[120] 
Members of the family differ in stereochemistry at their benzylic sites. Ramonanins 
A, B and C bear a cis configuration of methoxyphenol rings either side of the 
tetrahydrofuran, while ramonanin D bears a mixed trans/cis arrangement. 
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2.2 Proposed Biosynthetic Origins of the Ramonanins 
 
Already intrigued by the structures of these molecules, our interest escalated further 
on consideration of their biological origins. Schroeder and coworkers initially 
proposed that the ramonanins arise from a Diels-Alder dimerisation of a hypothesised 
monomeric precursor. Drawing upon this one may make the following biosynthetic 
proposal: 
 
 
Figure	  2.2.	  A	  basic	  biosynthetic	  proposal	  for	  ramonanins	  A-­‐D.	  
 
The ramonanins conceivably form from the dimerisation of a monomer, a structure 
which is itself dimeric. A phenylpropanoid progenitor likely dimerises to give 
ramonanin monomers 2.2a and 2.2b. The achiral and chiral forms of this monomer 
bear Cs and C2 symmetry respectively. Homodimerisation of two equivalents of 2.2a 
gives ramonanins A, B and C, while heterodimerisation of 2.2a and 2.2b gives 
ramonanin D. This dimerisation has a desymmetrising effect on the monomer, and 
forms the unprecedented spirocyclic core of the natural products. As can be seen from 
the review of Diels-Alder dimers in chapter 1, the ramonanins occupy a unique place 
in the scientific literature. 
 
 
2.2.1 Proposed Biosynthesis of the Ramonanin Monomer 
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Two plausible pathways may be proposed for the biosynthesis of ramonanin monomer 
2.2. These are illustrated below: 
 
 
Figure	  2.3.	  Two	  plausible	  biosyntheses	  of	  the	  proposed	  ramonanin	  monomer.	  
 
The first possible pathway begins with the dimerisation of two monolignol precursors, 
such as coniferyl alcohol or a biosynthetic equivalent thereof. Current opinion is that 
such a transformation is likeliest to begin with an enzymatically-controlled β-β 
oxidative phenolic coupling, followed by subsequent α-α oxidation to give 
intermediate 2.3.[121] This could be followed by a double-dehydration event to give the 
diene system of the proposed monomer 2.2.  
 
Alternatively one could imagine a β-β coupling, α-α oxidation sequence of an 
allylphenol such as isoeugenol to give intermediate 2.4. This could then undergo 
oxidation to give the diene system of the proposed monomer 2.2.  
 
Both pathways are with biosynthetic precedent, with the β-β coupling, α-α oxidation 
products of both coniferyl alcohol and isoeugenol being known to nature (neo-olivil 
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and nectandrin B respectively).[122,123] A mono-oxidised variant of nectandrin B 
(ribesin D) has also recently been isolated.[120] 
 
 
2.2.2 Potential Modes of Dimerisation 
 
Three potential means of dimerisation might reasonably be proposed: a Diels-Alder 
dimerisation between two equivalents of the ramonanin monomer; a Diels-Alder 
dimerisation involving the para-quinone methide of the ramonanin monomer; or a 
formal Diels-Alder dimerisation involving the radical cation of the ramonanin 
monomer. These are discussed below. 
 
 
2.2.2.1 Diels-Alder Dimerisation of the Ramonanin Monomer 
 
This potential mode of dimerisation is depicted below: 
 
 
Figure	  2.4.	  Diels-­‐Alder	  dimerisation	  of	  the	  ramonanin	  monomer.	  
 
Under this possibility two equivalents of the monomer would undergo a spontaneous 
Diels-Alder reaction to form the central cyclohexene ring of the ramonanins. 
 
It is without literature precedent that an exocyclic diene on a five membered ring 
undergoes dimerisation at ambient temperatures, unless it is in some way activated by 
additional functionality.[124] 1,2-Dimethylenecyclopentane has been noted to dimerise 
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at 97 °C,[125] but this is well above the temperature at which a reaction could occur 
biosynthetically. 
 
This raises the potential involvement of a Diels-Alderase. While the existence of 
intramolecularly-acting Diels-Alderases is well established, the existence of 
intermolecularly-acting Diels-Alderases is not.[126,127] However, this alone is not proof 
of their absence. Indeed, there are numerous reports in the literature which suggest at 
the intermolecularly-acting Diels-Alderase’s possible existence.[72,112] 
 
 
2.2.2.2 Diels-Alder Dimerisation of a para-Quinone Methide of 
the Ramonanin Monomer 
 
It is conceivable that the ramonanin monomer could tautomerise to form the 
dendralenic para-quinone methide 2.5, which could conceivably be more activated 
than cyclised monomer 2.2 towards Diels-Alder dimerisation. This is illustrated 
below in figure 2.5: 
 
 
Figure	   2.5.	   Diels-­‐Alder	   dimerisation	   of	   the	   ramonanin	   monomer’s	   para-­‐quinone	   methide	  
tautomer.	  
 
This process could conceivably be promoted using a Brønsted acid catalyst. Once 
formed, dendralenic para-quinone methide 2.5 could potentially participate in a 
dimerisation through either a polar or non-polar [4+2] cycloaddition pathway. 
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A polar [4+2] cycloaddition would likely proceed by the following pathway: 
 
 
Figure	  2.6.	  Proposed	  polar	  [4+2]	  cycloaddition	  transition	  state.	  
 
It is likeliest that in such a pathway the para-quinone methide would serve as the 
dienophile, while an unisomerised equivalent of the monomer would act as the diene. 
The central alkene of the hypothesised dendralene moiety is positively polarised 
through conjugation to the para-quinone methide, potentially activating this alkene as 
a dienophile. 
 
As for a possible non-polar [4+2] cycloaddition, one can propose two potential means 
by which such a dimerisation may occur: heterodimerisation between one equivalent 
of the para-quinone methide and one equivalent of the unisomerised monomer, or 
homodimerisation between two equivalents of the para-quinone methide: 
 
 
Figure	  2.7.	  Proposed	  non-­‐polar	  [4+2]	  cycloaddition	  transition	  states.	  
 
The propensity of dendralenes to undergo dimerisation through non-polar pathways 
has been exhaustively studied within the Sherburn group.[128,129] A key finding from 
these studies was the accelerative effect on dimerisation of conjugated electron-poor 
substituents. Such findings suggest that the homodimerisation of the para-quinone 
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methide would be an exceptionally rapid event. Conceivably the para-quinone 
methide could also react with the unisomerised monomer – the species likely to be 
present in greater abundance during the reaction. Which pathway would prevail is 
difficult to anticipate, but the outcome would likely be determined by the relative 
rates at which dienic and dendralenic monomer react with another equivalent of the 
dendralenic monomer, versus the concentration of either species in solution. 
 
 
2.2.2.3 Radical Cation-Mediated Formal Diels-Alder 
Dimerisation 
 
It is also possible that the radical cation of the ramonanin monomer is disposed 
towards dimerisation. This possibility is illustrated below in figure 2.8: 
 
 
Figure	  2.8.	  Radical	  cation-­‐mediated	  formal	  [4+2]	  dimerisation	  of	  the	  ramonanin	  monomer.	  
 
Limited but not unsubstantial evidence exists for the radical cation Diels-Alder 
reaction being known to biosynthesis. Proposals have been made by Yoon and 
coworkers in their synthesis of heitziamide A,[130] and Porco and coworkers in their 
syntheses of panduratin A[131] and brosimones A and B.[35] This said, the main body of 
work concerns the aforementioned syntheses of the kingianin natural products,[106-109] 
plus some additional studies undertaken by Sherburn and coworkers concerning the 
kingianic acids.[132] Given the apparent unlikelihood of the exocyclic diene of the 
ramonanin monomer participating in a spontaneous Diels-Alder dimerisation 
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reaction, the existence a radical cation intermediate in the biosynthesis should be 
considered as a possibility. 
 
 
  
TOTAL SYNTHESIS OF THE RAMONANINS 57 
2.3 Past Syntheses of Lignans with Diene 
Functionalities 
 
While the ramonanins occupy a thoroughly unique place in the literature with regard 
to their structural attributes, there is a small but not unsubstantial body of work on 
the syntheses of lignans containing a central acyclic diene, similar in structure to that 
of our proposed ramonanin monomer. The following section will offer a brief 
overview of past approaches towards their synthesis. 
 
 
2.3.1 Cross-Coupling Approaches 
 
Two syntheses can be placed under this category: the sp2-sp2 bond forming approach 
adopted by Corey and coworkers’ in their synthesis of wodeshiol,[133] and the sp2-sp3 
bond forming approach adopted by Shimizu and coworkers in their synthesis of 
anolignan B.[134] 
 
 
2.3.1.1 Wodeshiol 
 
Corey and coworkers’ synthesis of wodeshiol is summarised in scheme 2.1 below: 
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Scheme	   2.1.	   Retrosynthetic	   analysis	   and	   summarised	   forward	   synthesis	   of	   wodeshiol	   by	  
Corey	  and	  coworkers.	  
(a)	  Pd(PPh3)4,	  CuCl,	  CuCl2,	  DMSO,	  60	  °C,	  2	  h,	  82%.	  
 
Corey and coworkers disconnected wodeshiol back to diene 2.6, which was 
disconnected further at its central sp2-sp2 carbon-carbon bond to allylic alcohol 2.7a. 
This is an obvious strategy, owing to both the symmetry of diene 2.6 and the ease by 
which sp2-sp2 carbon-carbon bonds can typically be formed by cross-coupling. 
 
In the forward sense, stannane 2.7b was accessed in six steps from commercially-
available piperonal. The stannane was coupled through an unconventional but 
effective Stille-like dimerisation, after which the resulting diene 2.6 was elaborated to 
wodeshiol in three additional steps. 
 
 
2.3.1.2 Anolignan B 
 
Shimizu and coworkers’ synthesis of anolignan B is summarised in scheme 2.2 below: 
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Scheme	   2.2.	   Retrosynthetic	   analysis	   and	   forward	   synthesis	   of	   anolignan	   B	   by	   Shimizu	   and	  
coworkers.	  
(a)	  Pd(OAc)2,	  PPh3,	  KOH,	  dioxane,	  90	  °C,	  2h;	  (b)	  KOH,	  EtOH,	  25	  °C,	  14	  h	  56%	  (two	  steps).	  
 
Shimizu and coworkers took a different approach to Corey and coworkers in their 
synthesis of anolignan B, opting instead to disconnect at the sp2-sp3 hybridised bond 
either side of the diene. Using this approach, diacetate 2.10 was assembled in a three-
component operation from one equivalent of boronic acid pinacol ester 2.9b and two 
equivalents of chloride 2.8b. The product of this reaction was then deprotected to 
give anoligan B. 
 
 
2.3.2 Enyne Metathesis Approach 
 
This approach was adopted by Mori and coworkers in their synthesis of anoligans A 
and B.[135] Their approach to anolignan A is summarised in scheme 2.3 below: 
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Scheme	   2.3.	   Retrosynthetic	   analysis	   and	   summarised	   forward	   synthesis	   of	   anolignan	   A	   by	  
Mori	  and	  coworkers.	  
(a)	  Grubbs	  II,	  ethylene,	  toluene,	  80	  °C,	  36	  h,	  86%.	  
 
Retrosynthetically, Mori and coworkers opted to disconnect anolignan B at its diene 
functionality, back to alkyne 2.11. This was a reasonable disconnection to make, 
owing largely to the group’s pioneering work performing enyne metathesis with 
ethylene. Intermediate 2.11 could be disconnected back to aryl systems 2.12 and 2.14, 
and acetylene (2.13).  
 
In the forward sense, Mori and coworkers accessed alkyne 2.15 in three steps from 
piperonal. Enyne metathesis was then used to convert the alkyne of 2.15 to the diene 
of 2.16. Diene 2.16 was converted to anolignan A over two additional steps. A similar 
approach was used in the group’s synthesis of anolignan B. 
 
 
2.3.3 Sakurai Allylation Approach 
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This approach was applied by Hatakeyama and coworkers to the total synthesis of 
anolignan A.[136] This is summarised in scheme 2.4 below: 
 
 
Scheme	   2.4.	   Retrosynthetic	   analysis	   and	   summarised	   forward	   synthesis	   of	   anolignan	   A	   by	  
Hatakeyama	  and	  coworkers.	  
(a)	  TiCl4,	  MeCN,	  CH2Cl2,	  −78	  °C,	  76%.	  
 
Hatakeyama and coworkers disconnected anolignan A adjacent to its diene, back to 
allene 2.17 and aryl system 2.14. Allene 2.17 could be disconnected back to silyl 
reagent 2.19, arene 2.12, and propargyl alcohol (2.20). 
 
In the forward direction, allene 2.17 was made in five steps from piperonal. This was 
subjected to Sakurai allylation conditions, providing diene 2.22, bearing a fortuitously 
transposed acetyl group. The resulting secondary acetate was removed, and the 
phenolic acetate cleaved to give anolignan A in two additional steps. 
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2.3.4 Dehydration Approach 
 
This approach was adopted by Yamauchi and coworkers.[137,138] A representative 
example – their synthesis of nectandrin B, is provided below: 
 
 
Scheme	  2.5.	  Synthesis	  of	  nectandrin	  B	  by	  Yamauchi	  and	  coworkers.	  
(a)	  MsCl,	  Et3N,	  CH2Cl2,	  25	  °C,	  0.5	  h;	  (b)	  LiEt3BH,	  THF,	  25	  °C,	  2.5	  h;	  (c)	  H2,	  Pd/C,	  EtOAc,	  25	  °C,	  
4h,	  24%	  (3	  steps).	  
 
As part of a diversity-orientated study, Yamauchi and coworkers sought to acquire all 
stereoisomers of tetrahydrofuran lignans bearing the connectivity of nectandrin B. As 
part of the process of dehydroxylating the various enantiomers of diol 2.23, the 
alcohols were eliminated giving dienes of the form 2.24. 
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2.4 Retrosynthetic Analysis of the Ramonanins 
 
With our interest in the ramonanins now informed by the aforementioned 
investigations, we initiated plans towards their synthesis. The first part of our 
retrosynthetic analysis of the ramonanins is depicted below in figure 2.9: 
 
 
Figure	  2.9.	  Disconnection	  of	  ramonanins	  A-­‐D	  (2.1)	  to	  the	  proposed	  ramonanin	  monomer	  2.2.	  
 
The primary motivation for our undertaking the synthesis of the ramonanins was to 
investigate the nature of the Diels-Alder dimerisation event that we propose as part of 
their biosynthesis. In order to do this, it was exceedingly obvious that the first 
disconnection we made should be the Diels-Alder disconnection marked above. This 
simplifies the structure of ramonanins A-D (2.1) to the proposed biosynthetic 
ramonanin monomer 2.2. Note that ramonanins A-C disconnect back to two 
equivalents of the achiral monomer 2.2a, while ramonanin D disconnects back to one 
equivalent each of the achiral monomer 2.2a and chiral monomer 2.2b. 
 
From this point, our intention was to access monomer 2.2 as succinctly as possible. 
The most obvious and most appealing route to monomer 2.2 was the biomimetic 
dimerisation of two equivalents of coniferyl alcohol or isoeugenol. However, as 
desirable as such a strategy was deemed to be, we were doubtful we would be able to 
adequately mimic the enzymatic processes that we believe were operative 
biosynthetically. Hence we investigated some alternative, bidirectional approaches. 
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Figure	  2.10.	  Disconnection	  of	   the	  cyclic	  ether	   in	   the	  proposed	  ramonanin	  monomer	  2.2	   to	  
diol	  2.25.	  
 
Under a bidirectional approach, the most obvious bond for us to target 
retrosynthetically was the carbon-oxygen bond of the tetrahydrofuran ring of structure 
2.2. Such a bond should be easily formed in the forward sense through a dehydrative 
etherification reaction.  
 
It is foreseeable that both the achiral (Cs symmetrical) and chiral (C2 symmetrical) 
diastereomers should form from this transformation. The etherification appears likely 
to occur through a dissociative mechanism, and so the stereochemistry of diol 2.25 is 
unlikely to be of consequence in determining the ratio of diastereomers formed. 
While high selectivity for the achiral diastereomer would be ideal for a high yielding 
synthesis of ramonanins A-C, some quantity of the chiral diastereomer is also 
required for the synthesis of ramonanin D.  
 
There were numerous ways in which we could reasonably disconnect intermediate 
2.25. The possibilities are set out in figure 2.11 below: 
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Figure	  2.11.	  Three	  potential	  disconnections	  for	  diol	  2.25.	  
 
Preliminary investigations suggested that neither the cross-coupling[139] or Sakurai 
allylation[140] routes were likely to be successful. Accordingly we opted for the 
metathesis disconnection of diene 2.25 to alkyne 2.26. The aforementioned work of 
Mori and coworkers provides excellent precedent for such a transformation.[135] 
 
 
Figure	  2.12.	  Disconnection	  of	  alkyne	  2.26	  to	  commercially	  available	  starting	  materials.	  
 
From this point the disconnection that most appealed to us is that depicted in figure 
2.12, in which the alkyne is disconnected to two equivalents of vanillin, plus one 
equivalent of acetylene. Such a disconnection could conceivably be enacted in the 
forward sense through the double nucleophilic addition of dilithioacetylene to two 
equivalents of vanillin, a starting material which conveniently bears the 
methoxyphenol functionality of the ramonanins. 
 
The overall approach is summarised below: 
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Figure	  2.13.	  Retrosynthetic	  analysis	  of	  ramonanins	  A-­‐D.	  
 
 
  
HO
O
HO
OH
O
OH
HO
O
OCH3
HO OCH3
OH
HO
H3CO
HO
OH
HO
H
HO
OH
H3CO
HO
OH
O
H3CO
H3CO
OCH3
OCH3
H3CO
OCH3
OCH3OH
H
O
OCH3
Diels-Alder
dimerisation etherification
metathesis
double
nucleophilic
addition
2.25
2.26
2.27
vanillin
2.13
acetylene
2.27
vanillin
2.1 2.2a
HO
O
OCH3
HO OCH3
2.2b
TOTAL SYNTHESIS OF THE RAMONANINS 67 
2.5 First Generation Approach to the Ramonanin 
Monomer 
 
Our first generation approach to the ramonanins was an enactment of the 
aforementioned retrosynthetic analysis, employing TBS groups for protection of the 
phenolic alcohols, and acetate groups for protection of the secondary alcohols. 
Protection of the secondary alcohols is necessary to enable the metathesis step, as 
unprotected alcohols will chelate to the ruthenium metathesis catalyst. The use of a 
protecting group on the phenols was deemed desirable due to the general reactivity of 
phenols, and the complications which could arise from their presence concerning both 
synthetic transformations and purification. 
 
The first step – the conversion of the phenolic alcohol of vanillin to its TBS ether, 
was performed according to the protocol of Snapper, Hoveyda and coworkers: 
 
 
Scheme	  2.6.	  Conversion	  of	  vanillin	  (2.27)	  to	  its	  TBS	  ether	  2.30.	  
(a)	  Imidazole,	  THF,	  25	  °C	  	  0	  °C	  10	  min;	  then	  TBSCl	  in	  THF,	  0	  °C	  	  25	  °C,	  1	  h,	  72%.	  
 
Vanillin 2.27 was reacted with TBS-chloride in the presence of imidazole to form 
aldehyde 2.30. This transformation is known to the literature and proceeded 
smoothly.[141] 
 
The next transformation was the addition of dilithioacetylene (2.32) to two 
equivalents of aldehyde 2.30. Precedent for such a transformation comes from the 
work of Kiji and coworkers:[142] 
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Scheme	  2.7.	  Synthesis	  of	  diol	  2.33	  by	  Kiji	  and	  coworkers.	  
(a)	  BuLi,	  THF,	  −78	  °C	  	  25	  °C,	  2	  h;	  (b)	  2.34,	  THF,	  −78	  C	  	  25	  °C,	  16	  h.	  
 
In Kiji and coworkers’ study, diol 2.33 was formed through the double nucleophilic 
addition of dilithioacetylene (2.32) (generated in-situ) to two equivalents of ketone 
2.34. Such work appeared to provide adequate precedent for our own transformation. 
Indeed, when the conditions were applied to aldehyde 2.30, the desired reaction 
proceeded smoothly: 
 
 
Scheme	  2.8.	  Synthesis	  of	  diol	  2.35	  from	  aldehyde	  2.30	  and	  dilithioacetylene.	  	  
(a)	  TCE,	  THF	  then	  BuLi,	  THF,	  −78	  °C	  	  25	  °C,	  2	  h;	  then	  2.30,	  THF,	  −78	  °C	  	  25	  °C,	  16	  h,	  34%,	  
d.r.	  1:1.	  
 
Note that this reaction yielded a 1:1 mixture chiral and achiral diastereomers, which 
proved inseparable using the HPLC resources that were available. Assignment of the 
products as a 1:1 mixture of diastereomers was made through analysis of the 1H NMR 
spectrum, which showed a distinct benzylic proton environment for either product. 
Despite complicating characterisation of the product, the presence of a mixture of 
diastereomers at this point was anticipated to be inconsequential. 
 
In preparation for the enyne metathesis step, the secondary alcohols of 2.35 were 
protected as acetates: 
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Scheme	  2.9.	  Synthesis	  of	  diacetate	  2.36	  from	  diol	  2.35.	  
(a) Pyridine,	  Ac2O,	  CH2Cl2,	  0	  °C	  	  25	  °C,	  16	  h,	  89%,	  d.r.	  1:1.	  
 
This reaction proceeded smoothly, giving the desired diacetate as an inconsequential 
1:1 mixture of achiral and chiral diastereomers. Again, the mixture of diastereomers 
proved inseparable by HPLC, but the presence of two products in 1:1 ratio could be 
determined using 1H NMR. 
 
A telescoped procedure was developed in which diacetate 2.36 could be prepared in 
the one pot from aldehyde 2.30: 
 
 
Scheme	   2.10.	   Telescoped	   synthesis	   of	   diacetate	   2.36	   from	   aldehyde	   2.30	   and	  
dilithioacetylene	  (2.32).	  
(a)	  BuLi,	  THF,	  −78	  °C	  	  25	  °C,	  2	  h;	  (b)	  2.30,	  THF,	  −78	  °C	  	  25	  °C,	  16	  h;	  (b)	  Ac2O,	  −78	  °C	  	  25	  
°C,	  1.5	  h,	  37%.	  
 
In this procedure, the addition of two equivalents of aldehyde 2.30 to one equivalent 
of dilithioacetylene (2.32) was performed per the aforementioned approach, and the 
resulting bisalkoxide 2.37 was quenched directly with acetic anhydride. Such an 
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approach not only reduces the need for chromatography, it also brings about an 
increase in yield, with a 37% yield now realised using the one-pot procedure, versus a 
30% yield from the two-pot approach. 
 
Accessing diacetate 2.36 set the stage for one of our key transformations – the 
formation of diene 2.39 through enyne metathesis between 2.36 and ethylene (2.38). 
This transformation proved non-trivial. A selection of relevant results is presented 
below in table 2.1: 
 
 
	  
Entry Catalyst Loading 
(mol. %) 
Temperature  
(° C) 
Pressure 
(atm.) 
Yield 
(%) 
1 Grubbs II 10 80 1 36 
2 Grubbs II 10 110 1 39 
3 Grubbs II 30 80 1 67 
4 Grubbs II 10 80 ca. 10 46 
5 Hoveyda-
Grubbs II 
10 80 1 65 
6 Hoveyda-
Grubbs II 
10 110 1 63 
Table	  2.1.	  Optimisation	  of	  the	  conversion	  of	  alkyne	  2.36	  to	  diene	  2.39.	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Entry 1 is the application of the approach prescribed by Mori and coworkers.[143] 
With only 10 mol. % catalyst this reaction was always observed to stall short of 
completion, even after repeated refinements were made to experimental technique. 
Increasing the reaction temperature (entry 2) had a negligible effect on yield. 
 
Entry 3 is the application of the approach prescribed by Mori and coworkers, but with 
a higher catalyst loading. Reactions performed using this approach would run closer 
to completion, albeit at considerable expense. For this reason, such an approach was 
not deemed acceptable for application in the early stages of a total synthesis. 
 
Entry 4 was an attempt at improving reaction outcomes using elevated pressure. The 
use of pressure as a means of accelerating enyne metathesis reactions with Grubbs II 
catalyst is well precedented in the literature.[144-146] The reaction was performed in a 
pressure vessel into which an excess of ethylene was condensed. The vessel is designed 
to release pressure if pressure rises above 10 atmospheres. Application of these 
conditions led to a small improvement in yield, but with reactions still stalling short of 
completion. 
 
In entry 5 an alternative catalyst was used – Hoveyda-Grubbs II. Literature precedent 
is stronger for the use of Grubbs II catalyst in enyne metathesis reactions, although 
there is some precedent for the use of Hoveyda-Grubbs II as well. For reasons that 
are not entirely obvious, the use of this catalyst led to a considerable increase in 
conversion and overall yield, approaching the levels that we felt were acceptable. 
Increasing the reaction temperature further (entry 6) had a negligible effect on 
conversion and yield. 
 
Curiously, the above reaction conditions gave mixtures of diene 2.39 containing an 
approximately 3:2 mixture of diastereomers, from a 1:1 diastereomeric mixture of 
alkyne 2.36. The reasons for this are not entirely obvious, however monitoring of the 
reactions by NMR did reveal that one diastereomer of starting alkyne was reacting 
faster under the reaction conditions than the other – something observed when 
aliquots of reaction solution taken successively throughout the reaction were analysed 
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using 1H NMR. Pleasantly, the diastereomers produced from this reaction could be 
separated using flash chromatography. This allowed for characterisation of the more 
abundant product as the chiral diastereomer 2.39b, and characterisation of the less 
abundant product as the achiral diastereomer 2.39a. 
 
Taking the developed enyne metathesis conditions as acceptable, if not entirely 
desirable, our focus turned to the next step – deacetylation of the diacetate 2.39, 
forming diol 2.40. 
 
 
Scheme	  2.11.	  Deacetylation	  of	  diacetate	  2.39,	  forming	  diol	  2.40.	  
(a)	  Cs2CO3,	  MeOH/THF	  (10:1),	  25	  °C,	  75	  min,	  22%.	  
 
Optimised conditions for this transformation are depicted above in scheme 2.11. This 
transformation proved deceptively challenging – the TBS ethers of 2.39 were 
exceptionally susceptible to base-mediated cleavage, even by weak bases such as 
carbonate. Matters were further complicated by the fact that the acetate side-product 
of deacetylation was itself basic enough to promote cleavage of the silyl ethers. In the 
end, it was through careful monitoring of this reaction by TLC that the ideal 
conditions were developed.  
 
The use of quantitative NMR techniques indicated that diol 2.40 was forming in 
approximately 55% yield, however yields after chromatography never exceeded 22%. 
This was the case irrespective of the chromatographic medium employed (silica, 
phosphate-buffered silica, triethylamine-treated silica and neutral alumina were all 
tested). It isn’t unexpected that the products of this reaction would be sensitive to 
both acid and base – the TBS ethers have already been demonstrated to be sensitive to 
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base, while the alcohols of 2.40, which are both allylic and benzylic, would be 
expected to eliminate under acidic conditions. Still, the extent to which this 
compound was sensitive to chromatographic media was disappointing. 
Diastereomerically pure samples of diol 2.40 could be prepared from 
diastereomerically pure samples of diacetate 2.39 for characterisation. 
 
At this point we moved on with the next step of the synthesis – synthesis of the 
tetrahydrofuran ring: 
 
 
Scheme	  2.12.	  Dehydrative	  etherification	  of	  diol	  2.40,	  forming	  tetrahydrofuran	  2.41.	  
(a)	  CSA,	  CHCl3,	  25	  °C,	  5	  min,	  33%.	  
 
Diol 2.40 etherified rapidly on treatment with a catalytic quantity of camphorsulfonic 
acid, even at high dilution (0.0056 mol. L-1 with respect to camphorsulfonic acid). 
However, chromatographic purification remained a problem. Quantitative NMR 
techniques indicated that tetrahydrofuran 2.41 was forming in approximately 80% 
yield from diol 2.40, however yields after purification never exceeded 33%. 
 
Fortunately, the chiral and achiral diastereomers of furan 2.41 were separable by 
column chromatography. Chiral HPLC indicated that the desired achiral 
diastereomer of 2.41a was forming with 2:1 selectivity, from a 3:2 mixture of chiral to 
achiral diol 2.40. This supports our earlier prediction that the stereochemistry of the 
ramonanin monomers would be set at the etherification step. 
 
This fortuitous selectivity encouraged us to persevere with this synthetic route a little 
further: 
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Scheme	   2.13.	   Telescoped	   deacetylation,	   etherification	   sequence,	   forming	   tetrahydrofuran	  
2.41	  from	  diacetate	  2.39.	  
(a)	  Cs2CO3,	  MeOH/THF	  (10:1),	  25	  °C,	  75	  min;	  (b)	  CSA,	  CHCl3,	  25	  °C,	  5	  min,	  34%	  (2	  steps).	  
 
Given the difficulties encountered in the chromatographic purification of diol 2.40, 
an attempt was made to avoid this process by directly subjecting crude diol to the 
dehydrative etherification protocol. This approach was successful, and we were able to 
access tetrahydrofuran 2.41 in an improved yield of 34% over two steps from diacetate 
2.39. 
 
With the limited amounts of material that could be procured through this route, an 
attempt was made at removal of the TBS ethers to form the ramonanin monomer: 
 
 
Scheme	  2.14.	  Attempted	  synthesis	  of	  the	  ramonanin	  monomer	  2.2	  from	  TBS-­‐protected	  2.41.	  
(a)	  Cs2CO3,	  MeOH/THF	  (13:1),	  25	  °C,	  16	  h.	  
 
Cleavage of the TBS ethers appeared to proceed when protected monomers 2.41 were 
treated with cesium carbonate. However, it was to our extreme disappointment that 
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despite repeated attempts, no quantity of pure material could be isolated using column 
chromatography or any other method tested.F It was this final disappointment that 
prompted us to adopt a new strategy.
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  F	  Characterisation of the crude product as the ramonanin monomer was later 
confirmed through experiments I performed in which the ramonanin monomer was 
synthesised through an alternative route. 	  
	  
2.6 Second Generation Approach to the Ramonanin 
Monomer 
 
Our revised approach to the ramonanin monomer was to substitute the phenolic TBS 
protecting groups for sulfonates. We anticipated that this would solve a number of the 
problems we had encountered in the earlier route: 
 
1) Selective cleavage of the acetate protecting groups: cleaving acetate groups in the 
presence of phenolic TBS groups had proven exceptionally challenging. Sulfonates are 
far less easily hydrolysed than acetates, typically cleaved with hydroxide or carbonate 
nucleophiles only at elevated temperatures and concentration. 
 
2) Greater stability of intermediates to chromatographic media: we suspected that the 
cause of our problems in this regard arose from the sensitivity of the secondary 
alcohols of 2.40 or the ether of 2.41 to acid: 
 
 
Figure	  2.14:	  intermediates	  2.40	  and	  2.41.	  
 
Both the alcohol and the ether functionalities are allylic and benzylic, presumably 
disposing them to acid-catalysed elimination. This problem is exacerbated by how 
electron rich the benzylic functionality is. Reducing the electron richness of the 
phenolic functionality with an electron-withdrawing sulfonate could potentially 
decrease the extent to which the benzylic oxygen is activated towards elimination. 
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3) Purification of the ramonanin monomer: in order to conduct any sort of detailed 
study on the dimerisation of the ramonanin monomer, it will have to be isolated as a 
pure compound. Cleavage of a sulfonate protecting group on the ramonanin 
monomer could conceivably result in a product that could be purified without 
chromatographic purification, owing to the polarity of the sulfonate byproducts versus 
the product. 
 
It was for these reasons that we proceeded with the second-generation approach, 
opting for the use of a benzenesulfonate protecting group for the phenol. 
 
The second-generation route began with the protection of vanillin using 
benzenesulfonyl chloride: 
 
 
Scheme	  2.15.	  Conversion	  of	  vanillin	  (2.27)	  to	  benzenesulfonate	  2.42.	  
(a)	  PhSO2Cl,	  Et3N,	  CH2Cl2,	  25	  °C,	  18	  h,	  90%.	  
 
Surprisingly, the synthesis of compound 2.42 has not previously been reported. 
Nevertheless, it could be prepared following a literature protocol for the protection of 
analogous compounds.[135] 
 
We next sought to implement the addition of two equivalents of 2.42 to 
dilithioacetylene (2.32), in line with the earlier approach taken with TBS-protected 
aldehyde 2.30.  
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Scheme	  2.16.	  Attempted	  addition	  of	  two	  equivalents	  of	  2.42	  to	  dilithioacetylene	  (2.32).	  
(a)	  TCE,	  THF	  then	  BuLi,	  THF,	  −78	  °C	  	  25	  °C,	  2	  h;	  then	  2.42,	  THF,	  −78	  C	  	  25	  °C,	  16	  h,	  34%.	  
 
Unfortunately, this reaction appears to be incompatible with the benzenesulfonyl 
protecting groups: no product was observed to form in this reaction, just a complex 
mixture of products. One suspects nucleophilic addition of an organolithium 
intermediate to the benzenesulfonate group, however the vast mixture of products 
formed prevents one from concluding this definitively. 
 
Following this, a stepwise approach was attempted, beginning with the nucleophilic 
addition of ethynylmagnesium bromide to aldehyde 2.42: 
 
 
Scheme	  2.17.	  Addition	  of	  ethynylmagnesium	  bromide	  to	  aldehyde	  2.42.	  
(a)	  HCCMgBr,	  THF,	  0	  °C	  	  25	  °C,	  0.25	  h,	  93%.	  
 
The results of this reaction were pleasing, with ethynylmagnesium bromide adding 
selectively to aldehyde 2.42, generating the desired alkyne in good yield. 
 
The next step involved addition of alkyne 2.44 to a second equivalent of aldehyde 
2.42: 
 
 
Scheme	  2.18.	  Addition	  of	  alkyne	  2.44	  to	  aldehyde	  2.42.	  
(a)	  EtMgBr,	  THF,	  0	  °C	  to	  25	  °C,	  0.25	  h;	  then	  2.42	  in	  THF,	  0	  °C	  	  25	  °C,	  2	  h,	  66%.	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Initial attempts at effecting this transformation were made using butyllithium as the 
base. However despite repeated attempts, these conditions only ever resulted in the 
unselective formation of a large number of products. In contrast, when the reaction 
was performed using ethylmagnesium bromide as the base the reaction was observed 
to proceed smoothly. Two equivalents of ethylmagnesium bromide were added to a 
solution of propargylic alcohol 2.44, the first deprotonating the alcohol, the second 
deprotonating the alkyne. To this solution was added aldehyde 2.42, giving the 
desired product. 
 
These two transformations were then telescoped into a one-pot procedure: 
 
 
Scheme	  2.19.	  Telescoped	  synthesis	  of	  diol	  2.43	  from	  aldehyde	  2.44.	  
(a)	  HCCMgBr,	  THF,	  0	  °C	  	  25	  °C,	  0.25	  h;	   (b)	  EtMgBr,	  THF,	  0	  °C	  to	  25	  °C,	  0.25	  h;	   (c)	  2.42	   in	  
THF,	  0	  °C	  	  25	  °C,	  2	  h,	  67%.	  
 
Ethynylmagnesium bromide was added to aldehyde 2.42, forming alkoxide 
intermediate 2.45. To this was added one equivalent of ethylmagnesium bromide, 
forming dianionic intermediate 2.46. This was quenched with an equivalent of 
aldehyde 2.42, forming diol 2.43 as a 1:1 mixture of diastereomers. Not only does this 
approach give diol 2.43 from aldehyde 2.42 in a single pot, it also improves overall 
yield, from a 61% yield over two pots to a 67% yield in just one.  
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Diols 2.43a and 2.43b were formed as a 1:1 mixture of chiral and achiral 
diastereomers. Diastereomers were inseparable using column chromatography, and 
efforts were not made to perform the separation using HPLC. The mixture of 
products was assigned as a 1:1 mixture of diastereomers using 1H NMR, with each 
diastereomer bearing a unique benzylic proton environment. 
 
The next step was to acetylate diol 2.43a, giving diacetate 2.47. 
 
 
Scheme	  2.20.	  Acetylation	  of	  diol	  2.43	  to	  form	  diacetate	  2.47.	  
(a)	  Pyridine,	  Ac2O,	  CH2Cl2,	  0	  °C	  	  25	  °C,	  1.5	  h,	  quant..	  
 
Application of the conditions previously employed for acetylation of the TBS-
protected diol worked excellently. Diacetate 2.47 was formed in quantitative yield, 
without the need for purification after workup.G 
 
Synthesis of the diacetates set the stage for the key enyne metathesis reaction: 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  G	  In the published version of this work, a telescoped one-pot synthesis of 2.47 from 
2.42 was disclosed, as developed by Emily Mackay. 
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Scheme	  2.21.	  Enyne	  metathesis	  of	  alkyne	  2.47	  and	  ethylene	  (2.38),	  forming	  diene	  2.48.	  
(a)	  Hoveyda-­‐Grubbs	  II,	  ethylene,	  toluene,	  110	  °C,	  2h,	  74%.	  
 
An initial screening of conditions using the Grubbs II metathesis catalyst was 
disappointing, with yields achieved that were roughly consistent with those gained on 
the TBS-protected substrate. However, on switching to the Hoveyda-Grubbs II 
catalyst a remarkable improvement was observed. Fully-optimised conditions are 
depicted in scheme 2.21, in which diene 2.48 was prepared on 5 g scale from a 
mixture of alkyne 2.47, using a 5 mol. % catalyst loading. This reaction was noted to 
suffer from some scaling difficulties, with an optimum yield of 89% achieved when 
the reaction was performed on 1 g scale. Still, considering the improvement gained 
upon results using TBS-protected precursor 2.36 as the starting material, this result 
was very happily received. 
 
Diene 2.48 was observed to form in a 1:1 diastereomeric ratio, matching that of the 
starting material. No difference was observed in the rate at which the diastereomers of 
alkyne 2.48 reacted under these conditions, in contrast to TBS-protected 2.36. 
Diastereomers were inseparable by flash chromatography, but could be assigned as a 
1:1 mixture of diastereomers using 1H NMR, with reference to the benzylic and 
terminal alkene proton environments of either product. 
 
Already feeling some slight vindication for our decision to change protecting groups, 
we pressed on with the major challenge – the deacetylation, etherification sequence 
that had so troubled us previously. 
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Scheme	  2.22.	  Synthesis	  of	  diol	  2.49	  through	  deacetylation	  of	  diacetate	  2.48.	  	  
(a)	  KOH,	  MeOH/THF,	  1	  h,	  25	  °C,	  85%.	  
 
With TBS ethers switched for benzenesulfonates, this step became a considerably 
simpler proposition. Some difficulties were encountered dissolving the starting 
material in a solvent appropriate for deacetylation – with a starting material bearing 
four benzene rings, solubility issues are predictable. The solution was relatively 
simple, if a little unorthodox: dissolving diacetate 2.48 in the THF component of the 
solvent mixture, then adding methanol. This was not observed to cause the starting 
material to precipitate out of solution. When potassium hydroxide was then added the 
reaction was observed to proceed as would be expected. 
 
Pleasantly, the product of this reaction was vastly more stable to purification than the 
corresponding TBS ether 2.40. When phosphate-buffered silica was used, no 
appreciable quantities of material were lost on purification. While we expected the 
sulfonate protecting group to have some effect on the stability of the system, we were 
thrilled to see an effect so pronounced. 
 
From a 1:1 mixture of diastereomers of diacetate 2.48, a 1:1 mixture of diastereomers 
of diol 2.49 was obtained. 
 
With the diol acquired we proceeded with the dehydrative etherification to form 
tetrahydrofuran 2.50. Selected conditions from the optimisation of this reaction are 
presented below in table 2.2: 
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Entry Acid Conc. (wrt. 
acid) (mol/L) 
Temp.     
(° C) 
Yield 
(%) 
d.r.               
(2.50a : 
2.50b) 
1 (±)-10-
camphorsulfonic 
acid 
0.019 (1.2 eq.) 60 67 69:31 
2 Toluenesulfonic 
acid 
0.019 (1.2 eq) 60 70 58:42 
3 Trifluoroacetic 
acid 
0.075 (4.8 eq.) 25 63 49:51 
Table	  2.2.	  Optimisation	  of	  the	  conversion	  of	  tetrahydrofuran	  2.49	  to	  diol	  2.50.	  
 
Preliminary experiments revealed that reaction conditions could have a profound 
impact on the diastereoselectivity observed. Three illustrative sets of reaction 
condition are shown in table 2.2. Using the conditions of entry 1, tetrahydrofurans 
2.50a and 2.50b were formed in a 69:31 ratio.H In entry 2, selectivity fell to 58:42. In 
entry 3, diastereoselectivity was negligible. 
 
Drawing upon these insights an optimised protocol was developed, presented below 
in scheme 2.23: 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
H The identities of each diastereomer were not known at this time. 
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Scheme	  2.23.	  Optimised	  conditions	  for	  the	  synthesis	  of	  tetrahydrofuran	  2.50.	  
(a)	  CSA,	  CHCl3,	  61	  °C,	  2.5	  h,	  67%.	  
 
Earlier iterations of the protocol suffered from excessive reaction times, with the 
reaction in entry 1 of table 2.2 taking 3 days to complete. Ultimately, conditions were 
developed in which the reaction was performed at 0.3 M concentration, with 1.0 
equivalents of camphorsulfonic acid. Under such conditions, the reaction proceeded 
to completion in only 2.5 hours, with no loss of diastereoselectivity.I 
 
In spite of how cleanly reactions were noted to proceed, reaction yields were always 
quite low. Some scaling issues were also noticed, in which smaller-scale reactions 
typically resulted in higher yields of product after chromatography. Quantitative 
NMR experiments revealed that substantial amounts (ca. 20%) of tetrahydrofuran 
2.50 were lost during chromatography, something not totally unexpected given 
previous experience with its TBS-protected homologue. This explains why larger-
scale columns would typically yield less of the desired product, as they typically take 
longer to complete. 
 
It is interesting how profoundly this transformation is influenced by the identity of 
the phenolic protecting group. As was noted earlier, the dehydrative etherification of 
TBS-protected diol 2.40 was noted to proceed almost instantaneously at room 
temperature, even at low concentration. In contrast, the conditions required for 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
I In the published version of this work, crude diol 2.49 was converted to 
tetrahydrofuran 2.50, in a protocol developed and performed by Emily Mackay. 
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dehydrative etherification of benzenesulfonyl-protected homologue 2.49 were 
considerably more forcing. 
 
Tetrahydrofurans 2.50a and 2.50b were inseparable by column chromatography, 
however they could be isolated as pure compounds using preparative HPLC. It was 
our wish to assign either diastereomer as chiral or achiral using chiral HPLC. 
Unfortunately, the material was not soluble in any of the solvents that are compatible 
with the school’s collection of chiral HPLC columns. Stereochemistry of the 
monomers was ultimately assigned through the outcome of dimerisation experiments, 
as will be detailed in section 2.7. 
 
With protected forms of the ramonanin monomers in hand, we set about unmasking 
them to access the ramonanin monomers themselves. This transformation is 
illustrated in scheme 2.24: 
 
 
Scheme	  2.24.	  Deprotection	  of	  disulfonate	  2.50,	  forming	  ramonanin	  monomer	  2.2.	  
(a)	  NaOH,	  MeOH/THF,	  30	  min,	  65	  °C,	  86%.	  
 
It was with some trepidation that we embarked upon this transformation. As 
convenient as the benzenesulfonate protecting groups had made the earlier stages of 
the synthesis, their removal seemed far more formidable a task than the cleavage of 
phenolic TBS ethers. Not only this, but we anticipated substantial challenges 
purifying the products of this reaction if the transformation did not proceed cleanly.  
 
Fortunately, our concerns were revealed to be ill-founded. The poor solubility of 
disulfonate 2.50 in solvents appropriate for sulfonate hydrolysis created some trouble, 
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however once overcome, the reaction proceeded cleanly in high yield. With an 
appropriate workup, the monomer could be isolated as a pure compound, without the 
need for column chromatography. 
 
No change in the diastereomeric ratio of starting materials was noticed over the 
course of this reaction, with a 2:1 diastereomeric mixture of disulfonate 2.50 giving a 
2:1 diastereomeric mixture of diphenol 2.2. Additionally, when diastereomerically-
pure samples of 2.50a or 2.50b were deprotected according to these conditions, pure 
samples of 2.2a or 2.2b were formed. Accessing diastereomerically-pure samples was 
necessary for the dimerisation studies detailed in section 2.7 
 
With pure samples of both achiral monomer 2.2a, and the chiral monomer 2.2b in 
hand, the stage was finally set for the key Diels-Alder dimerisation. 
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2.7 Dimerisation of the Ramonanin Monomer 
 
A series of studies were performed on the dimerisation of both the protected 
ramonanin monomer 2.50, and the deprotected monomer 2.2. These are discussed 
below. 
 
 
2.7.1 Dimerisation of the Protected Ramonanin Monomer 
 
Having accessed large quantities of the protected ramonanin monomer, we sought to 
investigate whether it itself was disposed towards Diels-Alder dimerisation. These 
efforts are detailed in the following section. 
 
 
2.7.1.1 Dimerisation Under High Pressure Conditions 
 
Our initial approach was to investigate dimerisation under high-pressure conditions. 
Our suspicions were that the protected monomer was likely to be quite inert to 
dimerisation. Previous studies within the Sherburn group suggested at the 
effectiveness of these conditions in promoting the Diels-Alder reaction on recalcitrant 
substrates.[147-149] 
 
As such, a sample of the more abundant diastereomer of ramonanin monomer was 
subjected to high-pressure reaction conditions: 
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Scheme	  2.25.	  High	  pressure	  dimerisation	  of	  protected	  monomer	  2.50a,	  forming	  a	  mixture	  of	  
protected	  ramonanins	  2.51.	  
(a)	  CH2Cl2,	  19	  kbar,	  48	  h.	  
 
 
 
Figure	  2.15.	  
Top:	  major	  diastereomer	  of	  protected	  ramonanin	  monomer	  (2.51a),	  CDCl3,	  400	  MHz.	  
Middle:	  crude	  product	  of	  high	  pressure	  dimerisation	  reaction,	  CDCl3,	  400	  MHz.	  
Bottom:	  isolation	  spectrum	  of	  ramonanin	  A	  (2.1a),	  CDCl3,	  500	  MHz.	  
 
The outcome of this experiment was warmly received. As can be seen in figure 2.15, 
protected monomer 2.50a has seemingly undergone dimerisation to form a multitude 
of ramonanin-like products. Note not just the complexity of the products formed 
PhO2SO
O
OSO2Ph
O
H3CO
OCH3
PhO2SO
OSO2Ph
H3CO
OCH3
PhO2SO
O
OCH3
PhO2SO
OCH3
a
2.50a 2.51
(ambiguous diastereomeric ratio)
		





TOTAL SYNTHESIS OF THE RAMONANINS 89 
from a far simpler starting material, but also the similarity of the crude product 
spectrum to that recorded for natural ramonanin A. 
 
With a mixture of what we believed to be protected ramonanins in hand, we set about 
unveiling them so as to access the natural product: 
 
 
Scheme	  2.26.	  Deprotection	  of	  benzenesulfonyl-­‐protected	  ramonanins,	  giving	  ramonanins	  A,	  
B	  and	  C	  (2.1a,	  2.1b	  and	  2.1c).	  
(a)	  KOH,	  MeOH/THF,	  1	  h,	  25	  °C.	  
 
Employing conditions similar to those used for deprotecting the ramonanin 
monomer, ramonanins A, B and C were accessed in a 6.5 : 2 : 3 ratio. Not only were 
we thrilled to access the natural products, this outcome also confirmed our assignment 
of the structures of the high-pressure reaction as the Diels-Alder dimers of the 
protected monomer. Ramonanins A, B and C were isolated as pure samples by 
preparative HPLC. The spectroscopic and physical properties of the samples were in 
full agreement with those reported by Schroeder and coworkers for the natural 
samples.[119] 
 
It was on this basis that we were tentatively able to assign the more abundant 
diastereomer of protected ramonanin monomer 2.50a as the achiral diastereomer. 
While we could not completely rule out the possibility of the protected monomer 
epimerising under high-pressure conditions, it was something we felt would be highly 
unlikely. 
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An alternative means of accessing the ramonanins was attempted where pure 
protected ramonanins would be isolated by HPLC, then deprotected individually to 
give ramonanins A, B and C: 
 
 
Scheme	  2.27.	  Synthesis	  and	  deprotection	  of	  benzenesulfonyl-­‐protected	  ramonanin	  A.	  
(a)	  CH2Cl2,	  19	  kbar,	  48	  h;	  (b)	  KOH,	  MeOH/THF,	  1	  h,	  25	  °C,	  48%.	  
 
Despite considerable effort, only a pure sample of dimer 2.51a could be isolated by 
these means. Ramonanin A was formed when dimer 2.51a was deprotected, allowing 
the assignment of dimer 2.51a as protected ramonanin A. 
 
 
2.7.1.2 Dimerisation Under Other Conditions 
 
Other investigations concerned the use of both thermal conditions, and the radical 
cation Diels-Alder conditions employed by the group in the synthesis of the 
kingianins.  
 
 
Scheme	   2.28.	   Attempted	   thermal	   and	   radical	   cation-­‐mediated	   dimerisation	   of	  
benzenesulfonyl	  protected	  monomer	  2.50a.	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(a)	  neat,	  100	  °C,	  16	  h;	  (b)	  Ledwith-­‐Weitz	  salt,	  CH2Cl2,	  25	  °C,	  1	  h.	  
 
Thermal conditions yielded a complex mixture of products. The crude mixture bore 
some similarity to that produced under high-pressure conditions, but with a greater 
number of products formed. No reaction occurred when the protected monomer was 
treated with the Ledwith-Weitz salt. 
 
 
2.7.2 Dimerisation of the Deprotected Ramonanin Monomer 
 
2.7.2.1 Preliminary Results 
 
To our great pleasure, this transformation proved perhaps to be the easiest of the 
synthesis. Ramonanin monomer once deprotected was observed to dimerise 
spontaneously at room temperature when stored as a neat gum:J 
 
 
Scheme	  2.29.	  Spontaneous	  dimerisation	  of	  the	  ramonanin	  monomer	  2.2.	  
(a)	  neat,	  25	  °C.	  
 
With this result, not only had we accessed our natural products by an alternative 
route, but we had done so under ambient, biomimetic conditions. A half-life 
experiment revealed that both the chiral and achiral diastereomers of the monomer 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
J The first batch of ramonanin monomer produced was left neat under vacuum for 15 
minutes and found to be contaminated with a mixture of ramonanins. The ramonanin 
monomer and the ramonanins were observed by NMR for the first time concurrently. 
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had a half-life of approximately 2 days at 25 °C, when dissolved in a minimal amount 
of solvent (14.6 M concentration). 
 
We were initially skeptical that this reaction could take place without catalysis at 
ambient temperature.  As discussed in section 2.2.2, the spontaneous dimerisation of 
an unactivated exocyclic diene on a five-membered ring at ambient temperature is 
without literature precedent (what limited precedent exists is for such reactions only 
occurring at greatly elevated temperatures). Our immediate suspicion was that the 
dimerisation was in fact acid catalysed, catalysed either by trace quantities of acid in 
the crude product after workup, or by the acidic phenol functionalities of the 
monomer.  
 
If dimerisation was occurring through an acid-catalysed process of the form we 
anticipated, epimerisation of the monomer should be observed as well, due to a 
competing intramolecular cyclisation pathway. This is illustrated below in figure 2.16: 
 
 
Figure	  2.16.	  Proposed	  acid-­‐catalysed	  dimerisation/epimerisation	  mechanism.	  
 
Accordingly, it was our proposition that if diastereomerically pure samples of 
monomer (such as 2.2a) could be observed to epimerise in the presence of acid, this 
would be potential evidence for the presence of an acid-catalysed dimerisation 
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pathway. If diastereomerically pure samples of monomer were not observed to 
epimerise under acidic conditions, this would be proof against the existence of an 
acid-catalysed dimerisation pathway, at least by the mechanism we considered 
feasible. 
 
To test this hypothesis, we performed the following two experiments: 
 
 
Scheme	   2.30.	   Tests	   to	   determine	   the	   propensity	   of	   achiral	   monomer	   to	   undergo	   acid-­‐
mediated	  epimerisation.	  
(a)	  AcOH,	  50	  °C,	  16	  h;	  (b)	  CDCl3,	  25	  °C,	  7	  days.	  
 
Under the first set of conditions, a pure sample of achiral ramonanin monomer 2.2a 
was dissolved in acetic acid and heated to 50 °C for 16 hours. The resulting mixture 
was observed to contain a mixture of unreacted achiral monomer and dimeric 
products, with no quantity of chiral monomer observable. Under the second set of 
conditions, a pure sample of achiral monomer was allowed to stand at room 
temperature in dilute solution for 1 week. The sample was not observed to have 
epimerised to any extent over this period. On this basis, the acid-catalysed 
dimerisation pathway was deemed an unlikely possibility. 
 
We also sought to explore whether the dimerisation of the deprotected monomer 
could be catalysed under radical cation Diels-Alder conditions. While we already 
knew that the dimerisation would occur thermally, we were still curious if radical 
cation catalysis could lead to formation of the product, potentially with varied 
selectivities: 
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Scheme	  2.31.	  Attempted	  radical	  cation-­‐mediated	  dimerisation	  of	  2.2.	  
(a)	  Ledwith-­‐Weitz	  salt,	  CH2Cl2,	  25	  °C,	  5	  min.	  
  
Treatment of a diastereomeric mixture of the ramonanin monomer with the Ledwith-
Weitz salt caused near-instantaneous decomposition of the starting material. No 
products bearing a resemblance to the ramonanins were observed amongst this 
mixture. While we could have persisted further, we suspected that oxidation of the 
diene was unlikely to be possible in the presence of the easily-oxidised phenolic 
functionalities. 
 
 
2.7.2.2 Synthesis of Ramonanins A, B and C 
 
On the basis of these preliminary results, we set about developing a practical synthesis 
of the ramonanins through the thermal dimerisation of ramonanin monomer. As 
mentioned, the monomer was observed to have a half-life of approximately two days 
at 25 °C at 14.6 M concentration. This was too slow for a practical synthesis. 
Accordingly we developed the following conditions, illustrated below in scheme 2.32: 
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Scheme	  2.32.	  Optimised	  thermal	  dimerisation	  of	  2.2a.	  
(a)	  DMF,	  50	  °C,	  30	  h,	  45%	  (+	  24%	  RSM).	  
 
Under optimised conditions, achiral monomer 2.2a was heated in minimal solvent at 
50 °C for 30 hours, resulting in the formation of ramonanins A, B and C in a 6:1:4 
ratio in 45% yield. Unfortunately attempts to bring this reaction to completion were 
unsuccessful, with longer reaction times or elevated temperatures resulting in 
quantities of decomposition product, which greatly complicated purification. As such, 
24% of the starting material was recovered from the experiment as it was typically 
performed. Despite the low yield of the reaction, purification was remarkably simple, 
with the bulk of side-products formed being insoluble in common solvents.  
 
 
Figure	  2.17.	  HPLC	  chromatograph	  of	   the	  crude	  product	   from	  the	  dimerisation	  of	  2.2a,	  210	  
nm	  wavelength.	  
 
As can be seen in the analytical chromatograph in figure 2.17, ramonanins A, B and 
C were formed with impressive selectivity. Note that the major observed side products 
i and ii (at 12.5 and 16.5 minutes) do not appear to be dimeric in character, instead 
appearing to be rearrangement products of the monomer – products were of 
comparable weight to the monomer when analysed using EIMS, but were missing the 
characteristic methylene environments of the starting material. 
 
Through this route, reasonable quantities of ramonanins A, B and C could be 
accessed without the need for high-pressure conditions. It’s on the basis of this result 
that the work can properly be called a biomimetic synthesis of ramonanins A, B and 
C. 
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2.7.2.3 Synthesis	  of	  Ramonanin	  D	  
 
With ramonanins A, B and C in hand, we set about targeting the final member of the 
family: ramonanin D. As covered earlier in section 2.2, ramonanin D is distinctive in 
that it appears as the Diels-Alder adduct from the heterodimerisation of one 
equivalent of the chiral monomer and one equivalent of achiral monomer: 
 
 
Figure	  2.18.	  Disconnection	  of	  ramonanin	  D	  to	  monomeric	  units	  2.2a	  and	  2.2b.	  
 
We set about accessing ramonanin D through the Diels-Alder heterodimerisation of 
the chiral and achiral monomer. To begin with conditions were screened in which 
2:1, 1:1 and 1:2 mixtures of the chiral and achiral monomer were dimerised under the 
optimised conditions under which ramonanins A, B and C were accessed, as 
described in section 2.7.2.2 above. Due to the complexity of the resulting 1H NMR 
spectra, the products of these test reactions were analysed by HPLC. HPLC 
chromatograms of these experiments are shown below in figure 2.19: 
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Figure	  2.19.	  
Top:	   HPLC	   chromatograph	   of	   the	   crude	   product	   from	   dimerisation	   of	   a	   1:2	   mixture	   of	  
2.2a/2.2b,	  210	  nm	  wavelength.	  
Middle:	   HPLC	   chromatograph	   of	   the	   crude	   product	   from	   dimerisation	   of	   a	   1:1	  mixture	   of	  
2.2a/2.2b,	  210	  nm	  wavelength.	  
Bottom:	  HPLC	   chromatograph	  of	   the	   crude	   product	   from	  dimerisation	   of	   a	   2:1	  mixture	   of	  
2.2a/2.2b,	  210	  nm	  wavelength.	  
 
As can be seen, the chromatograms are very complex, with a large number of products 
being formed in the course of the reaction. There is also a minimal difference between 
chromatographs, with only some differences in the ratios of products formed. The 
limited conclusions that could be drawn using NMR techniques supported this 
conclusion. 
 
Ultimately, the decision was made to attempt formation of ramonanin D using a 2:1 
mixture of achiral:chiral monomer. With minimal differences observed from variation 
of the ratios of chiral and achiral monomer, we opted to simply dimerise the mixture 
of monomers generated in the course of our synthesis. Accordingly, the following 
reaction was performed: 
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Scheme	  2.33.	  Heterodimerisation	  of	  2.2a	  and	  2.2b.	  
(a)	  DMF,	  50	  °C,	  30	  h.	  
 
After two HPLC separations, a product was isolated from this mixture which bore a 
strong resemblance to ramonanin D by 1H NMR, as illustrated below in figure 2.20: 
 
 
 
Figure	  2.20:	  
Top:	  isolation	  spectrum	  of	  ramonanin	  D	  (C6D6,	  600	  MHz	  1H	  NMR).	  
Bottom:	  putative	  synthetic	  ramonanin	  D	  (C6D6,	  300	  MHz	  1H	  NMR).	  
 
Unfortunately, this product was isolated in sub-milligram quantities, giving 
insufficient material from which to acquire a 13C NMR spectrum or an HMBC 
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spectrum.K Based on this result it appears extremely unlikely that if nature generates 
ramonanin D through the direct dimerisation of 2.2a and 2.2b the process occurs in 
the absence of an enzyme. 
 
This noted, there is another possibility for how ramonanin D might form 
biosynthetically: 
 
 
Figure	  2.21.	  Stereochemical	  relationship	  between	  ramonanin	  D	  and	  ramonanins	  A	  and	  C.	  
 
Ramonanin D is stereochemically most similar to ramonanins A and C, differing by 
only one stereogenic centre. Is it possible that ramonanin D forms biosynthetically 
through the epimerisation of one of these centres? If so, is it possible to mimic this 
process in the laboratory? 
 
Our limited investigations into this area suggest that such a transformation is likely to 
prove challenging. Certainly, neither ramonanins A or C (or B) have been observed to 
epimerise spontaneously, with solutions of each product allowed to stand for 
prolonged periods at room temperature without showing any signs of decomposition. 
It is possible that such an epimerisation might be acid catalysed, driven by a similar 
mechanism to that earlier proposed for an acid-catalysed dimerisation of the 
monomer. However, no visible quantities of ramonanin D were observed to have 
formed under these conditions, even when appreciable quantities of ramonanins A 
and C were present. Nevertheless, epimerisation of ramonanins A or C cannot fully 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
K Emily Mackay later generated adequate quantities of this product for full 
characterisation and assignment of this product as ramonanin D, through repetition 
of this protocol. 
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be ruled out as a means by which ramonanin D could potentially be accessed, either 
through synthesis or by nature. 
 
 
2.7.2.4 Mechanistic and Computational Investigations into the 
Dimerisation Mechanism 
 
It became obvious to us in the course of these investigations that we were observing 
some rather unique reactivity. Two things puzzled us in particular: why we were 
observing the product ratios that we were observing from the dimerisation, and what 
might the reason be for the unprecedented rate at which dimerisation was occurring? 
These are considered below. 
 
 
2.7.2.4.1 Ratios of Products Observed to Form  
 
Conceivably there are eight potential transition states by which the achiral ramonanin 
monomer may dimerise. These derive from three factors affecting selectivity: 
 
 
Figure	  2.22.	  Aspects	  of	  selectivity	  in	  the	  dimerisation	  of	  the	  achiral	  ramonanin	  monomer	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As can be seen in figure 2.22, the three factors determining selectivity in the Diels-
Alder reaction are endo versus exo selectivity in the Diels-Alder reaction, and the syn 
versus anti positioning of substituents on both diene and dienophile. Two possibilities 
for each give rise to eight potential transition states. 
 
However, these eight potential transition states only give rise to four potential dimers. 
This is because each of these four dimers can form through two different transition 
states, one endo and one exo for each.L Each transition state can give rise to either 
enantiomer of product, as the monomer is achiral. This is illustrated below in figure 
2.23: 
 
 
Figure	  2.23.	  Transition	  states	  leading	  to	  ramonanins	  A,	  B,	  C	  (2.1a,	  2.1b	  and	  2.1c)	  and	  the	  
unobserved	  dimer	  2.1e.	  
 
Conceivably, by calculating the energies of these potential transition states, one could 
obtain an explanation for the ratios of products observed to form experimentally. To 
this end a series of computational experiments were performed by Professor Paddon-	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
L The reader might like to make a model of the monomer to aid their understanding 
of this point. 
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Row, at the B3LYP level of theory. The outcomes of these calculations are 
summarised below in table 2.3: 
 
       
Table	   2.3.	   Calculated	   distribution	   of	   products	   from	   the	   dimerisation	   of	   achiral	   ramonanin	  
monomer	  2.2a.	  
 
As can be seen, experimental and computational results are in extremely good 
agreement. Interestingly, while ramonanins A and B were both calculated to form 
through a single transition state, for ramonanin C two transition states of comparable 
energy were calculated. 
 
Note that the computational investigation predicts that a fourth dimer should form 
under these conditions. While we did not observe this structure experimentally, it’s 
entirely possible that it did form, just in insufficient abundance for us to detect.  
 
All transition states were calculated to proceed through a bis-pericyclic transition 
state. Interestingly, all transition states were calculated to be highly asynchronous, 
with the shorter of the newly formed bonds calculated as being between 1.72 and 1.97 
 Mode Predicted 
Ratio (%) 
Total 
Predicted 
Ratio (%) 
Experimentally-
Observed Ratio 
(%) 
ramonanin A 
endo-anti-anti 58.6 
59 54 
exo-syn-anti 0.1 
ramonanin B 
endo-anti-syn 3.7 
4 9 
exo-syn-syn 0 
ramonanin C 
endo-syn-anti 17.4 
35 37 
exo-anti-anti 17.8 
unobserved 
dimer 
endo-syn-syn 0.1 
2 - 
exo-anti-syn 2.3 
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Å in length, and the longer calculated as between 3.04 and 3.69 Å. A visual 
representation of the endo-anti-anti and endo-syn-syn transition states is provided 
below in figure 2.24: 
 
 
Figure	  2.24.	  Transition	  state	  models	  for	  the	  endo-­‐anti-­‐anti	  and	  endo-­‐syn-­‐syn	  transition	  
states.	  
 
 
2.7.2.4.2 Rate	  of	  Dimerisation	  
 
Prevailing theory is that the rate at which Diels-Alder reactions occur is to a large 
extent determined by the distance between the C1-C4 termini of the diene. This was 
frequently provided as an explanation for the rapid dimerisation of cyclopentadiene, 
amongst other dimerising diene systems.[150] The distance between C1 and C4 of 
simulacrum 2.52 is calculated as being considerably greater than that between C1 and 
C4 of cyclopentadiene (3.139 Å versus 2.363 Å). So if this hypothesis holds, why 
would the ramonanin monomer spontaneously dimerise in such a similar manner? 
 
In an attempt to answer these questions, Professor Paddon-Row calculated the M06-
2X activation enthalpies and free energies for a range of relevant systems. This work is 
summarised below in table 2.4: 
Nss TSNaa TS
1.87 Å
3.40 Å
1.72 Å
3.69 Å
dienophile
diene
dienophile
diene
phenyl truncated
for clarity
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Entry Reactant Δ∆H‡ (kJ mol-1) Δ∆G‡ (kJ mol-1) 
1  60.7 121.7 
2  64.2 125.0 
3  59.8 122.2 
4 
 
58.0 132.2 
Table	  2.4.	  ΔH‡	  and	  ΔG‡	  values	  (kJ/mol,	  25	  °C)	  for	  DA	  dimerization	  of	  various	  dienes.	  	  
M06-­‐2X/6-­‐31G(d)-­‐[PCM=THf]//M06-­‐2X/6-­‐31G(d)	  activation	  energies	  from	  the	  lowest	  energy	  
(endo)	  path.	  
 
Interestingly the activation enthalpies of all systems were calculated to be roughly 
equivalent. This is in spite of the differences in the distance between the termini of 
the dienes in system 1 versus systems 2-4, the presence or absence of the oxygen atom 
in system 3 versus system 2, or the presence or absence of the phenyl rings in system 4 
versus system 3. However, there is an appreciable difference in the free energy for the 
dimerisation of simulacrum 2.52 versus that in the other systems. This 10 kJ mol-1 
difference translates to an approximately 50-fold decrease in the rate of dimerisation. 
This effect can most likely be ascribed to effects caused by the rotation of the phenyl 
rings on system 4 that are absent from systems 1-3. 
 
These computational results, plus those of the preceding section, give additional 
support for the ramonanin monomer dimerising spontaneously in the absence of any 
sort of catalyst. They also give evidence for the dimerisation occurring as a concerted 
cycloaddition event, in both the synthesis and biosynthesis of the ramonanin natural 
products. 
 
 
O
O
Ph
Ph
2.52
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2.8 Conclusion 
 
This chapter has detailed our total synthesis of the ramonanin family of natural 
products. The ramonanins are a structurally-unique family of natural products, 
bearing a distinctive and unprecedented spirocyclic core. Both ourselves and 
Schroeder and coworkers propose a biosynthesis in which the ramonanins form 
through the dimerisation of a lignan monomer, which is itself formed from the 
dimerisation of two phenylpropanoid precursors.  
 
 
Figure	  2.25.	  Summary	  of	  our	  proposed	  biosynthesis	  of	  ramonanins	  A-­‐D.	  
 
We were able to access the proposed monomer in just eight steps, through the 
implementation of a bidirectional synthetic strategy. This sequence featured an enyne 
metathesis transformation as its central step. 
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Scheme	  2.34.	  Synthesis	  of	  the	  ramonanin	  monomer.	  
(a)	  PhSO2Cl,	  Et3N,	  CH2Cl2,	  25	  °C,	  18	  h,	  90%;	  (b)	  EtMgBr,	  THF,	  0	  °C	  to	  25	  °C,	  0.25	  h;	  then	  2.42	  in	  
THF,	   0	   °C	  	   25	   °C,	   2	   h,	   66%;	   (c)	   Pyridine,	   Ac2O,	   CH2Cl2,	   0	   °C	  	   25	   °C,	   1.5	   h,	   quant.;	   (d)	  
Hoveyda-­‐Grubbs	  II,	  ethylene,	  toluene,	  110	  °C,	  2h,	  74%;	  (e)	  KOH,	  MeOH/THF,	  1	  h,	  25	  °C,	  85%;	  
(f)	  CSA,	  CHCl3,	  2.5	  h,	  51%;	  (g)	  NaOH,	  MeOH/THF,	  30	  min,	  65	  °C,	  86%.	  
 
Dimerisations could be performed on both the protected monomer and the 
deprotected monomer. While dimerisation of the protected monomer only occurred 
selectively under high-pressure conditions, the deprotected monomer was observed to 
dimerise spontaneously at room temperature, with pure samples of the achiral 
monomer dimerising to form ramonanins A, B and C with impressive selectivity. 
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Scheme	  2.35.	  Dimerisation	  of	  2.2a.	  
(a)	  DMF,	  50	  °C,	  30	  h,	  45%	  (+	  24%	  RSM).	  
 
A computational investigation into these results suggest that this reaction occurs 
through a bis-pericyclic Diels-Alder mechanism, reactivity which to date appears 
relatively underutilised in natural product synthesis. Given the potential for this 
dimerisation to occur during the isolation process, it remains unclear whether the 
ramonanins form in nature, or are products of isolation. 
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CHAPTER 3 
 
EXPERIMENTAL  
FOR  
PART 1 
 
3.1 General Experimental Procedures 
 
NMR spectroscopy 
Proton (1H) and carbon (13C) NMR spectra were recorded on Varian Gemini, Varian 
XL, Varian MR, Bruker Ascend and Bruker Avance machines operating at 300 and 
75 MHz, 400 and 100 MHz, 500 and 125 MHz, 600 and 151 MHz and 800 and 200 
MHz. Unless otherwise specified, spectra were acquired at 25 °C in deuterated 
chloroform (CDCl3) that had been stored over anhydrous potassium carbonate and 
4Å molecular sieves. Chemical shifts are recorded as δ values in parts per million 
(ppm). Residual solvent peaks were used as an internal reference for 1H NMR spectra 
(CDCl3 δ 7.26, MeOD δ 3.31) and 13C NMR spectra (CDCl3 δ 77.16 ppm, MeOD 
δ 49.00 ppm). Coupling constants (J) are quoted to the nearest 0.1 Hz. All NMR 
spectra presented within were processed using MestReNova v8.1.2. 
 
Infrared spectroscopy 
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Infrared spectra (νmax) were recorded on a Perkin-Elmer 1800 Series FTIR 
Spectrometer and samples were analysed as thin films on NaCl plates (for liquids) or 
as a KBr disk (for solids).  
 
Mass spectrometry 
Low and high resolution ESI mass spectra were recorded in positive-ion mode on a 
MicroMass-Waters LC-ZMD single quadrupole liquid chromatograph mass 
spectrometer while low and high resolution EI mass spectra were recorded on a 
MicroMass-Waters AUTOSPEC-Premier instrument.  
 
Melting point analysis 
Melting points were measured on a Stanford Research Systems Optimelt-Automated 
Melting Point System and are uncorrected.  
 
Analytical thin layer chromatography 
Analytical thin layer chromatography (TLC) was performed on aluminium-backed 
0.2 mm thick silica gel 60 F254 plates as supplied by Merck. Eluted plates were 
visualized using a 254 nm UV lamp and/or by treatment with a dip containing 
phosphomolybdic acid : ceric sulfate : sulfuric acid (conc.) : water (37.5 g : 7.5 g : 37.5 
g : 720 mL) followed by heating. The retardation factor (Rf) values cited here have 
been rounded to the first decimal point.  
 
Flash chromatography 
Flash chromatographic separations were carried out following protocols defined by 
Still and coworkers.[151] with silica gel 60 (40-63 µm) as the stationary phase and using 
the AR-grade solvents indicated. When specified silica was buffered prior to use (200 
g silica : 1 L 0.2 M aqueous disodium hydrogen phosphate, pH adjusted to 7 with 
phosphoric acid, filtered and oven dried before use).  
 
High Performance Liquid Chromatography 
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Analytical HPLC was performed using an Agilent 1100 quaternary pump, automatic 
liquid sampler, column compartment and diode array detector. Preparative HPLC 
was conducted using an Agilent 1100 preparative binary pump system, preparative 
automatic liquid sampler, and diode array detector with a preparative flow cell. Chiral 
analytical HPLC was performed using an Agilent 1200 quaternary pump, automatic 
liquid sampler, column compartment, diode array detector and a laser polarimeter. 
 
Experimental procedures, reagents and solvents 
Starting materials and reagents were generally available from the Sigma-Aldrich, 
Merck, AK Scientific, Anvia or BOC Chemical Companies and were either used as 
supplied or, in the case of liquids, distilled when specified. Drying agents and other 
inorganic salts were purchased from the BDH or Unilab Chemical Companies. THF, 
CH2Cl2, toluene and MeOH were dried using a Glass Contour solvent purification 
system that is based upon a technology originally described by Grubbs and 
coworkers.[152] Toluene was dried further by storage over 3Å molecular sieves in line 
with the protocol of Williams and coworkers.[153] Chloroform was purchased as an 
analytical grade solvent with 0.6% to 1.0% ethanol as stabiliser, and was purified by 
washing with 5 portions of water then drying over MgSO4, then storing over 3Å 
molecular sieves for 48 h before use. Spectroscopic grade solvents were used for all 
analyses. Reactions were performed under a nitrogen atmosphere as necessary.  
 
High-pressure reactions 
High pressure reactions were performed using a Psika high pressure reactor. 
 
Reaction yield and scale 
The yields reported in the communication are shown as a range of isolated yields 
obtained on various scales, we herein provide experimental details for the largest scale 
procedures conducted.  
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3.2 First-Generation Approach to the Ramonanin 
Monomer 
 
4-((tert-butyldimethylsilyl)oxy)-3-methoxybenzaldehyde (2.30) 
 
 
 
This protocol was adapted from that reported by Snapper and coworkers.[141]  
 
Imidazole (14.8 g, 217 mmol) was added to a solution of vanillin (30.0 g, 197 mmol) 
in THF (100 mL). The solution was cooled to 0 °C and a solution of TBS chloride 
(23.7 g, 217 mmol) in THF (100 mL) was added dropwise over 5 min. The solution 
was warmed to room temperature and allowed to stir for 1 h, upon which the reaction 
was cooled to 0 °C and diluted with EtOAc (100 mL) and water (100 mL) and left to 
stir for 15 min. The organic layer was collected and the aqueous layer extracted with 
EtOAc (2 × 100 mL). Organic layers were combined, washed with brine (1 × 100 
mL), dried over MgSO4 and concentrated under reduced pressure to give the crude 
product as a brown oil. This was subjected to flash chromatography (silica, 15:85 
EtOAc/hexane) to give the title aldehyde 2.3 (38.0 g, 142 mmol, 72% yield) as a clear 
oil. Spectroscopic data and physical data were in accordance with reported values.[154] 
 
1H NMR (300 MHz, CDCl3) δ 9.85 (s, 1H), 7.38 (m, 2H), 6.95 (d, J = 7.8 Hz, 1H), 
3.85 (s, 3H), 0.99 (s, 9H), 0.18 (s, 6H).  
 
 
 
1,4-bis(4-((tert-butyldimethylsilyl)oxy)-3-methoxyphenyl)but-2-yne-1,4-diol 
(2.35) 
OTBS
O
OCH3
OH
O
OCH3
H H
TBSCl,
imidazole
THF
1 h, 25 °C
72%
2.27 2.30
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BuLi (163 mL, 1.31 M hexane solution, 214 mmol) was diluted with THF (26.3 mL) 
and cooled to −78 °C. To this was added a solution of trichloroethylene (6.42 mL, 
71.4 mmol) in THF (11.3 mL) dropwise over 15 min, and the resulting solution was 
warmed to room temperature and stirred for 3 h. This solution was then cooled to 
−78 °C and a solution of aldehyde 2.30 (38.0 g, 148 mmol) in THF (37.5 mL) was 
added dropwise over 15 min. The reaction warmed to room temperature and stirred 
overnight, then cooled to 0 °C and quenched with NH4Cl (100 mL, saturated 
aqueous solution) and diluted with EtOAc (100 mL). The organic layer was collected 
and the aqueous layer extracted with ethyl acetate (2 × 100 mL). Organic layers were 
then combined and washed with brine (1 × 100 mL), dried over MgSO4, then 
concentrated under reduced pressure to give the crude product as a dark brown oil. 
This was subjected to flash chromatography (silica, 40:60 EtOAc/hexane) to give the 
title alkyne 2.35 as a 1:1 mixture of diastereomers (13.7 g, 24.3 mmol, 34% yield) as a 
clear yellow oil.  
 
Rf = 0.3 (40:60 EtOAc/hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 7.00 (m, 8H), 6.82 (m, 4H), 5.50 (s, 2H), 5.48 (s, 
2H), 3.78 (s, 6H), 3.77 (s, 6H), 2.20 (s, 4H), 0.99 (s, 36H), 0.14 (s, 24H);  
 
13C NMR (100 MHz, CDCl3) δ 151.2, 145.5, 144.8, 134.6, 133.7, 120.9 (two peaks), 
119.7, 119.3, 111.3, 110.8, 83.8, 74.7, 65.5, 64.5, 55.6 (two peaks), 25.9, 18.6, -4.5 
(two peaks);  
 
OTBS
O
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H
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BuLi
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HO
OTBS
2.30
2.35
(d.r. 1:1)
OCH3
OCH3
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νmax (NaCl) 3497, 2957, 2928, 2884, 2856, 1605, 1512, 1292 cm-1;  
 
MS (ESI+, 70 eV) m/z 582 (25%), 581 (M+•+23Na, 60), 542 (100), 303 (55); 
 
HRMS (ESI+, 70 eV) found 581.2731 (C30H46O6Si223Na requires M+ 581.2731).  
 
 
 
1,4-bis(4-((tert-butyldimethylsilyl)oxy)-3-methoxyphenyl)but-2-yne-1,4-diyl 
diacetate (2.36) 
 
Procedure starting from diol 2.35: 
 
 
 
Pyridine (39.4 mL, 489 mmol) was added to a solution of diol 2.35 (13.6 g, 24.4 
mmol) in CH2Cl2 (135 mL). The solution was cooled to 0 °C and treated with Ac2O 
(18.5 mL, 196 mmol) dropwise over 15 min, then stirred at 25 °C for 18 h . The 
reaction was diluted with MeOH (50 mL) and stirred at 25 °C for 15 min, after 
which the organic layer was separated and the aqueous layer extracted with CH2Cl2 (2 
× 100 mL). Organic layers were combined and washed with brine (1 × 100 mL), dried 
over MgSO4 and concentrated under reduced pressure to give the crude product as a 
brown oil. This was subjected to flash chromatography (silica, 15:85 EtOAc/hexane) 
to give the title diacetate 2.36 as a 1:1 mixture of diastereomers (14.1 g, 21.7 mmol, 
89% yield) as an amorphous yellow solid. 
 
HO
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Procedure starting from aldehyde 2.30: 
 
 
 
n-BuLi (11.7 mL, 1.44 M hexane solution, 16.8 mmol) was diluted in THF (2.0 mL) 
and cooled to −78 °C. To this was added a solution of trichloroethylene (0.50 mL, 5.6 
mmol) in THF (1.0 mL) dropwise over 15 min, and the resulting solution was stirred 
at 25 °C for 3 h. This solution was cooled to −78 °C, and treated with a solution of 
aldehyde 2.30 (3.00 g, 11.3 mmol) in THF (3.0 mL) dropwise over 15 min. The 
reaction warmed to room temperature and stirred for 18 h. The reaction was then 
cooled to −78 °C and Ac2O (4.26 mL, 45.1 mmol) was added dropwise over 5 min. 
The reaction was warmed to 25 °C and stirred for 1.5 h, then cooled to 0 °C and 
quenched with NH4Cl (10 mL, saturated aqueous solution) and diluted with EtOAc 
(10 mL). The organic layer was separated and the aqueous layer extracted with ethyl 
acetate (2 × 10 mL). Organic layers were then combined and washed with brine (1 × 
10 mL), dried over MgSO4, then concentrated under reduced pressure to give the 
crude product as a dark brown oil. This was subjected to flash chromatography (silica, 
10:90 EtOAc/hexane) to give the title diacetate 2.36 as a 1:1 mixture of diastereomers 
(1.40 g, 2.18 mmol, 37% yield) as an amorphous yellow solid. 
 
Rf = 0.3 (15:85 EtOAc/hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 7.02 (m, 4H), 6.98 (m, 4H), 6.81 (m, 4H), 6.50 (s, 
2H) 6.48 (s, 2H), 3.79 (s, 6H), 3.77 (s, 6H), 2.09 (s, 6H) (two peaks), 0.99 (s, 36H), 
0.15 (s, 24H);  
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H
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(d.r. 1:1)
OCH3
OCH3
EXPERIMENTAL FOR PART 1 116 
13C NMR (100 MHz, CDCl3) δ 169.9, 151.1, 146.0 (two peaks), 130.0 (two peaks), 
120.9, 120.8 (two peaks), 112.1, 112.0, 83.9 (two peaks), 65.6 (two peaks), 55.6 (two 
peaks), 25.8, 21.3, 18.6, -4.4;  
 
νmax (NaCl) 2955, 2931, 2886, 2857, 1744, 1515, 1226 cm-1;  
 
MS (ESI+, 70 eV) m/z 707 (3%), 682 (11), 668 (20), 667 (50), 666 (M+•, 100), 606 
(19), 585 (23), 584 (56), 543 (20), 542 (46) 524 (7). 
 
HRMS (ESI+, 70 eV) found 665.2943 (C34H50O8Si223Na requires M+ 665.2942).  
 
 
 
1,4-bis(4-((tert-butyldimethylsilyl)oxy)-3-methoxyphenyl)-2,3-
dimethylenebutane-1,4-diyl diacetate (2.39) 
 
 
 
Alkyne 2.36 (1.00 g, 1.56 mmol) as a 1:1 mixture of diastereomers and Hoveyda-
Grubbs 2nd generation catalyst (0.396 g, 156 µmol) were dissolved in toluene (65 mL). 
The solution was degassed (freeze-pump-thaw, 5 × 5 min pump cycles) then placed 
under an ethylene atmosphere and heated to 80 °C for 16 h. The flask was cooled to 
25 °C then opened and left to stir under air for 5 minutes, after which the contents 
were concentrated under reduced pressure to give a brown opaque oil. The crude was 
purified by flash chromatography (silica gel, 10:90 EtOAc/hexane) to give the title 
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diene 2.39 as a 3:2 mixture of diastereomers (0.679 g, 1.01 mmol, 65% yield) as a pale 
yellow amorphous solid. Partial separation of the meso and chiral diastereomers was 
achieved using flash chromatography (silica, 8:92 EtOAc/hexane), and chiral HPLC 
(normal phase, Chiralcel OD/H 150 mm × 4.6 mm column, 99.8:0.2 hexane:iPrOH, 
1 mL/min) was used to assign the more polar and more abundant diastereomer as 
chiral, and the less polar and less abundant diastereomer as achiral. 
 
 
Achiral diene 2.39a: 
 
 
 
Rf = 0.2 (10:90 EtOAc/hexane on silica);  
 
tR = 14.1 min (Chiralcel OD/H 150 mm × 4.6 mm column, 99.8:0.2 hexane:iPrOH, 
1 mL/min); 
 
1H NMR (300 MHz, CDCl3) δ 6.76 (m, 6H), 6.43 (s, 2H), 5.24 (s, 2H), 5.20 (s, 
2H), 3.76 (s, 6H), 2.07 (s, 6H), 0.98 (s, 18H), 0.14 (s, 12H);  
 
13C NMR (100 MHz, CDCl3) δ 169.9, 150.9, 145.2, 144.5, 131.5, 120.7 (two peaks), 
115.7, 112.0, 75.4, 55.6, 25.8, 21.4, 18.6, -4.5;  
 
νmax (NaCl) 2954, 2930, 2895, 2857, 1744, 1514 cm-1;  
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MS (ESI+, 70 eV) m/z 695.8 (19%), 694.8 (50), 693.7 (M+•, 100), 552.6 (16), 551.7 
(39); 
 
HRMS (ESI+, 70 eV) found 693.3244 (C36H54O8Si223Na requires M+ 693.3255).  
 
 
Chiral diene 2.39b: 
 
 
 
Rf = 0.2 (10:90 EtOAc/hexane on silica);  
 
tR = 13.8 and 15.5 min (Chiralcel OD/H 150 mm × 4.6 mm column, 99.8:0.2 
hexane:iPrOH, 1 mL/min); 
 
1H NMR (300 MHz, CDCl3) δ 6.68 (m, 6H), 6.49 (s, 2H), 5.27 (s, 2H), 5.20 (s, 
2H), 3.70 (s, 6H), 2.07 (s, 6H), 0.98 (s, 18H), 0.14 (s, 12H);  
 
13C NMR (100 MHz, CDCl3) δ 169.8, 150.8, 145.1, 143.9, 131.3, 120.6 (two peaks), 
115.0, 112.0, 75.2, 55.5, 25.8, 21.4, 18.6, -4.5;  
 
νmax (NaCl) 2955, 2931, 2896, 2858, 1744, 1514 cm-1;  
 
MS (ESI+, 70 eV) m/z 695.8 (20%), 694.8 (50), 693.7 (M+•, 100), 552.6 (14), 551.7 
(31), 102.1 (26);  
 
AcO
AcO
OTBS
H3CO
H3CO
OTBS
2.39b
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HRMS (ESI+, 70 eV) found 693.3244 (C36H54O8Si223Na requires M+ 693.3255). 
 
 
 
1,4-bis(4-((tert-butyldimethylsilyl)oxy)-3-methoxyphenyl)-2,3-
dimethylenebutane-1,4-diol (2.40) 
 
 
 
Diacetate 2.39 (50.0 mg, 74.5 µmol) as a 3:2 mixture of diastereomers was dissolved 
in a solution of methanol and THF (1 mL of a 10:1 mixture). Cs2CO3 (48.6 mg, 149 
µmol) was added and the solution was stirred for 1.25 h at 25 °C. The reaction was 
diluted with EtOAc (5 mL) and water (5 mL), the organic layer separated and the 
aqueous layer was extracted with ethyl acetate (2 × 5 mL). Organic layers were 
combined, washed with brine (5 mL), dried over MgSO4 and concentrated under 
reduced pressure to give the crude product as a dark brown oil. This was subjected to 
flash chromatography (silica, 30:70 EtOAc/hexane) to give the title diol 2.40 as a 3:2 
mixture of diastereomers (9.80 mg, 16.7 µmol, 22% yield) as a yellow oil. 
 
Pure samples of diol were produced by subjecting diastereomerically pure 2.39 to the 
above conditions. 
 
 
Achiral diol 2.40a: 
 
Cs2CO3
10:1 MeOH/THF
1.25 h, 25 °C
22%
AcO
AcO
OTBS
H3CO
H3CO
OTBS
HO
HO
OTBS
H3CO
H3CO
OTBS
2.40
(d.r. 2:3)
2.39
(d.r. 2:3)
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Rf = 0.3 (30:70 EtOAc/hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 6.79 (m, 6H), 5.30 (s, 2H), 5.21 (s, 2H), 5.12 (s, 
2H), 3.77 (s, 6H), 0.99 (s, 18H), 0.14 (s, 12H);  
 
13C NMR (100 MHz, CDCl3) δ 151.0, 148.3, 144.7, 135.5, 120.7, 119.5, 115.6, 
110.8, 75.5 (two peaks), 55.6, 55.5, 25.9, 18.6, -4.5 (two peaks);  
 
νmax (NaCl) 3368, 2955, 2930, 2895, 2857, 1603, 1511, 1285 cm-1;  
 
MS (ESI+, 70 eV) m/z 612 (17%), 611 (46) 610 (M+•23Na, 100), 570 (10), 552 (13), 
510 (5), 332 (4); 
 
HRMS (ESI+, 70 eV) found 609.3049 (C32H50O6Si223Na requires M+ 609.3044).  
 
 
Chiral diol 2.40b: 
 
HO
HO
OTBS
H3CO
H3CO
OTBS
2.40a
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Rf = 0.3 (30:70 EtOAc/hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 6.73 (m, 6H), 5.30 (s, 2H), 5.23 (s, 2H), 5.09 (s, 
2H), 3.73 (s, 6H), 2.52 (s, 2H), 0.99 (s, 18H), 0.14 (s, 12H);  
 
13C NMR (100 MHz, CDCl3) δ 151.1, 148.9, 144.8, 135.4, 120.8, 119.7, 115.2, 
111.0, 75.6, 55.6, 25.9, 18.6, -4.5;  
 
νmax (NaCl) 3352, 2955, 2930, 2895, 2858, 1603, 1586, 1512 cm-1;  
 
MS (ESI+, 70 eV) m/z 612 (17%), 611 (44), 610 (M+•, 100), 570 (8), 552 (14), 510 
(4), 332 (4); 
 
HRMS (ESI+, 70 eV) found 609.3049 (C32H50O6Si223Na requires M+ 609.3044).  
 
 
 
(((3,4-dimethylenetetrahydrofuran-2,5-diyl)bis(2-methoxy-4,1-
phenylene))bis(oxy))bis(tert-butyldimethylsilane) (2.41) 
 
HO
HO
OTBS
H3CO
H3CO
OTBS
2.40b
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(±)-Camphorsulfonic acid (0.011 g, 46 µmol) was added to a solution of diol 2.40 
(0.27 g, 460 µmol) in CH2Cl2 (10 mL) and stirred for 2 h at 25 °C. The reaction was 
diluted with hexane (20 mL) and water (20 mL), the organic layer separated, and the 
aqueous layer extracted with hexane (2 × 10 mL). The organic layers were combined, 
washed with brine (1 × 20 mL), dried over MgSO4 and concentrated under reduced 
pressure to give the crude product as a brown oil. This was subjected to flash 
chromatography (silica, 5:95 EtOAc/hexane) which gave the title furan 2.41 as a 2:1 
mixture of diastereomers (0.086 g, 150 µmol, 33% yield) as a clear oil. Partial 
separation of the diastereomers was achieved using flash chromatography (silica, 8:92 
diethyl ether/hexane), and chiral HPLC (normal phase, Chiralcel OD/H 150 mm × 
4.6 mm column, 99.6:0.4 hexane:iPrOH, 1 mL/min) was used to assign the less polar 
and less abundant diastereomer as chiral, and the more polar and more abundant 
diastereomer as achiral. 
 
 
Achiral furan 2.41a: 
 
 
(±)-CSA
CH2Cl2
2 h, 25 °C
33%
TBSO
O
OCH3
TBSO OCH3
HO
HO
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(d.r. 2:3)
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Rf = 0.3 (5:95 EtOAc/hexane on silica);  
 
tR = 8.60 min (Chiralcel OD/H 150 mm × 4.6 mm column, 99.6:0.4 hexane:iPrOH, 
1 mL/min) 
 
1H NMR (300 MHz, CDCl3) δ 6.87 (m, 3H), 5.50 (d, 2.2 Hz, 2H), 5.35 (s, 2H), 
4.65 (d, 2.2 Hz, 2H), 3.79 (s, 6H), 0.99 (s, 18H), 0.14 (s, 12H);  
 
13C NMR (100 MHz, CDCl3) δ 151.1, 149.3, 145.2, 134.2, 120.8 (2 peaks), 111.9, 
105.8, 83.7, 55.6, 25.9, 18.6, -4.5;  
 
νmax (NaCl) 2954, 2930, 2895, 2857, 1605, 1513 cm-1;  
 
MS (ESI+, 70 eV) m/z 615 (5%), 594 (13), 593 (42), 592 (M+•, 100) 589 (10), 552 (5). 
 
HRMS (ESI+, 70 eV) found 591.2939 (C34H50O8Si223Na requires M+ 591.2938).  
 
 
Chiral furan 2.41b: 
 
 
 
Rf = 0.3 (5:95 EtOAc/hexane on silica);  
 
TBSO
O
OCH3
TBSO OCH3
2.41b
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tR = 8.38 and 9.81 min (Chiralcel OD/H 150 mm × 4.6 mm column, 99.6:0.4 
hexane:iPrOH, 1 mL/min) 
 
1H NMR (300 MHz, CDCl3) δ 6.90 (s, 2H), 6.82 (m, 4H), 5.60 (d, J = 1.8 Hz, 2H), 
5.54 (s, 2H), 4.86 (d, J = 1.8 Hz, 2H), 3.80 (s, 6H), 0.98 (s, 18H), 0.14 (s, 12H);  
 
13C NMR (100 MHz, CDCl3) δ 151.1, 148.1, 145.0, 134.6, 120.7, 120.0, 111.5, 
106.0, 82.9, 55.7, 25.9, 18.6, -4.5;  
 
νmax (NaCl) 2958, 2930, 2896, 2857, 1603, 1512 cm-1;  
 
MS (ESI+, 70 eV) m/z 624 (12%), 614 (20), 593 (43), 592 (M+•, 100) 570 (17), 552 
(19), 332 (6); 
 
HRMS (ESI+, 70 eV) found 591.2939 (C34H50O8Si223Na requires M+ 591.2938).  
 
 
 
4,4'-((2R,5R)-3,4-dimethylenetetrahydrofuran-2,5-diyl)bis(2-methoxyphenol) 
(2.2) 
 
 
 
TBS-protected monomer 2.41 (0.086 g, 150 µmol) was dissolved in a mixture of 
methanol and THF (14 mL of a 13:1 mixture). Cs2CO3 (0.116 g, 356 µmol) was 
added, and the resulting solution was stirred at 25 °C for 16 h. The reaction solution 
TBSO
O
OCH3
TBSO OCH3
Cs2CO3
13:1 MeOH/THF 
16 h, 25 °C
HO
O
OCH3
HO OCH3
2.22.41
(d.r. 2:1)
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was diluted with ethyl acetate (15 mL) and water (15 mL) was added. The organic 
layer was isolated, and the aqueous layer was extracted with EtOAc (4 × 15 mL). 
Organic layers were then combined, washed with brine (1 × 50 mL), dried over 
MgSO4 and concentrated under reduced pressure to give the crude product as a 
brown oil, in which a quantity of the deprotected monomer 2.2 could be observed. 
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3.3 Second-Generation Approach to the Ramonanin 
Monomer 
 
4-formyl-2-methoxyphenyl benzenesulfonate (2.42) 
 
 
 
Triethylamine (68.8 mL, 493 mmol) was added to a solution of vanillin (25.0 g, 164 
mmol) in CH2Cl2 (500 mL). The solution was cooled to 0 °C and benzenesulfonyl 
chloride (31.4 mL, 177 mmol) was added dropwise over 5 min. The solution was 
warmed to 25 °C and allowed to stir for 18 h, after which the solution was cooled to 0 
°C and quenched with NH4Cl (500 mL, saturated aqueous solution). The organic 
layer was separated and the aqueous layer extracted with CH2Cl2 (3 × 500 mL), the 
organic layers were then combined and washed with brine (1 L), dried over MgSO4 
and concentrated under reduced pressure to give the crude product as a brown oil. 
This was subjected to flash chromatography (silica, 25:75 EtOAc/hexane) to give the 
title aldehyde 2.42 (43.2 g, 148 mmol, 90% yield) as a white crystalline solid. 
 
Rf = 0.3 (25:75 EtOAc/hexane on silica);  
 
m.p. = 67.2 °C – 67.4 °C (recrystallised from Et2O/hexane); 
 
1H NMR (300 MHz, CDCl3) δ 9.93 (s, 1H), 7.87 (d, J = 9.3 Hz, 2H), 7.68 (m, 1H), 
7.53 (m, 2H), 7.41 (m, 3H), 3.59 (s, 3H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 190.9, 152.6, 142.9, 136.0, 135.9, 134.4, 129.0, 
128.6, 124.7, 124.3, 111.2, 55.8 ppm;  
 
OSO2Ph
O
OCH3
OH
O
OCH3
H H
PhSO2Cl,Et3N
CH2Cl218 h, r.t.
90%
2.27 2.42
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νmax (NaCl) 3070, 2941, 2850, 1702, 1599, 1499 cm-1;  
 
MS (EI+, 70 eV) m/z 292.1 (M+•, 83%), 151.1 (100), 140.1 (37), 95.1 (40), 77.0 (73);  
 
HRMS (EI+, 70 eV) found m/z 292.0404 (C14H12O5S requires M+• 292.0405).  
 
 
 
4-(1-hydroxyprop-2-yn-1-yl)-2-methoxyphenyl benzenesulfonate (2.44) 
 
 
 
Aldehyde 2.42 (15.0 g, 51.3 mmol) was dissolved in THF (75 mL) and cooled to 0 
°C. To this solution was added a solution of ethynylmagnesium bromide (157.9 mL, 
0.39 M THF solution, 61.6 mmol) dropwise over 10 min. The solution was allowed 
to stir at 0 °C for 15 min, then warmed to 25 °C and stirred for an additional 15 min. 
The reaction was again cooled to 0 °C then quenched with NH4Cl (150 mL, 
saturated aqueous solution) and diluted with CH2Cl2 (150 mL). The organic layer 
was separated and the aqueous layer extracted with CH2Cl2 (3 × 100 mL). The 
organic layers were then combined, washed with brine (200 mL), dried over MgSO4 
and concentrated under reduced pressure to give the crude product as a brown oil. 
This was subjected to flash chromatography (silica, 50:50 EtOAc/hexane) to give the 
title alkyne 2.4 (15.6 g, 47.8 mmol, 93% yield) as a pale yellow oil. 
 
Rf = 0.5 (50:50 EtOAc/hexane on silica) 
 
1H NMR (300 MHz, CDCl3) δ 7.88 (m, 2H), 7.65 (m, 1H), 7.52 (m, 2H), 7.15 (m, 
1H), 7.07 (m, 2H), 5.42 (d, J = 2.3 Hz, 1H), 3.55 (s, 3H), 2.68 (d, J = 2.3 Hz, 1H) 
ppm;  
 
OSO2Ph
O
OCH3
H
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15 min, 25 °C
93%
HO
OSO2Ph
OCH3
2.42 2.44
C2HMgBr
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13C NMR (75 MHz, CDCl3) δ 167.0, 155.3, 153.4, 151.4, 149.2, 144.0, 143.8, 
139.3, 133.9, 126.2, 98.2, 90.5, 79.1, 70.8 ppm;  
 
νmax (NaCl) 3513, 3400, 3287, 3068, 3010, 2968, 2940, 2917, 2876, 2848, 1604, 
1503, 1449, 1370 cm-1;  
 
MS (EI+, 70 eV) m/z 319.1 (14%), 318.1 (M+•, 83), 292.0 (52), 177.1 (85), 151.0 
(56), 145.0 (47), 77.0 (100);  
 
HRMS (EI+, 70 eV) found m/z 318.0558 (C16H14O5S requires M+• 318.0562).  
 
 
 
(1,4-dihydroxybut-2-yne-1,4-diyl)bis(2-methoxy-4,1-phenylene) 
dibenzenesulfonate (2.43) 
 
 
 
Alkyne 2.44 (12.9 g, 40.4 mmol) was dissolved in THF (75 mL) and cooled to 0 °C. 
To this solution was added a solution of ethylmagnesium bromide (202 mL, 0.40 M 
THF solution, 80.9 mmol) dropwise over 10 min. The solution was warmed to r.t. 
over 5 min using a water bath, then stirred at 25 °C for 15 min. The solution was then 
cooled to 0 °C and a solution of aldehyde 2.42 (17.7 g, 60.6 mmol) in THF (50 mL) 
was added dropwise over 5 min. The solution was warmed to 25 °C then stirred for 2 
h, then cooled to 0 °C and quenched with NH4Cl (200 mL, saturated aqueous 
solution) and diluted with EtOAc. The organic layer was then separated and the 
aqueous layer extracted with EtOAc (3 × 150 mL). The organic layers were then 
THF
2 h, 25 °C
66% HO
OSO2Ph
HO
OSO2Ph
OCH3
OCH3
2.43
(d.r. 1:1)
C2H5MgBr
then  2.42HO
OSO2Ph
OCH3
2.44
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combined, washed with brine (300 mL), dried over MgSO4 and concentrated under 
reduced pressure to give the crude product as a brown oil. This was subjected to flash 
chromatography (silica, 60:40 EtOAc/hexane) to give the title diol 2.43 as a mixture 
of chiral and achiral diastereomers (16.2 g, 26.5 mmol, 66% yield) as a yellow oil. 
 
Rf = 0.3 (60:40 EtOAc/hexane on silica) 
 
1H NMR (300 MHz, CDCl3) δ 7.87 (d, J = 7.6, 4H), 7.66 (dd, J = 7.6 and 7.6, 2H), 
7.51 (dd, J = 7.6 and 7.6, 4H), 7.13 (m, 2H), 7.02 (m, 4H), 5.48 (s, 2H), 3.50 (s, 
6H), 2.46 (s, 2H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 151.9, 140.6, 138.1, 136.2, 134.3, 129.0, 128.6, 
124.1, 118.8, 111.2, 86.3, 63.9, 55.7 ppm;  
 
νmax (NaCl) 3402, 3072, 3011, 2962, 2936, 2850, 1603, 1503, 1449, 1372 cm-1;  
 
MS (ESI+, 70 eV) m/z 635.4 (17%), 634.4 (35), 633.4 (M++23Na, 100), 628.5 (15);  
 
HRMS (ESI+, 70 eV) found m/z 633.0869 (C30H26O10S223Na requires M+ 633.0865).  
 
 
 
(1,4-dihydroxybut-2-yne-1,4-diyl)bis(2-methoxy-4,1-phenylene) 
dibenzenesulfonate (2.43) 
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O
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H
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A solution of aldehyde 2.42 (100 mg, 342 µmol) in THF (0.50 mL) was cooled to 0 
°C and ethynylmagnesium bromide (0.91 mL, 0.45 M THF solution, 411 µmol) was 
added dropwise over 2 min. The reaction was allowed to stir at 0 °C for 15 min, then 
warmed to 25 °C over 5 min using a water bath and stirred for an additional 15 min. 
The reaction was again cooled to 0 °C and ethylmagnesium bromide (0.280 mL, 1.22 
M THF solution, 342 µmol) was added dropwise over 2 min. The solution was 
warmed to 25 °C over 5 min using a water bath, then stirred at 25 °C for 15 min. The 
solution was then cooled to 0 °C and solid aldehyde 2.42 (170 mg, 582 µmol) was 
added in one portion. The solid was observed to dissolve over the course of 1 min, 
after which the reaction was warmed to 25 °C over 5 min using a water bath. The 
reaction was stirred at 25 °C for 2 h then cooled to 0 °C and quenched with NH4Cl 
(10 mL, saturated aqueous solution) and diluted with EtOAc. The organic layer was 
then separated and the aqueous layer extracted with EtOAc (3 × 10 mL). The organic 
layers were then combined, washed with brine (40 mL), dried over MgSO4 and 
concentrated under reduced pressure to give the crude product as a brown oil. This 
was subjected to flash chromatography (silica, 60:40 EtOAc/hexane) to give the title 
diol 2.43 as a 1:1 mixture of diastereomers (140 mg, 229 µmol, 67% yield) as a yellow 
oil. 
 
Rf = 0.3 (60:40 EtOAc/hexane on silica); 
 
1H NMR (300 MHz, CDCl3) δ 7.87 (d, J = 7.6, 4H), 7.66 (dd, J = 7.6 and 7.6, 2H), 
7.51 (dd, J = 7.6 and 7.6, 4H), 7.13 (m, 2H), 7.02 (m, 4H), 5.48 (s, 2H), 3.50 (s, 
6H), 2.46 (s, 2H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 151.9, 140.6, 138.1, 136.2, 134.3, 129.0, 128.6, 
124.1, 118.8, 111.2, 86.3, 63.9, 55.7 ppm;  
 
νmax (NaCl) 3402, 3072, 3011, 2936, 2850, 1603, 1503, 1449 cm-1;  
 
MS (ESI+, 70 eV) m/z 635.4 (17%), 634.4 (35), 633.4 (M++23Na, 100), 628.5 (15);  
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HRMS (ESI+, 70 eV) found m/z 633.0869 (C30H26O10S223Na requires M+ 633.0865).  
 
 
 
1,4-bis(3-methoxy-4-((phenylsulfonyl)oxy)phenyl)but-2-yne-1,4-diyl 
diacetate (2.47) 
 
 
 
Pyridine (42.7 mL, 530 mmol) was added to a solution of diol 2.43 (16.2 g, 26.5 
mmol) (as a 1:1 mixture of diastereomers) in CH2Cl2 (110 mL). The solution was 
cooled to 0 °C and acetic anhydride (20.0 mL, 212 mmol) was added dropwise. The 
solution was warmed to 25 °C and stirred for 1.5 h, then cooled to 0 °C and quenched 
with NH4Cl (80 mL, saturated aqueous solution) and diluted with EtOAc (150 mL). 
The organic layer was washed with successive quantities of HCl (200 mL, 1 M 
aqueous solution), NaHCO3 (200 mL, saturated aqueous solution), CuSO4 (200 mL, 
saturated aqueous solution) and brine (200 mL). The solution was then dried over 
MgSO4 and concentrated under reduced pressure to give the title diacetate 2.47 as a 
1:1 mixture of diastereomers (18.4 g, 26.5 mmol, quantitative yield) as an orange 
gum, which did not require any further purification. 
 
1H NMR (300 MHz, CDCl3) δ 7.90 (m, 4H), 7.67 (m, 2H), 7.53 (m, 4H), 7.14 (m, 
2H), 7.00 (m, 4H), 6.45 (s, 2H), 6.44 (s, 2H), 3.55 (s, 6H), 3.53 (s, 6H), 2.11 (s, 
6H), 2.10 (s, 6H) ppm;  
 
HO
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13C NMR (75 MHz, CDCl3) δ 184.7, 167.1, 154.0, 151.6 (two peaks), 149.3, 139.5, 
135.2, 127.5, 127.4, 98.9, 98.8, 80.0, 70.9 (two peaks), 36.2 ppm;  
 
νmax (NaCl) 3070, 2963, 2848, 1745, 1604, 1505, 1449 cm-1;  
 
MS (ESI+, 70 eV) m/z 733.4 (11%), 719.4 (19), 718.4 (34), 717.4 (M++23Na, 100), 
712.4 (16);  
 
HRMS (ESI+, 70 eV) found m/z 717.1080 (C34H30O12S223Na requires M+ 717.1076).  
 
 
 
1,4-bis(3-methoxy-4-((phenylsulfonyl)oxy)phenyl)-2,3-dimethylenebutane-
1,4-diyl diacetate (2.48) 
 
 
 
Alkyne 2.47 (7.04 g, 10.1 mmol) as a 1:1 mixture of diastereomers and Hoveyda-
Grubbs 2nd generation catalyst (0.318 g, 0.507 µmol) were dissolved in toluene (493 
mL). The solution was degassed (freeze-pump-thaw, 5 × 5 min pump cycles) then 
placed under an ethylene atmosphere and heated at 110 °C for 2.5 h. The flask was 
cooled to 25 °C then opened and left to stir under air for 5 minutes, after which the 
contents were concentrated under reduced pressure to give a brown opaque oil. The 
crude product was purified by flash chromatography (buffered silica, 2:98 
EtOAc/CH2Cl2) to give the title diene 2.48 as a 1:1 mixture of diastereomers (5.43 g, 
7.51 mmol, 74% yield) as a brown amorphous solid. 
Hoveyda-Grubbs II
ethylene
PhCH3
2.5 h, 110°C,
74%AcO
OSO2Ph
AcO
OSO2Ph
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AcO
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Rf = 0.3 (2:98 EtOAc/CH2Cl2 on buffered silica); 
 
1H NMR (300 MHz, CDCl3) δ 7.87 (m, 4H), 7.66 (m, 2H), 7.51 (m, 4H), 7.08 (m, 
2H), 6.74 (m, 4H), 5.21 (m, 4H), 3.50 (s, 6H), 3.46 (s, 6H), 2.08 (two 
diastereomers) (s, 6H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 184.7, 166.9, 166.8, 158.9, 158.8, 153.3, 153.1, 
151.5, 149.2, 144.0, 143.7, 139.2, 139.1, 135.1, 135.0, 131.2, 127.3, 127.2, 89.7, 70.8 
(two peaks), 36.3 ppm;  
 
νmax (NaCl) 3069, 2939, 2845, 2258, 1743, 1603, 1505, 1449 cm-1;  
 
MS (ESI+, 70 eV) m/z 762.3 (17%), 746.5 (46), 745.4 (M++23Na, 100), 740.5 (15); 
found:  
 
HRMS (ESI+, 70 eV) found m/z 745.1390 (C36H34O12S223Na requires M+ 745.1389).  
 
 
 
(1,4-dihydroxy-2,3-dimethylenebutane-1,4-diyl)bis(2-methoxy-4,1-
phenylene) dibenzenesulfonate (2.49) 
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Diacetate 2.48 (5.43 g, 7.51 mmol) as a 1:1 mixture of diastereomers was dissolved in 
THF (135 mL). After diacetate 2.48 was observed to have fully dissolved (stirring at 
25 °C for c.a. 30 min), MeOH (135 mL) and KOH (1.05 g, 18.8 mmol) were added 
and the solution was stirred at 25 °C for 1 h. The reaction solution was then treated 
with NH4Cl (200 mL, saturated aqueous solution) and partitioned with CH2Cl2 (200 
mL). The organic layer was separated and the aqueous layer extracted with CH2Cl2 (3 
× 200 mL). The organic layers were then combined, washed with brine (400 mL), 
dried over MgSO4 and concentrated under reduced pressure to give the crude product 
as a light brown solid. The crude product was purified using flash chromatography 
(buffered silica, 20:80 EtOAc/CH2Cl2) to give the title diol 2.49 as a 1:1 mixture of 
diastereomers (4.07 g, 6.37 mmol, 85% yield) as a light brown amorphous solid. 
 
Rf = 0.3 (20:80 EtOAc/CH2Cl2 on buffered silica); 
 
1H NMR (300 MHz, CDCl3) δ 7.86 (m, 4H), 7.64 (m, 2H), 7.50 (m, 4H), 7.12 (m, 
2H), 6.78 (m, 4H), 5.32 (s, 2H), 5.30 (s, 2H), 5.20 (s, 2H), 5.17 (s, 2H), 5.12 (s, 
2H), 5.05 (s, 2H), 3.44 (s, 6H), 3.42 (s, 6H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 151.5, 150.9, 148.0, 147.6, 142.0, 137.4, 136.1, 
134.0, 128.8, 128.5, 123.7 (two peaks), 119.0, 118.7, 117.1, 116.5, 111.0, 110.8, 75.3, 
75.2, 55.5 ppm;  
 
νmax (NaCl) 3533, 3400, 3069, 2964, 2844, 2257, 1601, 1502 cm-1;  
 
MS (ESI+, 70 eV) m/z 663.4 (18%), 662.4 (36), 661.4 (M++23Na, 100), 656.4 (19);  
 
HRMS (ESI+, 70 eV) found m/z 661.1179 (C32H30O10S223Na requires M+ 661.1178). 
 
 
 
(3,4-dimethylenetetrahydrofuran-2,5-diyl)bis(2-methoxy-4,1-phenylene) 
dibenzenesulfonate (2.50) 
EXPERIMENTAL FOR PART 1 135 
 
 
 
Diol 2.49 (4.07 g, 6.37 mmol) as a 1:1 mixture of diastereomers was dissolved in 
chloroform (20.5 mL) and (±)-camphorsulfonic acid (1.48 g, 6.37 mmol) was added. 
The solution was heated to 61 °C for 2.5 h then cooled to 25 °C after which 
NaHCO3 was added (20 mL, saturated aqueous solution). The organic layer was 
separated, and the aqueous layer extracted with CH2Cl2 (3 × 20 mL). The organic 
layers were then combined, washed with brine (100 mL), dried over MgSO4 and 
concentrated under reduced pressure to give the crude product as a brown oil. The 
crude was purified using flash chromatography (buffered silica, 35:65 EtOAc/hexane) 
to give the title furan 2.50 as a 2:1 mixture of achiral and chiral diastereomers (2.01 g, 
3.24 mmol, 51% yield) as a light brown oil. 
 
A 0.250 g portion of the purified diastereomeric mixture was separated into 
diastereomerically-pure samples by preparative HPLC (normal phase, Phenomenex 
Luna 5 µ silica 150 mm × 21.2 mm column, 99.7:0.3 CH2Cl2:EtOAc, 17 mL/min) to 
give the achiral diastereomer 2.50a (0.0833 g, 0.133 mmol, 33% mass recovery) as a 
pale yellow oil and the chiral diastereomer 2.50b (0.0411 g, 0.0662 mmol, 16% mass 
recovery) as a pale yellow oil. 
 
 
Achiral furan 2.50a 
 
(±)-CSA
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tR = 23.3 min (Phenomenex Luna 5 µ silica 150 mm × 21.2 mm column, 99.7:0.3 
CH2Cl2:EtOAc, 17 mL/min); 
 
1H NMR (800 MHz, CDCl3) δ 7.87 (m, 4H), 7.64 (m, 2H), 7.50 (m, 4H), 7.19 (d, J 
= 8.2 Hz, 2H), 6.93 (dd, J = 8.5 and 2.0 Hz, 2H), 6.85 (d, J = 2.0 Hz, 2H), 5.53 (d, J 
= 2.4, 2H), 5.37 (dd, J = 2.4 and 2.1, 2H), 4.67 (d, J = 2.1, 2H), 3.50 (s, 6H) ppm; 
 
13C NMR (200 MHz, CDCl3) δ 152.0, 148.1, 140.7, 138.4, 136.5, 134.1, 128.9, 
128.8, 124.3, 120.1, 112.1, 106.6, 83.4, 55.7 ppm; 
 
νmax (NaCl) 3069, 2962, 2847, 1603, 1504 cm-1; 
 
MS (ESI+, 70 eV) m/z 643.2 (M++23Na, 70), 638.3 (30), 208.3 (100); 
  
HRMS (ESI+, 70 eV) found m/z 643.1077 (C32H28O9S223Na requires M+ 643.1072). 
 
 
Chiral furan 2.50b 
 
PhO2SO
O
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tR = 28.2 min (Phenomenex Luna 5 µ silica 150 mm × 21.2 mm column, 99.7:0.3 
CH2Cl2:EtOAc, 17 mL/min); 
 
1H NMR (400 MHz, CDCl3) δ 7.89 (m, 4H), 7.63 (m, 2H), 7.52 (m, 4H), 7.15 (d, J 
= 8.0 Hz, 2H), 6.90 (m, 4H), 5.62 (d, J = 2.1, 2H), 5.53 (m, 2H), 4.89 (d, J = 1.5, 
2H), 3.54 (s, 6H) ppm; 
 
13C NMR (100 MHz, CDCl3) δ 151.8, 147.7, 140.9, 138.0, 136.4, 133.9, 128.7, 
128.5, 123.9, 119.2, 111.3, 106.8, 82.5, 55.6 ppm; 
 
νmax (NaCl) 3408, 3068, 2938, 2846, 1602, 1502, 1449 cm-1; 
 
MS (ESI+, 70 eV) m/z 643.6 (M++23Na, 50%), 490.7 (70), 473.8 (50), 385.6 (69); 
  
HRMS (ESI+, 70 eV) found m/z 643.1080 (C32H28O9S223Na requires M+ 643.1072). 
 
 
 
4,4'-(3,4-dimethylenetetrahydrofuran-2,5-diyl)bis(2-methoxyphenol) (2.2) 
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Dibenzenesulfonate 2.50 (200 mg, 322 µmol) as a 2:1 mixture of achiral:chiral 
diastereomers was dissolved in THF (16 mL) and MeOH (8 mL) was then added. 
After the dibenzenesulfonate was observed to have remained fully dissolved, NaOH 
(515 mg, 12.9 mmol) was added and the reaction solution heated to 65 °C for 30 min. 
The reaction solution was then cooled to 25 °C, partitioned between Et2O (30 mL) 
and water (30 mL), and the aqueous phase acidified with 1 M aqueous HCl to a pH 
of 3-4. The organic layer was separated, and the aqueous phase extracted with Et2O 
(3 × 30 mL). The organic layers were combined, washed with brine (100 mL), dried 
over Na2SO4, and concentrated under reduced pressure to give the crude diphenol 2.2 
as a 2:1 mixture of diastereomers (93.9 mg, 276 µmol, 86% yield) as a yellow 
amorphous solid, which did not require any further purification. 
 
Diastereomerically-pure samples of diphenol 2.2 were prepared from corresponding 
samples of diastereomerically-pure dibenzenesulfonate 2.50, in accordance with the 
above procedure: achiral dibenzenesulfonate 2.50a (40 mg, 64 µmol) gave achiral  
diphenol 2.2a (17 mg, 49 µmol, 76% yield) as a yellow amorphous solid, and chiral 
dibenzenesulfonate 2.50b (25 mg, 40 µmol) gave chiral diphenol 2.2b (10 mg, 30 
µmol, 74% yield) as a yellow amorphous solid. 
 
 
Achiral diphenol 2.2a 
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1H NMR (300 MHz, CDCl3) δ 6.92 (m, 6H), 5.64 (s, 2H), 5.53 (d, J = 2.6 Hz, 2H), 
5.36 (m, 2H), 4.69 (d, J = 2.1 Hz, 2H), 3.88 ppm; 
 
13C NMR (100 MHz, CDCl3) δ 149.2, 146.7, 145.8, 132.7, 121.4, 114.3, 110.5, 
105.9, 83.7, 56.0 ppm; 
 
νmax (NaCl) 3419, 2962, 2937, 2844, 1605, 1515 cm-1; 
 
MS (EI+, 70 eV) m/z 340.1 (M+•, 31%), 216.1 (12); 
  
HRMS (EI+, 70 eV) found m/z 340.1309 (C32H28O9S223Na requires M+• 340.1311). 
 
 
Chiral diphenol 2.2b 
 
 
 
1H NMR (400 MHz, CDCl3) δ 6.90 (m, 6H), 5.62 (m, 4H), 5.54 (m, 2H), 4.89 (d, J 
= 1.5 Hz, 2H), 3.9 (s, 6H) ppm; 
HO
O
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13C NMR (100 MHz, CDCl3) δ 148.0, 146.8, 145.7, 133.1, 120.6, 114.2, 109.9, 
106.2, 82.9, 56.1 ppm; 
 
νmax (NaCl) 3401, 2960, 2928, 2852, 1603, 1514 cm-1; 
 
MS (EI+, 70 eV) m/z 340.1 (M+•, 50%), 216.1 (51); 
  
HRMS (EI+, 70 eV) found m/z 340.1310 (C20H20O5 requires M+• 340.1311). 
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3.4 Dimerisation of the Ramonanin Monomer 
 
Ramonanins A-C (2.1a, 2.1b and 2.1c) plus putative ramonanin D (2.2d) 
 
 
 
Diphenol 2.2 (93.9 mg, 276 µmol) as a 2:1 mixture of achiral:chiral diastereomers was 
placed in a reactor vial and dissolved in EtOAc (19 µL) to form a thick gum. The 
reactor vial was sealed and the sample heated to 50 °C for 48 h to give the crude 
product containing ramonanins A-C plus the unknown product in a 6:1:4:2 ratio of A 
: B : C : putative D, plus unreacted starting material and numerous minor products. 
The crude product appeared as a brown gum and was used in subsequent procedures 
without further purification. 
 
A 40 mg portion of crude product was fractionated by preparative HPLC (reverse 
phase, Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min) to give impure samples of ramonanins A, C and 
putative ramonanin D plus a pure sample of ramonanin B (1.0 mg, 1.4 µmol, 2% 
extrapolated yield). The impure samples of ramonanins A and C were purified further 
by preparative HPLC (reverse phase, Waters XBridge C 18 5 µ silica 150 mm × 19 
mm column, 35:65:0.1 MeCN:H2O:HCO2H, 17 mL/min) to give ramonanin A (1.0 
mg, 1.4 µmol, 2% extrapolated yield) and ramonanin C (0.7 mg, 1.0 µmol, 2% 
extrapolated yield). 
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The remaining quantity of crude product was fractionated as above by preparative 
HPLC (reverse phase, Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 
55:45:0.1 MeOH:H2O:HCO2H, 17 mL/min), and the fraction containing the 
unknown dimer XX was combined with the corresponding fraction acquired 
previously. This material was then purified further by preparative HPLC (reverse 
phase, Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 35:65:0.1 
MeCN:H2O:HCO2H, 17 mL/min) to give putative ramonanin D 2.1d (1.7 mg, 2.5 
µmol, 2% yield). 
 
 
Ramonanin A (2.1a) 
 
 
 
tR = 18.2 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min);  
tR = 27.6 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 35:65:0.1 
MeCN:H2O:HCO2H, 17 mL/min). 
 
1H NMR (800 MHz, CDCl3) δ 6.97 (m, 2H), 6.91 (m, 2H), 6.81 (m, 6H), 6.74 (d, J 
= 1.9 Hz, 1H), 6.69 (dd, J = 8.1 and 1.8 Hz, 1H), 5.59 (two peaks) (s, 1H) (s, 1H), 
5.55 (s, 1H), 5.54 (m, 1H), 5.52 (s, 1H), 5.39 (dd, J = 2.2 Hz and 2.2 Hz, 1H), 5.15 
(d, J = 2.6 Hz, 1H), 4.94, (d, J = 2.0 Hz, 1H), 4.60 (s, 1H), 3.90 (s, 3H), 3.78 (s, 3H), 
3.77 (s, 3H), 3.76 (s, 3H), 2.14 (m, 1H), 2.02 (m, 1H), 1.97 (m, 1H), 1.80 (m, 1H), 
1.64 (m, 1H), 0.93 (ddd, J = 13.3 Hz, 11.3 Hz, 5.1 Hz, 1H) ppm; 
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13C NMR (200 MHz, CDCl3) δ 157.7, 146.7, 146.5, 146.4, 146.1, 145.6, 145.4, 
145.3, 136.1, 133.2, 132.9, 132.8, 132.4, 128.6, 120.5, 120.3 (two peaks), 119.9, 
114.3, 114.1 (two peaks), 113.8, 110.3, 110.1 (two peaks), 109.8, 107.0, 89.0, 88.7, 
88.0, 55.9, 55.8, 47.8, 30.9, 30.3, 26.1, 18.7 ppm; 
 
νmax (NaCl) 3508, 3409, 2958, 2937, 2842, 1604, 1515 cm-1; 
 
MS (ESI+, 70 eV) m/z 703.1 (M++23Na, 63%), 698.5 (74), 698.0 (70); 
  
HRMS (ESI+, 70 eV) found m/z 703.2521 (C40H40O1023Na requires M+ 703.2519).\ 
 
 
Ramonanin B (2.1b) 
 
 
 
tR = 21.8 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min).  
 
1H NMR (800 MHz, CDCl3) δ 6.92 (m, 2H), 6.88 (d, J = 8 Hz, 1H), 6.79 (m, 2H), 
6.75 (d, J = 8.2 Hz, 1H), 6.70 (d, J = 1.8 Hz, 1H), 6.68 (dd, J = 7.9 and 1.8 Hz, 1H), 
6.60 (d, J = 1.8 Hz, 1H), 6.51 (dd, J = 8.1 and 1.8 Hz, 1H), 6.48 (dd, J = 8.0 and 1.8 
Hz, 1H), 5.59 (s, 1H), 5.58 (s, 1H), 5.57 (s, 1H), 5.54 (s, 1H), 5.49 (m, 1H), 5.54 
(m, 1H), 5.37 (dd, J = 2.3 and 2.3 Hz, 1H), 5.02 (d, J = 2.5 Hz, 1H), 4.76 (d, J = 2.2 
Hz, 1H), 4.67 (s, 1H), 3.87 (s, 3H), 3.82 (s, 3H), 3.71 (s, 3H), 3.67 (s, 3H), 2.12 (m, 
1H), 2.00 (m, 3H), 1.88 (m, 1H), 1.80 (m, 1H) ppm; 
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13C NMR (200 MHz, CDCl3) δ 159.4, 146.5, 146.0, 145.5, 145.4, 145.3, 145.1, 
133.9, 133.5, 132.7, 132.5, 132.3, 130.9, 120.9, 120.6, 120.3, 119.2, 114.2, 114.1, 
113.9, 113.8, 110.7, 110.4, 110.0, 109.8, 106.6, 89.6, 89.1, 89.0, 82.3, 55.9, 55.8, 
55.7, 55.6, 48.2, 32.8, 30.9, 30.0, 20.0 ppm (one set of overlapping peaks); 
 
νmax (NaCl) 3515, 3435, 2958, 2934, 2844, 1604, 1515 cm-1; 
 
MS (ESI+, 70 eV) m/z 744.7 (57%), 719.6 (M++39K, 40), 704.3 (49), 703.6 (M++23Na, 
100); 
  
HRMS (ESI+, 70 eV) found m/z 703.2523 (C40H40O1023Na requires M+ 703.2519). 
 
 
Ramonanin C (2.1c) 
 
 
 
tR = 7.4 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min);  
tR = 18.0 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 35:65:0.1 
MeCN:H2O:HCO2H, 17 mL/min). 
 
1H NMR (600 MHz, MeOD) δ 7.01 (d, J = 1.9 Hz, 2H), 6.99 (d, J = 1.9 Hz, 1H), 
6.96 (d, J = 1.9 Hz, 1H), 6.89 (m, 3H), 6.85 (dd, J = 8.1 and 1.7 Hz, 2H), 6.80 (m, 
5H), 5.57 (m, 1H), 5.44 (m, 1H), 5.33 (dd, J = 2.1 and 2.1 Hz, 1H), 5.16 (d, J = 2.4 
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Hz, 1H), 4.85 (m, 1H, partially obscured by solvent peak), 4.62 (s, 1H), 3.86 (s, 3H), 
3.82 (s, 3H), 3.80 (s, 3H), 3.78 (s, 3H), 2.28 (m, 1H), 1.93 (m, 1H), 1.75 (m, 2H), 
1.67 (ddd, J = 13.4, 4.2 and 4.2 Hz, 1H), 1.11 (ddd, J = 13.3, 7.8 and 7.8 Hz, 1H) 
ppm; 
 
13C NMR (151 MHz, MeOD) δ 160.2, 149.1, 149.0, 148.8, 148.5, 147.7, 147.6, 
147.5, 147.4, 135.8, 135.4, 133.9, 133.3, 133.0, 129.5, 121.6, 121.4, 121.3, 121.1, 
116.0 (two peaks), 115.9, 115.6, 112.2 (two peaks), 112.0 (two peaks), 107.3, 90.2 
(two peaks), 89.5, 84.0, 56.3 (three peaks), 56.2, 49.4 31.3, 27.9, 19.9 ppm; 
 
νmax (NaCl) 3401, 2917, 2844, 1603, 1514 cm-1; 
 
MS (EI+, 70 eV) m/z 680.1 (M+•, 7%), 529.2 (7); 
  
HRMS (EI+, 70 eV) found m/z 680.2621 (C40H40O10 requires M+• 680.2621); 
 
 
Putative Ramonanin D (2.1d) 
 
 
 
tR = 10.7 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min);  
tR = 47.3 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 35:65:0.1 
MeCN:H2O:HCO2H, 17 mL/min); 
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1H NMR (400 MHz, CDCl3) δ 7.36 – 6.75 (m, 12H), 5.92 (m, 1H), 5.76 (m, 1H), 
5.46 (s, 1H), 5.42 (s, 1H), 5.40 (s, 1H), 5.39 (m, 1H), 5.38 (s, 1H), 5.23 (d, J = 2.4 
Hz, 1H), 4.88 (d, J = 1.9 Hz, 1H), 4.61 (s, 1H), 3.22 (s, 3H), 3.19 (s, 3H), 3.15 (s, 
3H), 3.13 (s, 3H), 2.19 (m, 1H), 2.10 (m, 1H), 1.82 (m, 1H), 1.70 (m, 1H) 1.32 (m, 
1H), 1.08 (m, 1H) ppm; 
 
νmax (NaCl) 3469, 2962, 2917, 2849, 1996, 1604, 1515 cm-1; 
 
MS (ESI+, 70 eV) m/z 704.6 (41%), 703.6 (M++23Na, 100); 
 
HRMS (ESI+, 70 eV) found m/z 703.2519 (C32H28O9S223Na requires M+ 703.2519). 
 
 
 
Ramonanins A-C (2.1a, 2.1b and 2.1c) 
 
 
 
Achiral diphenol 2.2a (14 mg, 41 µmol) was placed in a reactor vial and dissolved in 
DMF (14 µL) to form a thick gum. The reactor vial was sealed and the sample heated 
to 50 °C for 30 h. Solvent was removed under reduced pressure to give the crude 
product as a thick brown gum. The crude was purified using flash chromatography 
(C18 reverse phase silica, 70:30 MeOH/H2O) to give ramonanins A, B and C plus 
unreacted starting material in a 6:1:4:6 ratio (9.7 mg, 69% mass recovery) as a thick 
brown oil. 
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A 10 mg portion of the crude product was purified by preparative HPLC (reverse 
phase, Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min) to give ramonanin A (2.3 mg, 3.4 µmol, 23% 
extrapolated yield) as a pale yellow oil, ramonanin B (0.2 mg, 0.3 µmol, 2% 
extrapolated yield) as a pale yellow oil, and ramonanin C (1.9 mg, 2.8 µmol, 19% 
extrapolated yield) as a pale yellow oil. 
 
 
Ramonanin A (2.1a) 
 
 
 
tR = 17.1 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min). 
 
 
Ramonanin B (2.1b) 
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tR = 21.0 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min). 
 
 
Ramonanin C (2.1c) 
 
 
 
tR = 7.1 min (Waters XBridge C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 
MeOH:H2O:HCO2H, 17 mL/min). 
 
 
 
Protected ramonanins A-C (2.51) 
 
 
 
Diene 2.50a (106.7 mg, 171.9 µmol) was dissolved in CH2Cl2 (0.5 mL) and placed 
inside a high-pressure reactor vial. The vial was pressurised to 19 kbar at r.t. for 72 h, 
then concentrated under reduced pressure to give the crude product as a yellow oil. 
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The crude was purified using flash chromatography (buffered silica, 50:50 
EtOAc/hexane) to give the title dimer 2.51 as a mixture of diastereomers (57.3 mg, 
54% yield), as a light yellow oil, which was used directly in subsequent 
transformations.  
 
Alternatively, a pure sample of protected ramonanin A 2.51a could be isolated from 
the crude product mixture by preparative HPLC. A 55.0 mg portion of crude product 
was subjected to HPLC (normal phase, Phenomenex Luna 5 µ silica 150 mm × 21.2 
mm column, 55:45 EtOAc:hexane, 17 mL/min) to give protected ramonanin A (17.3 
mg, 13.9 µmol, 31% mass recovery) as a yellow amorphous solid. 
 
Protected ramonanin A (2.51a) 
 
 
 
1H NMR (800 MHz, CDCl3) δ 7.90 (m, 4H), 7.85 (m, 2H), 7.82 (m, 2H), 7.67 (m, 
2H), 7.62 (m, 2H), 7.53 (m, 4H), 7.47 (m, 4H), 7.19 (m, 4H), 7.13 (d, J = 7.9 Hz, 
1H), 7.10 (d, J = 7.9 Hz, 1H), 6.96 (m, 2H), 6.80 (m, 2H), 6.74 (m, 1H), 6.70 (m, 
2H) 5.61 (s, 1H), 5.55 (s, 1H), 5.39 (s, 1H), 5.14 (d, 1.8 Hz, 1H), 4.98 (d, 1.8 Hz, 
1H), 4.61 (s, 1H), 3.56 (s, 3H), 3.44 (s, 3H), 3.41 (s, 3H), 3.38 (s, 3H), 2.04 (s, 2H), 
1.9 (m, 1H), 1.74 (m, 1H), 1.51 (m, 1H), 0.78 (m, 1H); 
 
13C NMR (200 MHz, CDCl3) δ 156.4, 152.3, 152.1, 152.0, 151.7, 141.2, 140.5, 
140.2, 138.3, 138.2, 138.1, 136.6 (two peaks), 136.5 (two peaks), 136.4, 136.3, 134.2 
(two peaks), 134.1 (two peaks), 133.0, 129.0, 128.9 (three peaks), 128.7, 128.6 (three 
peaks), 124.3 (two peaks), 124.2, 123.9, 119.3 (two peaks), 118.9, 118.8, 112.0, 
PhO2SO
O
H3CO
PhO2SO
H3CO
OSO2Ph
O
OSO2Ph
OCH3
OCH3
2.51a
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111.8, 111.6, 111.4, 110.1, 108.0, 88.9, 88.6, 87.7, 82.4, 55.8, 55.7 (three peaks), 
48.0, 30.1, 26.2, 18.7; 
 
νmax (NaCl) 3071, 3007, 2961, 2936, 2847, 2257, 1656, 1602, 1503, 1449, 1372 cm-1;  
 
MS (ESI+, 70 eV) m/z 1279.7 (M++39K, 27), 1263.7 (M++23Na, 100), 490.8 (43), 
311.3 (52), 129.9 (88); 
  
HRMS (ESI+, 70 eV) found m/z 1263.2251 (C64H56O1823NaS4 requires M+ 
1263.2247). 
 
 
 
Ramonanins A-C (2.1a, 2.1b and 2.1) 
 
 
 
Tetrabenzenesulfonate 2.51 (43 mg, 35 µmol) was dissolved in THF (4.5 mL) and 
MeOH (2.2 mL) was then added. NaOH (55 mg, 1.4 mmol) was added and the 
reaction solution was heated to 65 °C for 30 min. The reaction solution was then 
cooled to 25 °C and partitioned between Et2O (8 mL) and water (8 mL), and the 
aqueous phase was acidified with 1 M aqueous HCl to a pH of 3-4. The organic layer 
was separated, and the aqueous phase extracted with Et2O (3 × 8 mL). The organic 
layers were combined, washed with brine (20 mL), dried over Na2SO4, and 
concentrated under reduced pressure to give the crude product, containing a 
HO
O
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O
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ramonanins A, B and C and an unknown dimer in a 6.5:2:3:1 ratio respectively as a 
yellow oil that did not require further purification.  
 
Diastereomers were separated by preparative HPLC (reverse phase, Waters XBridge 
C 18 5 µ silica 150 mm × 19 mm column, 55:45:0.1 MeOH:H2O:HCO2H, 17 
mL/min) to give ramonanin A (13.0 mg, 19.1 µmol, 30% yield) as a pale yellow oil, 
ramonanin B (2.2 mg, 2.9 µmol, 5% yield) as a pale yellow oil, and ramonanin C (4.3 
mg, 6.3 µmol, 10% yield) as a pale yellow oil. 
 
 
 
Half-life of the ramonanin monomer under biomimetic dimerisation 
conditions 
 
 
 
Diphenol 2.2 (25 mg, 73 µmol) as a 2:1 mixture of achiral/chiral diastereomers was 
dissolved in EtOAc (5 µL) to form a thick gum. The gum was split evenly between 4 
reactor vials, which were then sealed and kept at a constant 25 °C. Vials were opened 
at 24 h, 48 h, 96 h, 192 h intervals, and 1H NMR spectra were recorded by dissolving 
the entirety of the contents of each vial in exactly 400 µL of anhydrous CDCl3. The 
extent of conversion of starting material to product was determined by measuring the 
integration of peaks associated with the starting material against CHCl3 present in the 
NMR sample. 
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Under the conditions of the experiment, the ramonanin monomer was observed to 
have a half-life of approximately two days. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  
 
 
 
 
PART 2:  
THE SYNTHESIS OF CROSS-CONJUGATED 
HYDROCARBONS USING 
TRICARBONYLIRON-DIENE  
BUILDING BLOCKS 
  
   
	  
 
CHAPTER 4 
 
SYNTHESIS OF CROSS-CONJUGATED 
TRICARBONYLIRON-DIENE COMPLEXES AND 
SYNTHESIS AND CROSS-COUPLING OF 
TRICARBONYLIRON-HALODIENE COMPLEXES 
 
4.1   Tricarbonyliron Complexes of Dienes: A Polyene 
Protection Strategy 
 
4.1.1  Unstable Polyenes 
 
Polyenes are ubiquitous structures throughout organic chemistry. Such functionality 
imparts not just structural complexity (and corresponding intrigue) to a synthetic 
target, but can also serve as useful functionality en route to other destinations. Classic 
examples of either exist in the structure of spirangien,[155] and Nicolaou and 
coworkers’ synthesis of endiandric acids A and B,[156] respectively: 
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Figure	  4.1:	  Intriguing	  polyenes:	  spirangien	  (with	  its	  (E,E,Z,E,E)	  polyenic	  tail)	  and	  Nicolaou	  and	  
coworkers’	  approach	  to	  certain	  endiandric	  acids	  via	  polyenes	  4.1	  and	  4.2.	  
 
Polyenic structures have consistently challenged synthetic chemists throughout 
history, with reactive variants often prone to rearrangement through 
electrocyclisation, cis/trans isomerisation or transposition type reactions. This section 
will focus on one of the tactics which has been used to overcome these challenges – 
the protection of dienic subunits as their tricarbonyliron complexes. 
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4.1.2  Protection of Reactive Polyenes as their 
Tricarbonyliron Complexes 
 
Since the initial synthesis of a tricarbonyliron-diene complex in 1930,[157] 
tricarbonyliron complexation has been adopted by organic chemists as a means of 
stabilising a range of reactive polyenes. While complexes may be formed of dienes and 
many other carbonyl metal species, tricarbonyliron complexes are preferable for 
organic synthesis due to the relative ease by which they may be synthesised, the 
selectivity typically observed for formation of the monomeric tricarbonyliron-diene 
complex, the relative stability of the resultant complex, and the ease by which these 
complexes may be characterised. These considerations will be elaborated upon in the 
passages that follow. 
 
 
4.1.3  Synthesis of Tricarbonyliron-Diene Complexes 
 
Numerous sets of conditions have been developed for the synthesis of tricarbonyliron-
diene species.  
 
Traditionally, tricarbonyliron-diene complexes are prepared from a diene and an 
inorganic source of tricarbonyliron. The first synthesis was performed using 
pentacarbonyliron at elevated pressure and temperature,[157] however milder and more 
selective conditions were developed soon after. These typically involved the use of the 
carbonyliron clusters nonacarbonyldiiron or dodecacarbonyltriiron.[158] Complexations 
using these reagents could typically be performed at temperatures ranging between 
60-80 °C, versus 135-140 °C for reactions using pentacarbonyliron. Alternatively, 
photochemically-promoted complexations can be performed using 
pentacarbonyliron,[159] and ultrasound-promoted complexations have been reported 
using nonacarbonyldiiron.[160] Complexations have also been reported using Collman’s 
reagent.[161] A summary of these conditions is presented below in scheme 4.1. 
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Scheme	  4.1.	  Conditions	  for	  the	  synthesis	  of	  tricarbonyliron-­‐diene	  complexes	  using	  inorganic	  
sources	  of	  tricarbonyliron.	  
 
The exact mechanism by which complexation occurs is dependent on the reaction 
conditions and any additives which might be present. However, it should be noted 
that pentacarbonyliron, nonacarbonyldiiron and dodecacarbonyltriiron are all 18 
electron, coordinatively-saturated species. It is likeliest that complexation begins with 
the dissociation of a carbon monoxide ligand from the iron carbonyl species, forming 
a 16 electron species that may then be bound by an alkene. From this point, loss of an 
additional carbon monoxide ligand and association of the second alkene unit gives the 
tricarbonyliron-diene complex.[162] Complexations using nonacarbonyldiiron and 
dodecacarbonyltriiron also require the dissociation of tricarbonyliron or a progenitor 
thereof from the cluster at some point in this sequence. For illustrative purposes, the 
mechanism for the tricarbonyliron complexation of butadiene using pentacarbonyliron 
is presented below: 
 
 
Figure	   4.2.	  Mechanism	   for	   the	   complexation	   of	   butadiene	   (4.3)	  with	   tricarbonyliron	   using	  
pentacarbonyliron	  (4.5).	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Alternatively, complexations can be performed using tricarbonyliron complexed to an 
organic transfer agent. A comprehensive review of these reagents has recently been 
published by Knölker.[162] Some examples of these transfer agents are depicted below 
in figure 4.3: 
 
 
Figure	  4.3.	  Organic	  transfer	  agents	  for	  the	  tricarbonyliron	  complexation	  of	  butadienes.	  
 
In each of these cases the tricarbonyliron complex is weakly bound to the enone, 
azadiene, or alkenes to which it is bound, and so will quickly transfer under mild 
conditions to any system to which it coordinates more strongly, such as a 1,3-diene 
with favourable steric and/or electronic attributes. An illustrative mechanism – the 
transfer of tricarbonyliron from enone 4.9 to butadiene (4.3), is presented below: 
 
 
Figure	   4.4.	  Mechanism	   for	   the	   complexation	   of	   cyclohexadiene	  with	   tricarbonyliron	   using	  
complex	  4.9.	  
 
Tricarbonyl(benzylideneacetone)iron (4.9) is perhaps the most classic example of such 
a reagent,[163] while azadiene complex 4.10 is a more reactive, more recently developed 
variant which works through similar principles.[164] Complex 4.11 is formed from a 
chiral camphor derivative, and has been used in the asymmetric complexation of 
O(OC)3Fe
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O
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prochiral dienes with moderate enantioselectivity.[165,166] Azadiene reagents 4.10 and 
4.11 have been used catalytically in conjunction with an inorganic source of 
tricarbonyl iron.[164-­‐166] Complex 4.12 (“Grevels’ reagent”) is perhaps the most 
reactive source of tricarbonyliron of all, capable of complexing dienes which are 
otherwise completely inert to complexation (such as styrenes or 1,3-cyclooctadienes) 
at temperatures below 0 °C.[167] However this reactivity comes at a price, being the 
extreme amount of effort one must expend in preparing and handling the reagent.M 
 
 
4.1.4  Cleavage of Tricarbonyliron from Tricarbonyliron-
Diene Complexes 
 
Tricarbonyliron groups are typically cleaved from dienes under oxidative conditions, 
although some alternatives exist as well. These are summarised below in table 4.1: 
 
1 e- oxidants 2 e- oxidants Other 
CAN TMANO hν 
FeCl3 NMO NaOH 
CuCl2 H2O2 / NaOH Raney Ni 
 Pb(OAc)4 Δ∆ 
Table	  4.1.	  Reagents	  for	  the	  cleavage	  of	  tricarbonyliron	  groups	  from	  dienes.	  
 
Typically, a one-electron oxidant is used for the cleavage of tricarbonyliron groups 
from butadienes. Cerium ammonium nitrate[170] is perhaps the most frequently used, 
favoured for its mildness and selectivity as an oxidant. However, iron(III) chloride[171] 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
M Grevels’ reagent’s potency as a complexation reagent is matched by its instability. 
The complex decomposes rapidly in solution at temperatures above −35 °C.[167] Its 
synthesis requires custom glassware, with numerous experimentalists so equipped 
having commented on the challenges associated with its preparation.[168,169] 
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and copper(II) chloride[172] have also been reported to act effectively.N A range of two-
electron oxidants have also been used, amongst them trimethylamine N-oxide,[173] N-
methylmorpholine N-oxide,[174] hydrogen peroxide / sodium hydroxide[175] and 
lead(IV) acetate.[176] 
 
Other approaches that have proven effective include photolysis,[177,178] and treatment 
of the complex with sodium hydroxide.[179] Complexes have also been cleaved using 
Raney nickel and methanol (with concomitant hydrogenation of the diene),[180] as well 
as under thermolytic conditions (destructively, on analytical scale).[181] 
 
 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  N	  This list is likely far from exhaustive – in the course of the author’s own 
investigations tetracyanoethylene was also discovered to be effective for these 
purposes.	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4.2   Tricarbonyliron Protection of Unstable Polyenes 
 
4.2.1  Strategies for the Preparation of Tricarbonyliron 
Complexes of Unstable Polyenes 
 
There are three basic strategies for the synthesis of polyenic tricarbonyliron 
complexes. These are outlined below: 
 
 
Scheme	   4.2.	   Strategies	   for	   the	   synthesis	   of	   the	   tricarbonyliron	   complexes	   of	   reactive	  
molecules.	  
(a)	  Na2[Fe(CO)4],	  hexane,	  22	  °C,	  48	  h,	  29%;	  (b)	  Fe2(CO)9,	  Et2O,	  25	  °C,	  24	  h,	  70%;	  (c)	  Fe2(CO)9,	  
C6H6;	  (d)	  MeLi,	  Et2O,	  then	  “acid”.	  
 
The first approach involves the direct complexation of the hydrocarbon. This strategy 
works when the hydrocarbon is sufficiently stable to not decompose under the 
conditions of the complexation. This approach was used in the synthesis of the 
tricarbonyliron complex of o-xylyene (4.18), in which free o-xylyene (4.17) was 
generated in situ, then complexed using Collman’s reagent.[182-184] 
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SYNTHESIS AND CROSS-COUPLING OF TRICARBONYLIRON-DIENE COMPLEXES 163 
The second approach involves reacting a precursor to the ligand of the desired 
complex with an iron source, generating the ligand in the process. An example of this 
is the synthesis of the tricarbonyliron complex of trimethylenemethane (4.20), formed 
from the reaction of dichloride 4.19 with nonacarbonyldiiron, amongst other 
routes.[185] 
 
The third approach involves synthesis of a tricarbonyliron complex which can be 
converted to the desired complex through further chemical transformations. 
Tricarbonyl(buta-1,3-dienol)iron (4.23) was prepared using such a strategy, in which 
the trimethylsilyl-protected complex 4.22 was prepared and isolated, after which the 
trimethylsilyl group was cleaved to give the target complex.[184] 
 
 
4.2.2  Categories of Unstable Polyenes Prepared as their 
Tricarbonyliron Complexes 
 
The propensity of tricarbonyliron groups to stabilise reactive polyenic systems has 
been extensively utilised throughout the history of synthetic chemistry. A summary of 
various hydrocarbons prepared by these means, classified by mode of decomposition, 
is presented below in figure 4.5. 
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Figure	  4.5.	  A	  graphical	  summary	  of	  unstable	  polyenic	  systems	  prepared	  using	  tricarbonyliron	  
protection	  strategies.	  
 
A full review of the synthesis and reactivity of these complexes is beyond the scope of 
this chapter, although the reader is invited to look out for the soon-to-be published 
review on the subject by Toombs-Ruane and Sherburn.[253] Rather, the remainder of 
this section will focus on the use of tricarbonyliron groups in the synthesis of 
dendralenic cross-conjugated systems. 
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4.2.3  Synthesis of Tricarbonyiron Complexes of 
Dendralenes 
 
The first synthesis of a tricarbonyliron dendralene complex was reported by Greene 
and coworkers:[186] 
 
 
Scheme	  4.3.	  Synthesis	  of	  bis-­‐tricarbonyliron	  complex	  of	  [4]dendralene	  from	  bromoprene.	  
(a)	  Fe2(CO)9,	  hexane,	  68	  °C,	  2	  h,	  0.1%.	  
 
Greene and coworkers were engaged in a broader study concerning the reactivity of 
halogenated dienes with carbonyliron clusters. In the course of these investigations 
they isolated a minimal quantity of the depicted bis-tricarbonyliron [4]dendralene 
complex 4.50. This assignment was confirmed by a second synthesis of complex 4.50 
starting from [4]dendralene:  
 
 
Scheme	  4.4.	  Synthesis	  of	  mono-­‐	  and	  bis-­‐tricarbonyliron	  complexes	  of	  [4]dendralene.	  
(a)	  Fe2(CO)9,	  ligroin,	  42-­‐48	  °C,	  1	  h	  	  reflux,	  50	  min,	  26%	  (4.52)	  and	  15%	  (4.50).	  
 
[4]Dendralene (4.51) was prepared following a literature procedure,[187] then 
complexed with tricarbonyliron directly using nonacarbonyldiiron. Through this 
approach mono-complexed [4]dendralene and both diastereomers of bis-complexed 
[4]dendralene were accessed. 
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SYNTHESIS AND CROSS-COUPLING OF TRICARBONYLIRON-DIENE COMPLEXES 166 
A synthesis of the tricarbonyliron complex of 2,2’-dimethyl[3]dendralene (4.55) was 
later published by Lillya and coworkers.[188,189]  
 
 
Scheme	  4.5.	  Synthesis	  of	  the	  tricarbonyliron	  complex	  of	  2,2’-­‐dimethyl[3]dendralene.	  
(a)	  FSO3H,	  −65	  °C;	  (b)	  −65	  °C	  	  −49	  °C	  	  −65	  °C	  then	  MeOH,	  72%.	  
 
This synthesis was developed as part of a broader study exploring the reactivity of 
tricarbonyliron-diene cations. Complex 4.53 was treated with fluorosulfonic acid, 
forming a cation of the proposed form 4.54. When this intermediate was warmed 
above 50 °C for a few minutes before quenching, dendralene complex 4.55 was 
observed to form selectively. 
 
The synthesis of a tricarbonyliron complex of a cyclic dendralene was reported by 
Stephenson and coworkers:[190] 
 
 
Scheme	  4.6.	  Synthesis	  of	  the	  tricarbonyliron	  complex	  of	  a	  cyclic	  dendralene.	  
(a)	  p-­‐toluenesulfonic	  acid,	  C6H6,	  80	  °C,	  5	  d,	  94%.	  
 
Stephenson and coworkers sought to access a range of tricarbonyliron-complexed 
cyclohexadienes bearing various olefinic side chains. In the course of these studies, 
cyclic dendralenic complex 4.57 was formed through the dehydration of precursor 
4.56. 
 
Martina and Brion developed the first synthesis of the tricarbonyliron complexes of  
1-(E)-[3]dendralenes and 1-(Z)-[3]dendralenes:[191] 
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Scheme	   4.7.	   Synthesis	   of	   tricarbonyliron	   complexes	   of	   1-­‐(E)-­‐[3]dendralenes	   and	   1-­‐(Z)-­‐
[3]dendralenes.	  
(a)	  4.63,	  NaH,	  DME,	  25	  °C,	  1	  h,	  95%;	  (b)	  BF3.Et2O,	  C6H6,	  80	  °C,	  2	  h,	  95%.	  
 
Martina and Brion sought to study the synthesis and reactivity of tricarbonyliron 
butadiene complexes substituted with aldehydes or esters in the 2-position. As part of 
these investigations, aldehyde 4.58 was converted by a Horner-Wadsworth-Emmons 
reaction to the 1-(E)-[3]dendralene complex 4.59. This was then isomerised with 
boron trifluoride to give regioisomeric complex 4.60. Martina and Franck-Neumann 
and coworkers later applied this approach to the synthesis complexes 4.61 and 4.62, 
produced as mixtures of (E/Z) isomers.[192] 
 
Franck-Neumann and coworkers also prepared two keto-homologues of complex 4.58 
(4.63 and 4.64), then utilised them in the synthesis of their respective 2-
trimethylsilyloxy functionalised [3]dendralenes:[193] 
 
 
Scheme	   4.8.	   Synthesis	   of	   two	   tricarbonyliron	   complexes	   of	   2-­‐trimethylsilyloxy-­‐substituted	  
[3]dendralenes.	  
(a)	  TMSOTf,	  Et3N,	  CH2Cl2,	  0	  °C,	  85%	  for	  4.65,	  90%	  for	  4.66.	  
 
Chen and Li have prepared a few examples of tricarbonyliron complexes of cyclic 
dendralenes using a cross-coupling approach:[194] 
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SYNTHESIS AND CROSS-COUPLING OF TRICARBONYLIRON-DIENE COMPLEXES 168 
 
 
Substituent (-R) Yield (%) Product ratio (a:b) 
Ph (4.68) 83 1:0 
COCH3 (4.69) 57 1:1 
CHO (4.70) 62 3:1 
CO2CH3 (4.71) 42 6:1 
Table	  4.2:	  Synthesis	  of	  tricarbonyliron	  complexes	  of	  cyclic	  [3]dendralenes.	  
(a)	  Pd(OAc)2,	  PPh3,	  CH3CN,	  60	  °C,	  1	  h.	  
 
The authors sought to investigate the effect that a tricarbonyliron group might have 
in activating or deactivating a butadiene towards cross-coupling (to be discussed 
further in section 4.3.2 below). In the course of these studies the four dendralenes 
4.68-4.71 were prepared. Complexes 4.69-4.71 were noticed to isomerise under 
reaction conditions, with the tricarbonyliron groups of each being observed to migrate 
from the cyclic position to the semicyclic position of the dendralene. 
 
In 2011 Sherburn and coworkers published the first paper which focused specifically 
on the preparation on the preparation of tricarbonyliron complexes of dendralenes.[195] 
 
 
Scheme	  4.9:	  Synthesis	  of	  tricarbonyliron	  complexes	  of	  [3]dendralene	  and	  [4]dendralene.	  
(OC)3Fe
Cl
R
(OC)3Fe
R
Fe(CO)3
Ra
4.67 a b
(OC)3Fe
Fe(CO)3
(OC)3Fe
Fe(CO)3
(OC)3Fe Fe(CO)3
67 : 23 : 10 ratio
NPMP Ph
4.74
a
b
4.72 4.73
4.51 4.50a 4.50b 4.75
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(a)	  Fe2(CO)9,	  4.74,	  DME,	  60	  °C,	  4	  h,	  71%;	  (b)	  Fe2(CO)9,	  4.74,	  DME,	  60	  °C,	  140	  h,	  73%	  (67:23:10	  
4.50a,	  4.50b	  and	  4.75).	  
 
Tricarbonyliron complexes of [3]dendralene and [4]dendralene were prepared 
through direct complexation of the parent dendralene, using diironnonacarbonyl and 
the azadiene catalyst 4.74. Three products were generated from the complexation of 
[4]dendralene, being a mixture of diastereomeric bis-complexes 4.50a and 4.50b, plus 
the internally complexed mono-complex 4.75. 
 
The [3]dendralene complex 4.73 could be elaborated into a range of substituted 
[3]dendralene complexes using cross metathesis: 
 
 
Scheme	   4.10:	   Synthesis	   of	   a	   range	   of	   1-­‐(E)-­‐substituted	   tricarbonyliron	   complexes	   of	  
[3]dendralene.	  
(a)	  Grubbs	  II,	  DCM,	  40	  °C,	  16	  h.	  
 
This transformation highlights the utility of tricarbonyliron protection in polyene 
synthesis, with such transformations not being possible on the free ligand.O 1-(Z)-
functionalised [3]dendralenes are extremely reactive, and so a protecting group 
strategy such as this is a necessary part of their synthesis.[128] 
 
Tricarbonyliron complex 4.73 can also undergo a self-metathesis reaction: 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  O	  It is believed that this is because the central alkene of the dendralene chelates the 
ruthenium catalyst, inhibiting turnover.[196] 	  
(OC)3Fe (OC)3Fe
RR a
4.73
4.76: R = Ph  74%
4.77: R = 4-NO2Ph  52%
4.78: R = 4-CH3OPh  67%
4.79: R = ferrocenyl  70%
4.80: R = CO2CH3  85%
4.81: R = CH2OAc  76%
(OC)3Fe
(OC)3Fe
Fe(CO)3
a
4.73 4.82
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Scheme	  4.11.	  Self	  metathesis	  of	  tricarbonyliron	  complex	  4.73.	  
(a)	  Grubbs	  II,	  DCM,	  40	  °C,	  16	  h,	  95%.	  
 
Decomplexation of this unusual bis-tricarbonyliron complex 4.82 gave the free ligand, 
a reactive and intriguing cross-conjugated hydrocarbon that had not been prepared 
previously. 
 
Additional tricarbonyliron-dendralene complexes (and tricarbonyliron-
dehydrodendralene complexes) have prepared using a cross-coupling approach on 
complexes of chlorobutadienes. A discussion of their preparation is more 
appropriately placed in the following section. 
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4.3   Synthesis and Cross-Coupling of Halide- and 
Pseudohalide-Functionalised Tricarbonyliron-
Diene Complexes 
 
The original research to be detailed in this chapter will explore attempts to prepare 
dendralenes and other cross-conjugated structures through the cross coupling of 
halide- and pseudohalide-functionalised diene units. Accordingly, it is fitting to 
review prior art in the area, concerning both the preparation of halide- and 
pseudohalide-functionalised butadienes, and their use in cross-coupling chemistry. 
 
 
4.3.1  Synthesis of Tricarbonyliron Complexes of 
Halogenated Acyclic Dienes 
 
A great body of work exists concerning the synthesis of halide and pseudohalide 
functionalised tricarbonyliron-diene complexes. For the sake of relevance and brevity, 
discussion of the synthesis of cyclic variants will be limited to instances in which there 
are no examples of an acyclic complex having been prepared.  
 
 
4.3.1.1  Synthesis of Tricarbonyliron Complexes of Chlorinated 
Butadienes 
 
4.3.1.1.1  Synthesis of Mono-Chlorinated Tricarbonyliron-Butadiene 
Complexes  
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Syntheses of tricarbonyl(1-(E)-chlorobutadiene)iron (4.84) have been reported by 
Brune and coworkers,[197] Nelson and coworkers[198] and Chen and Li.[194] These 
approaches are summarised below in scheme 4.12: 
 
 
Scheme	  4.12.	  Synthesis	  of	  tricarbonyl(1-­‐(E)-­‐chlorobutadiene)iron	  (4.84).	  
(a)	  Fe3(CO)12,	  THF,	  60	  °C,	  3	  h,	  27%;[197]	  (b)	  Fe3(CO)12,	  THF,	  66	  °C,	  2	  h,	  14%;[198]	  (c)	  4.85,	  BuLi,	  
−78	  °C	  	  25	  °C;	  (d)	  Fe3(CO)12,	  hexane,	  68	  °C,	  24	  h,	  10%	  over	  two	  steps.[194]	  
  
Brune and coworkers and Nelson and coworkers both prepared complex 4.84 through 
similar approaches, preparing the target in 27% and 14% yields respectively from 1-
(E)-chlorobutadiene (4.83). Li and coworkers also applied a direct complexation 
approach but started from acrolein (4.86), reporting a 10% yield over two steps. 
 
Syntheses of tricarbonyl(chloroprene)iron (4.88) have been reported by Brune and 
coworkers,[199] Nelson and coworkers[198] and Yeh and coworkers.[200] These 
approaches are summarised below in scheme 4.13: 
 
 
Scheme	  4.13.	  Synthesis	  of	  tricarbonyl(chloroprene)iron	  (4.88).	  
(a)	  Fe3(CO)12,	  THF,	  60	  °C,	  3	  h,	  21%;[199]	  (b)	  Fe2(CO)9,	  hexane,	  68	  °C,	  2	  h,	  3%;[198]	  (c)	  Fe3(CO)12,	  
THF,	  66	  °C,	  2	  h,	  4%;[198]	  (d)	  Fe2(CO)9,	  toluene,	  110	  °C,	  5	  h,	  32%.[200]	  
Cl (OC)3Fe Cl
a or b
O (OC)3Fe Cl
c d
Cl
Ph3P Cl
Br
4.85
4.86 4.844.83
4.83 4.84
(OC)3Fe
a, b or c
(OC)3Fe
d
Cl Cl
S
O2
Cl
Cl Cl
4.87 4.88
4.89 4.884.87
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Brune and coworkers report synthesising complex 4.88 in 21% yield directly from 
chloroprene, a result considerably better than those reported by Nelson and coworkers 
under their two sets of conditions. Yeh and coworkers took a different approach, 
preparing chloroprene by thermolysis of sulfone 4.89, which was rapidly complexed in 
situ using diironnonacarbonyl. 
 
Interestingly, the synthesis of tricarbonyl(1-(Z)-chlorobutadiene)iron (4.90) has never 
been reported. This is perhaps due to the steric hindrance which would result from 
the inward-pointing chloride of such a complex. 
 
 
Figure	   4.6.	   Steric	   interactions	   between	   the	   tricarbonyliron	   and	   chloride	   groups	   of	   a	  
hypothetical	  tricarbonyl(1-­‐(Z)-­‐chlorobutadiene)iron	  complex	  (4.90).	  
 
 
4.3.1.1.2  Synthesis of Bis-Chlorinated Tricarbonyliron-Butadiene 
Complexes 
 
A synthesis of tricarbonyl(1,2-dichlorobutadiene)iron (4.93) has been reported by 
Brune and coworkers:[197] 
 
 
Scheme	  4.14.	  Synthesis	  of	  tricarbonyl(1,2-­‐dichlorobutadiene)iron	  (4.93).	  
(a)	  Cl2,	  CHCl3;	  (b)	  KOH,	  MeOH;	  (c)	  Fe3(CO)12,	  THF,	  60	  °C,	  3	  h,	  14%.	  
 
Trichlorobutene 4.91 was synthesised from the addition of chlorine to chloroprene. 
Hydrogen chloride was selectively eliminated from 4.91 to produce what Brune and 
(OC)3Fe
Cl( (
4.90
Cl a ClCl
Cl
b Cl
Cl
c
(OC)3Fe
Cl
Cl
4.87 4.924.91 4.93
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coworkers suspected to be 1,2-dichlorobutadiene (4.92). This was complexed directly 
with triirondodecacarbonyl to give complex 4.93, which could be fully characterised. 
 
A synthesis of tricarbonyl(1,4-dichlorobutadiene)iron has also been reported by Brune 
and coworkers:[201] 
 
 
Scheme	  4.15.	  Synthesis	  of	  tricarbonyl(1,4-­‐dichlorobutadiene)iron	  (4.98).	  
(a)	  Cl2;	  (b)	  DMAD;	  (c)	  Δ;	  (d)	  Fe3(CO)12,	  THF,	  60	  °C,	  3	  h,	  24%	  (29%	  b.r.s.m.).	  
 
Cyclooctatetraene (4.94) was reacted with chlorine, which electrocyclised under the 
conditions of the reaction to give dichloride 4.95 as a mixture of stereoisomers. This 
mixture was reacted with dimethyl acetylenedicarboxylate to give adduct 4.96 (plus 
other stereoisomers). This mixture was subjected to pyrolysis conditions, with the 
trans-stereoisomers decomposing to give 1,4-dichlorobutadiene (4.97), which was 
reacted with triirondodecacarbonyl to give complex 4.98. 
 
Tricarbonyl(2,3-dichlorobutadiene)iron (4.100) has been prepared by Brune and 
coworkers,[199,202] and Nelson and coworkers:[198] 
 
 
Scheme	  4.16.	  Synthesis	  of	  tricarbonyl(2,3-­‐dichlorobutadiene)iron	  (4.100).	  
(a)	  Fe3(CO)12,	  THF,	  60	  °C,	  3	  h,	  5%;[202]	  (b)	  Fe3(CO)12,	  THF,	  66	  °C,	  2	  h,	  3%;[198]	  
a Cl
Cl
b
CO2CH3
H3CO2C
Cl
Cl
H
H
c
Cl
Cl d
(OC)3Fe Cl
Cl
4.94 4.96
(plus other stereoisomers)
4.95
(plus other stereoisomers)
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(OC)3Fe
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Cl
Cl
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4.99 4.100
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Both groups prepared complex 4.100 by similar means, reacting 2,3-
dichlorobutadiene (4.99) directly with triirondodecacarbonyl.  
 
The remaining tricarbonyliron bis-chlorobutadiene complex – tricarbonyl(1,3-
dichlorobutadiene)iron, is yet to be prepared. No examples have been prepared of a 
bis-chlorobutadiene complex bearing an inward-pointing chloride at the 1- or 4-
position. 
 
 
4.3.1.1.3  Synthesis of Tris-Chlorinated Tricarbonyliron-Butadiene 
Complexes and Higher 
 
A synthesis of tricarbonyl(1,2,3-trichlorobutadiene)iron (4.106) has been reported by 
Brune and coworkers:[203] 
 
 
Scheme	  4.17.	  Synthesis	  of	  tricarbonyl(1,2,3-­‐trichlorobutadiene)iron	  (4.106).	  
(a)	  HCl,	  CuCl,	  NH4Cl;	  (b)	  Cl2;	  (c)	  Cl2;	  (d)	  KOH,	  MeOH;	  (e)	  Fe3(CO)12,	  THF,	  60	  °C,	  4	  h,	  2%.	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Trichloride 4.105 was prepared over four steps from chloroprene, through a series of 
chlorinations and eliminations. The tricarbonyliron group was added directly using 
triirondodecacarbonyl, giving complex 4.106. 
 
In the same publication Brune and coworkers also detailed their synthesis of 
tricarbonyl(1,2,4-trichlorobutadiene)iron (4.111): 
 
 
Scheme	  4.18.	  Synthesis	  of	  tricarbonyl(1,2,4-­‐trichlorobutadiene)iron	  (4.111).	  
(a)	  Cl2,	  CH3CO2H;	  (b)	  KOH,	  CH3OH;	  (c)	  Δ;	  (d)	  Fe3(CO)12,	  THF,	  60	  °C,	  4	  h,	  3%.	  
 
Trichloride 4.110 was formed in three steps from the known compound 3,4-dichloro-
1-butene (4.109). Complexation was performed directly using triirondodecacarbonyl 
to give complex 4.111. 
 
Ullah and coworkers have reported the synthesis of 
tricarbonyl(hexachlorobutadiene)iron (4.113):[204] 
 
	    
Scheme	  4.19.	  Synthesis	  of	  tricarbonyl(1,2,4-­‐trichlorobutadiene)iron	  (4.113).	  
(a)	  Fe(CO)5,	  hν,	  65%.	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This is the only example of a reported complex bearing inward-pointing chlorides, 
and is a complex which Brune and coworkers report being unable to prepare under 
various conditions.[199] 
 
Brune and coworkers also report preparing three chlorobutadiene species which they 
were unable to complex with a tricarbonyliron group: 
 
  
Figure	  4.7.	  Chlorobutadienes	  which	  could	  not	  be	  complexed	  with	  tricarbonyliron.	  
 
Butadienes 4.114 and 4.115 could not be complexed,[197,203] presumably due to the 
steric influence of the inward-pointing chlorides in either example. Tetrachloride 
4.116 could not be complexed either,[197] for reasons which are not immediately 
apparent. 
 
 
4.3.1.2  Synthesis of the Tricarbonyliron Complexes of 
Brominated Butadienes. 
 
The sole examples in this category – tricarbonyl(1-bromobutadiene)iron and 
tricarbonyl(2-bromobutadiene)iron, were reported in a paper by Greene and 
coworkers:[186] 
 
 
Cl
Cl
Cl
Cl
Cl
Cl
Cl
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Cl Cl
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4.114 4.1164.115
(OC)3Fe
a
(OC)3Fe
a
Br Br
BrBr
4.117 4.118
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Scheme	   4.20.	   Synthesis	   of	   tricarbonyl(1-­‐bromobutadiene)iron	   (4.118)	   and	   tricarbonyl(2-­‐
bromobutadiene)iron	  (4.119).	  	  
(a)	  Fe2(CO)9,	  hexane,	  68	  °C,	  2	  h,	  0.4%	  for	  4.118,	  6%	  for	  4.119.	  
 
These complexes were both prepared by direct complexation of the bromobutadiene 
using diironnonacarbonyl. Yields of both complexes (especially 1-bromo complex 
4.118) are considerably lower than those recorded for the corresponding chlorides. 
One can speculate that this might be due to the greater propensity of iron to interact 
with carbon-bromine bonds over a carbon-chlorine bonds, although this has not been 
proven definitively. 
 
 
4.3.1.3  Synthesis of the Tricarbonyliron Complexes of 
Pseudohalide-Functionalised Butadienes. 
 
No examples have been prepared of acyclic dienes bearing “pseudohalide” 
functionality. However, there are a few examples of complexes of cyclic dienes with 
such functionality. For the purposes of this discussion, the term “pseudohalide” will 
be limited in definition to triflate, tosylate or mesylate groups. 
 
The sole example of a tricarbonyliron diene complex with a pseudohalide at the 1-
position comes from the work of Stephenson and coworkers:[205] 
 
 
Scheme	  4.21.	  Synthesis	  of	  triflate	  complex	  4.123.	  
H3CO a
H3CO
(OC)3Fe
b O
(OC)3Fe
c
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4.123
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(a)	  Fe(CO)5,	  benzene,	  25	  °C,	  50	  h,	  24%;	  (b)	  triphenylmethyl	  fluoroborate,	  CH2Cl2,	  25	  °C,	  82%;	  
(c)	  Tf2O,	  CH2Cl2,	  25	  °C	  then	  BF4H;	  Li(tBuO)3AlH,	  THF,	  −100	  °C,	  70%	  over	  2	  steps.	  
 
The tricarbonyliron complex of cyclohexa-2,4-dien-1-one (4.122) was prepared 
according to the protocol of Lewis and coworkers,[159] which was converted to the 
triflate 4.123 via its tetrafluoroborate salt. 
 
The synthesis of tricarbonyliron diene complexes with a pseudohalide at the 2-
position has been reported by Okauchi and coworkers: 
 
 
Scheme	  4.22.	  Synthesis	  of	  triflate	  4.125	  and	  mesylates	  4.126-­‐4.129.	  
(a)	  Tf2O,	  Et3N,	  CH2Cl2,	  0	  °C	  	  25	  °C,	  0.5	  h,	  91%.	  Yields	  for	  4.126-­‐4.129	  were	  not	  provided.	  
 
In their initial publication, Okauchi and coworkers detail the conversion of alcohol 
4.124P to triflate 4.125.[206]  In a subsequent publication they report the synthesis of 
mesylates 4.126-4.129 using this same approach.[207] Note that complex 4.129 bears a 
methyl group pointing inwards towards the tricarbonyliron group – a rare example of 
such a complex. 
 
 
4.3.2  Cross-coupling of Halide- and Pseudohalide-
Functionalised Tricarbonyliron-Diene Complexes 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
P It appears that alcohol 4.124 was synthesised from its corresponding trimethylsilyl 
ether, although the reporting of this detail was ambiguous. 
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Prior to our group’s efforts in this area, a limited but not unsubstantial body of work 
existed concerning the cross-coupling of functionalised tricarbonyliron butadiene 
complexes. This work will be summarised below, followed by the efforts of previous 
workers within the Sherburn group. 
 
The first work in this area was performed by Bunz and coworkers, on the related 
cyclobutadiene-tricarbonyliron system.[208,209] A representative example of their work is 
provided below in scheme 4.23. 
 
 
Scheme	   4.23.	   Synthesis	   of	   tricarbonyliron-­‐complexed	   tetraethynylcyclobutadienes	   4.131-­‐
4.133	  from	  tricarbonyl(tetraiodocyclobutadiene)iron	  4.130.	  
(a)	  Pd2(dba)3,	  AsPh3,	  DMF,	  20	  °C,	  18	  h.	  
 
In the depicted example, tetraiodo complex 4.130 was coupled under Stille conditions 
with a limited range of alkynyl stannanes, giving tetraethynylcyclobutadienes 4.131-
4.133. 
 
Stephenson and coworkers later detailed their efforts concerning the cross-coupling of 
triflate-functionalised cyclohexadienes:[205] 
 
Fe(CO)3
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4.130 4.131: R = tBu, 20%
4.132: R = TMS, 83%
4.133: R = octyl, 25%
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Scheme	  4.24.	  Cross-­‐coupling	  of	  triflate-­‐functionalised	  cyclohexadiene	  complex	  4.123.	  
(a)	  Pd(PPh3)2Cl2,	   LiCl,	  NMP,	  25	   °C,	  16	  h,	  81%;	   (b)	  Pd(PPh3)2Cl2,	  CuI,	   iPr2NH,	  THF,	  66	   °C,	  6	  h,	  
93%.	  
 
Triflate 4.123 was cross-coupled under Stille conditions with vinyl stannane 4.134 to 
give triene complex 4.135. The same triflate was cross-coupled under Sonogashira 
conditions with trimethylsilylacetylene (4.136) to give dienyne complex 4.137. This is 
the only reported example of a triflate-functionalised tricarbonyliron-diene complex 
undergoing cross-coupling. 
 
In another study, Fairlamb and coworkers report the cross-coupling of the 
tricarbonyliron-bromopyrone complex 4.138:[168] 
 
 
Scheme	  4.25.	  Cross-­‐coupling	  of	  tricarbonyliron-­‐complexed	  bromopyrone	  4.138.	  
(a)	  Pd(OAc)2,	  PPh3,	  Na2CO3,	  benzene/EtOH,	  25	  °C,	  2	  h,	  64%	  and	  67%	  respectively.	  
 
Bromopyrone complex 4.138 (painstakingly synthesised using Grevels’ reagent) was 
coupled under Suzuki conditions with the appropriate boronic acid to give complexes 
4.139 and 4.140. In their report, Fairlamb and coworkers comment on the apparent 
increased reactivity of the complexed pyrone 4.138 versus its uncomplexed congener. 
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The most comprehensive (and most relevant) study is that reported by Chen and 
Li:[194] 
 
 
Scheme	  4.26.	  Heck	  and	  Sonogashira	  cross-­‐couplings	  using	  chlorinated	  tricarbonyliron-­‐diene	  
complexes.	  
(a)	  Pd(OAc)2,	  PPh3,	  Cs2CO3,	  CH3CN,	  60	  °C,	  1	  h;	  (b)	  Pd(PPh3)2Cl2,	  CuI,	  Et3N,	  60	  °C,	  3	  h.	  
 
In the first comprehensive study of the cross-coupling of chlorinated tricarbonyliron-
diene complexes, Chen and Li prepared chlorides 4.141, 4.167 and 4.84, then 
subjected them to Heck and Sonogashira cross-coupling conditions using a range of 
vinyl and ethynyl coupling partners. Note that cyclic dendralene complexes 4.68a-
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4.71a were prepared, as well as the cyclic dehydrodendralene complexes 4.154-4.156. 
The authors note the enhanced reactivity of the tricarbonyliron complex in cross-
coupling versus the free diene, noting that uncomplexed chloride 4.158 is inert to the 
Heck and Sonogashira conditions that were effective in cross-coupling of the 
complex: 
 
 
Scheme	  4.27.	  Attempted	  cross-­‐coupling	  of	  1-­‐chloro-­‐1,3-­‐cyclohexadiene	  (4.158)	  under	  Heck	  
and	  Sonogashira	  conditions.	  
(a)	  Pd(OAc)2,	  PPh3,	  Cs2CO3,	  CH3CN,	  60	  °C,	  1	  h,	  0%;	  (b)	  Pd(PPh3)2Cl2,	  CuI,	  Et3N,	  60	  °C,	  3	  h,	  0%.	  
 
It was at this point that investigations commenced in the Sherburn group towards the 
application of this methodology to the synthesis of a wider range of cross-conjugated 
tricarbonyliron complexes. Initial investigations were performed by Henry Toombs-
Ruane:[253] 
 
 
Scheme	   4.28.	   Suzuki	   cross-­‐couplings	   of	   chloroprene	   complex	  4.88	   and	   dichloride	   complex	  
4.100.	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(a)	   Pd2(dba)3.CHCl3,	   SPhos,	   Cs2CO3,	   THF/H2O,	   100	   °C,	   1	   h,	   67%	   for	  4.73,	   65%	   for	   4.75;	   (b)	  
Pd(dppf)Cl2,	  (BPin)2,	  KOAc,	  DMSO,	  105	  °C,	  “overnight”,	  35%;	  
 
Moderate success was achieved in the cross coupling of chloroprene complex 4.88 
under Suzuki conditions. The tricarbonyliron complex of [3]dendralene, plus 
internally-complexed [4]dendralene could be accessed in moderate yields under a 
standard set of conditions. The bis-complex of [4]dendralene could also be accessed, 
using a Miyaura borylation, Suzuki cross-coupling sequence.  
 
Cross-couplings were also performed under a range of other conditions. These results 
are summarised below: 
 
 
Scheme	   4.29.	   Cross-­‐couplings	   of	   chloroprene	   complex	   4.88	   and	   dichloride	   complex	   4.100	  
under	  other	  conditions.	  
(a)	  Pd(OAc)2,	  XPhos,	  DMF,	  60	  °C,	  15	  h,	  80%;	  (b)	  Pd(PPh3)4,	  THF,	  25	  °C,	  3	  h,	  79%	  for	  4.52,	  89%	  
for	  4.164;	  (c)	  Pd(OAc)2,	  PPh3,	  Cs2CO3,	  MeCN,	  1	  h,	  44%.	  
 
Cross coupling of chloroprene complex 4.88 with stannane 4.134 provided an 
alternative preparation of the tricarbonyliron-[3]dendralene complex. Negishi 
conditions proved effective for the synthesis of the dendralene complexes 4.52 and 
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4.164. Application of the Heck cross-coupling conditions developed by Chen and Li 
provided the 1-(E)-[3]dendralene complex 4.76, in admittedly modest yield. 
 
In addition to this, two rather curious structures were made using sp-sp2 cross 
couplings. These structures and their syntheses are illustrated below: 
 
 
 
Scheme	  4.30.	  sp-­‐sp2	  cross	  couplings	  of	  chloroprene	  complex	  4.88.	  
(a)	  Pd(PPh3)2Cl2,	  CuI,	  Et3N,	  45	  °C,	  3	  h,	  84%	  for	  4.166,	  74%	  for	  4.168,	  81%	  for	  4.170;	  (b)	  K2CO3,	  
MeOH,	  25	  °C,	  30	  min,	  91%.	  
 
The first part of scheme 4.30 depicts the synthesis of the unusual cross-conjugated 
bis-tricarbonyliron complex 4.168. Chloroprene complex 4.88 was coupled with 
trimethylsilylacetylene to give dehydrodendralene complex 4.166. The trimethylsilyl 
group of this complex was cleaved to give dehydrodendralene complex 4.167, which 
was subjected to a second cross-coupling with chloroprene complex 4.88 to give the 
bis-tricarbonyliron complex 4.168.  
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These same conditions were applied in tandem to generate tris-tricarbonyliron 
complex 4.170 from chloroprene complex 4.88 and 1,3,5-triethynylbenzene (4.169). 
 
 
 
 
 
  
	  
 
CHAPTER 5  
 
SYNTHESIS OF 1-[3]DEHYDRODENDRALENES 
AND 1-(Z)-[3]DENDRALENES FROM 
TRICARBONYLIRON-BUTADIENE PRECURSORS 
 
5.1 Synthesis and Cross-Coupling of Pseudohalide-
Functionalised Tricarbonyliron-Butadiene 
Complexes 
 
5.1.1 Target Complexes and Potential Approaches Towards 
their Synthesis 
 
Original research in this area began with an approach towards the synthesis and cross-
coupling of pseudohalide functionalised tricarbonyliron-diene complexes. As 
identified in the preceding literature review, this is an underdeveloped area in the 
literature as it presently stands. This presents an opportunity: not only are 
pseudohalides potentially extremely reactive under cross-coupling conditions,[210] but 
their synthesis is far more practical than the preparation of their corresponding 
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chlorides.Q This is of particular importance if this methodology is to later be applied 
to more complex diene-bearing systems. 
 
For the basic methods-driven investigation, the following complexes were identified 
as useful targets for synthesis: 
 
 
Figure	  5.1.	  Useful	  sulfonate-­‐functionalised	  tricarbonyliron-­‐diene	  complexes.	  
 
Complexes 5.1-5.8 could conceivably be accessed expediently through the application 
of a standard approach in the literature:[211,212] 
 
 
Figure	  5.2.	  A	  potential	  strategy	  for	  the	  synthesis	  of	  pseudohalide-­‐functionalised	  
tricarbonyliron-­‐diene	  complexes.	  
 
An illustrative approach is provided above in the preparation of the 2-functionalised 
complexes 5.3 and 5.4 from methyl vinyl ketone (5.9), although the approach could 
conceivably be applied to the preparation 1-functionalised, 1,4-functionalised and 
2,3-functionalised complexes starting from crotonaldehyde (5.11) succinaldehyde and 
biacetyl respectively. Methyl vinyl ketone could be converted to its TMS ether 4.21, 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Q The synthesis of which invariably involves the use of chlorine gas at some point in 
the process. 
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which could then be reacted with a tricarbonyliron source giving complex 4.22. This 
could then be converted to its triflate 5.3 or tosylate 5.4, through a desilylation, 
sulfonylation sequence via alcohol 4.23.  
 
This route was deemed preferable in the first instance to the attempted direct 
complexation of a triflate or tosylate functionalised butadiene: 
 
 
Figure	  5.3.	  Alternative	  route	  to	  pseudohalide-­‐functionalised	  tricarbonyliron-­‐butadiene	  
complexes.	  
 
Not only is there the potential for iron to insert into the carbon-sulfur bond of 
precursor 5.10, but such electron-poor dienes are also predisposed to dimerisation. 
The complexation of triflate- or tosylate-functionalised butadienes is without 
precedent in the literature. That said, if successful this sequence would provide more 
expedient access to the target complexes. It was decided that this route to the target 
tricarbonyliron complex would only be explored after complexes prepared through the 
more conventional route had been successfully cross-coupled. 
 
 
5.1.2 Synthesis of Pseudohalide-Functionalised 
Tricarbonyliron-Butadiene Complexes. 
 
The first complex targeted was the 1-functionalised tricarbonyliron-butadiene 
complex 5.1. Such a target was an obvious choice for synthesis, owing to its usefulness 
for the synthesis of a range of polyenic systems bearing a 1-functionalised diene.  
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Scheme	  5.1.	  Attempted	  synthesis	  of	  1-­‐functionalised	  tricarbonyl-­‐butadiene	  complex	  5.1.	  
(a)	  ZnCl2,	  TMSCl,	  Et3N,	  Et2O,	  35	  °C,	  5	  d,	  31%;	  (b)	  Fe3(CO)12,	  THF,	  60	  °C,	  3.5	  h,	  65%.	  
 
Silyl ether 5.12 was prepared following the protocol of Cui and coworkers.[213] Yields 
were low, but could likely be improved by refinements to experimental technique. 
 
Efforts then turned to the conversion of silyl ether 5.12 to its tricarbonyliron complex 
5.13. Preliminary investigations were performed using diironnonacarbonyl as the 
complexation reagent, under thermal or ultrasonic conditions as previously reported 
by Stone and Ley respectively.[158,160] While complex 5.13 was observed to form under 
these conditions, substantial quantities of byproduct were generated, from which the 
desired complex could not be purified. Greater success was encountered using 
triirondodecacarbonyl as the complexation reagent, applying some original conditions 
previously developed for the synthesis of tricarbonyl(1,4-diiodobutadiene)iron 
complexes.[140] Under these conditions, TMS ether-substituted complex 5.13 was 
prepared in synthetically-useful yields. 
 
Efforts then turned to the conversion of TMS ether 5.13 to triflate 5.1: Considerable 
effort was made to effect this transformation, without any success. Under a wide 
range of conditions, only the formation of crotonaldehyde was observed – the 
decomplexed, rearranged product of hypothesised intermediate 5.14. Isolation of this 
material suggests that while cleavage of the trimethylsilyl group was occurring, 
intermediate 5.14 was too unstable under the conditions screened for sulfonylation to 
be possible. This is in part supported by the findings of DePuy and coworkers, who 
have commented on the inherent instability of this complex (although they did 
manage to trap minimal amounts of the alcohol using benzoyl bromide).[184]  
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In the same study, DePuy and coworkers commented that the 2-hydroxybutadiene 
complex 4.23 is appreciably more stable than the 1-hydroxybutadiene complex 5.14, 
being an isolable species (albeit with considerable care invested in the process). Such 
studies provided reasonable support for the synthesis of 2-substituted complexes being 
possible by this route where synthesis of the 1-substituted complex had failed. While 
we weren’t entirely comfortable abandoning attempts towards the synthesis of 1-
functionalised complex 5.1 at this point, we felt that lessons learned in a successful 
preparation of the 2-functionalised complex could perhaps assist in its synthesis later 
on. Accordingly, work commenced on the following sequence.  
 
 
Scheme	  5.2.	  Synthesis	  of	  2-­‐functionalised	  tricarbonyliron-­‐butadiene	  complex	  5.3.	  
(a)	  LiBr,	  TMSCl,	  Et3N,	  THF,	  40	  °C,	  18	  d,	  41%;	  (b)	  Fe3(CO)12,	  THF,	  60	  °C,	  16	  h,	  35%;	  (c)	  TBAF,	  
DCM,	  0	  °C,	  1	  min;	  (d)	  iPr2NEt,	  Comins’	  reagent,	  25	  °C,	  30	  min,	  50%.	  
 
To begin with, methyl vinyl ketone was converted to the known silyl ether 4.21, 
following the protocol of Hansson and Carlson.[214]  
 
Attention then turned to the synthesis of the tricarbonyliron complex 4.22. By 
applying conditions used for the preparation of 1-substituted complex 5.13, pure 
quantities of complex 4.22 could accessed, albeit in slightly lower yields. Optimisation 
of this protocol revealed that the reaction could be performed using just a single 
equivalent of triirondodecacarbonyl with negligible effects on yield. Surprisingly, the 
product of this reaction (a trimethylsilyl ether) could be purified by column 
chromatography on silica with only minimal losses of product in the process (ca. 90% 
of starting material recovered). 
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Focus then shifted to the conversion of silyl ether 4.22 to its corresponding triflate 
5.3. Pleasingly this transformation proved possible on the 2-substituted complex, 
providing access to triflate 5.3 on practical scale. Initial attempts at this reaction were 
unsuccessful: alcohol 4.23 was observed to form on exposure to TBAF, but the 
alcohol could not be trapped as its triflate using Comins reagent – no conversion was 
observed. These reactions were performed in THF – the solvent typically used for the 
cleavage of trimethylsilyl ethers using TBAF. Success came when the solvent was 
switched to DCM – that most commonly used in conjunction with Comins’ reagent, 
but one very rarely used in conjunction with TBAF.R Despite the likely effect of this 
solvent choice on the structure and reactivity of TBAF,S the reaction was a success. 
The reaction proved scalable, with triflate 5.3 prepared on 900 mg scale through this 
approach. Pleasingly, alcohol intermediate 4.23 also proved isolable, however it was 
observed to rapidly decompose in the presence of oxygen. 
 
The structure of triflate 5.3 was assigned using 1H and 13C NMR spectroscopy, and 
mass spectrometry. The 1H NMR spectrum showed that the five diene protons had 
the distinctive upfield shift characteristic of tricarbonyliron complexation. On the 13C 
NMR spectrum one could see that the carbon environment of the triflate had been 
split into a quartet through coupling to the three fluorides to which it is bonded. The 
mass spectrum showed the loss of three successive carbonyl groups from the iron 
complex – a fragmentation pattern highly characteristic of tricarbonyliron-diene 
complexes.  
 
This approach could be adapted for the synthesis of the tosylate homologue 5.4: 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
R A search on SciFinder performed on 20/12/15 revealed only four examples of a 
trimethylsilyl ether being cleaved using TBAF with DCM as the solvent. 
S TBAF is a poorly defined reagent, existing with numerous equilibria influenced at 
least in part by solvent effects.[215] 
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Scheme	  5.3.	  Synthesis	  of	  tosylate	  5.4.	  
(a)	  TBAF,	  DCM,	  0	  °C,	  1	  min;	  (b)	  iPr2NEt,	  TsCl,	  25	  °C,	  24	  h,	  49%.	  
 
Tosylate 5.4 could be easily prepared by applying the conditions used for the synthesis 
of triflate 5.3, but using tosyl chloride in place of Comins’ reagent. The product 
proved highly crystalline, making for an easy, scalable purification. 
 
 
5.1.3 Cross-Coupling of Pseudohalide-Functionalised 
Tricarbonyliron-Butadiene Complexes 
  
With adequate quantities of triflate and tosylate butadiene complexes 5.3 and 5.4 now 
available, work began on their cross coupling.  
 
After screening a range of cross-coupling conditions, an initial success was 
encountered in the Sonogashira cross coupling of the triflate with TMS-acetylene, 
using conditions first published by Stephenson and coworkers:[205] 
 
 
Scheme	  5.4.	  Sonogashira	  cross-­‐coupling	  of	  triflate	  5.3	  with	  TMS-­‐acetylene	  (4.165).	  
(a)	  Pd(PPh3)2Cl2,	  CuI,	  iPr2NH,	  THF,	  60	  °C,	  30	  min,	  70%.	  
 
This result encouraged us. Examples of “dehydrodendralenes” have been prepared 
before,[216-231] but a general methodology for their synthesis was yet to be developed, 
and this seemed like an interesting approach to take. Iron complexation has the bonus 
effect of blocking the diene site of the dehydrodendralene, potentially allowing for 
selective functionalisation of the alkyne for the synthesis of a range of substituted 
[3]dendralenes: 
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Figure	  5.4.	  Cis-­‐	  or	  trans-­‐functionalisation	  of	  dehydrodendralenes	  for	  the	  synthesis	  of	  a	  range	  
of	  functionalised	  [3]dendralenes.	  
 
Unfortunately, this initial excitement soon turned to persistent disappointment. The 
aforementioned cross-coupling conditions so successful for the cross-coupling of the 
triflate 5.3 with TMS-acetylene proved largely incompatible with any other sort of 
alkyne coupling partner, never generating product in yields above 30% (although this 
itself is ambiguous, owing to the poor purity of products isolated). 
 
A second set of conditions were optimised, this time using phenylacetylene as the 
coupling partner: 
 
 
Scheme	  5.5.	  Heck	  alkynylation	  of	  triflate	  5.3.	  
(a)	  Pd(PPh3)2Cl2,	  Et3N,	  DMF,	  70	  °C,	  15	  min.	  
 
After a lengthy screening of conditions it was found that Heck alkynylation (copper-
free Sonogashira) conditions outperformed copper co-catalysed Sonogashira 
conditions. Optimal conditions presented were developed starting from a protocol for 
the Heck alkynylation of aryl triflates first reported by Chen and Yang.[232]  
 
Unfortunately the reaction could not be optimised past the point indicated, with a 
43% yield of phenyl-substituted complex 5.15 being the highest yield obtainable. The 
conditions also proved limited in scope, with butyl derivative 5.16 isolated in only a 
24% yield, and benzyl ether 5.17 only observed to form in trace quantities under the 
(OC)3Fe
R1 cis- or trans-
functionalisation
(OC)3Fe
R2
R1
R3
or
(OC)3Fe
R2
R1
R3
(OC)3Fe
OTf R a
(OC)3Fe
R
5.15  R = Ph  43%
5.16  R = nBu  24%
5.17  R = CH2OCH2Ph  trace
5.3
1-[3]DEHYDRODENDRALENES AND 1-(Z)-[3]DENDRALENES 195 
same conditions.T Large quantities of insoluble matter were observed to form in the 
course of these reactions, although attempts to characterise the material only provided 
ambiguous results. 
 
Unfortunately, tosylate-functionalised complex 5.4 also proved not to be useful for 
cross-coupling chemistry. Optimised conditions for its use are presented below: 
 
 
Scheme	  5.6.	  Heck	  alkynylation	  of	  tosylate	  5.4	  with	  phenylacetylene	  (4.160).	  
(a)	  Pd(MeCN)2Cl2,	  XPhos,	  Cs2CO3,	  MeCN,	  80	  °C,	  30	  min,	  ca.	  20%.	  
 
The best outcomes were observed using a set of conditions published by Gelman and 
Buchwald.[233] However, quantities of product formed were well below that which is 
synthetically useful, and had to be determined approximately through quantitative 
NMR techniques, owing to large quantities of inseparable impurity formed during the 
reaction. Curiously, tosylate 5.4 was observed to undergo homocoupling under the 
reaction conditions. When tosylate 5.4 was subjected to the reaction conditions in the 
absence of a coupling partner, the following reaction was observed to occur, albeit in 
yields that were not synthetically useful: 
 
 
Scheme	  5.7.	  Homocoupling	  of	  tosylate	  5.4	  under	  Heck	  alkynylation	  conditions.	  
(a)	  Pd(MeCN)2Cl2,	  XPhos,	  Cs2CO3,	  MeCN,	  80	  °C,	  30	  min,	  18%.	  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
T The presence of complex 5.17 in the crude material was later confirmed by 
comparison of the crude 1H NMR spectrum from this experiment against that 
recorded on pure material which I prepared by alternative means. 
(OC)3Fe
OTs Ph a
(OC)3Fe
Ph
5.155.4 4.160
(OC)3Fe
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It was at this point that we decided to change approach, opting instead to develop our 
methodology using chloride electrophilic coupling partners.  
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5.2 Synthesis of 1-[3]Dehydrodendralenes and 1-(Z)-
[3]Dendralenes from Chloride-Functionalised 
Tricarbonyliron-Butadiene Complexes 
 
5.2.1 Synthesis of Chloride-Functionalised Tricarbonyliron-
Butadiene Complexes 
 
Considerable work was performed in this area by Henry Toombs-Ruane, who 
developed protocols using either diironnonacarbonyl or triirondodecacarbonyl as the 
complexation reagent.[253] Unfortunately, financial considerations necessitated their 
revision.U After a range of conditions were screened it was ultimately those earlier 
developed for complexation of silyl ether 5.12 which proved most useful: 
 
 
Scheme	  5.8.	  Complexation	  of	  chloroprene	  (4.87)	  with	  tricarbonyliron.	  
(a)	  Fe3(CO)12,	  THF,	  60	  °C,	  3.5	  h,	  43%.	  
 
Note that this protocol gives a considerably higher yield of the tricarbonyliron 
complex than previously reported protocols,[198-200] (discussed earlier in section 
4.3.1.1.1) although it requires the use of a considerable excess of the complexation 
reagent (3.0 equivalents). The reaction is highly scalable, reliably producing decagram 
quantities of product. An inseparable side product, tricarbonyl(butadiene)iron was 
observed to form in the course of the reaction, providing the chloroprene and 
butadiene tricarbonyliron complexes in a 4:1 molar ratio. Fortunately, the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  U	  In the time of Henry’s work in this area (2010-13) chloroprene (4.87) was readily 
and cheaply available, making the tricarbonyliron source the more valuable reagent in 
this transformation. However, chloroprene and its precursors have since become far 
less available, making them the more valuable reagent.	  
Cl a
(OC)3Fe
Cl
4.884.87
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tricarbonyliron-butadiene complex is inert under cross-coupling conditions, and so 
can be carried through to the next step then removed using column chromatography. 
Relatively pure samples of chloroprene complex 4.88 (~96%) can however be prepared 
through successive rounds of distillation. 
 
We felt it could also be useful to prepare quantities of the 2,3-dichlorobutadiene 
complex 4.100: 
 
 
Scheme	  5.9.	  Synthesis	  and	  tricarbonyliron-­‐complexation	  of	  2,3-­‐dichlorobutadiene.	  
(a)	  Cu,	  CuCl,	  KCl,	  HCl,	  butyl	  digol;	  (b)	  Fe3(CO)12,	  THF,	  60	  °C,	  3.5	  h,	  1.5%	  over	  two	  steps.	  
 
Sizable quantities of this complex (c.a. 2.5 g) were prepared through modest 
refinement of a protocol developed by Henry Toombs-Ruane,[253] itself a refinement 
of a protocol developed by Stewart.[234] Under optimised conditions, dichloride 
complex 4.100 was accessed in a 1.5% yield over two steps from 1,4-butynediol (5.18). 
Despite the exceedingly low yield of this transformation, it still constitutes a fair 
improvement on the yields of literature protocols.[198,202] 
 
 
5.2.2 Synthesis of Tricarbonyliron-1-[3]Dehydrodendralene 
Complexes 
 
With a practical synthesis of the chloroprene complex 4.88 in hand, attention turned 
to its use in cross-coupling chemistry. We initially planned on using the chloride as an 
electrophilic coupling partner under a range of cross-coupling conditions (ideally 
Suzuki, Heck and Sonogashira conditions). However by this point we had become 
particularly drawn to the thought of preparing dehydrodendralenes, and exploring the 
chemistry we could perform on them. 
Cl b
(OC)3Fe
Cl
Cl Cl
aHO OH
4.995.18 4.100
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After a considerable screening and optimisation process, it was ultimately conditions 
derived from those employed by Chen and Li which proved most effective.[194] Using 
these conditions a range of dehydrodendralene iron complexes were prepared: 
 
 
Scheme	  5.10.	  Synthesis	  of	  dehydrodendralene-­‐tricarbonyliron	  complexes.	  
(a)	  Pd(PPh3)2Cl2,	  CuI,	  alkyne,	  Et3N,	  45	  °C,	  1h.	  
 
Results of this cross-coupling were consistently impressive, with high yields observed 
for the cross-coupling of every alkyne that was selected for the study. Given the 
consistent and persistent disappointments of our attempted cross-coupling of the 
triflate, this result was happily received. Examples were chosen with a view to testing 
the functional group tolerance of this transformation and any others we wished to 
perform on the complexes produced. Note that acetoxy-bearing complex 5.21 was 
produced as a mixture of diastereomers, owing to chirality at both the benzylic 
position and the tricarbonyliron group. It follows that all other complexes were 
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4.166
95%a
5.16
89%a
5.20
93%b
5.17
93%a
5.21
85%a
5.15
82%a
5.18
90%a
5.19
86%a
(OC)3Fe
a
4.88
1-[3]DEHYDRODENDRALENES AND 1-(Z)-[3]DENDRALENES 
 
200 
prepared as enantiomeric mixtures. Methyl-substituted [3]dehydrodendralene 
complex 5.20 was prepared under slightly different conditions to the other examples, 
with the reaction being performed under an atmosphere of propyne. Structures of 
complexes were assigned using a combination of NMR spectroscopy and mass 
spectrometry, noting the characteristic proton shifts on the tricarbonyliron-diene unit 
visible using 1H NMR, and the distinctive fragmentation pattern of tricarbonyliron 
complexes observed using mass spectrometry. 
 
In a repeat of existing protocols,[253] the trimethylsilyl group of complex 4.166 could 
be cleaved to give the tricarbonyliron complex of the parent [3]dehydrodendralene 
4.167: 
 
 
Scheme	  5.11.	  Preparation	  of	  the	  tricarbonyliron-­‐[3]dehydrodendralene	  complex	  4.167.	  
(a)	  K2CO3,	  MeOH,	  25	  °C,	  30	  min,	  91%.	  
 
 
5.2.3 Synthesis of Tricarbonyliron-1-(Z)-[3]Dendralene 
Complexes 
 
At this point we sought functionalise the alkyne functionality of the tricarbonyliron-
dehydrodendralene complexes prepared. An obvious option was an enyne metathesis 
approach, potentially providing access to a range of substituted [4]dendralenes: 
 
 
Figure	  5.5.	  Potential	  conversion	  of	  a	  dehydrodendralene-­‐tricarbonyliron	  complex	  to	  a	  
substituted	  [4]dendralene-­‐tricarbonyliron	  complex.	  
(OC)3Fe
a
(OC)3Fe
Si
4.166 4.167
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Unfortunately we had no success with this reaction. When the reaction was 
performed between a dehydrodendralene complex bearing a small R-substituent (such 
as a methyl group) and ethylene, reactions proceeded very slowly (incomplete after 24 
h at 110 °C) and a multitude of products were observed to form. When the reaction 
was performed on a dehydrodendralene complex bearing a larger substituent (such as 
a phenyl group), no conversion of starting materials was observed.  
 
This result surprised us. Normally, dienes produced from an enyne metathesis 
participate in subsequent cross-metatheses at a considerably slower rate than that at 
which the initial enyne metathesis occurs.[146] However, with the initial enyne 
metathesis being so slow, perhaps the rate of cross-metathesis became competitive. 
Alternatively, it could be that products of the enyne metathesis were rearranging 
under such forcing conditions. As for the initial sluggishness of the reaction, that is 
not overly surprising given the known steric bulk of tricarbonyliron-butadienes,V the 
known sensitivity of metathesis reactions to steric effects, and the positioning of the 
bulky tricarbonyliron-complexed diene directly in line with the alkyne.W 
 
Another possible transformation that we could perform on tricarbonyliron-complexed 
dehydrodendralenes is the partial reduction of their alkyne functionality to the 
corresponding (Z)-configured alkene: 
 
 
Figure	  5.6.	  Potential	  partial	  reduction	  of	  a	  1-­‐[3]dehydrodendralene-­‐tricarbonyliron	  complex	  
to	  a	  1-­‐(Z)-­‐[3]dendralene	  complex.	  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
V As shown through crystallographic studies.[195] 
W In the case of cross-metathesis reactions of tricarbonyliron-[3]dendralene 
complexes,[195] the tricarbonyliron-butadiene unit is not positioned directly in line 
with the alkene, and so will have less of a steric influence. 
(OC)3Fe(OC)3Fe
R partial
reduction
R
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No generalised method for the synthesis of 1-(Z)-[3]dendralenes has ever before been 
developed – it is a long-outstanding hole in the literature concerning the preparation 
of substituted dendralenes. This provided the opportunity to correct that situation. 
Accessing their tricarbonyliron complexes could also prove useful. 
 
Early results using Lindlar conditions disappointed, with the reaction being far too 
slow for practical use, especially on the more sterically-encumbered alkynes (c.a. 30% 
conversion of phenyl-substituted complex 5.15 over 3 days). However success was 
encountered using a hydroboration-protodeboronation sequence: 
 
 
Scheme	  5.12.	  Synthesis	  of	  tricarbonyliron	  complexes	  of	  1-­‐(Z)-­‐[3]dendralenes	  using	  a	  
hydroboration,	  protodeboronation	  approach.	  
(a)	  BH3.SMe2,	  cyclohexene,	  THF,	  0	  °C,	  1	  h;	  then	  alkynes	  4.116,	  5.15-­‐5.21,	  25	  °C,	  1h;	  then	  1-­‐
hexene,	  25	  °C,	  1h;	  then	  AcOH,	  1h.	  
 
Spectral data using NMR and mass spectrometry showed all products to have the 
characteristic features of tricarbonyliron-diene complexes, with a (Z)-alkene clearly 
distinguishable on the 1H NMR spectrum 
(OC)3Fe (OC)3Fe
(OC)3Fe(OC)3Fe (OC)3Fe
5.22
78%
5.23
68%
5.25
65%
5.24
75%
5.27
69%
5.26
78%
TMS
OBn
CH3
OCH3
R
(OC)3Fe (OC)3Fe
R
(OC)3Fe
(OC)3Fe
5.28
0%
NO2
(OC)3Fe
5.29
0%
AcO
OCH3
a
1-[3]DEHYDRODENDRALENES AND 1-(Z)-[3]DENDRALENES 203 
 
This approach to partial reductions was originally developed by Soderquist and 
coworkers as a means of partially reducing sterically-encumbered alkynes.[235,236] We 
hypothesised that reductions under Lindlar conditions were occurring slowly due to 
the steric effects of the tricarbonyliron-butadiene unit. With Lindlar reductions 
known to proceed slowly on sterically-encumbered alkynes, this approach struck us as 
something worth exploring. Optimised conditions were developed using aspects of 
those previously published separately by the groups of Yoon[237] and Zakarian,[238] in 
which an excess of dicyclohexylborane was generated in situ, after which the 
dehydrodendralene complex is added. Excess unreacted dicyclohexylborane was then 
quenched with a sacrificial alkene (1-hexene), followed by protodeboronation using 
acetic acid.  
 
Some issues were encountered with functional group tolerance in this sequence. 
Predictably the nitro group of complex 5.19 was susceptible to reduction, while 
acetoxy-bearing complex 5.21 was observed to decompose, something not overly 
surprising given the demonstrated challenges in handling benzylic acetates. X 
Otherwise, the conditions worked well. The reduction conditions were extremely 
selective, with no quantities of (E)-configured or over-reduced product observed to 
form. Even reactions on the most sterically hindered examples (for instance, 
trimethylsilyl-substituted dehydrodendralene complex 4.116) were observed to run 
fully to completion. 
 
 
5.2.4 Cleavage of Tricarbonyliron from 1-
[3]Dehydrodendralene and 1-(Z)-[3]Dendralene 
Complexes. 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
X See section 2.5. 
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With a collection of 1-[3]dehydrodendralene and 1-(Z)-[3]dendralenes now 
prepared, attention turned to their decomplexation, for the preparation and isolation 
of the basic hydrocarbon.  
 
 
Scheme	  5.13.	  Removal	  of	  tricarbonyliron	  from	  1-­‐[3]dehydrodendralene	  and	  1-­‐(Z)-­‐
[3]dendralene	  complexes.	  
(a)	  CAN,	  acetone,	  15	  min,	  0	  °C;	  (b)	  CAN,	  MeOH,	  15	  min,	  0	  °C;	  (c)	  TMANO,	  acetone,	  25	  °C,	  5	  
days.	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For reactions producing non-volatile, relatively stable hydrocarbons, ideal conditions 
were those using cerium ammonium nitrate in acetone. These are the most standard 
conditions for cleavage of tricarbonyliron groups from dienes, and were employed 
earlier by the group in previous studies on the synthesis of dendralenes via their 
tricarbonyliron complexes.[128,195] A variation on this technique was developed for 
preparation of the more volatile samples 5.30, 5.33, 5.38. These decomplexation 
reactions were performed in methanol, with the reaction solution then partitioned 
between water and d6-benzene. With copious washing the methanol could then be 
washed from the benzene layer, allowing for the isolation of pure samples of the 
volatile hydrocarbons in a solution of d6-benzene. 
 
Structures were assigned mainly with reliance on 1H and 13C NMR spectrometry. All 
products were observed to have the distinctively-coupled alkene proton environments 
characteristic of dendralenes. 
 
Some functionalities were observed to be incompatible with these decomplexation 
conditions. Attempts were made to cleave the tricarbonyliron groups of trimethylsilyl-
functionalised complexes 4.166 and 5.22 with a range of oxidants (CAN, TMANO, 
H2O2/NaOH, FeCl3 were all screened). Unfortunately, all that was observed under 
these conditions was unselective decomposition of the products, or in the case of the 
H2O2/NaOH conditions, cleavage of the TMS group. The paramethoxyphenyl-
substituted examples 5.18 and 5.26 were also noted to be sensitive to cerium 
ammonium nitrate. In the case of the dehydrodendralene complex 5.18, this challenge 
could be overcome simply through careful monitoring, ending the reaction before 
noticeable decomposition of the product could occur. In the case of the 1-(Z)-
[3]dendralene complex 5.26, decomposition of the product occurred at a rate that was 
more competitive with decomplexation, so alternative conditions were developed 
using the milder oxidant trimethylamine-N-oxide.  
 
 
5.3 Conclusion and Future Directions 
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This chapter has detailed a methods driven investigation into the synthesis of a range 
of 1-(Z)-[3]dendralenes and 1-[3]dehydrodendralenes: 
 
 
Scheme	  5.14.	  Summary	  of	  the	  methods-­‐driven	  component	  of	  this	  chapter.	  
(a)	  Fe3(CO)12,	  THF,	  60	  °C,	  3.5	  h,	  43%;	  (b)	  Pd(PPh3)2Cl2,	  CuI,	  alkyne,	  Et3N,	  45	  °C,	  1h;	  (c)	  
BH3.SMe2,	  cyclohexene,	  THF,	  0	  °C,	  1	  h;	  then	  alkynes	  4.116,	  5.15-­‐5.21,	  25	  °C,	  1h;	  then	  1-­‐
hexene,	  25	  °C,	  1h;	  then	  AcOH,	  1h;	  (d)	  CAN,	  acetone,	  15	  min,	  0	  °C;	  (e)	  CAN,	  MeOH,	  15	  min,	  0	  
°C;	  (f)	  TMANO,	  acetone,	  25	  °C,	  5	  days.	  
 
After some disappointing preliminary results with the cross-coupling of pseudohalide-
functionalised butadiene complexes, success was encountered with chloroprene-
tricarbonyliron complex 4.88. The chloroprene complex could be reliably prepared on 
decagram scale, then cross-coupled under Sonogashira conditions with a range of 
alkynes, giving a collection of tricarbonyliron-[3]dehydrodendralene complexes. 
These could then be selectively reduced to their 1-(Z)-[3]dendralene complexes using 
a hydroboration, protodeboronation sequence. The dehydrodendralene and (Z)-
dendralene complexes could be deprotected using cerium ammonium nitrate or 
trimethylamine-N-oxide under various conditions to give access to a range of 1-
[3]dehydrodendralenes and 1-(Z)-[3]dendralenes. This is the first general method to 
have been developed for the synthesis of hydrocarbons bearing these substructures. 
 
One possible future direction for this work is the direct preparation of 1-(Z)-
[3]dendralenes from chloroprene complex 4.88 and a (Z)-configured boronic acid. 
Preliminary investigations suggest that such an approach is feasible: 
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Scheme	  5.15.	  Suzuki	  cross-­‐coupling	  of	  tricarbonyl(chloroprene)iron	  with	  a	  (Z)-­‐configured	  
boronic	  acid.	  
(a)	  Pd(PPh3)4,	  Cs2CO3,	  THF,	  H2O,	  65	  °C,	  1	  h,	  83%	  
 
Such an approach allows for a shorter linear synthetic sequence. 1-(Z)-[3]dendralenes 
can be prepared from chloroprene in a longest linear sequence of 3 steps rather than 4. 
However, overall step count remains comparable, as the (Z)-configured boronic acid 
is something which itself must be prepared. 
 
Another area of investigation could be the preparation of 1-[3]dehydrodendralenes 
and 1-(Z)-[3]dendralenes directly from chloroprene: 
 
 
Figure	  5.7.	  Potential	  preparation	  of	  1-­‐[3]dehydrodendralenes	  or	  1-­‐(Z)-­‐[3]dendralenes	  
directly	  from	  chloroprene.	  	  
 
Such work was deemed outside the scope of this project, and therefore not pursued. 
However, previous work within the Sherburn group suggests at the possibility of 
performing this transformation under Negishi or Kumada conditions.[149] This could 
be an interesting direction for future work in the area. 
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CHAPTER 6 
 
HIGHER POLYENES 
AND 
MODEL APPLICATIONS 
 
 
6.1   Potential Extensions of Methods Developed 
 
With the general methods of chapter 5 developed, we sought to extend them to some 
more challenging applications. Two areas were chosen: the synthesis of higher 
polyenic systems, and the use of 1-(Z)-[3]dendralenes in cascade Diels-Alder 
sequences. These investigations will be detailed in the following sections. 
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6.2   Higher Polyenes and Polyenynes 
 
6.2.1  (Z)-3,6-Dimethyleneocta-1,4,7-triene 
 
In chapter 4, Henry Toombs-Ruane’s accomplishments were detailed concerning the 
synthesis of the self-metathesis product of [3]dendralene 6.1, and the bis-
tricarbonyliron complex of its alkyne-bearing homologue 4.168: 
 
 
Figure	  6.1.	  Relevant	  higher	  polyenes	  that	  have	  previously	  been	  synthesised.	  
 
One possible extension is the addition of a third member to this series – the (Z)-
configured polyene 6.3. This could foreseeably be prepared through the following 
sequence: 
 
 
Figure	  6.2.	  Potential	  route	  to	  the	  synthesis	  of	  (Z)-­‐3,6-­‐dimethyleneocta-­‐1,4,7-­‐triene.	  
 
Bis-tricarbonyliron complex 4.168 was previously prepared through sequential cross-
coupling of chloroprene complex 4.88 with TMS-acetylene, cleavage of the TMS 
group, then cross-coupling of the resulting dehydrodendralene complex 4.167 with a 
second equivalent of chloroprene complex 4.88 (see section 4.3.2). An alternative and 
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more expedient option would be the direct cross-coupling of two equivalents of 
chloroprene complex 4.88 with acetylene (2.13), providing bis-tricarbonyliron 
complex 4.168 directly from the chloroprene complex and acetylene. Efforts could be 
made at this point to isolate and characterise the free polyenyne 6.4 – an outstanding 
task in this area. Also, using the aforementioned hydroboration, protodeboronation 
approach bis-tricarbonyl complex 4.168 could also be reduced to (Z)-configured 
pentaene complex 6.2, which could then be decomplexed to give pentaene 6.3. 
 
Implementation of this plan is detailed in scheme 6.1 below: 
 
 
Scheme	  6.1.	  Synthesis	  of	  polyenyne	  6.4	  and	  (Z)-­‐configured	  pentaene	  6.3.	  
(a)	  Acetylene,	  Pd(PPh3)2Cl2,	  Et3N,	  DMF,	  70	  °C,	  30	  min,	  56%;	  (b)	  BH3.SMe2,	  cyclohexene,	  then	  
alkyne	  4.168,	  then	  1-­‐hexene,	  then	  AcOH,	  67%;	  (c)	  CAN,	  MeOH,	  83%	  for	  6.4	  and	  10%	  for	  6.3.	  
 
Pleasingly, chloroprene complex 4.88 was observed to react with acetylene under 
Heck alkynylation conditions to selectively give bis-complex 4.168 as a mixture of 
diastereomers. No quantities of mono-coupling product (the dehydrodendralene 
complex 4.167) were observed over the course of the reaction. Presumably this is 
because of the electron-withdrawing effect that tricarbonyliron-diene complex has on 
the alkyne to which it is conjugated, disposing the dehydrodendralene complex 4.167 
to react faster under Heck alkynylation conditions than acetylene:  
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Figure	  6.3.	  Rationalisation	  for	  the	  observed	  formation	  of	  bis-­‐complex	  4.168	  from	  
chloroprene	  complex	  4.88	  and	  acetylene.	  	  
 
This transformation did not occur cleanly under Sonogashira conditions. Presumably 
this was due to the influence of copper, reacting with the excess of acetylene present 
in a Glaser-type pathway. While these products were not isolated, the large number 
of heavy products observed using mass spectrometry on the crude mixture suggested 
their presence, as did the viscous nature of the crude reaction solution. 
 
Polyenyne 6.4 could be prepared as a d6-benzene solution from bis-complex 4.168 by 
applying the standard decomplexation conditions previously used for the preparation 
of volatile dehydrodendralenes and 1-(Z)-dendralenes. These conditions had to be 
used as polyenyne 6.4 was extremely unstable when concentrated, observed to 
decompose near instantaneously when neat. Isolation of the material in a solution of 
benzene conveniently solved that problem. 1H NMR spectroscopy showed a product 
with all the expected proton environments. A characteristic peak at 88.8 ppm was 
visible on the 13C NMR spectrum characteristic of the product’s alkyne carbon 
environment. 
 
Bis-complexed polyenyne 4.168 could be reduced to bis-complexed pentaene 6.2 
through application of the standard protocol, providing complex 6.2 as a ~1:1 mixture 
of diastereomers, clearly distinguishable by 1H NMR. It was surprising just how well 
this transformation worked given the extreme steric bulk of the two tricarbonyliron-
butadiene units positioned at either end of the alkyne. 
 
Bis-complexed pentaene 6.2 could then be decomplexed under the standard 
conditions for decomplexation of volatile or reactive hydrocarbons, providing pure 
pentaene 6.3 as a d6-benzene solution. The product was only isolated in a 10% yield, 
but with excellent purity. This was shown to be due to losses on workup – an NMR 
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experiment on unpurified material using quantitative NMR techniques with an added 
calibrant showed that 84% of the starting material had converted to form product. 
 
Pentaene 6.3 was observed to decompose during the process of workup, forming a 
structure which appeared to be an electrocyclisation product. This came as a 
considerable surprise. Pentaene 6.3 bears a through conjugated, (Z)-configured triene. 
Such polyenes typically only electrocyclise at temperatures exceeding 150 °C, at least 
in the absence of polar substituents.[239-241] Intrigued, we explored this reactivity in a 
kinetic experiment: 
 
 
Scheme	  6.2.	  Electrocyclisation	  of	  pentaene	  6.3,	  forming	  cyclic	  tetraene	  65.	  
(a)	  C6D6,	  60	  °C.	  
 
 
Graph	  6.1.	  Kinetic	  data	  for	  the	  electrocyclisation	  of	  pentaene	  6.3	  to	  tetraene	  6.5.	  
 
Pentaene 6.3 was observed to electrocyclise extremely rapidly, with a half-life of only 
39.9 minutes observed at 60 °C. Decomposition was shown to occur exclusively 
through first order processes, as demonstrated by both the kinetic results and the 
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isolation of known molecule tetraene 6.5 as the sole product of the reaction. The rate 
at which pentane 6.3 electrocyclises is extremely surprising when one considers the 
relative stability of its constitutional isomer tetravinylethylene, which only 
electrocyclises appreciably through thermal pathways at temperatures above 100 
°C.[242] 
 
 
6.2.2  (4Z,8Z)-3,6,7,10-Tetramethylenedodeca-1,4,8,11-
tetraene 
 
Given our successes in the synthesis of pentaene 6.3, we wondered if the methods 
developed could be extended further still. A particularly intriguing molecule that we 
hoped to prepare was decaene 6.8. This structure could potentially be prepared 
through the following route: 
 
 
Figure	  6.4.	  Potential	  route	  to	  decaene	  6.8.	  
 
Tris-complexed polyenyne 6.6 could be prepared through the double cross-coupling 
of dichloride complex 4.100 with two equivalents of dehydrodendralene complex 
4.167. This could be subjected to the same reduction and decomplexation conditions 
developed earlier to give decaene 6.8.  
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These plans were implemented in the following sequence: 
 
 
Scheme	  6.3.	  Attempted	  synthesis	  of	  decaene	  6.8	  and	  synthesis	  of	  polyenyne	  6.9.	  
(a)	  4.167,	  Pd(PPh3)2Cl2,	  CuI,	  Et3N,	  45	  °C,	  3	  h,	  46%;	  (b)	  CAN,	  MeOH,	  0	  °C,	  45	  min,	  7%;	  (c)	  
BH3.SMe2,	  cyclohexene,	  then	  alkyne	  6.6,	  then	  1-­‐hexene,	  then	  AcOH.	  
 
Dichloride complex 4.100 was successfully coupled with two equivalents of 
dehydrodendralene complex 4.167, giving tris-complex 6.6. The reaction proceeded 
considerably more slowly than previous reactions, for reasons which are not entirely 
clear. Analysis of the product using NMR spectroscopy proved troublesome, owing to 
the fact that three diastereomers were formed in the course of the reaction. However, 
the material could be decomplexed to give polyenyne 6.9 in a 7% yield with excellent 
purity. The structure of this material could be assigned definitively through the use of 
1H and 13C NMR spectrometry, with protons in the alkene region coupled 
appropriately, and two peaks on the 13C NMR spectrum at 89.7 and 88.7 ppm 
characteristic of the two alkyne carbon environments expected. Losses of material 
largely occurred on purification, with 60% of starting tris-complex 6.6 observed to 
convert to the free polyenyne using quantitative NMR techniques. 
 
When tris-complexed alkyne 6.6 was subjected to the hydroboration, 
protodeboronation protocol a multitude of products were formed, when one would 
expect only three diastereomers. Decomplexation of this mixture produced a sample 
Cl
(OC)3Fe
Cl
(OC)3Fe
Fe(CO)3
Fe(CO)3
(OC)3Fe
(OC)3Fe
(OC)3Fe
a c
b
4.100 6.76.6
6.86.9
HIGHER POLYENES AND MODEL APPLICATIONS 
 
216 
containing many more proton and carbon environments by NMR than one would 
expect from decaene 6.8.  
 
Unable to meaningfully analyse this sample, we attempted to prepare a simpler 
homologue of decaene 6.8, the (Z,Z)-configured [4]dendralene 6.12: 
 
 
Scheme	  6.4.	  Attempted	  synthesis	  of	  (Z,Z)-­‐[4]dendralene	  6.12	  and	  synthesis	  of	  polyenyne	  
6.13.	  
(a)	  Phenylacetylene,	  Pd(PPh3)2Cl2,	  CuI,	  Et3N,	  45	  °C,	  3	  h,	  76%;	  (b)	  CAN,	  acetone,	  0	  °C,	  15	  min,	  
73%;	  (c)	  BH3.SMe2,	  cyclohexene,	  then	  alkyne	  6.10,	  then	  1-­‐hexene,	  then	  AcOH.	  
 
Dichloride complex 4.100 was cross-coupled with phenylacetylene under the same 
conditions as for polyenyne complex 6.6, to produce polyenyne complex 6.10. This 
was decomplexed under standard conditions to give polyenyne 6.13.  
 
Attempted partial reduction of polyenyne complex 6.10 led to the apparent formation 
of two products. Pure samples of either product could not be obtained, although the 
materal appeared as one would expect of a mixture of mono- and bis- reduced 
products. This tentative and speculative assignment was based on the 13C NMR 
spectra, with an excessive number of 13C environments present, including two peaks 
in the alkyne region. It was also supported by the general complexity of the 1H NMR 
spectrum. One can propose mechanistic support for such speculation: 
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Figure	  6.5.	  Mechanistic	  rationalisation	  for	  the	  perceived	  outcome	  of	  the	  hydroboration,	  
protodeboronation	  of	  polyenyne	  complex	  6.10.	  
 
The orientation of the cyclohexylborane group from the first addition would likely 
have an effect on the rate of the second addition. If the cyclohexylborane from the 
first addition is positioned away from the remaining alkyne (intermediate 6.14), the 
steric effects it imposes are likely to be minimal. If however the cyclohexylborane is 
positioned towards the remaining alkyne (intermediate 6.16), it is conceivable that the 
group could slow a second addition through steric effects. If this is the case, it would 
explain why a mixture of mono- and bis- reduced products were formed for the 
hydroboration, protodeboronation sequence on both polyenyne complexes 6.6 and 
6.10. However, this conclusion must be considered as speculative, owing to our 
inability to actually isolate and characterise the products of these reactions. 
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6.3   Diels-Alder Cascades of 1-(Z)-[3]dendralenes 
 
The application of dendralenes and other cross-conjugated systems in total synthesis 
is an area of long-standing interest to the group. Unfortunately, 1-(E)-[3]dendralenes 
were quickly found to be inappropriate for such applications, owing to the fact that 
they dimerise far more quickly through bispericyclic processes than they react with a 
polar dienophile – something already studied comprehensively within the group.[128] 
This tendency is demonstrated through the following sequence:  
 
 
Scheme	  6.5.	  Attempted	  reaction	  of	  1-­‐(E)-­‐[3]dendralene	  4.76	  with	  N-­‐methylmaleimide.	  
(a)	  Pd(PPh3)4,	  Cs2CO3,	  THF,	  H2O,	  65	  °C,	  1	  h,	  83%;	  (b)	  N-­‐phenylmaleimide,	  acetone,	  then	  CAN.	  
 
1-(E)-[3]Dendralene complex 4.76 was prepared through the Suzuki coupling of 
chloroprene complex 4.88 with the (E)-configured boronic acid 6.18. This was 
decomplexed using cerium ammonium nitrate in the presence of a known reactive 
dienophile: N-phenylmaleimide. A large number of products formed in the course of 
the reaction, none of which bore any resemblance to the predicted major product 6.19 
or any other Diels-Alder adduct that might be expected to form. 
 
A potential workaround is the use of a 1-(Z)-[3]dendralene in such a sequence. 
Previous investigations have suggested that the 1-(Z)-[3]dendralene is not disposed to 
such a rapid dimerisation as is the 1-(E)-[3]dendralene.[128] One could imagine such a 
sequence unfolding as follows: 
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Figure	  6.6.	  A	  potential	  Diels-­‐Alder	  sequence	  starting	  from	  a	  1-­‐(Z)-­‐[3]dendralene.	  
 
One would predict the first Diels-Alder reaction occurring selectively at the site 
indicated on the 1-(Z)-[3]dendralene – the other site is blocked by the inward-
pointing substitutent. (Z)-Configured alkene could then be isomerised to the (E)-
configured alkene. One could then perform a second Diels-Alder reaction at the 
isomerised diene to generate the substituted decalin-type framework depicted. Four 
carbon-carbon bonds and six stereogenic centres could be formed in just a three-step 
sequence using this approach. 
 
Preliminary investigations were performed using the phenyl-substituted 1-(Z)-
[3]dendralene 5.41 and the maleimide dienophiles N-phenylmaleimide and N-
methylmaleimide: 
 
 
Scheme	  6.6.	  A	  Diels-­‐Alder	  sequence	  on	  a	  phenyl-­‐substituted	  1-­‐(Z)-­‐[3]dendralene	  using	  
maleimides.	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(a)	  CAN,	  acetone,	  0	  °C,	  15	  min;	  (b)	  NPM,	  CH2Cl2,	  25	  °C,	  18	  h,	  63%	  (two	  steps);	  (c)	  I2,	  hν,	  CHCl3,	  
25	  °C,	  1	  h,	  40%;	  (d)	  NMM,	  PhCH3,	  45	  °C,	  60	  h,	  13%.	  	  
 
The initial decomplexation, Diels-Alder sequence proceeded well, generating adduct 
6.20 in reasonable yield over two steps. The reaction proceeded with excellent 
regioselectivity, with no adduct observed to form from a reaction at the other diene 
site of the dendralene. 
 
This (Z)-alkene was then isomerised with iodine under visible light to give the (E)-
configured alkene 6.19, following a protocol developed by Lawrence Kwan.[244] 
Numerous side products were observed to form under the conditions of the reaction, 
suggesting that some amount of optimisation would be required. However, full 
conversion of the (Z)-alkene 6.20 to the (E)-configured alkene 6.19 was at least 
observed.  
 
(E)-configured alkene 6.19 was then subjected to a second Diels-Alder reaction, this 
time with N-methylmaleimide, to give the adduct 6.21. Pleasingly, this reaction 
occurred with excellent selectivity, with only minimal amounts of other potential 
adducts observed to form under reaction conditions. The reaction was however quite 
slow. NOESY analysis was used to assign the product as the endo adduct – something 
consistent with earlier findings in the group concerning the reactivity of the parent 
[3]dendralene.[245] Unfortunately the product of this reaction was not crystalline, 
preventing confirmation of this structure using X-ray crystallography. The low yield 
of this transformation was largely ascribed to scale issues.  
 
Generally speaking, the reaction outcomes observed in this sequence were well 
received. We had initially hoped it would be possible to perform the isomerisation of 
6.20 to 6.19 in the presence of dienophile, allowing a one-step synthesis of 6.21 from 
6.20. However with the isomerisation reaction known to require high dilutions for 
clean formation of product (ca. 0.03 M with respect to the alkene), and the Diels-
Alder reaction proceeding slowly even at considerable concentration (0.25 M with 
respect to the diene), this seemed unlikely to succeed. Yields were also a little 
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disappointing. However, excellent selectivities were observed for all transformations, 
suggesting the sequence held potential. 
 
Rather than optimising this sequence any further, we decided to proceed with 
something a little more challenging. Recent investigations within the group have 
demonstrated the usefulness of MacMillan’s phenylalanine-derived organocatalyst 
6.25 for generating Diels-Alder adducts of dendralenes with enantiomeric 
enrichment.[246] Performing the first Diels-Alder reaction under these conditions, we 
could potentially generate enantiomerically enriched decalin frameworks – something 
of considerable value if this work is to later be applied in target-driven synthesis.  
 
Accordingly, the following sequence was developed: 
 
 
Scheme	  6.7.	  Synthesis	  of	  enantiomerically	  enriched	  carbocyclic	  frameworks	  starting	  from	  
phenyl-­‐substututed	  1-­‐(Z)-­‐[3]dendralene	  complex	  5.27.	  
(a)	  CAN,	  acetone,	  0	  °C,	  15	  min;	  (b)	  acrolein,	  6.25,	  MeCN/H2O,	  18	  h,	  −10	  °C,	  then	  NaBH4,	  
THF/H2O,	  −	  10°C,	  10	  min,	  69%,	  93:7	  e.r.	  (three	  steps,	  two	  pots);	  (c)	  I2,	  hν,	  CHCl3,	  25	  °C,	  1	  h;	  
(d)	  NPM,	  CHCl3,	  45	  °C,	  60	  h,	  71%,	  4:1	  d.r.	  (two	  steps).	  	  
 
Phenyl-substituted 1-(Z)-[3]dendralene 5.41 was subjected to the standard 
conditions developed for Diels-Alder reactions on dendralenes.[246] The reaction 
proceeded smoothly, with the product of the decomplexation, Diels-Alder, reduction 
sequence isolated in 69% yield in a 93:7 enantiomeric ratio. Stereochemistry of the 
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adduct was inferred through reference to previously performed reactions on other 
dendralene systems.  
 
(Z)-alkene 6.22 was then isomerised to the (E)-configured alkene 6.23. Products of 
this reaction were quite unstable to the reaction conditions, so careful monitoring of 
the reaction was required. On the previous system (for generation of bis-adduct 6.21) 
this reaction had been performed under natural light, however greater reproducibility 
could be obtained by performing the reaction under a fluorescent fume hood light. 
Equilibrium for this reaction did not lie entirely with the (E)-configured alkene – 
trace quantities of (Z)-configured alkene were always present. Pure (E)-alkene 
separated easily from (Z)-alkene using flash chromatography and so could be isolated 
in high yield, although the crude product was typically used directly in the next step of 
the reaction. 
 
Finally, (E)-alkene 6.23 could be subjected to a Diels-Alder reaction with N-
phenylmaleimide, generating a 4:1 mixture of diastereomers of bis-adduct 6.24. 
NOESY analysis was used to confirm these as endo/exo isomers. Interestingly, strong 
facial selectivity was observed, with only minor quantities of material observed in the 
crude product that could have potentially arisen from reaction of the maleimide to the 
other face of the diene. Stereochemistry of the adducts was assigned with the 
maleimide having added to the opposite face of the diene to that on which the 
pendant alcohol is facing. This assignment cannot be made with absolute certainty 
however, as it is conceivable that the alcohol could direct the maleimide to the same 
face to which it is facing through a hydrogen-bonding interaction. However, 
geometric considerations suggest this is unlikely on this system. Unfortunately the 
products of this reaction were not crystalline, preventing confirmation of assignments 
using X-ray crystallography. However, there remains the possibility of derivatising the 
alcohol functionality of the product for these purposes in the future, or potentially 
performing the sequence on an alternatively-functionalised dendralene. 
 
Generally speaking we were satisfied with the outcome of this sequence. Decalin-type 
framework 6.24 was generated with reasonable enantioenrichment, with good 
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selectivity for the generation of four additional stereogenic centres in the subsequent 
Diels-Alder reaction. While the exact structure of structure 6.24 does not map on to 
any particular natural product, this is at least proof of concept for further 
investigations in the area. 
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6.4   Conclusion 
 
This chapter has detailed the extension of the methods of chapter 5 to the synthesis of 
some higher polyene and polyenyne systems.  
 
 
Figure	  6.7.	  Higher	  polyenes	  and	  polyenynes	  targeted	  for	  synthesis.	  
 
First syntheses of the reactive hydrocarbons pentaene 6.3 and polyenyne 6.4 were 
developed, with pentaene 6.3 discovered to undergo an exceptionally rapid 6π 
electrocyclisation. Unfortunately the higher polyene 6.8 could not be prepared by 
these means, although we were able to access polyenyne 6.9 in the process. 
 
This chapter has also detailed preliminary investigations into the potential 
applications of 1-(Z)-[3]dendralenes in target driven synthesis, by way of a cascade 
Diels-Alder sequence: 
 
 
Figure	  6.8.	  Synthesis	  of	  enantiomerically	  enriched	  carbocyclic	  frameworks	  starting	  from	  
phenyl-­‐substututed	  1-­‐(Z)-­‐[3]dendralene	  5.41.	  
 
The decalin-type framework of 6.24 was accessed in enantioenriched form from 
phenyl-substituted 1-(Z)-[3]dendralene 5.41 in just three steps, using a. Four carbon-
carbon bonds and five stereogenic centres were created in the process, with good 
6.4 6.3 6.9 6.8
5.41
3 steps
6.24a
N
O
O
Ph
H
H
HH
OH
6.24b
N
O
O
Ph
H
H
HH
OH
4:1 mixture of diastereomers
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selectivities and yields observed throughout. Such a result makes a promising start for 
further investigations in the area. 
 
 
	  
	  
 
CHAPTER 7 
 
EXPERIMENTAL 
FOR 
PART 2 
 
7.1 General Experimental Procedures 
 
NMR Spectroscopy 
Proton (1H) and carbon (13C) NMR spectra were recorded on Varian Mercury, 
Varian MR 400, Varian INOVA, and Bruker Avance machines operating at 300 and 
75 MHz, 400 and 100 MHz, 500 and 125 and 600 and 150 MHz respectively. 
Kinetic 1H NMR experiments were performed using a Bruker Avance machine 
operating at 600 MHz. Unless otherwise specified, spectra were acquired at 25 °C in 
deuterated chloroform (CDCl3) that had been stored over anhydrous K2CO3 and 4Å 
molecular sieves. Chemical shifts are recorded as δ values in parts per million (ppm). 
Residual solvent peaks were used as an internal reference for 1H NMR spectra 
(CDCl3 δ 7.26, C6D6 δ 7.16) and 13C NMR spectra (CDCl3 δ 77.16 ppm, C6D6 δ 
128.06 ppm). Coupling constants (J) are quoted to the nearest 0.1 Hz. All NMR 
spectra presented within were processed using MestReNova v8.1.2. 
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Infrared spectroscopy 
Infrared spectra (νmax) were recorded on a Perkin-Elmer 1800 Series FTIR 
Spectrometer and samples were analysed as thin films on NaCl plates (for liquids) or 
as a KBr disk (for solids).  
 
Mass spectrometry 
Low and high resolution EI mass spectra were recorded on a MicroMass-Waters 
AUTOSPEC-Premier instrument.  
 
Analytical thin layer chromatography 
Analytical thin layer chromatography (TLC) was performed on aluminium-backed 
0.2 mm thick silica gel 60 F254 plates as supplied by Merck. Eluted plates were 
visualized using a 254 nm UV lamp and/or by treatment with a dip containing 
phosphomolybdic acid : ceric sulfate : sulfuric acid (conc.) : water (37.5 g : 7.5 g : 37.5 
g : 720 mL) followed by heating. The retardation factor (Rf) values cited here have 
been rounded to the first decimal point.  
 
Flash chromatography 
Flash chromatographic separations were carried out following protocols defined by 
Still and coworkers.[151] with silica gel 60 (40-63 µm) as the stationary phase and using 
the AR-grade solvents indicated).  
 
Experimental procedures, reagents and solvents 
Starting materials and reagents were generally available from the Sigma-Aldrich, 
Merck, AK Scientific or BOC chemical companies and were either used as supplied 
or, in the case of liquids, distilled when specified. Drying agents and other inorganic 
salts were purchased from the BDH or Unilab Chemical Companies. THF, CH2Cl2, 
toluene and MeOH were dried using a Glass Contour solvent purification system that 
is based upon a technology originally described by Grubbs and coworkers.[152] 
Spectroscopic grade solvents were used for all analyses. 
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Reaction yield and scale 
The yields reported in the communication are shown as a range of isolated yields 
obtained on various scales, we herein provide experimental details for the largest scale 
procedures conducted.  
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7.2 Synthesis of Tricarbonyliron Complexation 
Reagents 
 
Triiron dodecacarbonyl (7.1) 
 
 
 
This protocol was first published by McFarlane and Wilkinson.[247] 
 
Fe(CO)5 (110 mL, 816 mmol) was mixed with deoxygenated water (sparged, 240 
mL) and Et3N (83 mL, 613 mmol) to create a biphasic solution. This solution was 
heated to 80 °C for 16 h, then cooled to 25 °C. A precipitate formed on cooling, 
which was isolated by filtration, then redissolved in MeOH (600 mL). To this 
solution was added HCl (1.00 L of an 18.5% aqueous solution), and the reaction 
solution was heated to 65 °C for 3 h, until the reaction solution had lost most of its 
opacity, and a forest green solid could be observed floating on the surface of the 
reaction solution. The product was collected by filtration, washed with water (200 
mL), MeOH (200 mL) and hexane (200 mL), then dried under vacuum to give the 
iron cluster 7.1 (87 g, 332 mmol, 41% yield) as forest green crystals. 
 
 
 
  
Fe(CO)5
1. Et3N, H2O2. HCl, MeOH
Fe3(CO)12
41%
4.5 7.1
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7.3 Synthesis of Triflate- and Tosylate-Functionalised 
Tricarbonyliron-Butadiene Complexes 
 
(E)-(buta-1,3-dien-1-yloxy)trimethylsilane (5.12) 
 
 
 
This protocol was modified from that of Cui et al.[213]  
 
ZnCl2 (0.700 g, 5.41 mmol) was added to Et3N (38.1 mL, 377 mmol) under nitrogen 
and stirred at 25 °C for 1 h. Et2O (170 mL) was added, followed by crotonaldehyde 
(14.8 mL, 171 mmol) and TMSCl (43.5 mL, 342 mmol) dropwise over 10 minutes. 
The solution was heated to 35 °C and stirred for 5 days, after which it was cooled to 
25 °C and filtered. This solution was fractionally distilled under vacuum to give the 
title silyl dienol ether 5.12 (9.41 g, 66.1 mmol, 31% yield) as a clear white oil (b.p. 62-
65 °C at 80 mbar). Spectroscopic and physical data were in accordance with literature 
values.[248] 
 
1H NMR (300 MHz, CDCl3) δ 6.54 (d, J = 11.5 Hz, 1H), 6.22 (ddd, J = 17.7, 9.5 
and 9.5 Hz, 1H), 5.72 (dd, J = 11.5 and 11.5 Hz, 1H), 4.99 (d, J = 17.6 Hz, 1H), 
4.82 (d, J = 10.4 Hz, 1H), 0.21 (s, 9H) ppm;  
 
 
 
Tricarbonyl((E)-(buta-1,3-dien-1-yloxy)trimethylsilane)iron (5.13) 
 
O
H
ZnCl2,
Et3N,
TMSCl
Et2O,
5 days, 25 °C,
31%
OTMS
5.11 5.12
 EXPERIMENTAL FOR PART 2 232 
 
 
Silyl dienol ether 5.12 (5.00 g, 35.1 mmol) was dissolved in THF (220 mL) under 
nitrogen and Fe3(CO)12 (26.6 g, 52.7 mmol) was added. The solution was heated to 
60 °C and stirred for 1.5 h. After this a second portion of Fe3(CO)12 (26.6 g, 52.7 
mmol) was added, and the reaction was stirred for an additional 2 h. The reaction 
solution was cooled to 25 °C, and solvent carefully removed under vacuum. The crude 
product was distilled under vacuum to give the title Fe(CO)3 complex 5.13 (6.48 g, 
23.0 mmol, 65% yield) as a forest green oil (b.p. 80-82 °C at 1.3 mbar). 
 
1H NMR (300 MHz, CDCl3) δ 5.19 (m, 1H), 5.05 (m, 1H), 3.44 (d, J = 6.0 Hz, 
1H), 1.50 (m, 1H), 0.21 (s, 9H), -0.11 (dd, J = 9.3 and 2.6 Hz, 1H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 212.8, 93.8, 78.9, 36.6, 29.9, 0.7 ppm;  
 
νmax (NaCl) 3060, 3004, 2962, 2917, 2849, 2042, 1962, 1485 cm-1;  
 
MS (EI+, 70 eV) m/z 282.0 (M+•, 12%), 254.0 (42), 226.0 (52), 198.0 (84), 129.9 
(100);  
 
HRMS (EI+, 70 eV) found m/z 282.0017 (C10H14O4Si56Fe requires M+• 282.0011).  
 
 
 
(buta-1,3-dien-2-yloxy)trimethylsilane (4.21) 
 
 
OTMS Fe3(CO)12
THF,
3.5 h, 60 °C,
65%
(OC)3Fe OTMS
5.12 5.13
LiBr,
TMSCl,
Et3N
THF,
18 h, 40 °C,
41%
OTMSO
5.9 4.21
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This protocol was modified from that of Hansson and Carlson.[214]  
 
LiBr (12.4 g, 143 mmol) was added to THF (143 mL) under nitrogen and stirred at 
25 °C for 30 min. TMSCl (36.2 mL, 285 mmol) was added dropwise, followed by 
methyl vinyl ketone (11.9 mL, 143 mmol) and Et3N (39.8 mL, 285 mmol). The 
solution was heated to 40 °C and stirred for 18 h, after which it was cooled to r.t. and 
filtered. The resulting solution was distilled under vacuum to give the title silyl dienol 
ether 4.21 (8.42 g, 59.2 mmol, 41% yield) as a clear white oil (b.p. 38-42 at 70 mbar). 
Spectroscopic and physical data were in accordance with literature values.[214] 
 
1H NMR (300 MHz, CDCl3) δ 6.20 (dd, J = 16.9 and 10.5 Hz, 1H), 5.48 (d, J = 
17.0 Hz, 1H), 5.09 (d, J = 10.4 Hz, 1H), 4.35 (s, 1H), 4.34 (s, 1H), 0.23 (s, 9H) 
ppm. 
 
 
 
Tricarbonyl((buta-1,3-dien-2-yloxy)trimethylsilane)iron (4.22) 
 
 
 
Silyl dienol ether 4.21 (9.00 g, 63.3 mmol) was dissolved in THF (396 mL) under 
nitrogen and Fe3(CO)12 (31.9 g, 63.3 mmol) was added. The solution was heated to 
60 °C and stirred for 16 h. The solution was then cooled to 25 °C, and solvent 
carefully removed under vacuum to give a brown oil. This was subjected to flash 
chromatography (silica, 3:97 EtOAc/hexane) to give the title Fe(CO)3 complex 4.22 
(6.36 g, 22.5 mmol, 36% yield) as a forest green oil. 
 
R f = 0.8 (3:97 EtOAc/hexane on silica);  
 
OTMS Fe3(CO)12
THF,
16 h, 60 °C,
36%
(OC)3Fe
OTMS
4.21 4.22
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1H NMR (300 MHz, CDCl3) δ 5.23 (dd, J = 7.5 and 7.5 Hz, 1H), 2.04 (m, 1H), 
1.43 (dd, J = 6.9 and 2.4 Hz, 1H), 0.31 (m, 10H), -0.40 (dd, J = 8.2 and 2.6 Hz, 1H) 
ppm;  
 
13C NMR (75 MHz, CDCl3) δ 212.1, 136.6, 73.9, 37.3, 31.5, -0.47 ppm;  
 
νmax (NaCl) 3057, 3001, 2963, 2049, 1967 cm-1;  
 
MS (EI+, 70 eV) m/z 282.0 (M+•, 6%), 254.0 (22), 226.0 (41), 198 (49), 130 (100);  
 
HRMS (EI+, 70 eV) found m/z 282.0004 (C10H1456FeO4Si requires M+• 282.0011).  
 
 
 
Tricarbonyl(buta-1,3-dien-2-ol)iron (4.23) 
 
 
 
Silyl dienol ether 4.22 (20.0 mg, 70.9 µmol) was dissolved in DMF (700 µL) under 
nitrogen, cooled to 0 °C, and stirred for 15 min. TBAF (78 µL of a 1.0 M THF 
solution) was then added and the resulting solution was stirred for 1 min. The 
solution was then diluted with water (2 mL) and hexane (2 mL) under a continued 
flow of nitrogen. The organic layer was isolated, and solvent removed under a stream 
of nitrogen to give a brown solid. This solid was dissolved in degassed CDCl3 (0.7 
mL), then filtered through a plug of silica under nitrogen directly into an NMR tube, 
giving an analytically pure sample of the title alcohol 4.23. Spectroscopic and physical 
data were in accordance with literature values.[184] 
 
(OC)3Fe
OTMS TBAF
DMF,
1 min, 0 °C
(OC)3Fe
OH
4.22 4.23
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1H NMR (300 MHz, CDCl3) δ 5.29 (t, J = 7.2 Hz, 1H), 4.37 (s, 1H), 2.07 (dd, J = 
4.6 and 2.0 Hz, 1H), 1.46 (dd, J = 6.9 and 2.7 Hz, 1H), 0.36 (d, J = 2.4 Hz, 1H), -
0.37 (s, J = 8.0 and 2.7 Hz, 1H) ppm;  
 
 
 
Tricarbonyl(buta-1,3-dien-2-yl trifluoromethanesulfonate)iron (5.3) 
 
 
 
Silyl dienol ether 4.22 (1.50 g, 5.32 mmol) was dissolved in CH2Cl2 (52.5 mL) under 
nitrogen, cooled to 0 °C, and stirred for 15 min. TBAF (5.85 mL of a 1.0 M THF 
solution, 5.85 mmol) was then added and the resulting solution was stirred for 1 min. 
DIPEA (1.02 mL, 5.85 mmol) was then added, and the solution was warmed to 25 
°C using a water bath and stirred for 15 min. Comins’ reagent (2.86 g, 7.97 mmol) 
was then added, and the solution was stirred at 25 °C for an additional 30 min. Water 
(50 mL) was added, the organic layer isolated, and the aqueous layer extracted with 
CH2Cl2 (2 × 50 mL). The combined organic layers were washed with brine (150 mL), 
dried over MgSO4 and concentrated under reduced pressure to give a brown oil. This 
was subjected to flash chromatography (silica, 3:97 EtOAc/hexane) to give the title 
triflate 5.3 (0.918 g, 2.68 mmol, 50% yield) as a yellow oil. 
 
R f = 0.5 (3:97 EtOAc/hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 5.84 (dddd, J = 8.5, 7.1, 1.7 and 1.1 Hz, 1H), 2.34 
(dd, J = 5.2 and 1.8 Hz, 2H), 1.61 (dd, J = 7.1 and 2.9 Hz, 1H), 0.55 (dd, J = 5.3 and 
1.1 Hz, 1H), -0.29 (dd, J = 8.5 and 2.9 Hz, 1H);  
 
(OC)3Fe
OTMS
DCM
50%
(OC)3Fe
OTf
TBAF then
DIPEA,
Comins' reagent
4.22 5.3
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13C NMR (75 MHz, CDCl3) δ 208.3, 131.5, 125.1, 120.8, 116.6, 81.1, 36.8, 31.1 
ppm;  
 
νmax (NaCl) 3070, 3012, 2917, 2068, 1990, 1426 cm-1;  
 
MS (EI+, 70 eV) m/z 341.91 (M+•, 1%), 285.9 (84), 257.9 (97), 233.9 (40), 205.9 
(35), 108.0 (100);  
 
HRMS (EI+, 70 eV) found m/z 341.9111 (C8H5O619F3S56Fe requires M+• 341.9108).  
 
 
 
Tricarbonyl(buta-1,3-dien-2-yl 4-methylbenzenesulfonate)iron (5.4) 
 
 
 
Silyl dienol ether 4.22 (500 mg, 1.77 mmol) was dissolved in CH2Cl2 (17.5 mL) 
under nitrogen, cooled to 0 °C, and stirred for 15 min. TBAF (1.95 mL of a 1.0 M 
THF solution, 1.95 mmol) was then added and the resulting solution was stirred for 1 
min. DIPEA (340 mL, 1.95 mmol) was then added, and the solution was warmed to 
25 °C using a water bath and stirred for 15 min. TsCl (507 mg, 2.66 mmol) was then 
added, and the solution was heated to 35 °C and stirred for 24 h. The reaction 
solution was cooled to 25 °C, diluted with hexane (50 mL), washed with water (3 × 50 
mL), brine (50 mL) and dried over MgSO4, then concentrated under reduced 
pressure to give the crude producat as a brown solid. This material was recrystallised 
(hexane) to give the title tosylate 5.4 (319 mg, 876 µmol, 49% yield) as light brown 
crystals. 
 
R f = 0.5 (hexane on silica);  
 
(OC)3Fe
OTMS
DCM
49%
(OC)3Fe
OTs
TBAF then
DIPEA,
TsCl
4.22 5.4
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1H NMR (300 MHz, CDCl3) δ 7.86 (d, J = 8.1 Hz, 2H), 7.39 (d, J = 8.1 Hz, 2H), 
5.55 (dd, J = 8.5 and 8.5, 1H), 2.48 (s, 3H), 2.01 (dd, J = 4.5 and 1.7, 1H), 1.47 (dd, J 
= 7.1 and 2.6, 1H), 0.31 (m, 1H), -0.41 (dd, J = 8.5 and 2.6, 1H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 209.3, 146.0, 132.4, 130.2, 129.4, 128.8, 80.9, 37.6, 
31.5, 21.9 ppm;  
 
νmax (NaCl) 2916, 2848, 2059, 1981 cm-1;  
 
MS (EI+, 70 eV) m/z 364.0 (M+•, <1%), 335.9 (10), 307.9 (48), 280.0 (100), 227.9 
(20), 164.0 (82);  
 
HRMS (EI+, 70 eV) found m/z 363.9705 (C14H12O6S56Fe requires M+• 363.9704).  
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7.4 Cross-Coupling of Triflate- and Tosylate-
Functionalised Tricarbonyliron-Butadiene 
Complexes 
 
General procedure 1, for the Sonogashira cross-coupling of triflates 
 
Pd(PPh3)2Cl2 (0.05 mol. equiv.) and CuI (0.10 mol. equiv.) were dissolved in THF 
(0.07 M w.r.t. triflate 5.3) under nitrogen and triflate 5.3 (1.0 mol. equiv.) was added, 
followed by the desired coupling partner (1.2 mol. equiv.) and iPr2NH (50 mol. 
equiv.). The solution was heated to 60 °C and stirred for 30 minutes or until the 
reaction was observed to have completed, after which the reaction solution was cooled 
to 25 °C and partitioned with Et2O and water. The aqueous layer was removed and 
the organic layer washed with water (3 portions) and brine (1 portion), then dried 
over MgSO4 and concentrated under reduced pressure to give the crude product. 
 
 
General procedure 2, for the Sonogashira cross-coupling of triflates 
 
Pd(PPh3)2Cl2 (0.05 mol. equiv.) was dissolved in THF (0.46 M w.r.t. triflate 5.3) 
under nitrogen and triflate 5.3 (1 mol. equiv.) was added, followed by the desired 
coupling partner (1.4 mol. equiv.) and Et3N (4 mol. equiv.). The solution was heated 
to 70 °C and stirred for 15 minutes or until complete conversion of starting material 
was observed, after which the solution was cooled to 25 °C and partitioned with Et2O 
and water. The aqueous layer was removed and the organic layer washed with water 
and brine, then dried over MgSO4 and concentrated under reduced pressure to give 
the crude product. 
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Tricarbonyl((trimethyl(3-methylenepent-4-en-1-yn-1-yl)silane)iron (4.166) 
 
 
 
Prepared according to general procedure 1 using Pd(PPh3)2Cl2 (10.3 mg, 14.6 µmol), 
CuI (5.6 mg, 29.2 µmol), triflate 5.3 (100 mg, 292 µmol), ethynyltrimethylsilane 
(49.6 µL, 351 µmol) and iPr2NH (2.05 mL, 14.6 mmol) in THF (4.4 mL). The crude 
product was purified using flash chromatography (silica, hexane) to give the title 
alkyne 4.166 (59.4 mg, 205 µmol, 70% yield) as a yellow oil. 
 
R f = 0.5 (hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 5.67 (dd, J = 8.1 and 8.1 Hz, 1H), 2.03 (m, 1H), 
1.76 (dd, J = 7.0 and 2.7 Hz, 1H), 0.30 (m, 1H), 0.21 (s, 9H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 210.3, 104.1, 91.4, 89.8, 84.3, 43.8, 39.6, -0.1 ppm;  
 
νmax (NaCl) 3068, 3008, 2962, 2901, 2164, 2055, 1980 cm-1;  
 
MS (EI+, 70 eV) m/z 304.1 (6) 290.0 (M+•, 2%), 262.0 (20), 234.0 (49), 206.0 (100), 
135.1 (30);  
 
HRMS (EI+, 70 eV) found m/z 290.0066 (C12H14O3Si56Fe requires M+• 290.0062).  
 
 
 
Tricarbonyl(3-methylenenon-1-en-4-yne)iron (5.16) 
 
(OC)3Fe
OTf
THF
30 min, 60 °C
70%
(OC)3Fe
TMS
Pd(PPh3)2Cl2
CuI
iPr2NH
TMS
5.3 4.165 4.166
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Prepared according to general procedure 2, using Pd(PPh3)2Cl2 (10.3 mg, 14.6 
µmol), triflate 5.3 (100 mg, 292 µmol), 1-hexyne (47.0 µL, 409 µmol) and Et3N (45 
µL, 1.17 mmol) in THF (0.88 mL). The crude product purified using flash 
chromatography (silica, hexane) to give the title alkyne 5.16 (19.0 mg, 69.3 µmol, 
24% yield) as a yellow oil. 
 
R f = 0.5 (hexane on silica);  
 
1H NMR (400 MHz, CDCl3) δ 5.60 (d, J = 8.1 Hz, 1H), 2.31 (t, J = 7.0 Hz, 2H), 
2.01 (m, 1H), 1.73 (dd, J = 7.0 and 2.7 Hz, 1H), 1.54 (m, 2H), 1.44 (m, 2H), 0.92 (t, 
J = 7.1 Hz, 3H), 0.32 (m, 1H), 0.14 (dd, J = 9.2 and 2.7 Hz, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 210.7, 89.0, 87.5, 86.4, 79.2, 43.8, 39.1, 30.7, 22.1, 
19.0, 13.7 ppm;  
 
νmax (NaCl) 3066, 3008, 2959, 2933, 2863, 2050, 1961 cm-1;  
 
MS (EI+, 70 eV) m/z 274.1 (M+•, 53%), 246.1 (48), 218.0 (53), 190.0 (100), 148.0 
(60);  
 
HRMS (EI+, 70 eV) found m/z 274.0304 (C13H14O356Fe requires M+• 274.0292).  
 
 
 
Tricarbonyl((3-methylenepent-4-en-1-yn-1-yl)benzene)iron (5.15) 
 
(OC)3Fe
OTf
DMF
15 min, 70 °C
24%
(OC)3Fe
nBu
Pd(PPh3)2Cl2
Et3N
nBu
5.3 7.2 5.16
EXPERIMENTAL FOR PART 2	   241 
 
 
Prepared according to general procedure 2, using Pd(PPh3)2Cl2 (10.3 mg, 14.6 
µmol), triflate 5.3 (100 mg, 292 µmol), phenylacetylene (45.0 µL, 409 µmol), Et3N 
(45 µL, 1.17 mmol) in THF (0.88 mL). The crude product purified using flash 
chromatography (silica, hexane) to give the title alkyne 5.15 (37.1 mg, 126 µmol, 43% 
yield) as a yellow oil. 
 
R f = 0.6 (hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 7.48 (m, 2H), 7.33 (m, 3H), 5.75 (dddd, J = 9.4, 
8.21, 1.2 and 1.2 Hz, 1H), 2.13 (dd, J = 2.7 and 1.4 Hz, 1H), 1.82 (dd, J = 7.0 and 
2.7 Hz, 1H), 0.41 (dd, J = 2.6 and 1.0 Hz, 1H), 0.26 (dd, J = 9.3 and 2.7 Hz, 1H) 
ppm;  
 
13C NMR (75 MHz, CDCl3) δ 210.4, 131.9, 128.8, 128.5, 122.6, 89.6, 88.4, 86.0, 
84.9, 43.5, 39.7 ppm;  
 
νmax (NaCl) 3060, 3009, 2927, 2049, 1969 cm-1;  
 
MS (EI+, 70 eV) m/z 293.9 (M+•, 12%), 266.0 (44), 238.0 (50), 210 (100) 184.0 (33), 
157.9 (30), 154.0 (30);  
 
HRMS (EI+, 70 eV) found m/z 293.9985 (C15H10O356Fe requires M+• 293.9979).  
 
 
 
Hexacarbonyl(3,4-dimethylenehexa-1,5-diene)diiron (4.50) 
 
(OC)3Fe
OTf
DMF
15 min, 70 °C
43%
(OC)3Fe
Ph
Pd(PPh3)2Cl2
Et3N
Ph
5.3 4.160 5.15
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Pd(MeCN)2Cl2 (3.56 mg, 13.7 µmol) and XPhos (19.6 mg, 41.2 µmol) were added to 
a Schlenk flask under nitrogen, and MeCN (550 µL) was added. Cs2CO3 (233 mg, 
714 µmol) was then added, followed by tosylate 5.4 (100 mg, 275 µmol). The flask 
was sealed and heated to 70 °C for 1.5 h, after which the reaction was cooled to 25 °C 
and diluted with Et2O (2 mL) and H2O (2 mL). The aqueous layer was removed and 
the organic layer washed with water (3 × 2 mL) and brine (1 × 2 mL), then dried over 
MgSO4 and concentrated under reduced pressure to give the crude product as a 
brown oil. This was subjected to flash chromatography (silica, hexane) to give the title 
dendralene 4.50 as a 4:3 mixture of diastereomers (9.40 mg, 24.4 µmol, 18% yield) as 
a yellow oil. Spectroscopic and physical data were in accordance with literature 
values.[195] 
 
1H NMR (300 MHz, CDCl3) δ 6.07 (dd, J = 8.1 and 8.1 Hz, 1H), 5.68 (dd, J = 8.1 
and 8.1 Hz, 1H), 2.46 (m, 1H), 2.16 (m, 1H), 1.91 (m, 2H), 0.40 (m, 2H), 0.24 (d, J 
= 2.9 Hz, 1H), 0.18 (d, 2.9 Hz, 1H) ppm.  
 
 
  
(OC)3Fe
OTs
(OC)3Fe
Fe(CO)3
Pd(MeCN)2Cl2
XPhos
Cs2CO3
MeCN
1.5 h, 70 °C
18%
5.4 4.50
(d.r. 4:3)
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7.5 Synthesis of Chloride-Functionalised 
tricarbonyliron-Butadiene Complexes 
 
Tricarbonyl(2-chlorobuta-1,3-diene)iron (4.88) 
 
 
 
Chloroprene (500 mg, 5.65 mmol) was dissolved in THF (38 mL) under nitrogen 
and Fe3(CO)12 (4.27 g, 8.47 mmol) was added. The solution was heated to 60 °C and 
stirred for 1.5 h. After this a second portion of Fe3(CO)12 (4.27 g, 8.47 mmol) was 
added, and the reaction was stirred for an additional 2 h. The reaction was cooled to 
25 °C, and solvent was carefully removed under vacuum to give the crude product as a 
forest green oil. This material was subjected to flash chromatography (silica, hexane) 
to give the title complex 4.88 (689 mg, 2.41 mmol, 43% yield) as a yellow oil, as a 4:1 
mixture with tricarbonyl(butadiene)iron. Spectroscopic and physical data was in 
accordance with literature values.[197] 
 
1H NMR (300 MHz, CDCl3) δ 5.19 (m, 1H), 5.05 (m, 1H), 3.44 (d, J = 6.0 Hz, 
1H), 1.50 (m, 1H), 0.21 (s, 9H), -0.11 (dd, J = 9.3 and 2.6 Hz, 1H) ppm.  
 
 
 
2,3-Dichlorobutadiene (4.99) 
 
 
Cl Fe3(CO)12
THF,
3.5 h, 60 °C,
65%
(OC)3Fe
Cl
4.87 4.88
Cl
Cl
HO
OH Cu, CuCl,
KCl, HCl
butyl digol
5.18 4.99
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This protocol was developed by combining elements of the protocols Henry Toombs 
Ruane[253] and Stewart.[234] 
 
Copper powder (6.35 g, 99 mmol), CuCl (79.1 g, 799 mmol), KCl (29.8 g, 400 
mmol) and BHT (1 crystal) were added to a multi-neck flask fitted with an equalizing 
addition funnel and a distillation apparatus. BHT (1 crystal) was added to the 
receiving flask of the distillation apparatus. The solids were dissolved in monobutyl 
diethylene glycol (124 mL) and HCl (297 mL, 37% aqueous solution). In a separate 
flask, 2-butyne-1,4-diol (172 g, 2.00 mol) was dissolved in HCl (144 mL of a 37% 
aqueous solution) with vigorous stirring, and the resulting solution was added to the 
addition funnel. The reaction solution was heated to an internal temperature of 80 °C, 
upon which dropwise addition of the solution of 2-butyne-1,4-diol in HCl was 
commenced. The reaction temperature was raised further to induce distillation of the 
product from the reaction solution, with care taken not to allow the temperature at 
the still-head to exceed 96 °C. The product was collected in the receiving flask as a 
biphasic mixture along with acidic water. The product was carefully decanted by 
syringe into a second flask, then neutralised and dried over anhydrous K2CO3 (10 g). 
The crude products of three iterations of this reaction were collected then purified by 
a second distillation into a flask containing BHT (1 crystal) to give the title 
compound 4.99 (121 g) as an opaque yellow oil (b.p. 26-30 °C at 100 mbar), 
contaminated with what was putatively oligomeric side products. The crude product 
of this reaction was used directly in subsequent transformations. 
 
 
 
Tricarbonyl(2,3-dichlorobutadiene)iron (4.100) 
 
 
 
Cl
Cl
Fe3(CO)12
THF
1.5% (OC)3Fe
Cl
Cl
4.99 4.100
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This protocol was based on that initially developed by Henry Toombs-Ruane.[253] 
 
Fe3(CO)12 (26.0 g, 50.8 mmol) was mixed with THF (80 mL) under nitrogen and a 
solution of crude dichloride 4.99 (25.0 g, 203 mmol) in THF (20 mL) was added. 
The resulting solution was heated to 60 °C for 2.5 h, then concentrated under 
reduced pressure to give the crude product. This was subjected to flash 
chromatography (silica, hexane) then distilled (Kugelrohr oven, 170-180 °C at 4.3 
mbar) to give the title complex 4.100 (3.45 g, 13.1 mmol, 1.5% extrapolated yield 
over two steps) as a yellow oil. Spectroscopic and physical data was in accordance with 
literature values.[199] 
 
1H NMR (300 MHz, CDCl3) δ 2.20 (d, J = 4.1 Hz, 2H), 0.25 (d, J = 4.1 Hz, 2H) 
ppm. 
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7.6 Synthesis of Tricarbonyliron-1-
[3]Dehydrodendralene Complexes 
 
General procedure 3, for the Sonogashira cross-coupling of chlorides with 
non-volatile alkynes. 
 
Pd(PPh3)2Cl2 (0.05 mol. equiv.) and CuI (0.05 mol. equiv.) were dissolved in Et3N 
(0.1 M conc. w.r.t. chloride complex 4.88) under nitrogen and chloride complex 4.88 
(1.0 mol. equiv.) and the desired alkyne (1.2 mol. equiv.) were added. The reaction 
was heated to 45 °C for 1 h, after which the reaction solution was cooled to 25 °C and 
diluted with Et2O and water. The organic phase was isolated and washed with water 
and brine, then dried over MgSO4 and concentrated under reduced pressure to give 
the crude product. 
 
 
 
Tricarbonyl(trimethyl(3-methylenepent-4-en-1-yn-1-yl)silane)iron (4.166) 
 
 
 
Prepared according to general procedure 3, using chloride 4.88 (470 mg, 2.06 mmol), 
ethynyltrimethylsilane (351 µL, 2.47 mmol), Pd(PPh3)2Cl2 (72 mg, 103 µmol) and 
CuI (19 mg, 103 µmol) in Et3N (20 mL). The crude product was purified using flash 
chromatography (silica, hexane) to give the title alkyne 4.166 (568 mg, 1.96 mmol, 
95% yield) as a yellow oil. 
 
Spectroscopic and physical properties were consistent with that reported in section 
7.4. 
(OC)3Fe
Cl
Et3N1 h, 45 °C
95%
(OC)3Fe
TMS
Pd(PPh3)2Cl2
CuI
TMS
4.88 4.165 4.166
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Tricarbonyl(3-methylenenon-1-en-4-yne)iron (5.16) 
 
 
 
Prepared according to general procedure 3, using chloride 4.88 (150 mg, 657 µmol), 
1-hexyne (64 µL, 788 µmol), Pd(PPh3)2Cl2 (23 mg, 32.8 µmol) and CuI (6.25 mg, 
32.8 µmol) in Et3N (9 mL). The crude product was purified using flash 
chromatography (silica, hexane) to give the title alkyne 5.16 (163 mg, 595 µmol, 91% 
yield) as a yellow oil.  
 
Spectroscopic and physical properties were consistent with that reported in section 
7.4. 
 
 
 
Tricarbonyl((3-methylenepent-4-en-1-yn-1-yl)benzene)iron (5.15) 
 
 
 
Prepared according to general procedure 3, using chloride 4.88 (300 mg, 1.31 mmol), 
phenylacetylene (173 µL, 1.58 mmol), Pd(PPh3)2Cl2 (46 mg, 65.7 µmol) and CuI (13 
mg, 65.7 µmol) in Et3N (18 mL). The crude product was purified using flash 
chromatography (silica, hexane) to give the title alkyne 5.15 (306 mg, 1.04 mmol, 
79% yield) as a yellow oil.  
 
(OC)3Fe
Cl
Et3N1 h, 45 °C
91%
(OC)3Fe
nBu
Pd(PPh3)2Cl2
CuI
nBu
4.88 7.2 5.16
(OC)3Fe
Cl
Et3N1 h, 45 °C
79%
(OC)3Fe
Ph
Pd(PPh3)2Cl2
CuI
Ph
4.88 4.160 5.15
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Spectroscopic and physical properties were consistent with that reported in section 
7.4. 
 
 
 
Tricarbonyl(1-methoxy-4-(3-methylenepent-4-en-1-yn-1-yl)benzene)iron 
(5.18) 
 
 
 
Prepared according to general procedure 3, using chloride 4.88 (300 mg, 1.31 mmol), 
alkyne 7.3[254] (208 mg, 1.58 mmol), Pd(PPh3)2Cl2 (46 mg, 65.7 µmol) and CuI (13 
mg, 65.7 µmol) in Et3N (18 mL). The crude product was purified using flash 
chromatography (silica, 5:95 EtOAc/hexane) to give the title alkyne 5.18 (398 mg, 
1.23 mmol, 93% yield) as a yellow oil. 
 
R f = 0.3 (2:98 EtOAc/hexane on silica);  
 
1H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 
5.72 (dd, J = 7.6 and 7.6 Hz, 1H), 3.82 (s, 3H), 2.12 (dd, J = 2.4 and 1.3 Hz, 1H), 
1.81 (dd, J = 7.0 and 2.7 Hz, 1H), 0.40 (d, J = 2.4 Hz, 1H), 0.24 (dd, J = 9.0 and 2.7 
Hz, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 210.5, 160.0, 133.4, 114.7, 114.2, 89.3, 87.0, 86.1, 
85.6, 55.5, 43.5, 39.5 ppm;  
 
νmax (NaCl) 3071, 3006, 2957, 2935, 2838, 2221, 2051, 1975, 1605, 1512, 1250 cm-1;  
 
(OC)3Fe
Cl
Et3N1 h, 45 °C
93%
(OC)3Fe
Pd(PPh3)2Cl2
CuI
PMP
PMP
PMP = p-methoxyphenyl
4.88 7.3 5.18
EXPERIMENTAL FOR PART 2	   249 
MS (EI+, 70 eV) m/z 323.9 (M+•, 5%), 296.0 (39), 268.0 (48), 240.0 (100), 214.0 
(43), 118.0 (38);  
 
HRMS (EI+, 70 eV) found m/z 324.0085 (C16H12O456Fe requires M+• 324.0085).  
 
 
 
Tricarbonyl(1-(3-methylenepent-4-en-1-yn-1-yl)-4-nitrobenzene)iron (5.19) 
 
 
 
Prepared according to general procedure 3, using chloride 4.88 (200 mg, 876 µmol), 
alkyne 7.4[249] (155 mg, 1.05 mmol), Pd(PPh3)2Cl2 (31 mg, 43.8 µmol) and CuI (8 
mg, 43.8 µmol) in Et3N (12 mL). The crude product was purified using flash 
chromatography (silica, 3:97 EtOAc/hexane) to give the title alkyne 5.19 (241 mg, 
709 µmol, 81% yield) as a yellow oil.  
 
R f = 0.3 (3:97 EtOAc/hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 8.21 (d, J = 8.7 Hz, 2H), 7.62 (d, J = 8.7 Hz, 2H), 
5.78 (dd, J = 8.4 and 8.4 Hz, 1H), 3.82 (s, 3H), 2.12 (dd, J = 2.6 and 1.2 Hz, 1H), 
1.88 (dd, J = 7.0 and 2.7 Hz, 1H), 0.42 (d, J = 2.4 Hz, 1H), 0.33 (dd, J = 9.4 and 2.7 
Hz, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 210.0, 147.4, 132.6, 129.5, 123.8, 94.0, 90.4, 84.0, 
82.9, 43.2, 40.3 ppm;  
 
νmax (NaCl) 3412, 3106, 3070, 2963, 2931, 2853, 2223, 2053, 1977, 1594, 1519, 1344 
cm-1;  
(OC)3Fe
Cl
Et3N1 h, 45 °C
81%
(OC)3Fe
Pd(PPh3)2Cl2
CuI
PNP
PNP
PNP = p-nitrophenyl
4.88 7.4 5.19
 EXPERIMENTAL FOR PART 2 250 
 
MS (EI+, 70 eV) m/z 338.9 (M+•, 15%), 311.0 (44), 283.0 (100), 255.0 (85), 225.0 
(73), 152.0 (39);  
 
HRMS (EI+, 70 eV) found m/z 338.9834 (C15H9NO556Fe requires M+• 338.9830).  
 
 
 
Tricarbonyl((((4-methylenehex-5-en-2-yn-1-yl)oxy)methyl)benzene)iron 
(5.17) 
 
 
 
Prepared according to general procedure 3, using chloride 4.88 (200 mg, 876 µmol), 
alkyne 7.5[250] (154 mg, 1.05 mmol), Pd(PPh3)2Cl2 (31 mg, 43.8 µmol) and CuI (8 
mg, 43.8 µmol) in Et3N (12 mL). The crude product was purified using flash 
chromatography (silica, 5:95 EtOAc/hexane) to give the title alkyne 5.17 (276 mg, 
817 µmol, 93% yield) as a yellow oil. 
 
R f = 0.4 (hexane on silica);  
 
1H NMR (400 MHz, CDCl3) δ 7.37 (m, 5H), 5.68 (dd, J = 7.8 and 7.8 Hz, 2H), 
4.63 (s, 2H), 4.31 (s, 3H), 2.04 (m, 1H), 1.80 (m, 1H), 0.35 (m, 1H), 0.22 (m, 1H) 
ppm;  
 
13C NMR (100 MHz, CDCl3) δ 210.3, 137.4, 128.6, 128.3, 128.1, 89.9, 85.5, 84.0, 
82.1, 71.9, 57.7, 43.5, 39.6 ppm;  
 
νmax (NaCl) 2960, 2919, 2850, 2054, 1995, 1971, 1726, 1451, 1372 cm-1;  
 
(OC)3Fe
Cl
Et3N1 h, 45 °C
93%
(OC)3Fe
Pd(PPh3)2Cl2
CuI
OBn
OBn
4.88 7.5 5.17
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MS (EI+, 70 eV) m/z 338.0 (M+•, 1%), 312.2 (7), 282.0 (6), 255.0 (43), 254 (100), 
148.0 (72);  
 
HRMS (EI+, 70 eV) found m/z 338.0246 (C17H14O456Fe requires M+• 338.0241).  
 
 
 
Tricarbonyl(1-(4-methoxyphenyl)-4-methylenehex-5-en-2-yn-1-yl 
acetate)iron (5.21) 
 
 
 
Prepared according to general procedure 3, using chloride 4.88 (200 mg, 876 µmol), 
alkyne 7.6Y (215 mg, 1.05 mmol), Pd(PPh3)2Cl2 (31 mg, 43.8 µmol) and CuI (8 mg, 
43.8 µmol) in Et3N (12 mL). The crude product was purified using flash 
chromatography (silica, 10:90 EtOAc/hexane) to give the title alkyne 5.21 (295 mg, 
745 µmol, 85% yield) as a yellow oil, as a mixture of diastereomers. 
 
R f = 0.4 (10:90 EtOAc/hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 7.47 (d, J = 8.0 Hz, 2H), 6.91 (d, J = 8.0 Hz, 2H), 
6.53 (s, 1H), 5.69 (dd, J = 8.0 Hz and 8.0 Hz, 1H), 3.82 (s, 4H), 2.09 (m, 4H), 1.79 
(dd J = 6.7 and 2.1 Hz, 1H), 0.34 (d, J = 2.0 Hz, 1H), 0.22 (dd, J = 9.2 and 2.0 Hz, 
1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 210.1, 170.0, 160.3, 129.5, 129.0, 128.9, 114.2, 90.0 
(two peaks), 86.0 (two peaks), 83.5, 83.4, 82.7 (two peaks), 65.6 (two peaks), 55.5, 
43.5, 43.4, 39.7 (two peaks) 21.2 ppm;  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Y Prepared in accordance with the protocols of chapter 3 from anisaldehyde 
(OC)3Fe
Cl
Et3N1 h, 45 °C
85% (OC)3Fe
Pd(PPh3)2Cl2
CuI
PMP = p-methoxyphenyl
PMP
PMPOAc
OAc
4.88 7.6 5.21
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νmax (NaCl) 3025, 2967, 2932, 2839, 2053, 1979, 1743, 1611, 1513, 1223 cm-1;  
 
MS (EI+, 70 eV) m/z 396.03 (M+•, <1%), 313.0 (34), 312.0 (100), 297.0 (39), 253.0 
(30), 197.1 (40);  
 
HRMS (EI+, 70 eV) found m/z 396.2097 (C19H16O656Fe requires M+• 396.2096).  
 
 
 
Tricarbonyl(3-methylenehex-1-en-4-yne)iron (5.20) 
 
 
 
Pd(PPh3)2Cl2 (115 mg, 164 µmol) and CuI (31 mg, 164 µmol) were dissolved in Et3N 
(30 mL) and chloride 4.88 (500 mg, 3.28 mmol) was added. The solution was placed 
under an atmosphere of propyne then heated to 45 °C for 1 h, after which the 
reaction solution was cooled to 25 °C and diluted with Et2O and water. The organic 
phase was isolated and washed with water and brine, then dried over MgSO4 and 
concentrated under reduced pressure to give the crude product as a dark brown oil. 
This was subjected to flash chromatography (silica, hexane) to give the title alkyne 
5.20 (473 mg, 2.04 µmol, 93% yield) as a yellow oil. 
 
R f = 0.6 (hexane on silica); 
 
1H NMR (300 MHz, CDCl3) δ 5.59 (ddd, J = 8.7, 7.4 and 1.2 Hz, 1 H), 1.99 Hz 
(dd, J = 2.5 Hz and 1.4 Hz, 1H), 1.94 (s, 3H), 1.73 (dd, 7.0 and 2.7 Hz, 1H), 0.30 (s, 
2.5 and 1.0 Hz ppm, 1H), 0.14 (dd, 9.0 and 2.7 Hz, 1H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 210.6, 89.1, 86.3, 82.3, 78.3, 43.6, 39.1, 4.3 ppm;  
(OC)3Fe
Cl
Et3N1 h, 45 °C
93%
(OC)3Fe
Pd(PPh3)2Cl2
CuI
CH3
CH3
4.88 7.7 5.20
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νmax (NaCl) 3068, 3006, 2921, 2852, 2241, 2052, 1974 cm-1;  
 
MS (EI+, 70 eV) m/z 232.0 (M+•, 17%), 204.0 (66), 176.0 (100), 148.0 (85), 108.0 
(37);  
 
HRMS (EI+, 70 eV) found m/z 231.9823 (C10H856FeO3 requires M+• 231.9823).  
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7.7 Synthesis of Tricarbonyliron-1-(Z)-Dendralene 
Complexes 
 
General procedure 4, for the reduction of tricarbonyliron-
dehydrodendralene complexes to tricarbonyliron 1-(Z)-dendralene 
complexes 
 
Cyclohexene (4.0 mol. equiv.) was dissolved in THF (3.7 M conc. w.r.t. cyclohexene) 
under nitrogen and cooled to 0 °C. BH3.SMe2 (2.0 mol. equiv., 10 M solution) was 
added dropwise, and the solution was stirred at 0 °C for 1 h. A solution of 
dehydrodendralene complex (1.0 mol. equiv.) in THF (0.72 M conc. w.r.t. alkyne) 
was then added, and the solution was stirred at 25 °C for 1 h or until full conversion 
of starting material was observed. 1-hexene (2.0 mol. equiv.) was then added, and the 
solution was stirred at 25 °C for an additional hour. The solution was then cooled to 0 
°C, AcOH (4.0 mol. equiv.) was added, and the solution was warmed to 25 °C for 2 
h. The mixture was partitioned between water and CH2Cl2, the organic layer isolated 
and the aqueous layer extracted with water (2 portions). Organic extracts were 
combined, washed with brine and dried over MgSO4, then concentrated under 
reduced pressure to give the crude product as an orange-yellow gum.  
 
 
 
Tricarbonyl((Z)-trimethyl(3-methylenepenta-1,4-dien-1-yl)silane)iron (5.22) 
 
 
 
Prepared according to general procedure 4, using alkyne 4.166 (100 mg, 345 µmol) 
in THF (0.37 mL), BH3.SMe2 (69 µL, 689 µmol) and cyclohexene (140 µL, 1.38 
(OC)3Fe
TMS
4.166
BH3.SMe2
then  1-hexene
then  AcOH
THF
78% (OC)3Fe
5.22
TMS
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mmol) in THF (0.47 mL), 1-hexene (86 µL, 689 µmol) and AcOH (79 µL, 1.38 
mmol). The crude product was purified using flash chromatography (silica, hexane) to 
give the title (Z)-alkene 5.22 (78.2 mg, 268 µmol, 78% yield) as a yellow oil. 
 
R f = 0.8 (hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 6.94 (d, J = 14.5 Hz, 1H), 5.76 (d, J = 14.5 Hz, 1H), 
5.43 (dd, J = 5.43 and 5.43, 1H), 2.13 (m, 1H), 1.81 (dd, J = 7.2 and 2.3 Hz, 1H), 
0.29 (m, 2H), 0.19 (s, 9H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 211.1, 145.8, 133.3, 102.8, 86.4, 41.8, 39.8, 0.7 ppm;  
 
νmax (NaCl) 2956, 2917, 2849, 2050, 1973 cm-1;  
 
MS (EI+, 70 eV) m/z 292.0 (M+•, 10%), 264.2 (23), 236.1 (37), 208.2 (69), 192.2 
(100), 190.1 (25);  
 
HRMS (EI+, 70 eV) found m/z 292.0224 (C12H1656FeO3 requires M+• 292.0218).  
 
 
 
Tricarbonyl((Z)-3-methylenenona-1,4-diene)iron (5.23) 
 
 
 
Prepared according to general procedure 4, using alkyne 5.16 (100 mg, 365 µmol) in 
THF (0.5 mL), BH3.SMe2 (73 µL, 730 µmol) and cyclohexene (148 µL, 1.46 mmol) 
in THF (0.6 mL), 1-hexene (91 µL, 730 µmol) and AcOH (89 µL, 1.46 mmol). The 
(OC)3Fe
nBu
5.16
BH3.SMe2
then  1-hexene
then  AcOH
THF
68% (OC)3Fe
5.23
nBu
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crude product was purified using flash chromatography (silica, hexane) to give the title 
(Z)-alkene 5.23 (68.3 mg, 247 µmol, 68% yield) as a yellow oil. 
 
R f = 0.7 (hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 6.05 (d, J = 11.4 Hz, 1H), 5.64 (dt, J = 11.4 and 7.4 
Hz, 1H), 5.36 (dd, J = 7.7 and 7.7 Hz, 1H), 2.41 (m, 2H), 2.08 m, 1H), 1.77 (dd, J = 
6.9 and 2.2 Hz, 1H), 1.39 (m, 4H), 0.92 (t, J = 7.1 Hz, 3H), 0.42 (m, 1H), 0.25 (dd, 
J = 9.2 and 2.3 Hz, 1H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 211.4, 135.1, 128.5, 100.7, 85.6, 42.8, 39.3, 32.3, 
28.9, 22.6, 14.1 ppm;  
 
νmax (NaCl) 3012, 2958, 2926, 2873, 2857, 2253, 2048, 1969, 1713 cm-1;  
 
MS (EI+, 70 eV) m/z 276.1 (M+•, 10%), 248.1 (43), 220.1 (46), 192.1 (77), 150.1 
(100);  
 
HRMS (EI+, 70 eV) found m/z 276.0449 (C13H1656FeO3 requires M+• 276.0449).  
 
 
 
Tricarbonyl((Z)-(3-methylenepenta-1,4-dien-1-yl)benzene)iron (5.27) 
 
 
 
Prepared according to general procedure 4, using alkyne 5.15 (100 mg, 340 µmol) in 
THF (0.37 mL), BH3.SMe2 (68 µL, 680 µmol) and cyclohexene (138 µL, 1.36 mmol) 
in THF (0.47 mL), 1-hexene (84 µL, 680 µmol) and AcOH (78 µL, 1.36 mmol). 
(OC)3Fe
Ph
5.15
BH3.SMe2
then  1-hexene
then  AcOH
THF
69% (OC)3Fe
5.27
Ph
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The crude product was purified using flash chromatography (silica, hexane) to give 
the title (Z)-alkene 5.27 (69.5 mg, 235 µmol, 69% yield) as a yellow oil. 
 
R f = 0.5 (hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 7.43 (m, 2H), 7.28 (m, 3H), 6.62 (d, J = 11.5 Hz, 
1H), 6.27 (d, J = 11.5 Hz, 1H), 5.43 (dd, J = 8.2 and 8.2 Hz, 1H), 1.88 (m, 1H), 1.77 
(dd, J = 6.9 and 2.3 Hz, 1H), 0.36 (d, J = 2.8 Hz, 1H), 0.31 (dd, J = 9.3 and 2.2 Hz, 
1H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 210.1, 136.9, 132.0, 130.3, 129.2, 128.4, 127.5, 
100.0, 87.1, 44.1, 39.6 ppm;  
 
νmax (NaCl) 3058, 3021, 2958, 2917, 2849, 2047, 1968 cm-1;  
 
MS (EI+, 70 eV) m/z 296.0 (M+•, 10%), 268.0 (5), 240.1 (30), 213.1 (38), 212.1 
(100), 210.1 (43), 184.1 (34), 134.1 (37), 128.2 (39);  
 
HRMS (EI+, 70 eV) found m/z 296.0136 (C15H1256FeO3 requires M+• 296.0136).  
 
 
 
Tricarbonyl((Z)-1-methoxy-4-(3-methylenepenta-1,4-dien-1-yl)benzene)iron 
(5.26) 
 
 
 
Prepared according to general procedure 4, using alkyne 5.18 (100 mg, 324 µmol) in 
THF (0.37 mL), BH3.SMe2 (62 µL, 617 µmol) and cyclohexene (125 µL, 1.23 mmol) 
(OC)3Fe
PMP
5.18
BH3.SMe2
then  1-hexene
then  AcOH
THF
78% (OC)3Fe
5.26
PMP
PMP = p-methoxyphenyl
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in THF (0.47 mL), 1-hexene (77 µL, 617 µmol) and AcOH (71 µL, 1.23 mmol). 
The crude product was purified using flash chromatography (silica, 5:95 
EtOAc/hexane) to give the title (Z)-alkene 5.26 (78.3 mg, 309 µmol, 78% yield) as a 
yellow oil. 
 
R f = 0.4 (5:95 EtOAc/hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 7.38 (d, J = 8.7 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 
6.54 (d, J = 11.6 Hz, 1H), 6.17 (d, 11.6 Hz, 1H), 5.44 (dd, J = 8.1 and 8.1 Hz, 1H), 
3.81 (s, 3H), 1.93 (m, 1H), 1.77 (dd, J = 7.0 and 2.4 Hz, 1H), 0.40 (d, J = 2.8 Hz, 
1H), 0.31 (dd, J = 9.3 and 2.3 Hz, 1H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 211.1, 159.0, 131.6, 130.5, 129.2, 128.8, 113.7, 
100.7, 86.9, 55.4, 44.25, 39.5 ppm;  
 
νmax (NaCl) 2917, 2849, 2317, 2046, 1964 cm-1;  
 
MS (EI+, 70 eV) m/z 326.1 (M+•, 1%), 298.0 (1), 270.0 (20), 242.0 (100), 214.0 (13), 
134.0 (15);  
 
HRMS (EI+, 70 eV) found m/z 326.0247 (C16H1456FeO4 requires M+• 326.0241).  
 
 
 
Tricarbonyl((Z)-(((4-methylenehexa-2,5-dien-1-yl)oxy)methyl)benzene)iron 
(5.24) 
 
 
 
(OC)3Fe
5.17
BH3.SMe2
then  1-hexene
then  AcOH
THF
75% (OC)3Fe
5.24
OBn
OBn
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Prepared according to general procedure 4, using alkyne 5.17 (100 mg, 296 µmol) in 
THF (0.38 mL), BH3.SMe2 (59 µL, 591 µmol) and cyclohexene (120 µL, 1.18 mmol) 
in THF (0.48 mL), 1-hexene (74 µL, 591 µmol) and AcOH (68 µL, 1.18 mmol). 
The crude product was purified using flash chromatography (silica, 7:93 
EtOAc/hexane) to give the title (Z)-alkene 5.24 (75.5 mg, 222 µmol, 75% yield) as a 
yellow oil. 
 
R f = 0.5 (hexane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 7.31 (m, 5H), 6.26 (d, J = 11.0, 1H), 5.87 (m, 1H), 
5.37 (dd, J = 8.1 and 8.1 Hz, 1H), 4.57 (d, J = 1.3 Hz, 2H), 4.37 (ddd, J = 12.2, 7.1 
and 1.4 Hz, 1H), 1.93 (dd, J = 2.5 and 1.5 Hz, 1H), 1.78 (dd, J = 6.7 and 2.5 Hz, 
1H), 0.33 (dd, J = 2.5 and 0.9 Hz, 1H), 0.25 (dd, J = 9.2 and 2.4 Hz, 1H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 211.0, 138.1, 131.9, 130.5, 128.6, 128.0, 127.9, 99.1, 
86.1, 72.7, 66.7, 42.2, 39.8 ppm;  
 
νmax (NaCl) 3030, 2923, 2851, 2253, 2048, 1970, 1712 cm-1;  
 
MS (EI+, 70 eV) m/z 340.0 (M+•, 1%), 312.0 (1), 284.0 (12), 256.1 (100), 184.0 (86), 
91 (79);  
 
HRMS (EI+, 70 eV) found m/z 340.0406 (C17H1656FeO4 requires M+• 340.0398).  
 
 
 
Tricarbonyl((Z)-3-methylenehexa-1,4-diene)iron (5.25) 
 
 
(OC)3Fe
5.20
BH3.SMe2
then  1-hexene
then  AcOH
THF
65% (OC)3Fe
5.25
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Prepared according to general procedure 4, using alkyne 5.20 (100 mg, 431 µmol) in 
THF (0.6 mL), BH3.SMe2 (86 µL, 862 µmol) and cyclohexene (174 µL, 1.72 mmol) 
in THF (0.75 mL), 1-hexene (108 µL, 862 µmol) and AcOH (99 µL, 1.72 mmol). 
The crude product was purified using flash chromatography (silica, pentane) to give 
the title (Z)-alkene 5.25 (65.6 mg, 280 µmol, 65% yield) as a yellow oil. 
 
R f = 0.8 (pentane on silica);  
 
1H NMR (300 MHz, CDCl3) δ 6.07 (dq, J = 11.4 and 1.7 Hz, 1H), 5.75 (dq, J = 11.4 
and 7.0 Hz, 1H), 5.38 (dd, J = 8.0 and 8.0 Hz, 1H), 2.09 (dd, J = 2.4 and 1.5 Hz, 
1H), 1.96 (dd, J = 7.2 and 1.7 Hz, 2H), 1.77 (dd, J = 6.9 and 2.4 Hz, 1H), 0.45 (dd, J 
= 2.3 and 0.9 Hz, 1H), 0.25 (dd, J = 9.3 and 2.3 Hz, 1H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 211.3, 129.6, 128.9, 100.6, 85.7, 43.0, 39.2, 15.1 
ppm;  
 
νmax (NaCl) 3006, 2921, 2850, 2254, 2047, 1967, 1713 cm-1;  
 
MS (EI+, 70 eV) m/z 234.1 (M+•, 10%), 206.0 (46), 178.0 (52), 148.0 (100);  
 
HRMS (EI+, 70 eV) found m/z 233.9981 (C10H1056FeO3 requires M+• 233.9979).  
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7.8 Cleavage of Tricarbonyliron from 1-
[3]Dehydrodendralene and 1-(Z)-[3]Dendralene 
Complexes. 
 
General procedure 5, for the removal of tricarbonyliron groups when the 
product is non-volatile and stable when neat. 
 
The tricarbonyliron complex (1.0 eq) was dissolved in acetone (0.05 M conc. w.r.t. 
tricarbonyliron complex) and the solution was cooled to 0 °C. CAN (6 mol. equiv.) 
was added, and the reaction solution was stirred at 0 °C for 15 min or until complete 
conversion of starting material was observed by TLC. NH4Cl (saturated aqueous 
solution) and pentane or Et2O were added, and the organic phase was isolated and 
washed with water (2 portions) and brine, then dried over MgSO4 and concentrated 
under reduced pressure to give the crude product, which did not require any further 
purification unless otherwise specified.  
 
NMR spectra were recorded by quickly redissolving isolated material in CDCl3, while 
samples were stored for prolonged periods as dilute solutions (0.01 M) at low 
temperature (−20 °C or −80°C) 
 
 
General procedure 6, for the removal of tricarbonyliron groups when the 
product is volatile or unstable when neat. 
 
The tricarbonyliron complex (1.0 eq) was dissolved in methanol (0.05 M conc. w.r.t. 
tricarbonyliron complex) and the solution was cooled to 0 °C. CAN (6 mol. equiv.) 
was added, and the reaction solution was stirred at 0 °C for 15 min or until complete 
conversion of starting material was observed by TLC. NH4Cl (saturated aqueous 
solution) and d6-benzene were added, the aqueous phase removed, and the organic 
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phase was washed with water (8 portions) and brine, then dried over MgSO4. Yields 
were determined by 1H NMR by reference to a known quantity of added calibrant 
(durene). 
 
 
 
3-Methylenenon-1-en-4-yne (5.31) 
 
 
 
Prepared according to general procedure 5, using tricarbonyliron complex 5.16 (96 
mg, 350 µmol) and CAN (854 mg, 2.10 mmol) in acetone (7 mL), giving the title 
alkyne 5.31 (22 mg, 164 µmol, 47% yield) as a clear oil. Spectroscopic and physical 
data were in accordance with literature values.[221] 
 
1H NMR (400 MHz, CDCl3) δ 6.35 (dd, J = 16.9 and 10.2Hz, 1H), 5.62 (d, J = 16.9 
Hz, 1H), 5.43 (s, 1H), 5.34 (s, 1H), 5.22 (d, J = 10.1 Hz, 1H), 2.38 (t, J = 7.2 Hz, 
2H), 1.56 (m, 2H), 1.46 (m, 2H), 0.93 (t, 3H) ppm.  
 
 
 
(3-Methylenepent-4-en-1-yn-1-yl)benzene (5.34) 
 
 
 
Prepared according to general procedure 5, using tricarbonyliron complex 5.15 (45 
mg, 153 µmol) and CAN (374 mg, 920 µmol) in acetone (3 mL), giving the title 
alkyne 5.34 (12.4 mg, 80 µmol, 52% yield) as a light yellow oil. 
nBu
acetone
15 min, 0 °C
47%
(OC)3Fe
nBu
CAN
5.16 5.31
Ph
acetone
15 min, 0 °C
52%
(OC)3Fe
Ph
CAN
5.15 5.34
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1H NMR (400 MHz, CDCl3) δ 7.50 (m, 2H), 7.33 (m, 3H), 6.43 (dd, J = 17.1 and 
10.1 Hz, 1H), 5.75 (d, J = 10.1 Hz, 1H), 5.62 (s, 1H), 5.50 (s, 1H), 5.31 (d, J = 10.1 
Hz, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 136.2, 131.8, 130.2 128.6, 128.5, 123.9, 123.2, 
180.0, 91.8, 85.9 ppm;  
 
νmax (NaCl) 2918, 2873, 2849 cm-1;  
 
MS (EI+, 70 eV) m/z 267.1 (63%), 202.1 (100), 167.1 (67), 154.1 (M+•, 35), 153.1 
(23), 115.1 (22), 77 (23);  
 
HRMS (EI+, 70 eV) found m/z 154.0783 (C12H10 requires M+• 154.0783).  
 
 
 
1-Methoxy-4-(3-methylenepent-4-en-1-yn-1-yl)benzene (5.35) 
 
 
 
Prepared according to general procedure 5, using tricarbonyliron complex 5.18 (20 
mg, 61.7 µmol) and CAN (150 mg, 370 µmol) in acetone (1.2 mL), giving the title 
alkyne 5.35 (7 mg, 39.1 µmol, 63% yield) as a yellow oil. 
 
1H NMR (300 MHz, CDCl3) δ 7.44 (d, J = 8.8 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 
6.42 (dd, J = 17.0 and 10.2 Hz, 1H), 5.74 (d, J = 17.0 Hz, 1H), 5.58 (s, 1H), 5.47 (s, 
1H), 5.30 (d, J = 10.2 Hz, 1H), 3.82 (s, 3H) ppm;  
 
PMP
acetone
15 min, 0 °C
63%
(OC)3Fe
PMP
CAN
5.18 5.35
PMP = p-methoxyphenyl
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13C NMR (100 MHz, CDCl3) δ 159.9, 136.4, 133.3, 130.3, 123.3, 117.9, 115.3, 
114.1, 91.9, 84.6, 55.5 ppm;  
 
νmax (NaCl) 3094, 3005, 2961, 2931, 2836, 2207, 1605, 1509, 1249 cm-1;  
 
MS (EI+, 70 eV) m/z 268.1 (17%), 184.1 (M+•, 100), 141.1 (40), 115.0 (39);  
 
HRMS (EI+, 70 eV) found m/z 184.0890 (C13H12O requires M+• 184.0888).  
 
 
 
1-(3-Methylenepent-4-en-1-yn-1-yl)-4-nitrobenzene (5.37) 
 
 
 
Prepared according to general procedure 5, using tricarbonyliron complex 5.19 (102 
mg, 301 µmol) and CAN (733 mg, 1.80 mmol) in acetone (6 mL), giving the title 
alkyne 5.37 (50 mg, 249 µmol, 83% yield) as a light yellow oil. 
 
1H NMR (400 MHz, CDCl3) δ 8.21 (d, J = 8.8 Hz, 2H), 7.26 (d, J = 8.8 Hz, 2H), 
6.44 (dd, J = 17.0 and 10.2 Hz, 1H), 5.72 (m, 2H), 5.61 (s, 1H), 5.35 (d, J = 10.2 Hz, 
1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 147.3, 135.7, 132.5, 130.1, 129.5, 125.6, 123.8, 
118.4, 91.2, 89.7 ppm;  
 
νmax (NaCl) 3393, 2930, 2866, 1995, 1593, 1343 cm-1;  
 
MS (EI+, 70 eV) m/z 199.1 (M+•, 100%), 171.0 (16), 152.1 (86), ;  
PNP
acetone
15 min, 0 °C
83%
(OC)3Fe
PNP
CAN
5.19 5.37
PNP = p-nitrophenyl
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HRMS (EI+, 70 eV) found m/z 199.0637 (C12H19NO2 requires M+• 199.0633).  
 
 
 
(((4-Methylenehex-5-en-2-yn-1-yl)oxy)methyl)benzene (5.23) 
 
 
 
Prepared according to general procedure 5, using tricarbonyliron complex 5.17 (129 
mg, 382 µmol) and CAN (930 mg, 2.29 mmol) in acetone (8 mL), giving the title 
alkyne 5.23 (65 mg, 329 µmol, 86% yield) as a clear oil. 
 
1H NMR (400 MHz, CDCl3) δ 7.34 (m, 5H), 6.37 (dd, J = 17.0 and 10.4 Hz, 1H), 
5.67 (d, J = 17.0 Hz, 1H), 5.56 (s, 1H), 5.47 (s, 1H), 5.27 (d, J = 10.4 Hz, 1H), 4.64 
(s, 2H), 4.37 (s, 2H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 137.6, 136.1, 129.7, 128.6, 128.3, 128.0, 124.4, 
118.0, 87.6, 83.2, 71.7, 57.9 ppm;  
 
νmax (NaCl) 3089, 2065, 3031, 2923, 2851, 1985, 1571, 1454 cm-1;  
 
MS (EI+, 70 eV) m/z 230.1 (20), 198.1 (M+•, 1%), 193.1 (9), 178.1 (8), 167.9 (9), 
151.1 (11), 91.1 (100);  
 
HRMS (EI+, 70 eV) found m/z 198.1044 (C14H14O requires M+• 198.1045).  
 
 
 
1-(4-Methoxyphenyl)-4-methylenehex-5-en-2-yn-1-yl acetate (5.36) 
acetone
15 min, 0 °C
86%
(OC)3Fe
CAN
5.17 5.23
OBn OBn
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Prepared according to general procedure 5, using tricarbonyliron complex 5.21 (144 
mg, 337 µmol) and CAN (886 mg, 2.18 mmol) in acetone (6.7 mL), giving the title 
alkyne 5.36 (56 mg, 219 µmol, 60% yield) as a clear oil. 
 
1H NMR (300 MHz, CDCl3) δ 7.50 (d, J = 8.5 Hz, 2H), 6.92 (d, J = 8.5 Hz, 2H), 
6.60 (s, 1H), 6.35 (dd, J = 17 and 10.2 Hz, 1H), 5.61 (m, 2H), 5.48 (s, 1H), 5.26 (d, J 
= 10.2 Hz, 1H), 3.82 (s, 3H), 2.10 (s, 3H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 170.0, 160.3, 135.9, 129.5, 129.4 (two peaks), 124.9, 
118.3, 114.2, 88.3, 83.5, 65.9, 55.5, 21.3 ppm;  
 
νmax (NaCl) 3007, 2956, 2919, 2850, 2838, 1740, 1610, 1512, 1225 cm-1;  
 
MS (EI+, 70 eV) m/z 312.0 (6%), 256.1 (M+•, 11), 214.1 (100), 197.1 (62), 196.3 
(43), 153.1 (55), 152.1 (48);  
 
HRMS (EI+, 70 eV) found m/z 256.1096 (C16H16O3 requires M+• 256.1099).  
 
 
 
3-Methylenehex-1-en-4-yne (5.33) 
 
 
 
acetone
15 min, 0 °C
60%(OC)3Fe
CAN
5.21 5.36
PMP PMP
OAc OAc
PMP = p-methoxyphenyl
MeOH
15 min, 0 °C
57%
(OC)3Fe
CAN
5.20 5.33
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Prepared according to general procedure 6, using tricarbonyliron complex 5.20 (60 
mg, 259 µmol) and CAN (630 mg, 1.55 mmol) in MeOH (5.2 mL), giving the title 
alkyne 5.33 (14 mg, 148 µmol, 57% calculated yield) as a d6-benzene solution. 
 
1H NMR (300 MHz, C6D6) δ 6.25 (dd, J = 17.0 and 10.1 Hz, 1H), 5.87 (d, J = 17.1, 
1H), 5.46 (s, 1H), 5.14 (m, 2H), 1.56 (s, 3H) ppm;  
 
13C NMR (100 MHz, C6D6) δ 137.3, 131.4, 122.9, 117.4, 88.5, 77.0, 3.8 ppm;  
 
MS (EI+, 70 eV) m/z 169.1 (31%), 153.1 (28), 141.1 (22), 128.1 (22), 115.1 (22), 
92.1 (M+•, 11), 91.1 (26), 84.1 (100);  
 
HRMS (EI+, 70 eV) found m/z 92.0626 (C7H8 requires M+• 92.0626).  
 
 
 
3-Methylenepent-1-en-4-yne (5.30) 
 
 
 
Prepared according to general procedure 6, using tricarbonyliron complex 4.167 
(100.0 mg, 459 µmol) and CAN (1.12 mg, 2.75 mmol) in MeOH (9.2 mL), giving 
the title alkyne 5.30 (19 mg, 238 µmol, 52% calculated yield) as a d6-benzene 
solution. 
 
1H NMR (300 MHz, C6D6) δ 6.11 (dd, J = 17.1 and 10.1 Hz, 1H), 5.80 (d, J = 17.1 
H, 1H), 5.43 (s, 1H), 5.09 (m, 2H), 2.62 (s, 1H) ppm;  
 
13C NMR (100 MHz, C6D6) δ 136.1, 129.9, 125.2, 118.1, 80.4 ppm;  
 
MeOH
15 min, 0 °C
52
(OC)3Fe
CAN
4.167 5.30
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MS (EI+, 70 eV) m/z 141 (48%), 128.1 (41), 115.1 (47), 109.1 (59), 94.0 (59), 78.0 
(M+•, 46), 77.0 (59), 65.0 (80), 51.0 (100);  
 
HRMS (EI+, 70 eV) found m/z 78.0470 (C6H6 requires M+• 78.0470).  
 
 
 
(Z)-3-Methylenenona-1,4-diene (5.39) 
 
 
 
Prepared according to general procedure 5, using tricarbonyliron complex 5.23 (65 
mg, 235 µmol) and CAN (542 mg, 1.41 mmol) in acetone (4.7 mL), giving the title 
(Z)-alkene 5.39 (23mg, 170 µmol, 72% yield) as a white oil. 
 
1H NMR (300 MHz, CDCl3) δ 6.41 (dd, J = 17.7 and 10.3 Hz, 1H), 5.97 (d, J = 11.3 
Hz, 1H), 5.65 (dt, J = 11.5 and 7.3 Hz, 1H), 5.2 (m, 2H), 5.05 (m, 2H), 2.14 (m, 
2H), 1.30 (m, 4H), 0.88 (t, J = 6.7 Hz, 3H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 143.1, 139.0, 134.5, 125.9, 117.6, 115.2, 32.2, 28.5, 
22.5, 14.1 ppm;  
 
νmax (NaCl) 2957, 2925, 2853, 2048, 1978 cm-1;  
 
MS (EI+, 70 eV) m/z 220.2 (4%), 192.1 (3), 175.1 (3), 166.2 (10), 136.1 (M+•, 17), 
107.1 (27), 93.1 (80), 79.1 (100);  
 
HRMS (EI+, 70 eV) found m/z 136.1256 (C10H16 requires M+• 136.1252).  
 
 
 
acetone
15 min, 0 °C
72%
CAN
(OC)3Fe
5.23
nBu
5.39
nBu
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((Z)-(3-Methylenepenta-1,4-dien-1-yl)benzene (5.41) 
 
 
 
Prepared according to general procedure 5, using tricarbonyliron complex .27 (66 
mg, 223 µmol) and CAN (542 mg, 1.34 mmol) in acetone (4.5 mL), giving the title 
(Z)-alkene 5.41 (28 mg, 181 µmol, 81% yield) as a white oil. 
 
1H NMR (300 MHz, CDCl3) δ 7.36 (m, 2H), 7.21 (m, 3H), 6.57 (d, J = 12.3 Hz, 
1H), 6.45 (dd, J = 17.4 and 10.5 Hz, 1H), 6.18 (d, J = 12.3 Hz, 1H), 5.34 (d, J = 17.4 
Hz, 1H), 5.13 (m, 3H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 144.1, 137.8, 137.0, 131.9, 129.0, 128.1 (two peaks) 
127.2, 118.3, 115.9 ppm;  
 
νmax (NaCl) 3080, 3057, 3025, 3007, 2924, 2965, 2851, 1584 cm-1;  
 
MS (EI+, 70 eV) m/z 235.2 (9%), 159.1 (M+•, 95), 141.1 (92), 128.1 (100), 151.1 
(71);  
 
HRMS (EI+, 70 eV) found m/z 156.0936 (C12H12 requires M+• 156.0939).  
 
 
 
 (Z)-(((4-Methylenehexa-2,5-dien-1-yl)oxy)methyl)benzene (5.40) 
 
 
 
acetone
15 min, 0 °C
81%
CAN
(OC)3Fe
5.27
Ph
5.41
Ph
acetone
15 min, 0 °C
86%
CAN
(OC)3Fe
5.24 5.40
OBn OBn
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Prepared according to general procedure 5, using tricarbonyliron complex 5.24 (74 
mg, 218 µmol) and CAN (530 mg, 1.31 mmol) in acetone (4.35 mL), giving the title 
alkyne 5.40 (38 mg, 187 µmol, 86% yield) as a white oil. 
 
1H NMR (300 MHz, CDCl3) δ 7.31 (m, 5H), 6.41 (dd, J = 17.6 and 10.7 Hz, 1H), 
6.24 (d, J = 11.8 Hz, 1H), 5.90 (dt, J = 11.5 and 6.5 Hz, 1H), 5.22 (m, 2H), 5.13 (d, J 
= 10.6 Hz, 1H), 4.96 (s, 1H), 4.49 (s, 2H), 4.16 (d, J = 6.7 Hz, 2H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 142.2, 138.5, 138.3, 130.6, 129.3, 128.5, 128.0, 
127.7, 118.7, 116.0, 72.4, 67.1 ppm;  
 
νmax (NaCl) 3064, 3089, 3029, 2925, 2854, 2048, 1977 cm-1;  
 
MS (EI+, 70 eV) m/z 200.1 (M+•, 2%), 182.1 (3), 156.1 (5), 109.0 (36), 91.0 (100), 
81.1 (33);  
 
HRMS (EI+, 70 eV) found m/z 200.1202 (C14H16O requires M+• 200.1201).  
 
 
 
(Z)-3-Methylenehexa-1,4-diene (5.38) 
 
 
 
Prepared according to general procedure 6, using tricarbonyliron complex 5.25 (66 
mg, 280 µmol) and CAN (683 mg, 1.68 mmol) in MeOH (5.6 mL), giving the title 
alkyne 5.38 (16 mg, 173 µmol, 62% yield) as a d6-benzene solution. 
 
MeOH
15 min, 0 °C
62%
CAN
(OC)3Fe
5.25 5.38
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1H NMR (300 MHz, CDCl3) δ 6.37 (dd, J = 17.2 and 10.9, 1H), 6.05 (d, J = 11.1, 
1H), 5.62 (dq, J = 11.5 and 6.9, 1H), 5.25 (d, J = 17.5, 1H), 5.13 (s, 1H), 5.00 (m, 
2H), 1.60 (dd, J = 7.1 and 1.8 Hz) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 143.1, 139.1, 127.3, 118.1, 115.2, 14.6 ppm (one 
overlapping peak);  
 
MS (EI+, 70 eV) m/z 169.1 (31%), 153.1 (28), 141.1 (22), 128.1 (22), 115.1 (22), 
92.1 (M+•, 11), 91.1 (26), 84.1 (100);  
 
HRMS (EI+, 70 eV) found m/z 92.0626 (C7H8 requires M+• 92.0626).  
 
 
 
(Z)-1-Methoxy-4-(3-methylenepenta-1,4-dien-1-yl)benzene (5.42) 
 
 
 
Tricarbonyliron complex 5.26 (100 mg, 307 µmol) was dissolved in acetone (12.4 
mL) and trimethylamine N-oxide (852 mg, 7.67 mmol) was added. The solution was 
stirred at 25 °C for 5 days, after which the reaction solution was partitioned with 
CH2Cl2 (25 mL) and water (25 mL), the organic layer isolated, and the aqueous layer 
extracted with CH2Cl2 (2 × 25 mL). Organic layers were washed with brine (75 mL), 
dried over MgSO4 and concentrated under reduced pressure to give the crude product 
as a yellow oil. This was purified using flash chromatography (silica, 1:99 
EtOAc/hexane), to give the title (Z)-alkene 5.42 (48.4 mg, 260 µmol, 85% yield) as a 
light yellow oil  
 
R f = 0.2 (1:99 EtOAc/hexane on silica);  
 
acetone
5 days, 25 °C
85%
TMANO
(OC)3Fe
5.26
PMP
5.42
PMP
PMP = p-methoxyphenyl
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1H NMR (400 MHz, CDCl3) δ 7.32 (d, J = 8.7 Hz, 2H), 6.78 (d, J = 8.7 Hz, 2H), 
6.47 (m, 2H), 6.07 (d, J = 12.3, 1H), 5.34 (d, J = 17.6 Hz, 1H), 5.14 (m, 3H), 3.79 (s, 
3H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 158.8, 144.4, 137.8, 131.2, 130.3, 129.7, 126.1, 
118.0, 115.8, 113.5, 55.3 ppm;  
 
νmax (NaCl) 3088, 3003, 2956, 2933, 2835 cm-1;  
 
MS (EI+, 70 eV) m/z 242.0 (23%), 186.1 (M+•, 100), 185.1 (64), 155.1 (74), 128.1 
(65), 115.1 (64);  
 
HRMS (EI+, 70 eV) found m/z 186.1046 (C13H14O requires M+• 186.1045).  
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7.9 Higher Polyenes and Polyenynes 
 
Hexacarbonyl(3,6-dimethyleneocta-1,7-dien-4-yne)diiron (4.168) 
 
 
 
Pd(PPh3)2Cl2 (76.9 mg, 109 µmol) was dissolved in DMF (6.6 mL) and chloride 4.88 
(750 mg, 3.28 mmol) and Et3N (916 µL, 6.57 mmol) were added. The solution was 
placed under an atmosphere of acetylene then heated to 70 °C for 30 min, after which 
the reaction solution was cooled to 25 °C and diluted with Et2O (30 mL) and water 
(30 mL). The organic layer was isolated and washed with water and brine, then dried 
over MgSO4 and concentrated under reduced pressure to give the crude product as a 
dark brown oil. This was subjected to flash chromatography (silica, hexane) to give 
the title alkyne 4.168 (380 mg, 927 µmol, 56% yield) as a yellow solid. Spectroscopic 
and physical data were in accordance with previously reported values.[253] 
 
R f = 0.4 (hexane on silica); 
 
1H NMR (400 MHz, CDCl3) δ 5.71 (dd, J = 8.5 and 7.7 Hz, 1H), 2.06 (m, 1H), 
1.81 (dd, 7.1 and 2.6 Hz, 1H), 0.36 (m, 1H), 0.24 (ddd, J = 9.5, 2.7 and 1.1 Hz, 1H) 
ppm;  
 
13C NMR (75 MHz, CDCl3) δ 210.1, 90.0 (two peaks) 85.1, 83.7 43.4, 43.3, 39.8 
(two peaks) ppm;  
 
νmax (NaCl) 3069, 3005, 2957, 2917, 2849, 2051, 1974 cm-1;  
 
(OC)3Fe
Fe(CO)3
(OC)3Fe
Cl
DMF
30 min, 70 °C
56%
Pd(PPh3)2Cl2
Et3N
4.88 2.13 4.168
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MS (EI+, 70 eV) m/z 409.9 (M+•, 7%), 381.9 (4), 353.9 (73), 325.9 (82), 269.9 (100), 
241.9 (95), 186.0 (60);  
 
HRMS (EI+, 70 eV) found m/z 409.9178 (C16H1056Fe2O6 requires M+• 409.9176).  
 
 
 
Tricarbonyl((Z)-3-methylenehexa-1,4-diene)iron (6.2) 
 
 
 
Prepared according to general procedure 4, using alkyne 4.168 (100 mg, 244 µmol) 
in THF (0.3 mL), BH3.SMe2 (49 µL, 488 µmol) and cyclohexene (99 µL, 976 µmol) 
in THF (0.4 mL), 1-hexene (61 µL, 488 µmol) and AcOH (99 µL, 976 µmol). The 
crude product was purified using flash chromatography (silica, pentane) to give the 
title (Z)-alkene 6.2 (65.6 mg, 280 µmol, 67% yield) as a yellow oil as an inseparable 
55:45 mixture of diastereomers. 
 
1H NMR major diastereomer (300 MHz, CDCl3) δ 6.31 (s, 2H), 5.48 (dd, J = 8.0 
and 8.0 Hz, 2H) 2.27 (m, 2H), 1.84 (m, 2H), 0.46 (d, J = 2.2 Hz, 2H), 0.36 (m, 2H) 
ppm;  
 
1H NMR minor diastereomer (300 MHz, CDCl3) δ 6.21 (s, 2H), 5.62 (dd, J = 8.1 
and 8.1 Hz, 2H), 2.14 (m, 2H), 1.83 (m, 2H), 0.50 (d, J = 2.5 Hz, 2H), 0.33 (m, 2H) 
ppm; 
 
13C NMR (100 MHz, CDCl3) δ 210.8, 132.0, 131.9, 99.7, 99.2, 87.5, 86.9, 44.1, 
43.6, 40.1, 39.6 ppm;  
 
4.168
BH3.SMe2
then  1-hexene
then  AcOH
THF
67%
6.2
(OC)3Fe
Fe(CO)3
(OC)3Fe
(OC)3Fe
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νmax (NaCl) 3061, 3007, 2930, 2854, 2045, 1966 cm-1;  
 
MS (EI+, 70 eV) m/z 411.9 (M+•, 4%), 383.9 (4), 355.9 (44), 327.9 (30), 299.9 (25), 
271.9 (65), 243.9 (100), 186.0 (33);  
 
HRMS (EI+, 70 eV) found m/z 411.9331 (C16H12O656Fe2 requires M+• 411.9333).  
 
 
 
3,6-Dimethyleneocta-1,7-dien-4-yne (6.4) 
 
 
 
Prepared using a modification of general procedure 6, using bis-tricarbonyliron 
complex 4.168 (73.2 mg, 179 µmol) and CAN (870 mg, 2.14 mmol (12 mol. equiv.)) 
in methanol (3.6 mL), giving the title alkyne 6.4 (19.2 mg, 147 µmol, 83% calculated 
yield) as a d6-benzene solution. 
 
1H NMR (300 MHz, CDCl3) δ 6.40 (dd, J = 16.8 and 9.9 Hz, 1H), 5.69 (d, J = 16.8 
Hz, 1H), 5.59 (s, 1H), 5.49 (s, 1H), 5.29 (d, J = 9.9 Hz, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 136.1, 130.0, 124.3, 118.0, 88.2 ppm;  
 
MS (EI+, 70 eV) m/z 130.1 (M+•, 37%), 128.1 (37), 117 (65), 75.0 (100);  
 
HRMS (EI+, 70 eV) found m/z 130.0784 (C10H10 requires M+• 130.0783);  
 
UV/Vis λmax = 272, 259, 232, 226, 217, 208 nm. 
 
 
MeOH
15 min, 0 °C
83%
CAN
(OC)3Fe
Fe(CO)3
4.168 6.4
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(Z)-3,6-Dimethyleneocta-1,4,7-triene (6.3) 
 
 
 
Prepared using a modification of general procedure 4, using bis-tricarbonyliron 
complex 6.2 (20.0 mg, 48.6 µmol) and CAN (237 mg, 583 mmol (12 mol. equiv.)) in 
MeOH (2.0 mL), giving the title (Z)-alkene 6.3 (0.66 mg, 5.0 µmol, 10% calculated 
yield) as a d6-benzene solution. 
 
An alternative experiment was performed in which tricarbonyliron complex 6.2 (3.1 
mg, 7.5 µmol) and CAN (37 mg, 90 mmol (12 mol. equiv.)) were combined in d6-
acetone (1.0 mL) in the presence of an internal standard (durene). Analysis of this 
mixture by NMR showed 84% conversion of complex 6.2 to pentaene 6.3. 
 
1H NMR (500 MHz, C6D6) δ 6.32 (dd, J = 17.2 and 10.5 Hz, 2H), 6.11 (s, 2H), 5.25 
(d, J = 17.5 Hz, 2H), 5.16 (s, 2H), 4.98 (m, 4H) ppm;  
 
13C NMR (500 MHz, C6D6) δ 143.5, 138.6, 129.9, 118.2, 115.1 ppm;  
 
MS (EI+, 70 eV) m/z 132.1 (M+•, 60%), 117.1 (100), 104.1 (58), 84.1 (50);  
 
HRMS (EI+, 70 eV) found m/z 132.0943 (C10H12 requires M+• 132.0939);  
 
UV/Vis λmax = 215 nm. 
 
 
 
6.2
(OC)3Fe
(OC)3Fe
MeOH
15 min, 0 °C
10%
CAN
6.3
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Nonacarbonyl(3,6,7,10-tetramethylenedodeca-1,11-dien-4,8-diyne)triiron 
(6.6) 
 
 
 
Pd(PPh3)2Cl2 (32.3 mg, 46.0 µmol) and CuI (8.80 mg, 46.0 µmol) were dissolved in 
Et3N (6 mL) under nitrogen and dichloride 4.100 (121 mg, 460 µmol) and alkyne 
4.167 (301 mg, 1.38 mmol) were added. The solution was heated to 45 °C for 3 h, 
after which it was cooled to 25 °C and diluted with CH2Cl2 (25 mL) and water (25 
mL). The organic layer was isolated, and the aqueous layer extracted with CH2Cl2 (2 
× 25 mL). Organic phases were combined, washed with brine (75 mL), then dried 
over MgSO4 and concentrated under reduced pressure to give the crude product as a 
black oil. This was subjected to flash chromatography (silica, 2:98 EtOAc/hexane) to 
give the title complex 6.6 (132 mg, 212 µmol, 46% yield) as a yellow oil as a mixture 
of diastereomers.  
 
R f = 0.3 (2:98 EtOAc/hexane on silica); 
 
1H NMR (300 MHz, CDCl3) δ 5.75 (dd, J = 8.5 and 8.5 Hz, 2H), 2.08 (m, 4H), 
1.83 (dd, J = 6.9 and 2.1 Hz, 2H), 0.40 (m, 2H), 0.34 (m, 2H), 0.28 (m, 2H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 210.1, 209.0, 90.3, 90.2 (two peaks), 88.9, 88.8 (three 
peaks), 87.8, 87.7 (two peaks) 83.9, 83.8 (two peaks), 84.4 (three peaks), 43.5, 43.4, 
43.3 (two peaks), 42.5 (two peaks), 42.4, 40.0 (two peaks) ppm;  
 
νmax (NaCl) 3069, 3006, 2919, 2848, 2052, 1976 cm-1;  
 
(OC)3Fe
Fe(CO)3
(OC)3Fe
Cl
4.100 6.6
Cl
(OC)3Fe
4.167
Fe(CO)3
Et3N
3 h, 45 °C
46%
Pd(PPh3)2Cl2
CuI
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MS (EI+, 70 eV) m/z 625.7 (M+•, 1%), 541.8 (100), 457.8 (33), 429.8 (83), 373.8 
(72), 317.9 (30);  
 
HRMS (EI+, 70 eV) found m/z 625.8678 (C25H14O956Fe3 requires M+• 625.8686).  
 
 
 
3,6,7,10-Tetramethylenedodeca-1,11-dien-4,8-diyne (6.9) 
 
 
 
Prepared using a modification of general procedure 6, using tricarbonyliron complex 
6.6 (43.1 mg, 68.9 µmol) and CAN (503 mg, 1.24 mmol (18 mol. equiv.)) in MeOH 
(7.0 mL), giving the title alkyne 6.9 (1.05 mg, 5.09 µmol, 7% yield) as a clear oil. 
 
An alternative experiment was performed in which tricarbonyliron complex 6.6 (8.0 
mg, 12.8 µmol) and CAN (94 mg, 230 mmol (18 mol. equiv.)) were combined in d6-
acetone (3.0 mL) in the presence of an internal standard (durene). Analysis of this 
mixture by NMR showed 60% of tricarbonyliron complex 6.6 had converted to 
polyenyne 6.9. 
 
1H NMR (300 MHz, CDCl3) δ 6.17 (m, 4H), 5.78 (d, J = 17.1, 2H), 5.66 (s, 2H), 
5.42 (s, 2H), 5.10 (m, 4H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 136.3, 130.3, 129.2, 125.2, 124.5, 118.1, 89.7, 88.6 
ppm;  
 
MS (EI+, 70 eV) m/z 206.1 (M+•, 70%), 205.1 (100), 198.1 (78), 178.1 (53), 165.1 
(43);  
(OC)3Fe
Fe(CO)3
6.6
Fe(CO)3
MeOH
45 min, 0 °C
7%
CAN
6.9
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HRMS (EI+, 70 eV) found m/z 206.1093 (C16H14 requires M+• 206.1096);  
 
UV/Vis λmax = 270, 257, 214 nm. 
 
 
 
(3,4-Dimethylenehexa-1,5-diyne-1,6-diyl)dibenzene (6.10) 
 
 
 
Pd(PPh3)2Cl2 (26.7 mg, 38.0 µmol) and CuI (7.30 mg, 38.0 µmol) were dissolved in 
Et3N (2 mL) and dichloride 4.100 (100 mg, 460 µmol) and phenylacetylene (125 µL, 
1.14 mmol) were added. The solution was heated to 45 °C for 2.5 h, after which it 
was cooled to 25 °C and diluted with CH2Cl2 (15 mL) and water (15 mL). The 
organic layer was isolated, and the aqueous layer extracted with CH2Cl2 (2 × 15 mL). 
Organic phases were combined, washed with brine (45 mL), then dried over MgSO4 
and concentrated under reduced pressure to give the crude product as a black oil. This 
was subjected to flash chromatography (silica, 0.5:99.5 EtOAc/hexane) to give the 
title complex 6.10 (114 mg, 288 µmol, 76% yield) as a yellow oil.  
 
R f = 0.3 (0.5:99.5 EtOAc/hexane on silica); 
 
1H NMR (400 MHz, CDCl3) δ 7.54 (m, 4H), 7.34 (m, 6H), 2.17 (d, J = 2.8 Hz, 
2H), 0.41 (d, J = 2.8 Hz, 2H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 209.4, 132.0, 128.9, 128.5, 122.7, 89.8, 88.7, 87.5, 
42.3 ppm;  
 
(OC)3Fe
(OC)3Fe
Cl
Et3N
3 h, 45 °C
76%
Pd(PPh3)2Cl2
CuI
4.100 6.10
Cl
4.160
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νmax (NaCl) 3080, 3064, 2920, 2848, 2062, 1992, 1985 cm-1;  
 
MS (EI+, 70 eV) m/z 394.0 (M+•, <1%), 366.0 (<1), 338.0 (20), 310.0 (100), 252.1 
(19);  
 
HRMS (EI+, 70 eV) found m/z 394.0297 (C23H1456FeO3 requires M+• 394.0292).  
 
 
 
Tricarbonyl((3,4-dimethylenehexa-1,5-diyne-1,6-diyl)dibenzene)iron (6.13) 
 
 
 
Prepared according to general procedure 4, using tricarbonyliron complex 6.10 (50.0 
mg, 127 µmol) and 310 (870 mg, 761 µmol) in acetone (2.5 mL), giving the title 
alkyne 6.13 (23.6 mg, 92.8 µmol, 73% calculated yield) as a white solid. 
 
1H NMR (400 MHz, CDCl3) δ 7.51 (m, 4H), 7.35 (m, 6H), 6.19 (s, 2H), 5.84 (s, 
2H) ppm;  
 
13C NMR (75 MHz, CDCl3) δ 131.8, 128.9, 128.7, 128.5, 124.6, 123.0, 92.7, 86.0 
ppm;  
 
νmax (NaCl) 3070, 3055, 3032, 2953, 2923, 2849, 2207 cm-1;  
 
MS (EI+, 70 eV) m/z 254.1 (M+•, 100%), 226.1 (21), 204.1 (19), 139.1 (29), 127.1 
(30), 115.1 (30);  
 
HRMS (EI+, 70 eV) found m/z 254.1099 (C20H14 requires M+• 254.1096);  
(OC)3Fe 6.10
acetone
15 min, 0 °C
73%
CAN
6.13
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UV/Vis λmax = 267, 327, 283, 255 nm. 
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7.10 Diels-Alder Cascades on 1-(Z)-[3]Dendralenes 
 
(Z)-2-Phenyl-5-styryl-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6.20) 
 
 
 
A sample of crude (Z)-dendralene 5.41 was prepared from its tricarbonyliron complex 
5.27 (341 mg, 1.15 mmol) following the protocol described earlier in this chapter. 
The crude material was dissolved in CH2Cl2 (11.5 mL) under nitrogen and N-
phenylmaleimide (220 mg, 1.27 mmol) was added. The resulting solution was stirred 
at 25 °C for 18 h, then concentrated under reduced pressure to give the crude product. 
This was subjected to flash chromatography (silica, 25:75 EtOAc/hexane) to give the 
title compound 6.20 (240 mg, 730 µmol, 63% yield) as a white crystalline solid.  
  
R f = 0.3 (25:75 EtOAc/hexane on silica); 
 
m.p. = 121.0 °C – 122.0 °C (recrystallised from CH2Cl2/hexane); 
 
1H NMR (400 MHz, CDCl3) δ 7.35 (m, 10 H), 6.46 (d, J = 12.1, 1H), 6.16 (d, J = 
12.1, 1H), 6.05 (m, 1H), 3.24 (ddd, J = 9.1, 7.6 and 2.8 Hz, 1H), 3.16 (ddd, J = 9.1, 
6.8 and 3.1 Hz, 1H), 2.77 (ddd, J = 15.6, 6.9 and 2.8 Hz, 1H), 2.60 (dd, J = 15.3 and 
3.1 Hz, 1H), 2.40 (m, 1H), 2.28 (m, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 178.1, 176.1, 139.8, 137.1, 132.0, 130.4, 129.3, 
128.8, 128.7, 128.5, 127.9, 126.6, 126.5, 121.7, 42.5, 39.5, 21.9, 21.3 ppm;  
 
νmax (NaCl) 3051, 3029, 2955, 2916, 2848, 1778, 1709 cm-1;  
 
5.41
Ph CH2Cl2
18 h, 25 °C
63% (two steps)
N-phenyl-
maleimide
Ph
N
O
OPh
acetone
15 min, 0 °C
CAN
(OC)3Fe
5.27
Ph
6.20
H
H
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MS (EI+, 70 eV) m/z 330.1 (23%), 329.1 (M+•, 100), 328.1 68), 188.1 (44), 181.1 
(78), 91.0 (68);  
 
HRMS (EI+, 70 eV) found m/z 329.1414 (C22H19NO2 requires M+• 329.1416).  
 
 
 
(E)-2-Phenyl-5-styryl-3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-dione (6.19) 
 
 
 
(Z)-alkene 6.20 (130 mg, 395 µmol) was dissolved in CHCl3 (9 mL) and iodine (5.6 
mg, 22.0 µmol) was added. The solution was stirred for 1 h at 25 °C, illuminated by a 
fluorescent light, then Na2S2O3 (10 mL of a saturated aqueous solution) was added. 
The organic phase was isolated, and the aqueous phase extracted with CH2Cl2 (2 × 10 
mL). Organic phases were combined, washed with brine (30 mL), dried over MgSO4 
and concentrated under reduced pressure to give the crude product as a brown oil. 
This was subjected to flash chromatography (silica, 30:70 EtOAc/hexane) to give the 
title compound 6.19 (51.9 mg, 158 µmol, 40% yield) as a white crystalline solid. 
 
R f = 0.3 (25:75 EtOAc/hexane on silica); 
 
m.p. = 137.7 °C – 138.7 °C (recrystallised from CH2Cl2/hexane); 
 
1H NMR (400 MHz, CDCl3) δ 7.31 (m, 10 H), 6.79 (d, J = 16.2, 1H), 6.65 (d, J = 
16.2, 1H), 6.05 (m, 1H), 3.39 (ddd, J = 9.2, 7.2 and 3.0 Hz, 1H), 3.31 (ddd, J = 9.1, 
7.3 and 2.8 Hz, 1H), 3.18 (dd, J = 15.3 and 3.0 Hz, 1H), 2.86 (ddd, J = 16.0, 6.7 and 
2.7 Hz, 1H), 2.48 (m, 2H) ppm;  
 
Ph
N
O
OPh
6.20 CHCl3,1 h, 25 °C
40%
I2
N
O
OPh
6.19
Ph
H
H
H
H
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13C NMR (100 MHz, CDCl3) δ 179.0, 178.6, 137.8, 137.1, 131.9, 129.1, 129.0, 
128.6 (two peaks), 127.6, 127.5, 126.9, 126.5, 126.4, 39.5, 39.4, 25.0, 23.5 ppm;  
 
νmax (NaCl) 3078, 3059, 3031, 2929, 2859, 1776, 1712 cm-1;  
 
MS (EI+, 70 eV) m/z 330.1 (27%), 329.1 (M+•, 78), 188.1 (30), 182.1 (100), 175.1 
(61), 167.1 (47), 91.0 (55);  
 
HRMS (EI+, 70 eV) found m/z 329.1404 (C22H19NO2 requires M+• 329.1416).  
 
 
 
(3a,6a,9a,10a,10b)-2-Methyl-4,8-diphenyl-3a,4,6,6a,9a,10,10a,10b-
octahydroisoindolo[5,6-e]isoindole-1,3,7,9(2H,8H)-tetraone (6.20) 
 
 
 
(E)-alkene 6.19 (50 mg, 152 µmol), was dissolved in toluene (600 µL) and N-
methylmaleimide (19 mg, 167 µmol) was added. The resulting solution was heated to 
45 °C for 60 h, then concentrated under reduced pressure to give the crude product as 
a yellow oil. This was subjected to flash chromatography (silica, 50:50 
EtOAc/hexane) to give the title compound 6.20 (12.5 mg, 28.4 µmol, 13% yield) as a 
white oil. 
 
R f = 0.3 (45:55 EtOAc/hexane on silica); 
 
1H NMR (400 MHz, CDCl3) δ 7.39 (m, 10H), 6.04 (m, 1H), 4.07 (dd, J = 6.4 and 
3.1 Hz, 1H), 3.68 (m, 1H), 3.52 (ddd, J = 9.4, 7.7 and 4.1 Hz, 1H), 3.45 (ddd, J = 
PhCH3
60 h, 45 °C
13%
N-methyl-
maleimide
N
O
OPh
6.20
Ph
N
O
O
H
H
H
H
H H
N
O
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H
H
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16.8, 8.4 and 6.4 Hz, 1H), 3.32 (m, 1H), 2.90 (s, 3H), 2.31 (m, 1H), 2.13 (m, 2H), 
1.75 (m, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 179.0, 178.6, 177.1, 175.7, 138.8, 137.5, 131.9, 
129.3, 128.8, 128.7, 128.5, 127.3, 126.4, 126.1, 46.9, 43.9, 42.3, 39.5 (two peaks), 
34.2, 29.7, 24.9, 23.7 ppm;  
 
νmax (NaCl) 3063, 3032, 2946, 2841, 2252, 1771, 1708, 1699 cm-1;  
 
MS (EI+, 70 eV) m/z 440.1 (M+•, 68%), 329.1 (19), 181.1 (17), 85.9 (81), 83.9 (100);  
 
HRMS (EI+, 70 eV) found m/z 440.1728 (C27H24N2O4 requires M+• 440.1736).  
 
 
 
(R,Z)-(4-Styrylcyclohex-3-en-1-yl)methanol (6.22) 
 
 
 
A sample of crude (Z)-dendralene 5.41 was prepared from its tricarbonyliron complex 
5.27 (300 mg, 1.01 mmol) following the protocol in this chapter. The crude material 
was dissolved in a mixture of MeCN and water (95:5, 1.69 mL) under nitrogen, 
cooled to –10 °C, and organocatalyst 6.25 (74.6 mg, 202 µmol) and acrolein (677 µL, 
10.1 mmol) were added. The reaction solution was stirred at –10 °C for 13 h, after 
which a solution of NaBH4 (500 mg, 13.2 mmol) in THF and water (3:2, 3 mL) was 
added. This solution was quenched with NH4Cl (5 mL of a saturated aqueous 
solution) then stirred vigorously for 30 min. The mixture was partitioned with 
CH2Cl2 (10 mL), the organic phase isolated, and the aqueous layer extracted with 
5.41
Ph 95:5 MeCN:H2O
18 h, −10 °C
69% (two steps)
93:7 e.r.
acrolein
then  NaBH4
Phacetone
15 min, 0 °C
CAN
(OC)3Fe
5.27
Ph
6.22
N
H2OTf
NO
Ph
OH
6.25
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CH2Cl2 (2 × 10 mL). Organic layers were combined, washed with brine (30 mL), 
dried over MgSO4 and concentrated under reduced pressure to give the crude 
product. This was subjected to flash chromatography (silica, 30:70 EtOAc/hexane) to 
give the title compound 6.22 (150 mg, 700 µmol, 69% yield over two steps) in 93:7 
e.r. as a white oil.  
 
The experiment was repeated using racemic organocatalyst 6.25 to generate a racemic 
sample of the title compound 6.22. 
 
R f = 0.4 (30:70 EtOAc/hexane on silica); 
 
[α]D = −23° (c = 1.2, CH2Cl2, 20 °C) 
 
Major enantiomer (−) t R = 27.5 min (ChiralCel OJ-H column, 250 mm × 15 mm 
column, 1.5:98.5 IPA:hexane, 1 mL/min);  
 
Minor enantiomer (+) t R = 25.3 min (ChiralCel OJ-H column, 250 mm × 15 mm 
column, 1.5:98.5 IPA:hexane, 1 mL/min);  
 
1H NMR (400 MHz, CDCl3) δ 7.24 (m, 5H), 6.34 (d, J = 12.3 Hz, 1H), 6.09 (d, J = 
12.3 Hz, 1H), 5.75 (m, 1H), 3.53 (m, 2H), 2.21 (m, 1H), 1.98 (m, 2H), 1.77 (m, 
3H), 1.22 (m, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 138.6, 135.7, 133.3, 128.9, 127.9, (two peaks), 
127.8, 126.7, 67.9, 36.1, 28.8, 27.7, 25.7 ppm;  
 
νmax (NaCl) 3339, 3077, 3054, 3021, 3004, 2916, 2875 cm-1;  
 
MS (EI+, 70 eV) m/z 214.1 (M+• 56%), 181.1 (48), 167.1 (49), 141.1 (70), 85.9 (76), 
83.9 (100);  
 
HRMS (EI+, 70 eV) found m/z 214.1355 (C15H18O requires M+• 214.1358).  
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(R,E)-(4-Styrylcyclohex-3-en-1-yl)methanol (6.23) 
 
 
 
(Z)-alkene 6.22 (90.0 mg, 420 µmol) was dissolved in CHCl3 (26.5 mL) and iodine 
(5.3 mg, 21.0 µmol) was added. The solution was stirred for 5 min at 25 °C, 
illuminated by a fluorescent light, then Na2S2O3 (5 mL of a saturated aqueous 
solution) was added. The organic phase was isolated, and the aqueous phase extracted 
with CH2Cl2 (2 × 5 mL). Organic phases were combined, washed with brine (15 
mL), dried over MgSO4 and concentrated under reduced pressure to give the crude 
product, which was typically used directly in subsequent transformations. 
 
Alternatively, the crude product could be subjected to flash chromatography (silica, 
30:70 EtOAc/hexane) to give the title compound 6.23 (85.4 mg, 398 µmol, 95%) as 
white oil. 
 
[α]D = −273° (c = 1.0, CH2Cl2, 20 °C) 
 
1H NMR (400 MHz, CDCl3) δ 7.40 (d, J = 7.5 Hz, 2H), 7.31 (dd, J = 7.5 and 7.3 
Hz, 2H), 7.20 (t, J = 7.3 Hz, 1H), 6.79 (d, J = 16.2 Hz, 1H), 6.45 (d, J = 16.2 Hz, 
1H), 5.89 (m, 1H), 3.59 (dd, J = 6.4 and 2.6 Hz, 2H), 2.45 (m, 1H), 2.29 (m, 2H), 
1.91 (m, 3H), 1.40 (m, 2H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 138.0, 136.0, 132.1, 129.4, 128.7, 127.1, 126.3, 
125.3, 67.8, 36.6, 29.2, 25.3, 24.1 ppm;  
 
νmax (NaCl) 3303, 3079, 3057, 3022, 2990, 2916, 2859, 2840 cm-1;  
Ph
6.22
CHCl3,
5 min, 25 °C
95%
I2
OH 6.23OH
Ph
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MS (EI+, 70 eV) m/z 214.1 (M+• 100%), 181.1 (64), 167.0 (63), 141.1 (84), 91.0 (84);  
 
HRMS (EI+, 70 eV) found m/z 214.1357 (C15H18O requires M+• 214.1358).  
 
 
 
(8R)-8-(Hydroxymethyl)-2,4-diphenyl-3a,4,6,7,8,9,9a,9b-octahydro-1H-
benzo[e]isoindole-1,3(2H)-dione (6.24) 
 
 
 
Crude (E)-alkene 6.23 (90.0 mg, 420 µmol of starting (Z)-alkene 6.22) was dissolved 
in toluene (840 µL) under nitrogen and N-phenylmaleimide (80.0 mg, 462 µmol) was 
added. The resulting solution was heated to 45 °C for 24 h, then concentrated under 
reduced pressure to give the crude product as a yellow oil. This was subjected to flash 
chromatography (silica, 60:40 EtOAc/hexane) to give the title compound 6.24 (116 
mg, 299 µmol, 71% yield over 2 steps) as a white oil as a 4:1 mixture of diastereomers, 
partially separable using flash chromatography. The major diastereomer was assigned 
as endo, and the minor diastereomer assigned as exo using NOESY NMR techniques. 
 
 
Endo diastereomer 
 
6.23OH
Ph
CHCl3
60 h, 45 °C
71%
N-phenyl-
maleimide
6.24a
OH
Ph
N
O
OPh
6.24b
OH
Ph
N
O
OPh
4:1 mixture of diastereomers
H H
H
H H HH
H
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R f = 0.3 (60:40 EtOAc/hexane on silica); 
 
[α]D = −27° (c = 1.3, MeOH, 20 °C) 
 
1H NMR (800 MHz, CDCl3) δ 7.30 (m, 8H), 6.79 (d, J = 7.3 Hz, 2H), 5.89 (s, 1H), 
3.81 (m, 1H), 3.68 (m, 2H), 3.48 (dd, J = 8.0 and 8.0 Hz, 1H), 3.31 (dd, J = 8.25 and 
8.25 Hz, 1H), 2.79 (m, 1H), 2.41 (ddd, J = 13.8, 11.4 and 5.6 Hz, 1H), 2.35 (m, 
1H), 2.30 (m, 1H), 2.25 (ddd, J = 14.1, 4.4 and 4.4 Hz, 1H), 2.20 (m, 1H), 1.85 
(ddd, J = 19.7, 6.9 and 5.7 Hz, 1H), 1.46 (m, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 176.3, 176.2, 140.4, 138.9, 131.4, 130.0, 128.8, 
128.6, 128.3, 127.7, 126.5, 119.9, 68.1, 45.1, 41.2, 41.1, 41.0, 35.6, 34.2, 33.1, 29.8 
ppm;  
 
νmax (NaCl) 3468, 3061, 3010, 2928, 2860, 1708 cm-1;  
 
MS (EI+, 70 eV) m/z 387.1 (M+• 100%), 214.1 (86), 167.1 (49), 91.1 (50);  
 
HRMS (EI+, 70 eV) found m/z 387.1828 (C25H25NO3 requires M+• 387.1834).  
 
 
Exo diastereomer 
 
6.24a
N
O
O
Ph
H
H
HH
OH
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R f = 0.3 (60:40 EtOAc/hexane on silica); 
 
1H NMR (800 MHz, CDCl3) δ 7.34 (m, 8H), 6.41 (m, 2H), 5.70 (d, J = 5.5, 1H), 
3.95 (dd, J = 5.9 and 5.9 Hz, 1H), 3.62 (m, 2H), 3.46 (dd, J = 7.8 and 7.8 Hz, 1H), 
3.39 (dd, J = 8.9, 1H), 2.79 (m, 1H), 2.69 (m, 1H), 2.48 (ddd, J = 13.9, 3.5 and 3.5 
Hz, 1H), 2.22 (m, 1H), 1.97 (m, 1H), 1.79 (m, 2H), 1.26 (m, 1H) ppm;  
 
13C NMR (100 MHz, CDCl3) δ 176.5, 175.9, 141.8, 139.4, 131.7, 129.4, 129.0, 
128.5 (two peaks), 127.3, 126.5, 121.1, 65.5, 46.4, 43.3, 41.6, 35.5, 32.5, 29.7, 27.9, 
26.2 ppm;  
 
νmax (NaCl) 3469, 3061, 3019, 2923, 2861, 1708, cm-1;  
 
MS (EI+, 70 eV) m/z 387.1 (M+• 100%), 214.1 (85), 167.1 (72), 91.1 (75);  
 
HRMS (EI+, 70 eV) found m/z 387.1836 (C25H25NO3 requires M+• 387.1834).  
 
 
  
6.24b
N
O
O
Ph
H
H
HH
OH
EXPERIMENTAL FOR PART 2	   291 
7.11 Miscellaneous experimental procedures 
 
Tricarbonyl(3-methylenepent-1-en-4-yne)iron (4.167) 
 
 
 
These conditions were developed by Henry Toombs-Ruane.[253] 
 
TMS-alkyne 4.166 (750 mg, 2.58 mmol) was dissolved in methanol (12.5 mL) and 
K2CO3 (714 mg, 5.17 mmol) was added. The reaction solution was stirred at 25 °C 
for 30 min, then NH4Cl (5 mL of a saturated aqueous solution) was added. The 
solution was extracted with CH2Cl2 (3 × 10 mL), dried over MgSO4 and concentrated 
under reduced pressure (>150 mbar) to give the crude product as a brown oil. This 
was subjected to flash chromatography (silica, pentane) to give the title alkyne 4.167 
(512 mg, 2.35 mmol, 91% yield) as a yellow oil. Spectroscopic and physical data were 
in accordance with previously reported values.[253] 
 
R f = 0.4 (hexane on silica); 
 
1H NMR (300 MHz, CDCl3) δ 5.71 (dd, J = 8.4 and 8.4 Hz, 1H), 2.75 (s, 1H), 2.04 
(m, 1H), 1.79 (dd, 6.9 and 2.7 Hz, 1H), 0.33 (m, 1H), 0.21 (dd, J = 9.3, 2.6 Hz, 1H) 
ppm;  
 
13C NMR (75 MHz, CDCl3) δ 210.1, 90.3, 83.2, 82.8, 74.1, 43.5, 39.6 ppm;  
 
νmax (NaCl) 3068, 3007, 2957, 2918, 2849, 2055, 1979 cm-1;  
 
MS (EI+, 70 eV) m/z 218.1 (M+•, 42%), 190.1 (74), 162.1 (71), 134.1 (100), 108.1 
(40);  
(OC)3Fe
TMS
MeOH
30 min, 25 °C
91%
K2CO3
(OC)3Fe
4.166 4.167
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HRMS (EI+, 70 eV) found m/z 217.9666 (C9H656FeO3 requires M+• 217.9666).  
 
 
 
General procedure 7, for the Suzuki cross-coupling of chlorides with 
boronic acids. 
 
Pd(PPh3)4 (0.05 mol. equiv.) and Cs2(CO)3 (2.0 mol. equiv.) were dissolved in a 10:1 
mixture of THF/H2O (0.1 M conc. w.r.t. chloride 4.88) and chloride 4.88 (1.0 mol. 
equiv.) and boronic acid (1.3 mol. equiv.) were added. The solution was heated to 65 
°C for 1 h, after which the reaction solution was cooled to 25 °C, NH4Cl (4 mL of a 
saturated aqueous solution) was added, and the mixture partitioned with CH2Cl2 (15 
mL). The organic phase was isolated and the aqueous phase extracted with CH2Cl2 (2 
× 15 mL). Organic phases were then combined, washed with brine (50 mL), dried 
over MgSO4 and concentrated under reduced pressure to give the crude product. 
 
 
 
Tricarbonyl((E)-(3-methylenepenta-1,4-dien-1-yl)benzene)iron (4.76) 
 
 
 
Prepared according to general procedure 7, using chloride 4.88 (100 mg, 438 µmol), 
boronic acid 6.18[251] (84.2 µL, 657 µmol), Pd(PPh3)4 (25.3 mg, 21.9 µmol) and 
Cs2CO3 (285 mg, 876 µmol) in THF/H2O (4.4 mL). The crude product was purified 
using flash chromatography (silica, hexane) to give the title 1-(E)-[3]dendralene 4.76 
(568 mg, 1.96 mmol, 83% yield) as a yellow oil. Spectroscopic and physical data was 
in accordance with literature values.[195] 
 
(OC)3Fe
Cl
10:1 THF/H2O
1 h, 65 °C
51%
(OC)3Fe
Pd(PPh3)4
Cs2CO3
4.88 6.18 4.76
(HO)2B
Ph Ph
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1H NMR (400 MHz, CDCl3) δ 7.46 (d, J = 7.6 Hz, 2H), 7.35 (dd, J = 7.6 and 7.6 
Hz, 2H), 7.28 (d, J = 7.6 Hz, 1H), 6.91 (s, 1H), 5.54 (dd, J = 8.2 Hz and 8.2 Hz, 
1H), 2.32 (m, 1H), 1.85 (dd, J = 6.9 and 2.5 Hz, 1H), 0.40 (dd, J = 9.3 and 2.3 Hz, 
1H), 0.23 (d, J = 2.5 Hz, 1H) ppm;  
 
 
 
Tricarbonyl((Z)-(3-methylenepenta-1,4-dien-1-yl)benzene)iron (5.27) 
 
 
 
Prepared according to general procedure 7, using chloride 4.88 (75 mg, 328 µmol), 
boronic acid 5.45 (63.0 µL, 427 µmol), Pd(PPh3)4 (19.0 mg, 16.4 µmol) and Cs2CO3 
(214 mg, 657 µmol) in THF/H2O (3.3 mL). The crude product was purified using 
flash chromatography (silica, hexane) to give the title 1-(Z)-[3]dendralene 5.27 (568 
mg, 1.96 mmol, 83% yield) as a yellow oil. Spectroscopic and physical data match that 
reported in section 7.7. 
 
 
 
Attempted synthesis of (E)-2-phenyl-5-styryl-3a,4,7,7a-tetrahydro-1H-
isoindole-1,3(2H)-dione (6.19) 
 
 
 
Complex 4.76 (59.0 mg, 198.24 µmol) was dissolved in acetone (4.0 mL) and N-
phenylmaleimide (23.3 mg, 198.24 µmol) then CAN (483 mg, 1.19 mmol) were 
added. The reaction solution was stirred for 16 h at 25 °C, after which the solution 
(OC)3Fe
Cl
10:1 THF/H2O
1 h, 65 °C
81%
(OC)3Fe
Pd(PPh3)4
Cs2CO3
4.88 5.45 5.27
(HO)2B
Ph Ph
(OC)3Fe
4.76
Ph
acetone
16 h, 25 °C
N-phenyl-
maleimide,
CAN
6.19
Ph
N
O
OPh
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was partitioned between CH2Cl2 (10 mL) and water (10 mL). The organic phase was 
isolated and the aqueous phase extracted with CH2Cl2 (2 × 10 mL). Organic phases 
were combined, washed with brine (30 mL) and dried over MgSO4, then 
concentrated under reduced pressure to give the crude product. Analysis by NMR 
revealed that no quantity of desired adduct 6.19 had formed under the reaction 
conditions. 
 
 
 
Electrocyclisation of pentaene 6.3 to tetraene 6.5 
 
 
 
A solution of pentaene 6.3 in d6-benzene was prepared according to the 
aforementioned protocol. An internal standard (durene, 2.7 mg, 20 µmol) was added, 
through use of which the concentration of the solution was calculated to be 0.0087 
mol L-1. The solution was placed inside an NMR machine, the interior of which had 
been heated to 60 °C. 1H NMR spectra were recorded automatically every 5 min. 
 
After complete conversion of pentaene 6.3 was observed, a spectrum of the resulting 
material was recorded in CDCl3. This spectrum was compared to literature data,[252] 
confirming the identity of the product of this reaction as tetraene 6.5. 
 
1H NMR data was processed to give the following graph: 
C6D6
30 min, 60 °C 6.56.3
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A summary of the data used to generate this graph is presented below: 
 
 
Through analysis of these results, the half-life of pentaene 6.3 was determined to be 
39.9 minutes at 60 °C, arising through a first-order process.  
Rate of electrocyclisation at 60 °C: r = 0.0172[pentaene] 
y = 0.0172x + 4.7707 
R² = 0.99985 
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Appendix 
 
Computational Data 
 
Density functional computation reports for the results reported in section 2.7.2.4 are 
provided on the DVD on the inside back cover of this thesis. DFT calculations were 
performed by Prof. Michael Paddon-Row using the Gaussian 03 program. 
 
Gaussian 03, Revision D.01, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, 
J. R. Cheeseman, J. A. Montgomery, Jr., T. Vreven, K. N. Kudin, J. C. Burant, J. M. Millam, S. S. 
Iyengar, J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. 
Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. 
Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. 
Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, 
J. W. Ochterski, P. Y. Ayala, K. Morokuma, G. A. Voth, P. Salvador, J. J. Dannenberg, V. G. 
Zakrzewski, S. Dapprich, A. D. Daniels, M. C. Strain, O. Farkas, D. K. Malick, A. D. Rabuck, K. 
Raghavachari, J. B. Foresman, J. V. Ortiz, Q. Cui, A. G. Baboul, S. Clifford, J. Cioslowski, B. B. 
Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. L. Martin, D. J. Fox, T. Keith, M. A. 
Al-Laham, C. Y. Peng, A. Nanayakkara, M. Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. 
W. Wong, C. Gonzalez, and J. A. Pople, Gaussian, Inc., Wallingford CT, 2004. 
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Publications 
 
Total Synthesis of Ramonanins A-D 
R. S. Harvey, E. G. Mackay, L. Roger, M. N. Paddon-Row, M. S. Sherburn, A. L. 
Lawrence, Angew. Chem. Int. Ed. 2015, 54, 1795. 
 
All structures on Scheme 2 and Scheme 3 were originally synthesised by RSH, 
following protocols developed by RSH, which were subsequently repeated by EGM, 
with the following exceptions: 
• EGM developed a protocol for the formation of compound 9 directly from 
compound 8, extending upon the protocol developed by RSH detailed on pp 78-
80 of this thesis. 
• EGM prepared compound 12 using crude compound 11 rather than purified 
compound 11, as was the case in the protocol developed by RSH. She adapted the 
protocol detailed on pp 82-85 of this thesis for this purpose. 
 
The SI for the paper was written using the experimental results collected by EGM. 
 
The analytically pure sample of ramonanin D was generated by EGM, following a 
protocol developed by RSH. 
 
The experiment testing the half-life of the ramonanin monomer was performed by 
RSH. 
 
RSH provided feedback on the figures and text of the manuscript. 
 
 
REFERENCES 	   303 
References 
 
 
[1] T. Voloshchuk, N. S. Farina, O. R. Wauchope, M. Kiprowska, P. 
Haberfield, A. Greer, J. Nat. Prod. 2004, 67, 1141. 
[2] Y. Morita, Y. Hayashi, Y. Sumi, A. Kodaira, H. Shibata, Biosci., Biotech. 
and Biochem. 1995, 59, 2008. 
[3] S. Takase, Y. Kawai, I. Uchida, H. Tanaka, H. Aoki, Tetrahedron 1985, 
41, 3037. 
[4] A. R. Pereira, C. F. McCue, W. H. Gerwick, J. Nat. Prod. 2010, 73, 217. 
[5] M. Vrettou, A. A. Gray, A. R. E. Brewer, A. G. M. Barrett, Tetrahedron 
2007, 63, 1487. 
[6] K. Moody, R. H. Thomson, E. Fattorusso, L. Minale, G. Sodano, J. 
Chem. Soc., Perkin Trans. 1 1972, 18. 
[7] J.-M. Fang, K.-C. Hsu, Y.-S. Cheng, Phytochemistry 1989, 28, 3553. 
[8] J. Miłobȩdzka, V. Kostanecki, V. Lampe, Ber. Dtsch. Chem. Ges. 1910, 
43, 2163. 
[9] J. P. Knox, A. D. Dodge, Plant, Cell & Environment 1985, 8, 19. 
[10] L. S. Fernandez, M. S. Buchanan, A. R. Carroll, Y. J. Feng, R. J. Quinn, 
V. M. Avery, Org. Lett. 2009, 11, 329. 
[11] T. Sagawa, Y. Takaishi, Y. Fujimoto, C. Duque, C. Osorio, F. Ramos, 
C. Garzon, M. Sato, M. Okamoto, T. Oshikawa, et al., J. Nat. Prod. 
2005, 68, 502. 
[12] W. Knop, Liebigs Ann. 2005, 49, 103. 
[13] M. Niwa, M. Iguchi, S. Yamamura, Tetrahedron Lett. 1975, 49, 4395. 
[14] Y.-P. Gao, Y.-H. Shen, S.-D. Zhang, J.-M. Tian, H.-W. Zeng, J. Ye, 
H.-L. Li, L. Shan, W.-D. Zhang, Org. Lett. 2012, 14, 1954. 
[15] J. Kobayashi, Y. Hirasawa, N. Yoshida, H. Morita, Tetrahedron Lett. 
2000, 41, 9069. 
[16] For a review which summarises the various means by which asymmetrical 
dimers might form see G. Lian, B. Yu, Chem. Biodiv. 2010, 7, 2660. 
[17] O. Diels, K. Alder, Liebigs Ann. 1928, 460, 98. 
[18] N. J. Green, M. S. Sherburn, Aust. J. Chem. 2013, 66, 267. 
[19] F. Tillequin, M. Koch, J.-L. Pousset, A. Cav, J. Chem. Soc., Chem. 
Commun. 1978, 826. 
[20] D. Schroeder, F. R. Stermitz, Tetrahedron 1985, 4309. 
[21] T. R. Hoye, S. M. Donaldson, T. J. Vos, Org. Lett. 1999, 1, 277. 
[22] B. Erb, H.-J. Borschberg, D. Arigoni, J. Chem. Soc., Perkin Trans. 1 
2000, 2307. 
[23] S. Al-Busafi, J. R. Doncaster, M. G. B. Drew, A. C. Regan, R. C. 
Whitehead, J. Chem. Soc., Perkin Trans. 1 2002, 476. 
[24] I. Kawasaki, N. Sakaguchi, A. Khadeer, M. Yamashita, S. Ohta, 
Tetrahedron 2006, 62, 10182. 
[25] J. Shiina, M. Oikawa, K. Nakamura, R. Obata, S. Nishiyama, Eur. J. 
Org. Chem. 2007, 2007, 5190. 
[26] J.-P. Lumb, K. C. Choong, D. Trauner, J. Am. Chem. Soc. 2008, 130, 
 REFERENCES 304 
9230. 
[27] E. Arkoudis, I. N. Lykakis, C. Gryparis, M. Stratakis, Org. Lett. 2009, 
11, 2988. 
[28] O. Simon, B. Reux, J. J. La Clair, M. J. Lear, Chem. Asian J. 2010, 5, 
342. 
[29] X. Wang, Z. Ma, J. Lu, X. Tan, C. Chen, J. Am. Chem. Soc. 2011, 133, 
15350. 
[30] J. Dardenne, S. Desrat, F. Guéritte, F. Roussi, Eur. J. Org. Chem. 2013, 
2013, 2116. 
[31] X. Wang, X. Wang, X. Tan, J. Lu, K. W. Cormier, Z. Ma, C. Chen, J. 
Am. Chem. Soc. 2012, 134, 18834. 
[32] R. Vallakati, J. A. May, J. Am. Chem. Soc. 2012, 134, 6936. 
[33] K. Wei, S. Wang, Z. Liu, Y. Du, X. Shi, T. Qi, S. Ji, Tetrahedron Lett. 
2013, 54, 2264. 
[34] D. H. Dethe, R. D. Erande, A. Ranjan, J. Org. Chem. 2013, 78, 10106. 
[35] C. Qi, H. Cong, K. J. Cahill, P. Müller, R. P. Johnson, J. A. Porco Jr., 
Angew. Chem. Int. Ed. 2013, 52, 8345. 
[36] X. Wang, Z. Ma, X. Wang, S. De, Y. Ma, C. Chen, Chem. Commun. 
2014, 50, 8628. 
[37] D. H. Dethe, R. D. Erande, B. D. Dherange, Org. Lett. 2014, 16, 2764. 
[38] Z. Ma, X. Wang, X. Wang, R. A. Rodriguez, C. E. Moore, S. Gao, X. 
Tan, Y. Ma, A. L. Rheingold, P. S. Baran, et al., Science 2014, 346, 219. 
[39] P. G. Bulger, S. K. Bagal, R. Marquez, Nat. Prod. Rep. 2008, 25, 254. 
[40] E. Gravel, E. Poupon, Eur. J. Org. Chem. 2008, 2008, 27. 
[41] S. A. Snyder, A. M. ElSohly, F. Kontes, Nat. Prod. Rep. 2011, 28, 897. 
[42] C. Li, X. Lei, J. Org. Chem. 2014, 79, 3289. 
[43] C. Wan, J. Deng, H. Liu, M. Bian, A. Li, Sci. China Chem. 2014, 57, 
926. 
[44] W. Ai, D. Liao, X. Lei, Chin. J. Org. Chem. 2015, 35, 1615. 
[45] A. Santana, J. M. G. Molinillo, F. A. Macías, Eur. J. Org. Chem. 2015, 
2015, 2093. 
[46] J. Han, A. Jones, X. Lei, Synthesis 2015, 47, 1519. 
[47] O. L. Chapman, M. R. Engle, J. P. Springer, J. C. Clardy, J. Am. Chem. 
Soc. 1971, 93, 6696. 
[48] For an extended discussion see K. C. Nicolaou, E. J. Sorensen, Classics in 
Total Synthesis, Wiley-VCH, New York, 1996. 
[49] C. Li, E. Lobkovsky, J. A. Porco, J. Am. Chem. Soc. 2000, 122, 10484. 
[50] J. C. Lee, G. A. Strobel, E. Lobkovsky, J. Clardy, J. Org. Chem. 1996, 61, 
3232. 
[51] G. Mehta, S. C. Pan, Org. Lett. 2004, 6, 3985. 
[52] C. Li, R. P. Johnson, J. A. Porco, J. Am. Chem. Soc. 2003, 125, 5095. 
[53] C. Li, E. A. Pace, M.-C. Liang, E. Lobkovsky, T. D. Gilmore, J. A. 
Porco, J. Am. Chem. Soc. 2001, 123, 11308. 
[54] H. Kakeya, R. Onose, H. Koshino, A. Yoshida, K. Kobayashi, S.-I. 
Kageyama, H. Osada, J. Am. Chem. Soc. 2002, 124, 3496. 
[55] H. Kakeya, R. Onose, A. Yoshida, H. Koshino, H. Osada, J. Antibiot. 
2002, 55, 829. 
[56] M. Shoji, J. Yamaguchi, H. Kakeya, H. Osada, Y. Hayashi, Angew. 
REFERENCES 	   305 
Chem. Int. Ed. 2002, 41, 3192. 
[57] M. Shoji, H. Imai, M. Mukaida, K. Sakai, H. Kakeya, H. Osada, Y. 
Hayashi, J. Org. Chem. 2005, 70, 79. 
[58] G. Sarakinos, E. J. Corey, Org. Lett. 1999, 1, 1741. 
[59] C. Li, S. Bardhan, E. A. Pace, M.-C. Liang, T. D. Gilmore, J. A. Porco, 
Org. Lett. 2002, 4, 3267. 
[60] C. Li, J. A. Porco, J. Org. Chem. 2005, 70, 6053. 
[61] X. Lei, R. P. Johnson, J. A. Porco, Angew. Chem. Int. Ed. 2003, 42, 3913. 
[62] J. E. Moses, L. Commeiras, J. E. Baldwin, R. M. Adlington, Org. Lett. 
2003, 5, 2987. 
[63] L. Commeiras, J. E. Moses, R. M. Adlington, J. E. Baldwin, A. R. 
Cowley, C. M. Baker, B. Albrecht, G. H. Grant, Tetrahedron 2006, 62, 
9892. 
[64] G. Mehta, S. S. Ramesh, Tetrahedron Lett. 2004, 45, 1985. 
[65] M. Matsuzawa, H. Kakeya, J. Yamaguchi, M. Shoji, R. Onose, H. 
Osada, Y. Hayashi, Chem. Asian J. 2006, 1, 845. 
[66] J. A. Porco, S. Su, X. Lei, S. Bardhan, S. D. Rychnovsky, Angew. Chem. 
Int. Ed. 2006, 45, 5790. 
[67] B. Halford, “Hexacyclinol Debate Heats Up,” Chemical and Engineering 
News 2008, 84(31), 11. 
[68] B. Schlegel, A. Härtl, H. M. Dahse, F. A. Gollmick, U. Gräfe, H. 
Dörfelt, B. Kappes, J. Antibiot. 2002, 55, 814. 
[69] S. D. Rychnovsky, Org. Lett. 2006, 8, 2895. 
[70] W. Zhang, S. Luo, Fang, Q. Chen, H. Hu, X. Jia, H. Zhai, J. Am. Chem. 
Soc. 2005, 127, 18. 
[71] K. Vokáč, Z. Samek, V. Herout, F. Sorm, Tetrahedron Lett. 1968, 9, 
3855. 
[72] C. Li, X. Yu, X. Lei, Org. Lett. 2010, 12, 4284. 
[73] C. Li, L. Dian, W. Zhang, X. Lei, J. Am. Chem. Soc. 2012, 134, 12414. 
[74] Z.-J. Wu, X.-K. Xu, Y.-H. Shen, J. Su, J.-M. Tian, S. Liang, H.-L. Li, 
R.-H. Liu, W.-D. Zhang, Org. Lett. 2008, 10, 2397. 
[75] H. Shang, J. Liu, R. Bao, Y. Cao, K. Zhao, C. Xiao, B. Zhou, L. Hu, Y. 
Tang, Angew. Chem. Int. Ed. 2014, 53, 14494. 
[76] X.-L. Chen, H.-L. Liu, J. Li, G.-R. Xin, Y.-W. Guo, Org. Lett. 2011, 
13, 5032. 
[77] D. Noutsias, G. Vassilikogiannakis, Org. Lett. 2012, 14, 3565. 
[78] L. Vasamsetty, F. A. Khan, G. Mehta, Tetrahedron Lett. 2013, 54, 3522. 
[79] D. S. Giera, C. B. W. Stark, RSC Adv. 2013, 3, 21280. 
[80] J.-P. Yin, C.-L. Tang, L.-X. Gao, W.-P. Ma, J.-Y. Li, Y. Li, J. Li, F.-J. 
Nan, Org. Biomol. Chem. 2014, 12, 3441. 
[81] J. Boukouvalas, M.-A. Jean, Tetrahedron Lett. 2014, 55, 4248. 
[82] T. Guney, G. A. Kraus, Org. Lett. 2013, 15, 613. 
[83] T. Wang, T. R. Hoye, Nat. Chem. 2015, 7, 641. 
[84] L. Vasamsetty, D. Sahu, B. Ganguly, F. A. Khan, G. Mehta, Tetrahedron 
2014, 70, 8488. 
[85] A. Nishiyama, H. Eto, Y. Terada, M. Iguchi, S. Yamamura, Chem. 
Pharm. Bull. 1983, 31, 2820. 
[86] L. Kurti, L. Szilagyi, S. Antus, M. Nogradi, Eur. J. Org. Chem. 1999, 
 REFERENCES 306 
2579. 
[87] E. N. Pitsinos, V. P. Vidali, E. A. Couladouros, ARKIVOC 2002, 8, 105. 
[88] C. K. Jankowski, A. Savoie, D. Lesage, J. Boivin, G. Leclaire, T. E. 
Diaz, R. Reyes-Chilpa, M. Jimenez-Estrada, H. Barrios, Pol. J. Chem. 
2005, 2, 429. 
[89] A. Bérubé, I. Drutu, J. L. Wood, Org. Lett. 2006, 8, 5421. 
[90] N. Lebrasseur, J. Gagnepain, A. Ozanne-Beaudenon, J.-M. Léger, S. 
Quideau, J. Org. Chem. 2007, 72, 6280. 
[91] L. Pouységu, S. Chassaing, D. Dejugnac, A.-M. Lamidey, K. Miqueu, 
J.-M. Sotiropoulos, S. Quideau, Angew. Chem. Int. Ed. 2008, 47, 3552. 
[92] S. Dong, E. Hamel, R. Bai, D. G. Covell, J. A. Beutler, J. A. Porco Jr., 
Angew. Chem. Int. Ed. 2009, 48, 1494. 
[93] S. A. Snyder, F. Kontes, J. Am. Chem. Soc. 2009, 131, 1745. 
[94] S. A. Snyder, F. Kontes, Isr. J. Chem. 2011, 51, 378. 
[95] M. J. Palframan, G. Kociok-Köhn, S. E. Lewis, Org. Lett. 2011, 13, 
3150. 
[96] N. Abe, T. Murata, A. Hirota, Biosci., Biotech. Biochem. 1998, 62, 2120. 
[97] K. C. Nicolaou, G. Vassilikogiannakis, K. B. Simonsen, P. S. Baran, Y.-
L. Zhong, V. P. Vidali, E. N. Pitsinos, E. A. Couladouros, J. Am. Chem. 
Soc. 2000, 122, 3071. 
[98] L. H. Pettus, R. W. Van De Water, T. R. R. Pettus, Org. Lett. 2001, 3, 
905. 
[99] R. Hong, Y. Chen, L. Deng, Angew. Chem. Int. Ed. 2005, 44, 3478. 
[100] B.-N. Su, Q.-X. Zhu, Z.-J. Jia, Tetrahedron Lett. 1999, 40, 357. 
[101] J. Gagnepain, F. Castet, S. Quideau, Angew. Chem. Int. Ed. 2007, 46, 
1533. 
[102] S. Dong, J. Zhu, J. A. Porco, J. Am. Chem. Soc. 2008, 130, 2738. 
[103] A. Leverrier, M. E. T. H. Dau, P. Retailleau, K. Awang, F. Guéritte, M. 
Litaudon, Org. Lett. 2010, 12, 3638. 
[104] D. Valentine, N. J. Turro, G. S. Hammond, J. Am. Chem. Soc. 1964, 86, 
5202. 
[105] P. Sharma, D. J. Ritson, J. Burnley, J. E. Moses, Chem. Commun. 2011, 
47, 10605. 
[106] H. N. Lim, K. A. Parker, Org. Lett. 2013, 15, 398. 
[107] S. L. Drew, A. L. Lawrence, M. S. Sherburn, Angew. Chem. Int. Ed. 
2013, 52, 4221. 
[108] H. N. Lim, K. A. Parker, J. Org. Chem. 2014, 79, 919. 
[109] J. C. Moore, E. S. Davies, D. A. Walsh, P. Sharma, J. E. Moses, Chem. 
Commun. 2014, 50, 12523. 
[110] X. Fu, B. Hossain, D. V. D. Helm, F. J. Schmitz, J. Am. Chem. Soc. 1994, 
116, 12125. 
[111] X. Fu, M. B. Hossain, F. J. Schmitz, D. van der Helm, J. Org. Chem. 
1997, 62, 3810. 
[112] M. E. Layton, C. A. Morales, M. D. Shair, J. Am. Chem. Soc. 2002, 124, 
773. 
[113] C. A. Morales, M. E. Layton, M. D. Shair, Proc. Natl. Acad. Sci. 2004, 
101, 12036. 
[114] D. J. Newman, G. M. Cragg, K. M. Snader, Nat. Prod. Rep. 2000, 17, 
REFERENCES 	   307 
215. 
[115] N. R. Farnsworth, O. Akerele, A. S. Bingel, D. D. Soejarto, Z. Guo, 
Bulletin of the World Health Organisation 1985, 63, 965. 
[116] M. K. Nobles, Can. J Bot. 1958, 36, 91. 
[117] D. C. Rockey, N. Engl. J. Med. 1999, 341, 38. 
[118] A. Warren, Laboratory Manual for the Detection of Poisons and Powerful 
Drugs, Blakiston, Philadelphia, 1915. 
[119] K. J. Chavez, X. Feng, J. A. Flanders, E. Rodriguez, F. C. Schroeder, J. 
Nat. Prod. 2011, 74, 1293. 
[120] Two more natural products with this core have been isolated since: T. 
Sasaki, W. Li, S. Zaike, Y. Asada, Q. Li, F. Ma, Q. Zhang, K. Koike, 
Phytochemistry 2013, 95, 333. 
[121] L. B. Davin, N. G. Lewis, Curr. Op. Biotech. 2005, 16, 398. 
[122] M. Schöttner, J. Reiner, F. Tayman, Phytochem. 1997, 46, 1107. 
[123] P. W. Le Quesne, J. E. Larrahondo, R. F. Raffauf, J. Nat. Prod. 1980, 
43, 353. 
[124] For example see W. S. Trahanovsky, T. J. Cassady, J. Am. Chem. Soc. 
1984, 106, 8197. 
[125] A. T. Bloomquist, J. Wolinsky, Y. C. Meinwald, D. T. Longone, J. Am. 
Chem. Soc. 1956, 78, 6057. 
[126] E. M. Stocking, R. M. Williams, Angew. Chem. Int. Ed. 2003, 42, 3078. 
[127] H. Oikawa, T. Tokiwano, Nat. Prod. Rep. 2004, 21, 321. 
[128] H. Toombs-Ruane, E. L. Pearson, M. N. Paddon-Row, M. S. Sherburn, 
Chem. Commun. 2012, 48, 6639. 
[129] M. N. Paddon-Row, M. S. Sherburn, Chem. Commun. 2012, 48, 832. 
[130] S. Lin, M. A. Ischay, C. G. Fry, T. P. Yoon, J. Am. Chem. Soc. 2011, 
133, 19350. 
[131] H. Cong, C. F. Becker, S. J. Elliott, M. W. Grinstaff, J. A. Porco Jr., J. 
Am. Chem. Soc. 2010, 132, 7514. 
[132] S. L. Drew, A. L. Lawrence, M. S. Sherburn, Chem. Sci. 2015, 6, 3886. 
[133] X. Han, E. J. Corey, Org. Lett. 1999, 1, 1871. 
[134] M. Shimizu, T. Kurahashi, K. Shimono, K. Tanaka, I. Nagao, S.-I. 
Kiyomoto, T. Hiyama, Chem. Asian J. 2007, 2, 1400. 
[135] M. Mori, K. Tonogaki, N. Nishiguchi, J. Org. Chem. 2002, 67, 224. 
[136] M. Luo, A. Matsui, T. Esumi, Y. Iwabuchi, S. Hatakeyama, Tetrahedron 
Lett. 2000, 41, 4401. 
[137] T. Nakato, S. Yamauchi, R. Tago, K. Akiyama, M. Maruyama, T. 
Sugahara, T. Kishida, Y. Koba, Biosci. Biotech. Biochem. 2014, 73, 1608. 
[138] H. Nishiwaki, K. Nakayama, Y. Shuto, S. Yamauchi, J. Agric. Food Chem. 
2014, 62, 651. 
[139] L. Roger, Unpublished Results, 2013. 
[140] R. S. Harvey, Unpublished results, 2013. 
[141] Z. You, A. H. Hoveyda, M. L. Snapper, Angew. Chem. Int. Ed. 2009, 48, 
547. 
[142] J. Kiji, Y. Kondou, M. Asahara, Y. Yokoyama, T. Sagisaka, J. Mol. Cat. A 
2003, 197, 127. 
[143] M. Mori, K. Tonogaki, A. Kinoshita, Org. Synth. 2004, 81, 1. 
[144] J. A. Smulik, S. T. Diver, J. Org. Chem. 2000, 65, 1788. 
 REFERENCES 308 
[145] S. T. Diver, A. J. Giessert, Chem. Rev. 2004, 104, 1317. 
[146] S. T. Diver, J. R. Griffiths, Olefin Metathesis: Theory and Practice 2014, 
153. 
[147] N. A. Miller, A. C. Willis, M. S. Sherburn, Chem. Commun. 2008, 1226. 
[148] C. G. Newton, S. L. Drew, A. L. Lawrence, A. C. Willis, M. N. 
Paddon-Row, M. S. Sherburn, Nat. Chem. 2014, 7, 82. 
[149] J. W. Boyle, PhD Thesis, 2016. 
[150] R. Sustmann, M. Böhm, J. Sauer, Chem. Ber. 1979, 112, 883. 
[151] W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923. 
[152] A. B. Pangborn, M. A. Giardello, R. H. Grubbs, Organometallics 1996, 
15, 1518. 
[153] D. B. G. Williams, M. Lawton, J. Org. Chem. 2010, 75, 8351. 
[154] C. A. Faler, M. M. Joullié, Org. Lett. 2007, 9, 1987. 
[155] J. Niggemann, N. Bedorf, U. Flörke, H. Steinmetz, K. Gerth, H. 
Reichenbach, G. Höfle, Eur. J. Org. Chem. 2005, 2005, 5013. 
[156] K. C. Nicolaou, N. A. Petasis, R. E. Zipkin, J. Uenishi, J. Am. Chem. Soc. 
1982, 104, 5555. 
[157] H. Reihlen, A. Gruhl, O. Pfrengle, Liebigs Ann. 1930, 482, 161. 
[158] R. B. King, T. A. Manuel, F. Stone, J. Inorg. Nucl. Chem. 1961, 16, 233. 
[159] A. J. Birch, P. E. Cross, J. Lewis, D. A. White, S. B. Wild, J. Chem. Soc., 
A 1968, 332. 
[160] S. V. Ley, C. Low, A. D. White, J. Organomet. Chem. 1986, 302, C13. 
[161] B. Johnson, J. Lewis, D. J. Thompson, Tetrahedron Lett. 1974, 15, 3789. 
[162] H. J. Knölker, Chem. Rev. 2000, 100, 2941. 
[163] J. Howell, B. Johnson, P. L. Josty, J. Lewis, J. Organomet. Chem. 1972, 
39, 329. 
[164] H. J. Knölker, P. Gonser, Synlett 1992, 6, 517. 
[165] H. J. Knölker, H. Goesmann, H. Hermann, D. Herzberg, Synlett 1999. 
[166] H. J. Knölker, H. Hermann, D. Herzberg, Chem. Commun. 1999, 831. 
[167] H. Fleckner, F. W. Grevels, D. Hess, J. Am. Chem. Soc. 1984, 106, 2027. 
[168] I. J. Fairlamb, S. M. Syvänne, A. C. Whitwood, Synlett 2003, 1693. 
[169] R. Widmaier, J. J. Alexander, J. Bauer, M. Srebnik, Inorg. Chim. Acta 
1999, 290, 159. 
[170] J. D. Holmes, R. Pettit, J. Am. Chem. Soc. 1963, 85, 2531. 
[171] R. Pettit, G. Emerson, J. Mahler, J. Chem. Educ. 1963, 40, 175. 
[172] D. J. Thompson, J. Organomet. Chem. 1976, 108, 381. 
[173] Y. Shvo, E. Hazum, J. Chem. Soc., Chem. Commun. 1974, 336. 
[174] J. D. Rainier, J. E. Imbriglio, J. Org. Chem. 2000, 65, 7272. 
[175] M. Franck-Neumann, M. P. Heitz, D. Martina, Tetrahedron Lett. 1983, 
24, 1615. 
[176] J. C. Barborak, R. Pettit, J. Am. Chem. Soc. 1967, 89, 3080. 
[177] J. M. Landesberg, J. Sieczkowski, J. Am. Chem. Soc. 1969, 91, 2120. 
[178] W. J. R. Tyerman, M. Kato, P. Kebarle, S. Masamune, O. P. Strausz, H. 
E. Gunning, Chem. Commun. (London) 1967, 497. 
[179] H. J. Knölker, E. Baum, H. Goesmann, Angew. Chem. Int. Ed. 1999, 38, 
702. 
[180] M. Franck-Neumann, P. Geoffroy, P. Bissinger, S. Adelaide, 
Tetrahedron Lett. 2001, 42, 6401. 
REFERENCES 	   309 
[181] P. H. Li, H. A. McGee, J. Chem. Soc. D 1969, 592. 
[182] R. C. Kerber, E. C. Ribakove, Organometallics 1991, 10, 2848. 
[183] W. R. Roth, J. D. Meier, Tetrahedron Lett. 1967. 
[184] C. H. DePuy, R. N. Greene, T. E. Schroer, Chem. Commun. (London) 
1968, 1225. 
[185] G. F. Emerson, K. Ehrlich, W. P. Giering, P. C. Lautebar, J. Am. Chem. 
Soc. 1966, 88, 3172. 
[186] R. N. Greene, C. H. DePuy, T. E. Schroer, J. Chem. Soc., C 1971, 3115. 
[187] C. A. Aufdermarsh, Process for Preparing 3,4-Dimethylene-1,5-Hexadiene, 
1966, 3,264,366. 
[188] B. R. Bonazza, C. P. Lillya, J. Am. Chem. Soc. 1974, 96, 2298. 
[189] B. R. Bonazza, C. P. Lillya, G. Scholes, Organometallics 1982, 1, 137. 
[190] A. L. Burrows, B. Johnson, J. Lewis, D. G. Parker, J. Organomet. Chem. 
1980, 194, C11. 
[191] D. Martina, F. Brion, Tetrahedron Letters 1982, 23, 865. 
[192] M. Franck-Neumann, D. Martina, M. P. Heitz, J Organomet. Chem. 
1986, 301, 61. 
[193] M. Franck-Neumann, P. J. Colson, P. Geoffroy, K. M. Taba, 
Tetrahedron Letters 1992, 33, 1903. 
[194] Q. Chen, C. Li, Organometallics 2007, 26, 223. 
[195] H. Toombs-Ruane, N. Osinski, T. Fallon, C. Wills, A. C. Willis, M. N. 
Paddon-Row, M. S. Sherburn, Chem. Asian J. 2011, 6, 3243. 
[196] K. Żukowska, K. Grela, in Olefin Metathesis Theory and Practice, Olefin 
Metathesis: Theory and Practice, Hoboken, 2014, pp. 37. 
[197] H. A. Brune, G. Horlbeck, W. Schwab, Tetrahedron 1972, 28, 4455. 
[198] S. M. Nelson, C. M. Regan, M. Sloan, J. of Organomet. Chem 1975, 96, 
383. 
[199] H. A. Brune, G. Horlbeck, W. Schwab, Tetrahedron 1972, 28, 2593. 
[200] M.-C. P. Yeh, T.-S. Chou, H.-H. Tso, C.-Y. Tsai, J. Chem. Soc., Chem. 
Commun. 1990, 897. 
[201] H. A. Brune, W. Schwab, H. Huther, Z. Naturforsch. B 1969, 1518. 
[202] H. A. Brune, W. Schwab, H. P. Wolff, Z. Naturforsch. B 1970, 25, 892. 
[203] H. A. Brune, G. Horlbeck, P. Müller, Z. Naturforsch. B 1972, 27, 911. 
[204] M. N. Abser, M. A. Hashem, S. E. Kabir, S. S. Ullah, Ind. J. Chem. A 
1991, 30A, 974. 
[205] T. M. Raynham, D. G. Smyth, G. R. Stephenson, Tetrahedron Letters 
1996, 37, 2731. 
[206] T. Okauchi, T. Teshima, K. Hayashi, N. Suetsugu, T. Minami, J. Am. 
Chem. Soc. 2001, 123, 12117. 
[207] T. Okauchi, N. Sata, A. Urakawa, M. Kitamura, Chem. Commun. 2015, 
51, 8454. 
[208] U. Bunz, V. Enkelmann, Angew. Chem. Int. Ed. 1993, 32, 1653. 
[209] U. Bunz, J. Wiegelmann-Kreiter, Chem. Ber. 1996, 129, 785. 
[210] For an account of the development of pseudohalides as cross-coupling 
partners see C. C. C. Johansson Seechurn, M. O. Kitching, T. J. 
Colacot, V. Snieckus, Angew. Chem. Int. Ed. 2012, 51, 5062. 
[211] A. J. Birch, L. F. Kelly, D. V. Weerasuria, J. Org. Chem. 1988, 53, 278. 
[212] S. Romanski, B. Kraus, M. Guttentag, W. Schlundt, H. Rücker, A. 
 REFERENCES 310 
Adler, J.-M. Neudörfl, R. Alberto, S. Amslinger, H.-G. Schmalz, Dalton 
Trans. 2012, 41, 13862. 
[213] Y. Cui, H. Jiang, Z. Li, N. Wu, Z. Yang, J. Quan, Org. Lett. 2009, 11, 
4628. 
[214] L. Hansson, R. Carlson, Acta Chem. Scand. 1989, 43, 188. 
[215] H.-Y. Li, H. Sun, S. G. DiMagno, Tetra- N-Butylammonium Fluoride, 
John Wiley & Sons, Ltd, Chichester, UK, 2001. 
[216] L. Eisenhuth, H. Siegel, H. Hopf, Chem. Ber. 1981, 114. 
[217] H. Priebe, H. Hopf, Angew. Chem. Int. Ed. 1982, 21, 635. 
[218] F. Lehrich, H. Hopf, Tetrahedron Lett. 1987, 28, 2697. 
[219] H. Bader, H. Hopf, H. Jäger, Chem. Ber. 1989, 122, 1193. 
[220] M. Zheng, K. J. DiRico, M. M. Kirchhoff, J. Am. Chem. Soc. 1993, 115, 
12167. 
[221] M. Hoshi, A. Arase, J. Chem. Soc., Perkin Trans. 1 1993, 2693. 
[222] H. Hopf, M. Theurig, Angew. Chem. Int. Ed. 1994, 33, 1099. 
[223] R. Faust, F. Mitzel, J. Chem. Soc., Perkin Trans. 1 2000, 3746. 
[224] A. K. Dash, M. S. Eisen, Org. Lett. 2000, 2, 737. 
[225] A. K. Dash, I. Gourevich, J. Q. Wang, J. Wang, M. Kapon, M. S. Eisen, 
Organometallics 2001, 20, 5084. 
[226] D. Dong, Y. Liu, Y. Zhao, Y. Qi, Z. Wang, Q. Liu, Synthesis 2005, 85. 
[227] M. Kim, R. L. Miller, D. Lee, J. Am. Chem. Soc. 2005, 127, 12818. 
[228] F. Lehrich, H. Hopf, J. Grunenberg, Eur. J. Org. Chem. 2011, 2011, 
2705. 
[229] L. Rubio-Pérez, R. Azpíroz, A. Di Giuseppe, V. Polo, R. Castarlenas, J. 
J. Pérez-Torrente, L. A. Oro, Chem. Eur. J. 2013, 19, 15304. 
[230] K.-P. Wang, E. J. Cho, S. Y. Yun, J. Y. Rhee, D. Lee, Tetrahedron 2013, 
69, 9105. 
[231] R. Azpíroz, L. Rubio-Pérez, R. Castarlenas, J. J. Pérez-Torrente, L. A. 
Oro, ChemCatChem 2014, 6, 2587. 
[232] Q. Y. Chen, Z. Y. Yang, Tetrahedron Lett. 1986, 27, 1171. 
[233] D. Gelman, S. L. Buchwald, Angew. Chem. Int. Ed. 2003, 42, 5993. 
[234] J. Stewart, Preparation of 2, 3-Dichlorobutadiene-1, 3, 1962 US3061653 
A. 
[235] J. A. Soderquist, B. Santiago, Tetrahedron Lett 1990, 31, 5113. 
[236] J. A. Soderquist, A. M. Rane, K. Matos, J. Ramos, Tetrahedron Lett. 
1995, 36, 6847. 
[237] T. R. Blum, Y. Zhu, S. A. Nordeen, T. P. Yoon, Angew. Chem. Int. Ed. 
2014, 53, 11056. 
[238] E. A. Ilardi, C. E. Stivala, A. Zakarian, Org. Lett. 2008, 10, 1727. 
[239] N. A. Magomedov, P. L. Ruggiero, Y. Tang, J. Am. Chem. Soc. 2004, 
126, 1624. 
[240] T. J. Greshock, R. L. Funk, J. Am. Chem. Soc. 2006, 128, 4946. 
[241] T.-Q. Yu, Y. Fu, L. Liu, Q.-X. Guo, J. Org. Chem. 2006, 71, 6157. 
[242] E. J. Lindeboom, A. C. Willis, M. N. Paddon-Row, M. S. Sherburn, J. 
Org. Chem. 2014, 79, 11496. 
[243] R. Wang, M. N. Paddon-Row, M. S. Sherburn, Org. Lett. 2013, 15, 
5610. 
[244] L. C. H. Kwan, PhD Thesis, 2007. 
REFERENCES 	   311 
[245] T. A. Bradford, A. D. Payne, A. C. Willis, M. N. Paddon-Row, M. S. 
Sherburn, J. Org. Chem. 2010, 75, 491. 
[246] N. J. Green, A. L. Lawrence, G. Bojase, A. C. Willis, M. N. Paddon-
Row, M. S. Sherburn, Angew. Chem. Int. Ed. 2013, 52, 8333. 
[247] W. McFarlane, G. Wilkinson, W. Hübel, Triiron Dodecacarbonyl, John 
Wiley & Sons, Inc., Hoboken, NJ, USA, 1966. 
[248] P. Cazeau, F. Duboudin, F. Moulines, O. Babot, Tetrahedron 1987, 43, 
2089. 
[249] J. P. Brand, C. Chevalley, R. Scopelliti, J. Waser, Chem. Eur. J. 2012, 18, 
5655. 
[250] D. Farran, A. M. Z. Slawin, P. Kirsch, D. O’Hagan, J. Org. Chem. 2009, 
74, 7168. 
[251] Z. He, A. K. Yudin, J. Am. Chem. Soc. 2011, 133, 13770. 
[252] M. C. Carreno, S. Garcia-Cerrada, A. Urbano, Chem. Eur. J. 2003, 9, 
4118. 
[253]          H. Toombs-Ruane, PhD Thesis, 2011. 
[254]         M. J. Sowden, Honours Thesis, 2015. 
 
 

	  

	  
Published manuscripts have been removed due to copyright limitations. 

	  
 
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
13
.16
24
.06
1.6
5
6.1
3
1.9
0
2.5
8
1.9
9
2.0
0
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
-4
.51
-4
.48
18
.59
25
.85
55
.58
55
.61
64
.48
65
.53
74
.73
83
.83
11
0.7
7
11
1.3
4
11
9.3
2
11
9.6
8
12
0.9
0
12
0.9
3
13
3.6
6
13
4.5
6
14
4.7
5
14
5.5
1
15
1.1
8
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
12
.47
19
.62
6.3
5
6.4
4
2.0
0
2.1
4
4.1
1
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
-4
.44
18
.59
21
.30
25
.83
55
.60
55
.62
65
.57
65
.64
83
.85
83
.91
11
2.0
2
11
2.0
5
12
0.8
0
12
0.8
3
12
0.8
6
12
9.9
5
12
9.9
8
14
5.9
7
14
6.0
0
15
1.0
8
16
9.9
0
0.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
RSHA184B
11
.50
21
.01
6.0
0
6.6
5
3.8
5
1.7
5
5.8
4
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
RSHB184B
-4
.47
18
.57
21
.40
25
.83
55
.56
75
.35
11
1.9
6
11
5.7
0
12
0.6
8
12
0.7
0
13
1.4
5
14
4.4
6
14
5.1
6
15
0.8
8
16
9.8
8
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
RSHB52C
5.8
1
10
.38
3.3
9
3.1
6
2.0
0
1.1
3
3.1
8
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
RSHB52C
-4
.47
18
.55
21
.39
25
.82
55
.45
75
.15
11
1.9
9
11
4.9
7
12
0.5
6
12
0.6
4
13
1.3
2
14
3.8
8
14
5.1
1
15
0.7
8
16
9.8
0
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
B87A
11
.43
17
.96
6.0
0
1.8
7
1.7
1
1.9
0
5.8
9
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
B87A
-4
.51
-4
.47
18
.59
25
.86
55
.51
55
.57
75
.48
75
.54
11
0.8
4
11
5.6
0
11
9.4
7
12
0.6
8
13
5.4
6
14
4.6
8
14
8.2
9
15
0.9
9
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
RSHB167A
10
.38
17
.53
6.4
0
1.7
5
1.8
4
1.8
8
6.0
0
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
RSHB167A2
Inova 300
13C
-4
.49
18
.60
25
.86
55
.59
75
.64
11
0.9
5
11
5.2
3
11
9.6
6
12
0.7
5
13
5.4
1
14
4.7
7
14
8.9
3
15
1.0
7
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
B70E
11
.31
20
.12
6.0
0
1.7
9
1.7
2
2.0
9
5.6
8
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
B70E
-4
.49
-4
.47
18
.60
25
.88
55
.55
76
.84
 cd
cl3
77
.16
 cd
cl3
77
.48
 cd
cl3
83
.73
10
5.7
7
11
1.9
3
12
0.8
2
13
4.1
9
14
5.2
2
14
9.2
6
15
1.1
0
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
RSHB96A3
remaining material columned on alumina
10
.07
17
.43
6.0
0
1.8
8
1.6
6
1.8
4
3.5
7
1.9
3
-100102030405060708090100110120130140150160170180190200
f1 (ppm)
B70C
-4
.46
18
.61
25
.88
55
.65
82
.94
10
6.0
2
11
1.4
5
12
0.0
3
12
0.7
0
13
4.5
8
14
5.0
3
14
8.0
8
15
1.1
4
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.010.5
f1 (ppm)
3.1
3
2.9
9
2.0
6
1.0
2
1.9
0
1.0
0
0102030405060708090100110120130140150160170180190
f1 (ppm)
135.5136.0136.5
f1 (ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
RSHD153AA2
4.1
4
1.0
0
1.9
2
1.0
8
1.9
0
1.0
0
1.8
4
0102030405060708090100110120130140150160170180190200
f1 (ppm)
RSHD153AA3
STANDARD CARBON PARAMETERS
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
6.0
8
6.2
7
1.9
7
4.0
1
2.0
9
4.0
7
2.0
9
4.0
0
0102030405060708090100110120130140150160170180190
f1 (ppm)
136137
f1 (ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
6.2
1
6.3
2
3.8
2
1.9
6
4.0
3
2.0
0
4.1
2
2.0
1
4.0
0
0102030405060708090100110120130140150160170180190
f1 (ppm)
169.5170.0
f1 (ppm)
110112114116118120122124126128130132134136138140142144146148150152
f1 (ppm)
7475
f1 (ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
2.6
6
6.2
2
3.9
6
1.9
4
3.9
9
2.0
9
4.0
7
2.2
3
4.0
0
0102030405060708090100110120130140150160170180190
f1 (ppm)
127128129130
f1 (ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
5.5
8
1.6
2
1.6
2
1.6
1
1.7
8
1.6
9
1.7
4
3.8
6
1.9
8
4.0
0
102030405060708090100110120130140150160170180190200
f1 (ppm)
128129130
f1 (ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
6.2
4
1.9
1
2.0
1
1.9
9
4.2
1
1.8
8
4.3
3
2.2
3
4.0
0
0102030405060708090100110120130140150160170180190200
f1 (ppm)
127.5128.0128.5129.0129.5
f1 (ppm)
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
6.8
8
2.2
5
1.9
2
2.2
3
1.7
5
6.0
0
0102030405060708090100110120130140150160170180190200
f1 (ppm)
C13_s2pul_001
RSHE3cr
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
RSHE2cr5
0102030405060708090100110120130140150160170180190200
f1 (ppm)
C13_s2pul_001
RSHE2cr4
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.0
2
1.0
4
0.9
1
1.7
2
1.0
1
2.9
9
6.1
4
2.8
1
1.0
0
0.9
7
0.9
9
0.9
7
0.9
0
1.1
5
1.0
4
3.2
2
0.9
5
0.9
9
6.6
7
2.2
7
2.2
9
6.76.86.97.0
f1 (ppm) 5.525.60f1 (ppm)
3.83.9
f1 (ppm)
0102030405060708090100110120130140150160170180190200
f1 (ppm)
145.8146.7
f1 (ppm) 132.6133.2f1 (ppm)
120.0120.8
f1 (ppm)
114.0114.3
f1 (ppm) 110.0110.4f1 (ppm) 88.288.8f1 (ppm) 55.956.1f1 (ppm)
two
peaks twopeaks
two
peaks
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
RSHD21F6
RSHD21F3
Avance 800
11 April 2014
0.9
4
0.9
1
0.8
6
1.6
8
0.5
9
2.9
7
3.0
1
3.0
1
3.1
5
0.9
7
0.9
7
0.9
7
0.9
8
0.9
5
0.9
5
0.9
1
0.9
1
0.9
1
0.9
3
0.9
6
1.0
1
0.9
8
0.9
8
0.9
8
0.9
3
1.9
5
0.9
4
3.0
0
6.56.66.76.86.9
f1 (ppm)
5.355.405.455.505.555.60
f1 (ppm) 1.71.81.92.02.12.2 f1 (ppm)
0102030405060708090100110120130140150160170180190200
f1 (ppm)
145.8146.7
f1 (ppm) 131132133134 f1 (ppm)
120121
f1 (ppm) 114.0f1 (ppm) 110111f1 (ppm)
89.089.5
f1 (ppm) 55.8f1 (ppm)
two
peaks
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
1.0
0
1.0
5
1.9
9
1.0
2
0.9
9
2.9
2
2.9
8
3.1
7
3.1
0
1.0
6
1.0
0
1.0
1
1.0
1
1.0
2
5.1
4
1.1
1
3.0
9
0.9
8
0.9
9
1.0
0
6.756.806.856.906.957.00
f1 (ppm)
1.01.21.41.61.82.02.22.4
f1 (ppm)
one peak 
obscured 
by water
0102030405060708090100110120130140150160170180190200
f1 (ppm)
133134135136
f1 (ppm)147.5148.0148.5149.0 f1 (ppm)
121.0121.5
f1 (ppm)
115.6116.0
f1 (ppm) 112.0112.2f1 (ppm)
56.256.4
f1 (ppm)
89.590.0
f1 (ppm)
two
peaks
two
peaks
three
peaks
one peak 
obscured 
by solvent
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.2
5
8.7
0
1.5
2
1.0
0
0.8
2
0.7
2
-0
.12
-0
.12
-0
.12
-0
.12
-0
.11
-0
.11
-0
.10
-0
.10
-0
.10
-0
.09
-0
.09
-0
.09
0.2
1
0.2
1
0.2
1
0.2
1
1.2
5
1.2
5
1.2
6
1.4
9
1.4
9
1.4
9
1.4
9
1.5
1
1.5
1
1.5
1
1.5
1
3.4
3
3.4
3
3.4
3
3.4
5
3.4
5
3.4
5
5.0
3
5.0
3
5.0
3
5.0
4
5.0
4
5.0
4
5.0
5
5.0
5
5.0
5
5.0
5
5.0
6
5.0
6
5.0
6
5.0
6
5.0
7
5.0
7
5.0
7
5.0
8
5.0
8
5.0
8
5.1
7
5.1
7
5.1
7
5.1
8
5.1
8
5.1
8
5.1
9
5.1
9
5.1
9
5.2
0
5.2
0
5.2
0
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
-0
.74
29
.86
36
.58
78
.85
93
.82
21
2.8
1
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.8
7
8.9
6
1.0
3
1.0
7
0.8
9
-0
.42
-0
.41
-0
.39
-0
.38
0.2
9
0.3
0
0.3
0
0.3
2
0.3
2
0.3
3
1.4
1
1.4
2
1.4
3
1.4
4
2.0
3
2.0
4
2.0
5
5.2
0
5.2
3
5.2
5
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
0.4
7
31
.51
37
.25
73
.91
13
6.6
3
21
2.0
7
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.1
2
1.2
1
1.2
8
1.2
2
1.0
0
-0
.31
-0
.30
-0
.28
-0
.27
0.5
4
0.5
5
0.5
6
0.5
6
0.5
6
1.6
0
1.6
1
1.6
2
1.6
3
2.3
3
2.3
4
2.3
5
2.3
5
5.8
1
5.8
2
5.8
2
5.8
2
5.8
4
5.8
4
5.8
5
5.8
5
5.8
7
5.8
7
5.8
8
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
30
.90
36
.58
80
.94
11
6.4
0
12
0.6
4
12
4.9
0
13
1.3
7
20
8.1
2
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.8
9
1.0
0
1.0
8
1.0
3
3.2
9
0.7
8
1.8
3
1.6
5
-0
.43
-0
.42
-0
.40
-0
.40
-0
.39
-0
.39
0.3
0
0.3
1
0.3
1
0.3
2
0.3
2
0.3
3
1.4
6
1.4
7
1.4
8
1.4
9
2.0
1
2.0
1
2.0
2
2.0
3
2.4
8
5.5
3
5.5
5
5.5
8
7.3
8
7.4
0
7.8
4
7.8
7
7.8
7
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
RSHFOTs
21
.92
31
.49
37
.62
80
.88
12
8.7
5
12
9.4
1
13
0.2
0
13
2.4
3
14
5.9
8
20
9.2
6
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
9.7
0
1.0
6
1.0
6
1.0
6
1.0
0
0.2
1
0.3
0
0.3
1
0.3
1
1.7
4
1.7
5
1.7
7
1.7
8
2.0
3
2.0
3
2.0
3
2.0
4
5.6
3
5.6
6
5.6
9
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
-0
.06
39
.59
43
.75
84
.32
89
.79
91
.49
10
4.0
5
21
0.3
2
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.0
2
1.0
6
3.9
3
5.2
6
0.9
7
1.0
2
2.3
8
1.0
0
0.1
3
0.1
3
0.1
5
0.1
5
0.3
2
0.9
0
0.9
2
0.9
4
1.3
9
1.4
1
1.4
3
1.4
4
1.4
6
1.4
8
1.5
0
1.5
2
1.5
4
1.5
6
1.5
7
1.7
1
1.7
2
1.7
2
1.7
3
1.7
4
1.7
4
2.0
1
2.0
1
2.2
9
2.3
1
2.3
2
5.5
8
5.6
0
5.6
2
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
13
.72
19
.00
22
.08
30
.72
39
.07
43
.84
79
.21
86
.42
87
.52
89
.02
21
0.6
5
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.0
3
1.1
0
1.1
7
1.1
4
1.0
0
2.9
7
2.0
1
0.2
5
0.2
6
0.2
8
0.2
9
0.4
0
0.4
1
0.4
1
0.4
1
1.8
1
1.8
2
1.8
3
1.8
4
2.1
3
2.1
3
2.1
4
2.1
4
5.7
2
5.7
5
5.7
8
7.3
3
7.3
4
7.3
5
7.4
7
7.4
8
7.5
0
7.5
0
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
39
.66
43
.46
84
.94
86
.03
88
.35
89
.64
12
2.6
2
12
8.5
1
12
8.7
8
13
1.9
4
21
0.3
9
128.0128.2128.4128.6128.8129.0129.2
f1 (ppm)
12
8.5
1
12
8.7
8
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
1.0
6
1.0
3
0.5
2
1.0
6
1.0
2
1.0
0
2.1
5
2.1
2
0.2
3
0.2
4
0.2
5
0.2
6
0.3
9
0.3
9
0.3
9
0.4
0
0.4
0
1.7
9
1.8
0
1.8
1
1.8
2
2.1
2
2.1
2
2.1
2
2.1
3
3.8
2
5.7
0
5.7
2
5.7
4
6.8
5
6.8
7
7.4
1
7.4
3
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
39
.37
43
.31
55
.33
85
.45
85
.96
86
.81
89
.18
11
4.0
2
11
4.5
2
13
3.2
9
15
9.9
0
21
0.3
5
113.8114.0114.2114.4114.6114.8
f1 (ppm)
11
4.0
2
11
4.5
2
858687888990
f1 (ppm)
85
.45
85
.96
86
.81
89
.18
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
f1 (ppm)
0.9
8
1.0
1
1.0
2
1.0
1
1.0
0
2.0
1
2.0
0
0.3
2
0.3
3
0.3
4
0.3
5
0.4
2
0.4
2
0.4
3
0.4
3
1.8
7
1.8
8
1.8
9
1.9
0
2.1
1
2.1
2
2.1
2
2.1
2
5.7
6
5.7
8
5.8
0
7.6
1
7.6
3
8.2
0
8.2
2
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
40
.30
43
.18
82
.94
84
.00
90
.42
93
.97
12
3.8
0
12
9.5
3
13
2.6
4
14
7.3
7
21
0.0
5
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.2
0
0.2
0
0.1
9
0.1
9
0.3
9
0.3
9
0.1
8
0.9
6
0.2
0
0.2
1
0.2
2
0.2
3
0.3
4
0.3
5
1.7
8
1.7
9
1.8
0
1.8
1
2.0
4
2.0
4
2.0
5
4.3
1
4.6
3
5.6
5
5.6
8
5.7
0
7.2
6
7.3
1
7.3
2
7.3
3
7.3
4
7.3
6
7.3
7
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
39
.64
43
.48
57
.74
71
.85
82
.09
84
.03
85
.54
89
.90
12
8.0
9
12
8.2
9
12
8.6
2
13
7.4
4
21
0.3
1
127.5128.0128.5129.0
f1 (ppm)
12
8.0
9
12
8.2
9
12
8.6
2
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.0
8
1.0
4
1.0
3
4.2
7
3.2
7
1.0
0
0.9
5
2.1
0
2.0
9
0.2
0
0.2
1
0.2
2
0.2
3
0.3
3
0.3
3
0.3
3
0.3
4
0.3
4
0.3
5
1.7
8
1.7
8
1.7
9
1.8
0
2.0
3
2.0
4
2.0
4
2.0
6
2.0
7
2.0
7
2.0
7
2.0
9
3.8
2
5.6
7
5.6
9
5.7
1
6.5
3
6.8
9
6.9
1
7.4
5
7.4
8
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
21
.24
39
.71
43
.41
43
.53
55
.48
65
.62
82
.66
82
.69
83
.40
83
.46
85
.95
86
.03
89
.97
90
.01
11
4.1
8
12
8.8
9
12
9.0
3
12
9.5
2
16
0.3
2
16
9.9
5
21
0.1
4
128.5129.0129.5130.0
f1 (ppm)
12
8.8
9
12
9.0
3
12
9.5
2
89.590.090.591.0
f1 (ppm)
89
.97
90
.01
83.283.483.6
f1 (ppm)
83
.40
83
.46
82.482.682.8
f1 (ppm)
82
.66
82
.69
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.9
8
0.9
9
1.0
0
2.8
1
1.0
3
0.8
6
0.1
2
0.1
3
0.1
5
0.1
5
0.3
0
0.3
0
0.3
1
0.3
1
1.7
2
1.7
2
1.7
3
1.7
4
1.9
5
1.9
6
1.9
9
1.9
9
2.0
0
2.0
0
5.5
7
5.5
7
5.5
7
5.5
9
5.5
9
5.5
9
5.5
9
5.6
0
5.6
1
5.6
1
5.6
1
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
4.2
7
39
.09
43
.59
78
.34
82
.96
86
.28
89
.09
21
0.6
0
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
7.7
0
1.9
0
1.0
4
1.0
6
0.9
4
0.9
7
1.0
0
0.1
9
0.1
9
0.2
6
0.2
7
0.2
9
0.3
0
0.3
1
0.3
2
1.7
9
1.8
0
1.8
2
1.8
2
2.1
2
2.1
2
2.1
2
2.1
3
5.4
0
5.4
3
5.4
5
5.7
3
5.7
8
6.9
1
6.9
6
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
0.6
7
39
.80
41
.75
86
.39
10
2.8
3
13
3.2
8
14
5.8
0
21
1.0
8
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.9
8
1.0
0
3.2
1
4.2
9
1.0
0
1.0
8
2.1
8
0.9
1
0.9
6
0.9
0
0.2
3
0.2
4
0.2
6
0.2
7
0.4
1
0.4
2
0.4
2
0.8
9
0.9
1
0.9
4
1.3
5
1.3
7
1.3
8
1.3
9
1.4
0
1.4
2
1.7
5
1.7
6
1.7
7
1.7
8
2.0
8
2.3
7
2.3
9
2.4
2
2.4
4
5.3
3
5.3
6
5.3
9
5.5
9
5.6
2
5.6
3
5.6
5
5.6
6
5.6
8
6.0
3
6.0
7
0102030405060708090100110120130140150160170180190200210220
f1 (ppm)
14
.12
22
.57
28
.91
32
.26
39
.29
42
.77
85
.64
10
0.7
4
12
8.4
9
13
5.0
7
21
1.3
5
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.0
9
0.5
5
0.5
3
0.4
8
0.5
2
0.5
2
2.0
4
1.0
0
0.2
9
0.3
0
0.3
2
0.3
3
0.3
6
0.3
7
1.7
5
1.7
6
1.7
8
1.7
8
1.8
8
1.8
8
1.8
9
5.4
0
5.4
3
5.4
6
6.2
4
6.2
8
6.6
0
6.6
4
7.2
1
7.2
4
7.2
9
7.3
1
7.3
4
7.4
2
7.4
4
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
39
.64
44
.10
87
.09
10
0.0
2
12
7.4
7
12
8.3
7
12
9.1
9
13
0.3
0
13
1.9
6
13
6.8
6
21
0.9
8
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
1.0
1
1.0
4
0.9
9
0.9
8
2.0
8
2.0
8
1.0
0
1.0
2
1.0
2
0.2
3
0.2
4
0.2
6
0.2
6
0.3
3
0.3
3
1.7
7
1.7
7
1.7
9
1.7
9
1.9
4
4.3
1
4.3
3
4.3
4
4.3
6
4.3
8
4.4
0
4.4
1
4.4
3
4.5
6
4.5
7
5.3
5
5.3
7
5.3
9
5.8
4
5.8
6
5.8
7
5.8
9
5.9
0
6.2
4
6.2
7
7.2
8
7.2
9
7.3
0
7.3
1
7.3
3
7.3
5
7.3
6
4.304.354.404.45
f1 (ppm)
4.3
1
4.3
3
4.3
4
4.3
6
4.3
8
4.4
0
4.4
1
4.4
3
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
39
.62
42
.03
66
.55
72
.51
85
.96
98
.92
12
7.7
5
12
7.8
8
12
8.4
3
13
0.3
0
13
1.7
7
13
7.9
3
21
0.8
2
127.5128.0128.5129.0
f1 (ppm)
12
7.7
5
12
7.8
8
12
8.4
3
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.0
5
1.0
4
1.0
6
1.0
2
3.2
7
1.0
0
1.0
2
1.0
1
2.0
6
2.0
4
0.2
2
0.2
3
0.2
4
0.2
5
0.3
3
0.3
3
1.6
8
1.6
9
1.7
0
1.7
0
1.8
6
1.8
7
3.7
4
5.3
5
5.3
7
5.3
9
6.0
9
6.1
1
6.4
6
6.4
9
6.7
6
6.7
8
7.3
0
7.3
2
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
39
.45
44
.24
55
.40
86
.87
10
0.6
9
11
3.7
7
12
8.7
7
12
9.2
5
13
0.5
4
13
1.6
3
15
9.0
4
21
1.0
4
128129130131132
f1 (ppm)
12
8.7
7
12
9.2
5
13
0.5
4
13
1.6
3
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.1
2
1.0
6
1.2
1
3.3
3
1.0
6
0.9
8
0.9
3
0.9
6
0.2
3
0.2
4
0.2
6
0.2
7
0.4
5
0.4
5
0.4
5
0.4
6
1.7
5
1.7
6
1.7
8
1.7
8
1.9
4
1.9
5
1.9
7
1.9
7
2.0
8
2.0
9
2.0
9
2.0
9
5.3
5
5.3
8
5.4
0
5.6
9
5.7
2
5.7
3
5.7
4
5.7
6
5.7
7
5.7
8
5.8
0
6.0
5
6.0
6
6.0
9
6.1
0
5.705.755.80
f1 (ppm)
5.6
9
5.7
2
5.7
3
5.7
4
5.7
6
5.7
7
5.7
8
5.8
0
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
15
.14
39
.23
42
.95
85
.65
10
0.6
0
12
8.8
5
12
9.6
1
21
1.3
4
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
3.2
5
4.8
6
1.9
4
1.0
0
0.9
7
0.9
3
0.9
5
0.7
8
0.9
1
0.9
3
0.9
6
1.3
7
1.4
0
1.4
2
1.4
4
1.4
7
1.4
9
1.5
2
1.5
4
1.5
5
1.5
7
1.5
9
1.6
1
2.3
6
2.3
8
2.4
0
5.2
0
5.2
4
5.3
5
5.4
4
5.6
0
5.6
5
6.3
1
6.3
4
6.3
7
6.4
0
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
13
.76
19
.13
22
.16
30
.99
93
.04
11
7.5
0
12
2.7
8
13
0.6
3
13
6.8
3
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.9
8
1.0
2
0.9
7
0.9
6
0.8
7
2.9
6
1.9
0
5.3
0
5.3
2
5.5
0
5.6
2
5.7
3
5.7
8
6.4
0
6.4
2
6.4
4
6.4
6
7.3
3
7.3
3
7.3
4
7.3
4
7.3
5
7.4
9
7.5
0
7.5
0
7.5
0
7.5
1
7.5
1
7.5
1
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
85
.92
91
.82
11
8.0
0
12
3.1
6
12
3.9
3
12
8.4
8
12
8.5
5
13
0.1
7
13
1.8
3
13
6.2
4
128.4128.5128.6128.7
f1 (ppm)
12
8.4
8
12
8.5
5
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.8
1
0.5
8
0.5
5
0.5
3
0.5
5
0.4
6
1.0
9
1.0
0
3.8
2
5.2
8
5.3
1
5.4
6
5.5
8
5.7
1
5.7
7
6.3
8
6.4
1
6.4
3
6.4
7
6.8
5
6.8
8
7.4
2
7.4
5
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
55
.30
84
.49
91
.72
11
3.9
8
11
5.1
2
11
7.6
9
12
3.1
7
13
0.1
9
13
3.1
3
13
6.2
4
15
9.7
2
1.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.5
f1 (ppm)
1.0
5
1.0
3
2.2
0
1.0
0
2.2
1
2.1
5
5.3
3
5.3
6
5.6
0
5.6
9
5.7
3
6.4
0
6.4
3
6.4
4
6.4
7
7.6
2
7.6
4
8.2
0
8.2
2
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
89
.56
91
.03
11
8.1
9
12
3.6
3
12
5.4
3
12
9.3
6
12
9.9
0
13
2.3
8
13
5.5
2
14
7.1
5
129.0129.5130.0130.5
f1 (ppm)
12
9.3
6
12
9.9
0
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
2.1
1
2.1
4
1.0
2
0.9
9
1.0
4
1.1
0
1.0
0
5.8
9
4.3
7
4.6
5
5.2
6
5.2
8
5.4
7
5.5
6
5.6
4
5.6
8
6.3
4
6.3
6
6.3
8
6.4
1
7.3
1
7.3
1
7.3
2
7.3
2
7.3
4
7.3
6
7.3
7
7.3
8
7.3
9
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
57
.97
71
.84
83
.26
87
.65
11
8.1
1
12
4.5
2
12
8.1
3
12
8.3
7
12
8.7
0
12
9.8
2
13
6.1
9
13
7.6
9
128.0128.5129.0
f1 (ppm)
12
8.1
3
12
8.3
7
12
8.7
0
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
3.5
4
3.9
4
1.2
5
1.1
9
2.4
8
1.0
0
0.9
7
2.4
3
2.3
2
2.1
0
3.8
2
5.2
4
5.2
8
5.4
8
5.5
8
5.6
4
6.3
1
6.3
4
6.3
7
6.4
0
6.5
9
6.9
0
6.9
3
7.4
8
7.5
1
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
21
.31
55
.48
65
.85
83
.54
88
.28
11
4.1
7
11
8.2
7
12
4.9
2
12
9.4
0
12
9.4
2
12
9.5
2
13
5.8
7
16
0.2
6
17
0.0
2
129.1129.3129.5129.7
f1 (ppm)
12
9.3
9
12
9.4
1
12
9.5
1
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
4.0
5
2.6
0
1.1
3
1.1
6
1.0
0
1.5
6
5.1
3
5.1
6
5.4
6
5.8
3
5.8
9
6.2
1
6.2
4
6.2
6
6.3
0
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
3.7
5
76
.97
88
.49
11
7.4
3
12
2.8
5
13
1.3
6
13
7.2
5
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.6
0
0.5
1
0.4
8
0.4
4
0.4
8
1.6
5
0.9
2
5.1
1
5.1
4
5.1
7
5.3
2
5.3
8
6.1
7
6.2
1
6.4
1
6.4
5
6.4
7
6.5
1
6.5
6
6.6
0
7.1
5
7.1
6
7.1
6
7.1
7
7.1
8
7.1
9
7.2
0
7.2
1
7.2
3
7.2
5
7.2
5
7.2
6
7.2
6
7.2
6
7.2
7
7.2
7
7.2
7
7.2
8
7.3
6
7.3
6
7.3
9
7.3
9
0102030405060708090100110120130140150160170180190200210
f1 (ppm)
11
5.8
5
11
8.2
7
12
7.2
0
12
8.0
7
12
8.1
4
12
8.9
7
13
1.8
7
13
7.0
1
13
7.7
6
14
4.1
1
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
3.7
2
5.1
5
2.2
1
2.2
9
2.2
5
1.0
5
1.0
2
1.0
0
0.8
6
0.8
8
0.9
0
1.3
1
1.3
2
1.3
2
1.3
2
1.3
3
1.3
3
1.3
4
1.3
5
1.3
6
2.1
1
2.1
3
2.1
3
2.1
3
2.1
5
2.1
5
2.1
6
5.0
2
5.0
6
5.0
9
5.1
9
5.2
3
5.2
3
5.6
2
5.6
4
5.6
5
5.6
6
5.6
7
5.6
9
5.9
5
5.9
6
5.9
8
5.9
9
6.3
8
6.4
0
6.4
2
6.4
5
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
14
.10
22
.50
28
.49
32
.24
11
5.2
0
11
7.6
3
12
5.9
4
13
4.4
8
13
8.9
5
14
3.0
9
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
3.6
8
2.9
4
0.8
9
1.0
0
1.8
6
2.2
0
2.1
9
3.7
9
5.0
9
5.1
2
5.1
2
5.1
3
5.1
3
5.1
8
5.1
8
5.1
8
5.3
2
5.3
2
5.3
6
5.3
6
6.0
5
6.0
8
6.4
2
6.4
4
6.4
6
6.4
8
6.5
1
6.7
7
6.7
9
7.3
1
7.3
3
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
55
.33
11
3.5
4
11
5.8
4
11
7.9
9
12
6.1
2
12
9.6
5
13
0.2
8
13
1.2
3
13
7.7
5
14
4.4
4
15
8.7
9
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
2.2
4
2.3
1
1.0
7
1.0
9
2.1
4
0.9
9
0.9
6
0.9
0
4.7
7
4.1
4
4.1
6
4.4
8
4.9
5
5.1
1
5.1
4
5.1
9
5.2
1
5.2
5
5.8
5
5.8
7
5.8
9
5.9
1
5.9
3
6.2
2
6.2
5
6.3
5
6.3
9
6.4
1
6.4
5
7.2
6
7.2
7
7.2
7
7.2
9
7.2
9
7.3
0
7.3
2
7.3
3
7.3
3
7.3
4
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
67
.09
72
.43
11
5.9
8
11
8.7
1
12
7.7
4
12
7.9
9
12
8.5
0
12
9.2
8
13
0.6
1
13
8.2
5
13
8.4
6
14
2.2
3
138.0138.2138.4138.6
f1 (ppm)
13
8.2
5
13
8.4
6
127.5128.0128.5129.0129.5
f1 (ppm)
12
7.7
4
12
7.9
9
12
8.5
0
12
9.2
8
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
3.4
5
2.2
5
1.0
5
1.0
4
1.0
1
0.9
9
0.9
8
1.5
9
1.6
0
1.6
1
1.6
2
4.9
8
5.0
1
5.1
3
5.2
2
5.2
8
5.5
6
5.5
9
5.6
0
5.6
1
5.6
2
5.6
3
5.6
5
5.6
7
6.0
3
6.0
7
6.3
2
6.3
6
6.3
8
6.4
2
5.505.555.605.655.705.75
f1 (ppm)
5.5
6
5.5
9
5.6
0
5.6
1
5.6
2
5.6
3
5.6
5
5.6
7
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
14
.62
11
5.2
3
11
8.0
7
12
7.3
3
13
9.0
9
14
3.0
5
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.1
4
1.1
4
1.2
4
1.1
8
0.9
3
1.0
0
0.1
9
0.2
0
0.2
2
0.2
3
0.3
3
1.7
7
1.7
8
1.8
0
1.8
1
2.0
4
2.7
6
5.6
8
5.7
1
5.7
4
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
4.2
7
39
.09
43
.59
78
.34
82
.96
86
.28
89
.09
21
0.6
0
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.9
1
2.3
6
1.1
5
1.1
5
1.0
0
2.6
1
5.0
9
5.1
1
5.4
3
5.7
7
5.8
3
6.0
7
6.1
0
6.1
2
6.1
6
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
80
.07
80
.38
11
8.0
6
12
5.1
5
12
9.9
2
13
6.1
4
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.8
3
0.8
6
0.8
3
0.8
2
0.8
0
0.2
5
0.2
6
0.2
6
0.2
8
0.2
8
0.2
9
0.3
9
1.8
2
1.8
3
1.8
4
1.8
5
2.0
9
5.7
1
5.7
3
5.7
5
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
39
.81
39
.85
43
.33
43
.42
83
.69
85
.09
90
.01
90
.04
21
0.1
5
89.990.090.190.2
f1 (ppm)
90
.01
90
.04
43.143.243.343.443.5
f1 (ppm)
43
.33
43
.42
39.739.839.9
f1 (ppm)
39
.81
39
.85
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
2.2
5
2.1
8
2.0
2
1.0
1
0.9
5
0.9
5
0.9
8
1.1
0
1.0
0
0.3
2
0.3
2
0.3
4
0.3
5
0.3
6
0.3
7
0.4
6
0.4
7
0.5
0
0.5
0
1.8
1
1.8
2
1.8
3
1.8
4
1.8
4
1.8
5
1.8
6
1.8
6
2.1
4
2.1
4
2.1
4
2.1
5
2.2
7
2.2
7
2.2
7
2.2
8
5.4
6
5.4
8
5.5
0
5.6
1
5.6
3
5.6
5
6.2
1
6.3
1
7.2
6
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
39
.46
39
.95
43
.21
43
.98
86
.79
87
.38
99
.03
99
.59
13
1.7
5
13
1.8
9
21
0.6
8
131.4131.6131.8132.0132.2
f1 (ppm)
13
1.7
5
13
1.8
9
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
2.2
0
1.0
7
1.0
4
1.0
0
5.0
9
5.1
2
5.1
4
5.4
4
5.8
2
5.8
6
6.1
5
6.1
8
6.1
9
6.2
2
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
88
.75
11
7.9
5
12
4.2
7
13
0.4
9
13
6.4
5
-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
4.1
0
2.0
7
2.0
2
2.0
3
2.0
0
4.9
7
4.9
9
5.0
1
5.0
1
5.1
7
5.2
4
5.2
7
6.1
1
6.2
9
6.3
1
6.3
3
6.3
5
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
11
5.1
1
11
8.2
1
12
9.8
6
13
8.5
8
14
3.5
1
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
2.1
0
2.0
0
5.8
9
3.7
6
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
42
.25
87
.53
88
.68
89
.84
12
2.7
4
12
8.5
2
12
8.9
0
13
2.0
4
20
9.4
2
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
f1 (ppm)
2.0
3
2.0
0
6.8
9
4.5
9
5.7
6
6.1
2
7.2
6
7.2
7
7.2
7
7.2
8
7.2
9
7.4
2
7.4
3
7.4
4
7.4
4
7.4
4
7.4
5
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
85
.86
92
.50
12
2.8
5
12
4.4
2
12
8.3
6
13
1.6
0
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
0.9
9
1.0
0
1.0
3
0.9
9
1.9
7
1.0
0
0.2
7
0.2
9
0.3
4
0.4
0
1.8
3
1.8
5
2.0
9
5.7
3
5.7
5
5.7
7
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
39
.85
42
.24
42
.38
43
.11
43
.18
43
.32
83
.21
83
.26
83
.65
83
.71
87
.57
88
.63
88
.74
90
.06
90
.13
20
8.8
1
20
9.8
9
87.087.588.088.589.089.590.090.5
f1 (ppm)
87
.57
88
.63
88
.74
90
.06
90
.13
82.583.083.584.084.5
f1 (ppm)
83
.21
83
.26
83
.65
83
.71
39.540.040.541.041.542.042.543.043.5
f1 (ppm)
39
.85
42
.24
42
.38
43
.11
43
.18
43
.32
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.1
0
0.5
3
0.5
5
0.5
3
1.0
0
5.0
8
5.0
8
5.0
8
5.0
8
5.0
8
5.0
9
5.1
1
5.1
1
5.1
1
5.1
2
5.1
2
5.1
2
5.1
3
5.1
3
5.1
4
5.1
4
5.4
2
5.6
6
5.6
7
5.6
7
5.7
5
5.7
5
5.7
5
5.7
5
5.8
1
5.8
1
5.8
1
6.1
3
6.1
6
6.1
9
6.1
9
6.1
9
6.2
2
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
88
.65
89
.74
11
8.0
6
12
4.4
4
12
5.1
1
12
9.2
4
13
0.3
2
13
6.3
1
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
f1 (ppm)
1.0
3
1.0
9
1.0
4
1.0
6
2.0
8
0.9
5
1.0
1
1.0
0
10
.78
2.2
3
2.2
5
2.2
7
2.2
9
2.3
8
2.5
5
2.5
6
2.5
9
2.6
0
2.7
2
2.7
2
2.7
3
2.7
4
2.7
5
2.7
6
2.7
7
2.7
8
3.1
2
3.1
3
3.1
4
3.1
5
3.1
5
3.1
6
3.1
7
3.1
9
3.2
0
3.2
1
3.2
2
3.2
2
3.2
4
3.2
4
6.0
1
6.1
2
6.1
5
6.4
3
6.4
6
7.2
1
7.2
3
7.2
3
7.2
4
7.2
6
7.2
7
7.2
8
7.3
0
7.3
5
7.3
7
7.3
8
7.4
3
7.4
5
7.4
6
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
24
.96
27
.75
39
.39
39
.90
12
6.5
0
12
7.2
7
12
7.6
7
12
8.2
5
12
8.6
6
12
8.9
1
12
9.2
2
12
9.8
6
13
0.5
7
13
2.1
4
13
7.9
8
13
8.1
4
17
8.5
5
17
9.1
4
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0
f1 (ppm)
1.9
7
1.1
6
1.0
7
1.9
8
0.9
3
0.9
1
1.0
0
11
.11
2.4
3
2.4
3
2.4
4
2.4
4
2.4
5
2.4
5
2.4
7
2.4
9
2.5
0
2.5
2
2.5
3
2.8
3
2.8
3
2.8
4
2.8
5
2.8
7
2.8
7
2.8
8
2.8
9
3.1
5
3.1
6
3.1
9
3.2
0
3.2
9
3.3
0
3.3
1
3.3
2
3.3
2
3.3
3
3.3
4
3.3
7
3.3
8
3.3
9
3.4
0
3.4
0
3.4
1
3.4
2
6.0
5
6.6
3
6.6
7
6.7
7
6.8
1
7.1
9
7.2
1
7.2
1
7.2
2
7.2
4
7.3
0
7.3
2
7.3
3
7.3
5
7.3
7
7.4
0
7.4
2
7.4
4
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
23
.52
25
.01
39
.39
39
.46
12
6.3
9
12
6.5
1
12
6.8
8
12
7.5
3
12
7.5
6
12
8.5
6
12
8.6
1
12
9.0
0
12
9.0
9
13
1.9
3
13
7.0
9
13
7.7
5
17
8.6
1
17
8.9
8
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.0
8
2.2
2
3.2
9
1.2
7
1.0
9
2.0
8
1.0
3
1.0
0
1.0
0
1.8
2
9.0
8
2.3
7
2.4
0
2.5
2
2.5
6
2.6
4
2.8
3
2.9
0
2.9
1
2.9
3
2.9
4
2.9
6
2.9
8
3.1
4
3.1
6
3.1
7
3.2
9
3.3
1
3.3
3
3.4
4
3.5
5
6.1
5
7.1
4
7.1
6
7.2
2
7.2
4
7.2
6
7.2
6
7.2
9
7.3
1
7.3
2
7.3
6
7.3
8
7.4
0
7.4
1
7.4
3
7.4
5
7.4
8
7.5
0
7.5
2
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
23
.67
24
.87
29
.69
34
.16
39
.45
39
.48
42
.26
43
.91
46
.94
12
6.0
9
12
6.3
6
12
7.3
1
12
8.4
5
12
8.7
5
12
8.8
4
12
9.3
3
13
1.9
2
13
7.4
6
13
8.7
9
17
5.7
1
17
7.0
7
17
8.5
9
17
9.0
1
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f2 (ppm)
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
f1
 (p
pm
)
RSHI17BNOESY
STANDARD PROTON PARAMETERS
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
2.2
1
5.5
7
1.2
2
2.1
9
1.0
0
1.0
4
1.0
1
10
.23
1.1
8
1.2
0
1.2
1
1.2
3
1.7
4
1.7
7
1.7
8
1.8
3
1.8
5
1.9
0
1.9
5
2.0
2
2.1
9
2.2
3
3.5
2
3.5
3
3.5
4
5.7
6
6.0
8
6.1
1
6.3
2
6.3
5
7.1
7
7.1
9
7.2
1
7.2
8
7.3
0
-100102030405060708090100110120130140150160170180190200210220
f1 (ppm)
25
.67
27
.67
28
.85
36
.12
67
.85
12
6.6
9
12
7.8
2
12
7.8
7
12
7.9
2
12
8.9
5
13
3.2
8
13
5.7
3
13
8.6
4
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
2.4
0
3.2
6
2.2
5
1.2
1
2.1
0
1.0
0
1.0
0
1.0
2
0.9
9
2.1
4
2.2
8
1.3
3
1.3
5
1.3
6
1.3
7
1.3
9
1.4
1
1.4
2
1.4
3
1.8
5
1.9
1
1.9
5
1.9
8
2.2
3
2.2
4
2.2
7
2.2
9
2.3
0
2.3
4
2.4
2
2.4
6
3.5
7
3.5
8
3.5
9
3.5
9
5.8
9
6.4
3
6.4
7
6.7
6
6.8
0
7.1
7
7.1
9
7.2
1
7.2
8
7.3
0
7.3
2
7.3
9
7.4
1
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
24
.11
25
.32
29
.18
36
.58
67
.76
12
5.3
0
12
6.3
0
12
7.0
7
12
8.6
9
12
9.3
9
13
2.1
4
13
5.9
7
13
8.0
1
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
2.5
0
1.1
0
5.5
7
1.0
3
1.1
0
1.2
6
2.3
2
1.3
0
1.0
0
2.0
6
8.5
7
1.4
4
1.4
6
1.4
7
1.4
9
1.8
3
1.8
4
1.8
6
1.8
8
1.8
9
2.2
1
2.2
3
2.2
8
2.3
2
2.3
4
2.3
8
2.3
9
2.4
2
2.4
4
2.4
6
2.7
9
3.3
0
3.3
1
3.3
3
3.4
4
3.4
6
3.4
8
3.6
7
3.6
9
3.8
1
5.8
9
6.7
8
6.8
0
7.2
7
7.3
0
7.3
1
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
26
.18
27
.85
29
.72
32
.45
35
.48
41
.55
43
.32
46
.42
65
.49
12
1.1
4
12
6.5
3
12
7.3
2
12
8.4
5
12
8.4
8
12
8.9
9
12
9.4
3
13
1.7
1
13
9.3
9
14
1.7
5
17
5.8
9
17
6.5
0
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f1 (ppm)
1.1
7
2.4
7
1.4
5
1.1
7
1.0
4
2.1
4
2.0
4
2.3
1
1.0
1
1.0
0
2.1
0
13
.03
1.2
1
1.2
4
1.2
6
1.2
9
1.7
5
1.7
8
1.8
0
1.9
5
1.9
8
2.1
9
2.2
2
2.2
5
2.4
6
2.4
9
2.5
0
2.6
7
2.6
9
2.7
7
2.7
9
2.8
1
3.3
7
3.3
9
3.4
2
3.4
4
3.4
6
3.4
8
3.6
0
3.6
2
3.6
3
3.9
4
3.9
5
3.9
7
5.6
9
5.7
0
6.4
1
6.4
1
6.4
2
7.2
2
7.2
2
7.2
3
7.2
5
7.2
8
7.3
0
7.4
3
7.5
3
-100102030405060708090100110120130140150160170180190200210
f1 (ppm)
29
.67
32
.95
34
.07
35
.40
40
.84
40
.95
41
.01
44
.97
67
.96
11
9.7
4
12
6.3
0
12
7.5
1
12
8.1
9
12
8.4
9
12
8.6
5
12
9.8
1
13
1.2
6
13
8.7
7
14
0.2
6
17
6.0
7
17
6.1
2
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f2 (ppm)
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
f1
 (p
pm
)
RSHI26C
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5
f2 (ppm)
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
8.0
8.5
f1
 (p
pm
)
RSHI26AA
